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Abstract 
The study of infectious disease in wildlife populations is of increasing importance to the field of 
public health. The majority of human diseases that have emerged over the last two decades have 
their origins in animal, and in particular wildlife, reservoirs. Bats appear to be overrepresented as 
natural reservoirs of many emerging viruses that are capable of causing severe disease and mortality 
in humans and other animal species as exampled by Severe Acute Respiratory Syndrome (SARS) 
coronavirus, Nipah virus, and Hendra virus. Bats have been the focus of many surveillance studies 
that have identified a vast diversity of viruses in bat species globally. However, there is a lack of 
understanding regarding the dynamics with which these viruses are maintained and transmitted 
within bat populations. Factors that precipitate virus transmission and infection in bat populations 
are also likely to increase the risk of cross-species transmission, or ‘spillover’, of viruses from 
reservoir host to humans and other animals. Identification of such factors may enable forecasting of 
future risk periods for emergence and the employment of risk mitigation strategies 
The study of bats in their natural environment is challenging due to their often large population 
sizes and individual differences in migration patterns, as well as the difficulties in determining 
causality when confounding factors are present. Such observational studies are necessary however, 
in order to make valid interpretations of data. This body of work describes an observational study of 
a single colony of pteropid fruit bats located in Geelong, Victoria, Australia. The aim of the study 
was to explore multi-pathogen dynamics in a single host species, Pteropus poliocephalus. An 
emphasis was placed on the detection of paramyxoviruses due to their wide circulation throughout 
Pteropus spp. in Australia as well as their demonstrated potential to cause zoonotic disease. This 
study pairs the surveillance of bat-borne paramyxoviruses with the collection of relevant biological 
and environmental data in order to understand drivers of virus excretion. 
This study identified periods of heightened risk for spillover, specifically times of increased 
paramyxovirus excretion from a bat colony. Seasonal ecological and biological factors were 
examined for their strength of association with virus excretion. Correlating stress with virus 
excretion was a major component of this project. Despite a lack of convincing empirical evidence, 
stress is commonly cited as a driver of disease emergence from wildlife populations. This study is 
unique in its approach of quantifying stress on a population-scale and correlating identified periods 
of stress with virus excretion. Periods of stress implied by increased cortisol measurements were 
identified however these periods did not consistently correlate with the periods of virus detection 
suggesting stress does not play an important role in driving virus excretion and thus spillover risk 
from the studied colony.  
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Two paramyxoviruses, Teviot paramyxovirus and Cedar virus, were isolated from urine samples 
collected from bats present in the Geelong colony. Both viruses showed sequence homologies to 
related viruses that were isolated from bats present at Cedar Grove, Queensland – a distance of over 
1,800 km from Geelong. However, results of this project, specifically the lack of detection of 
Hendra virus from the Geelong colony, suggest the dynamics of virus circulation differ according to 
location, time and/or species composition of the colony. The results of this study in combination 
with the growing amount of research on wildlife reservoirs of zoonotic disease worldwide 
contributes to a greater understanding of the factors that influence virus infection dynamics in 
pteropid bat populations.  
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CHAPTER 1 GENERAL INTRODUCTION 
1.1 INFECTIOUS DISEASE 
Since the ages of early civilizations, disease caused by infectious agents has significantly affected 
human health both at an individual and population scale (Brachman, 2003). Pertinent examples 
include smallpox, tuberculosis, leprosy, and influenza. National average life expectancies and 
population demographics have been significantly disturbed in the face of epidemics (Cohen, 2000). 
With the advent of modern vaccines and therapeutics, many diseases are now preventable (e.g. 
measles and polio), treatable (e.g. tuberculosis), and in one significant example, eradicated 
(smallpox) (Brachman, 2003). In the modern developed world, non-infectious chronic conditions 
such as heart disease now supersede infectious agents as the major causes of death in populations 
(Cohen, 2000).  
It may appear then that infectious diseases no longer pose such a grave concern to human health, at 
least in the developed world. This certainly is not the case as many diseases such as acquired 
immunodeficiency syndrome (AIDS) still remain uncontrolled and are a significant cause of 
morbidity and mortality both in the developing and developed world (Brachman, 2003). A current 
phenomenon is the re-emergence of previously controlled diseases such as polio and measles due to 
changes in attitudes and behaviours towards vaccination (Kata, 2010). Another concerning modern 
public health issue is the emergence of drug-resistant microbes which is associated with excessive 
and inappropriate use of antimicrobials (Cohen, 2000). Disease due to some infectious agents is 
predictable to a certain extent, such as the case with seasonal epidemics of influenza in humans 
(Lipsitch and Viboud, 2009). In a large number of circumstances the causative pathogens are known 
and well characterized which makes identification and control relatively uncomplicated. Challenges 
arise when the causative agent remains undetermined or is a novel pathogen. In these cases 
population immunity, diagnostic assays, epidemiological knowledge of transmission dynamics, 
predictive capacities, effective treatments and control options are often lacking. Such disease 
events, termed emerging infectious disease, undoubtedly pose an unpredictable and significant 
threat to human health.   
1.1.1 Emerging infectious disease 
Emerging infectious disease (EID) may apply to disease caused by novel pathogens or to situations 
where the causative pathogen is known but the disease occurs in a different location, at an increased 
frequency and/or with a different clinical manifestation to that previously described (Morens and 
Fauci, 2013). The latter situation is often referred to as re-emerging infectious disease. Emphasis 
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will be placed on EID of humans caused by novel viral pathogens, as such disease comprises a large 
proportion of recent EID events (Taylor et al., 2001). Apart from their direct effects on human 
health, over the last 20 years viral EID events have resulted in significant burdens on national and 
global economies, interruptions to food supplies, reduced confidence in food security, and public 
fear (Halpin et al., 2007). Important examples of viral EID agents include avian and swine influenza 
A viruses, Severe Acute Respiratory Syndrome (SARS) coronavirus, Nipah virus, Hendra virus, 
Australian Bat Lyssavirus, Ebola virus and Middle East Respiratory Syndrome (MERS) 
coronavirus. Inherent to infectious disease is a relationship between virus and host. Change in host 
(human) behaviour has been implicated as a major factor contributing to the emergence of novel 
disease (Morens and Fauci, 2013). For example, regular travel within and between countries permits 
the spread of pathogens to a greater number of susceptible individuals (Pavia, 2007). Such a change 
explains the ability of an emergent pathogen to become established in a population, but what are the 
initial sources of these novel viruses? A large proportion of EIDs are attributed to zoonotic viral 
pathogens; viruses capable of transmission from animal hosts to humans (Jones et al., 2008, Taylor 
et al., 2001, Cleaveland et al., 2001).  
1.1.2 Zoonotic viruses 
A number of studies have identified the majority of emerging pathogens as zoonoses with a large 
number of these viral (Howard and Fletcher, 2012, Jones et al., 2008, Taylor et al., 2001). Disease 
caused by zoonotic pathogens adds additional elements of complexity to the transmission and 
infection cycle: those of the animal, its environment, and its interactions with humans. Zoonotic 
viruses may be transmitted directly from reservoir host (discussed below) to humans or indirectly 
via intermediate host(s) (Daszak et al., 2000). Reservoir hosts and intermediate hosts may comprise 
wildlife and/or domestic animal species. Transmission of pathogens from domestic animals 
including livestock to humans is not surprising considering the historical and continued close 
relationships we have with these animals. Examples include avian influenza viruses (poultry), 
Nipah virus (pigs), Hendra virus (horses) and MERS coronavirus (camels). In light of the above 
statement, it is interesting to find then that the majority of zoonotic EIDs originate from wildlife 
species rather than domestic animal sources (Jones et al., 2008). In a large number of these cases, 
domestic animals act as intermediate hosts (Daszak et al., 2000). 
1.1.3 Wildlife as a source of emerging zoonotic viruses 
Wildlife populations are well recognized for the role they play as a source of novel pathogens 
capable of crossing species barriers. (Bengis et al., 2004, Daszak et al., 2000). Increased 
opportunities for contact between humans, domestic animals and wildlife are generally accepted to 
arise due to anthropogenic change to the environment (Daszak et al., 2001). Such changes include 
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destruction of and encroachment into native habitats, changed farming practices and enhanced 
movement of animals and animal-products globally (Bengis et al., 2004). Apart from bringing 
wildlife and humans into close proximity, these changes also play a role in altering virus-host 
dynamics in wildlife populations in a way that likely increases the risk of zoonotic disease 
emergence. The characteristics of these altered host-pathogen communities are certainly being 
studied, for example Gay et al. (2014), but a lot remains to be understood. Whether or not zoonotic 
disease is involved, disturbances to host-pathogen dynamics within wildlife populations may result 
in emerging disease and in some cases significant mortalities and challenges to species survival as 
is the case with chytridiomycosis in amphibians (Daszak et al., 1999), vesper bats and white-nose 
syndrome (Blehert et al., 2009) and apes with Ebola virus (Walsh et al., 2003). It is thought that 
EID events are more likely to occur where there is a large diversity or ‘pool’ of pathogens in a 
wildlife population, which occurs where there is a rich diversity of animal species and the 
microflora they host (Morse, 1995, Wolfe et al., 2005). It may be assumed then that biodiversity 
loss through anthropogenic influences including climate change would decrease the incidence of 
EID events by reducing this ‘pool.’ However, it is generally accepted by ecologists that biodiversity 
loss increases the risk of EID events (Patz et al., 1996, Maillard and Gonzalez, 2006). Pathogen 
richness, where a natural equilibrium exists between host and microbe community, may in fact be 
protective against emergence. Infection with certain microbes has been shown to confer cross-
protection to other potentially more virulent agents (Stapleton et al., 2004, Barton et al., 2007) thus 
a broad spectrum pathogen community within wildlife may prevent epidemics and reduce 
transmission risk. Emergence of zoonotic disease may occur when this natural balance is disrupted 
(Gottdenker et al., 2011).  
1.1.4 The mechanism of spillover of zoonotic viruses 
As mentioned previously, ‘spillover’ or cross-species transmission of viruses from wildlife 
reservoirs to humans involves a complex interplay of host, environmental and viral factors (Morens, 
Folkers and Fauci, 2004). On exposure to an infectious animal or infectious excreta, for RNA 
viruses in particular, an infectious sample consists of a multitude of viral variants of a particular 
virus strain, commonly referred to as viral quasispecies (Martell et al., 1992). Infection is a 
complicated process and involves the ability of the variant to enter and replicate within the new 
host, which requires amongst other things the correct surface receptors on the virus and host cells as 
well as the ability of the virus to overcome the host’s immune response (Childs et al., 2007, Parrish 
et al., 2008). RNA viruses are overrepresented as causative agents of EIDs (Cleaveland et al., 2001) 
likely owing to their high mutation and replication rates that increase the chance of exposure to a 
variant capable of causing infection. Successful infection is dependent also upon receiving a 
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sufficient infectious dose via the appropriate route of inoculation (Schmid-Hempel and Frank, 
2007). Infection may then progress to disease depending on the interactions between host factors, 
particularly immune and genetic, and the virus (Janeway et al., 2001). Features of modern life such 
as large and dense human populations and global travel may facilitate onward transmission of the 
pathogen from person to person (Racaniello, 2004).  
The basic reproductive number (R0) is an epidemiological concept used to essentially characterize 
infectious agents by their transmissibility (Dietz, 1993). In an entirely susceptible population, R0 is 
defined as the number of individuals infected by a single infectious individual during his or her 
infectious period (Heffernan et al., 2005). Using an interpretation of the schemas introduced by 
Wolfe et al. (2007) and Lloyd-Smith et al. (2009), the following examples will use the R0 concept 
and highlight four different epidemiological outcomes following human infection with a novel 
zoonotic virus. Each scenario is depicted graphically in Figure 1.1. These outcomes may represent 
stages of evolution to pandemic and endemic human disease.  
No human-human transmission 
Similar to Stage 2 presented by both Wolfe et al. (2007) and Lloyd-Smith et al. (2009), here humans 
are infected but do not transmit the virus. In these cases the animal acts as the main source of initial 
and subsequent/continued infection. Examples include rabies virus, hantavirus and Hendra virus. 
Significant mortalities may still result from this scenario as exampled by human infections with 
dog-associated rabies virus (Hampson et al., 2015). In the human transmission chain, R0 = 0 in this 
scenario. 
Human to human transmission (minimal) 
Similar to Stage 3 presented by both Wolfe et al. (2007) and Lloyd-Smith et al. (2009), in this 
situation, humans may transmit the virus to others however the animal remains the source of initial 
and subsequent/continued infection. Virus transmissibility may be low or human behaviours may 
reduce onward transmission. Examples include Ebola virus outbreaks prior to 2013-2015 and Nipah 
virus in Bangladesh and the Philippines (Ching et al., 2015). In the human transmission chain, R0 ≤ 
1 in this scenario. 
Human to human transmission (extensive) 
Similar to Stage 4 presented by both Wolfe et al. (2007) and Lloyd-Smith et al. (2009), in this 
scenario, after a small number of transmission events from animal to human, the animal acts as the 
initial but not the subsequent/continued source of infection. Instead, human to human transmission 
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is efficient, maintained and extends throughout the wider population. Maintained transmission may 
be facilitated by properties of the virus, the disease, human behaviours or a combination of all of 
these. Examples here include SARS coronavirus and the Ebola virus outbreak of 2013-2015. In the 
human transmission chain, R0 > 1 in this scenario. If the human to human chain of transmission is 
broken then the epidemic will end provided additional spillover events from the animal source do 
not occur. The Ebola virus outbreak of 2013-2015 highlights how societal factors such as urban 
density, human mobility and poor health care may influence the magnitude of an EID event 
(Osterholm et al., 2015). Assuming no change in the transmissibility of the virus, the unprecedented 
magnitude of this outbreak is thought to be due mainly to its occurrence in high density populations 
and other socioeconomic factors (Alexander et al., 2015).  
Human to human transmission (endemic) 
Similar to Stage 5 presented by Wolfe et al. (2007) and Stage 4 by Lloyd-Smith et al. (2009), this is 
an example where virus adaptation to the new host results in humans becoming the initial and 
subsequent/continued source of infection. The virus is now human specific and infection occurs 
independently of the animal source. The human immunodeficiency viruses are the prime examples 
of this scenario. After multiple transmission events from primates to humans, these viruses are now 
endemic in the human population (Wertheim and Worobey, 2009). In the human transmission 
chain, R0 ≥ 1 in this scenario. 
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Figure 1.1. Four scenarios following spillover from a wildlife reservoir 
Adapted from Wolfe et al. (2007) and Lloyd-Smith et al. (2009), a simplified representation of four possible 
outcomes following human infection with a novel virus from an animal source (zoonosis): (1) spillover from 
animal to human with no onward human to human transmission (e.g. Hendra virus); (2) spillover from animal to 
human with minimal/non-sustained human to human transmission (e.g. Nipah virus); (3) spillover from animal 
to human with sustained but finite human to human transmission (e.g. SARS coronavirus); and (4) historical 
spillover from animal to human with viral adaptation and maintenance of infection in human population 
independent of animal source (e.g. HIV). 
 
1.1.5 What constitutes a natural reservoir host? 
For many of the EIDs, the chain of infection involves multiple host species (Haydon et al., 2002). A 
natural reservoir population capable of sustaining pathogen replication must exist in order to 
provide a continued pathogen pool. The natural reservoir is an important component of the 
transmission chain but may or may not be the direct source of human infection (Haydon et al., 
2002). For example, waterfowl are the natural reservoirs of avian influenza type A viruses while 
transmission from terrestrial poultry and pigs is considered the main route for human infection 
(Kruse, Kirkemo and Handeland, 2004). Identifying both the source population and the natural 
reservoir is important to successfully control current and future outbreaks (Haydon et al., 2002). In 
the face of a novel EID outbreak, case-control studies are generally used to identify risk factors for 
infection (e.g. occupational) and thus point towards likely source populations (Mounts et al., 1999). 
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Natural reservoirs are generally more difficult to identify, particularly where they are not the direct 
source of human infection.  
Certain characteristics are generally considered indicative of a natural reservoir population and are 
summarized in Table 1.1. A natural reservoir population is capable of sustaining pathogen 
replication over time (Nishiura et al., 2009). A natural reservoir need not be confined to a single 
animal species nor a discrete animal population and may consist of pathogen transmission between 
multiple populations and multiple species (Haydon et al., 2002), including arthropod vectors. 
Factors that allow indefinite pathogen persistence within a natural reservoir will vary according to 
the pathogen. In wildlife systems there is a lack of evidence for rigid population thresholds that 
allow pathogen persistence (Lloyd-Smith et al., 2005). Instead a number of factors including 
population size, population density, animal behavior, population demographics and population 
interconnectedness all must be considered as potential contributors to pathogen persistence.   
A natural reservoir is thought to be one that has shared a protracted relationship with the pathogen, 
where over time a stable endemic state of pathogen transmission is achieved. Co-evolution of host 
species and pathogen is thought to result in a ‘trade off’ between pathogen replication (and thus 
transmission success) and virulence (de Roode, Yates and Altizer, 2008). According to 
conventional wisdom, pathogens evolve towards diminished virulence as pathogens that are too 
virulent risk driving their hosts, and themselves, to extinction (Lenski and May, 1994). However, 
others propose that the balance will vary according to pathogen and host, and does not necessarily 
lean towards avirulence (Lenski and May, 1994). Examples that suggest that optimal pathogen 
fitness occurs with high virulence in the reservoir host include rabies virus (dogs) (Fekadu, 1993) 
and bovine spongiform encephalitis (cattle) (Saegerman et al., 2004). Examples that suggest that 
optimal pathogen fitness occurs with low virulence in the reservoir host include Hendra virus (fruit 
bats) (Williamson et al., 1998) and influenza A (aquatic birds) (Kim et al., 2009).  
Purifying selection is thought to dominate with the co-evolution of pathogen and reservoir species 
over time (Bahl et al., 2009). Thus minimal non-synonymous genetic changes would be expected if 
the pathogen was isolated and sequenced longitudinally from the natural reservoir (Suarez, 2000). 
The detection of a high frequency of non-synonymous genetic changes for certain genetic regions of 
a pathogen genotype generally suggests a recent introduction of this pathogen into a non-natural 
reservoir where positive selection pressures dominate. This was exampled by the genetic changes 
observed after introduction and transmission of the SARS coronavirus in civet cats and humans 
(Wang and Eaton, 2007) and avian influenza viruses in chickens and turkeys (Suarez, 2000). That 
being said, apart from genetic conservation of a certain pathogen strain, a natural reservoir would be 
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expected to maintain a broader pathogen ‘pool’ comprised of diverse genotypes belonging to a 
particular pathogen genus or family as is seen with avian influenza viruses in ducks (Suzuki and 
Nei, 2002) and hantaviruses in rodents (Plyusnin and Morzunov, 2001).  
Longitudinal studies of an animal population are critical to establish the nature of the relationship 
between pathogen and host (Haydon et al., 2002). Serological analyses can be used to indicate the 
capacity of a population to be infected with a pathogen, however if samples are collected over a 
short period of time, endemic circulation of a pathogen versus a recent introduction into a non-
natural reservoir cannot be distinguished. Detection of pathogen genome and pathogen isolation at 
one point in time will also not allow differentiation of the above scenarios. It is the longitudinal, 
repeated sampling of a significant number of animals within a population that will enable an 
informed assessment of the transmission dynamics of a pathogen, the capacity of the population to 
maintain pathogen transmission and thus the role of said population in the infection chain of an 
EID.  
Table 1.1. General characteristics of natural reservoirs of zoonotic pathogens 
 May or may not be the direct source of human infection 
 May consist of multiple populations and multiple species including arthropods 
 Pathogen persistence over time is a dynamic and multifactorial process 
 Pathogen shares an long evolutionary history with the reservoir species 
 Infection in the reservoir host may cause a range of clinical manifestations from 
none to severe 
 Purifying selection predominates resulting in minimal non-synonymous genetic 
change of pathogen genotype over time 
 Natural reservoir supports a diverse pathogen ‘pool’ 
 
1.1.6 Important pathogens and wildlife reservoirs with greater risk for future EID events 
Numerous studies have identified wildlife populations as important sources for current and future 
EID outbreaks in humans (Jones et al., 2008, Bengis et al., 2004, Daszak et al., 2000). It is 
important to further identify characteristics of the wildlife species and the pathogens they carry that 
contribute to a greater risk of emergence in order to better predict the likely source of the next EID 
event. It is plausible to assume that cross-species transmission of pathogens would be more likely 
between host species that are phylogenetically close-related (DeFilippis and Villarreal, 2000). There 
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is very little evidence that EIDs of humans come from sources as distant as amphibians, reptiles, 
fish or plants (Childs et al., 2007). Rather, the majority of pathogens come from mammalian or 
avian sources. Of mammalian wildlife, there is not enough evidence available to determine whether 
pathogens of non-human primates are more likely to emerge than pathogens of other mammalian 
species (Childs et al., 2007). However, adaptation of the simian immunodeficiency viruses to the 
human host may suggest that when spillover does occur, such primate pathogens are more likely 
than those from other mammalian sources to maintain endemic transmission in the human 
population.  
In addition to host phylogenetic relatedness, ecological overlap of animal species is a factor that 
may contribute to the success of virus establishment after cross-species transmission (Mollentze, 
Biek and Streicker, 2014). In identifying potential natural wildlife reservoirs of zoonotic pathogens, 
there must always be a plausible route of transmission from reservoir to humans (with or without an 
intermediary host). For this reason, sympatric wildlife (those which share their environment with 
humans and/or domestic animal intermediate hosts) may play a more important role in EIDs simply 
due to the increased frequency of contact with humans. Rodents are an important example of a 
sympatric wildlife source of viral agents of EIDs including hantaviruses, arenaviruses and 
orthopoxviruses (Hill and Brown, 2011). 
In terms of the characteristics of pathogens that increase the risk of cross-species transmission, it 
has already been noted that viruses, particularly RNA viruses, are implicated more commonly as 
causative agents of EIDs (Cleaveland et al., 2001). Furthermore, Cleaveland et al. (2001) found that 
viruses that were more likely to emerge were those capable of infecting animals from more than one 
taxonomical order. The risk was further increased if the virus was capable of also infecting wildlife. 
In addition to the relatively high mutation rates of RNA viruses, reassortment and recombination 
are other mechanisms of genetic change employed by particular viral types that may increase the 
risk of successful cross-species transmission (Parrish et al., 2008, Childs et al., 2007). Classic 
examples of viruses that use reassortment include the influenza A viruses and examples of 
recombination include the human immunodeficiency viruses (Parrish et al., 2008).  
1.2 BATS: IMPORTANT NATURAL RESERVOIRS OF ZOONOTIC VIRUSES 
Bats (order Chiroptera) appear to be overrepresented as natural reservoirs of viruses capable of 
successfully crossing species barriers, resulting in often-fatal disease of humans, livestock and 
domestic animals worldwide (Calisher et al., 2006, Luis et al., 2013). Pertinent examples include 
Severe Acute Respiratory Syndrome (SARS) coronavirus (Ge et al., 2013, Li et al., 2005), Nipah 
virus (Chua et al., 2002), Hendra virus (Halpin et al., 2000), Marburg virus (Towner et al., 2009) 
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and rabies virus (McColl et al., 2000). The origin of the current unprecedented outbreak of Ebola 
virus in West Africa has been putatively linked to human contact with a fruit bat (Vogel, 2014). 
Detection of viral RNA sequences that cluster phylogenetically with Ebola Zaire virus from three 
species of African fruit bat suggests that these animals play an important role in the chain of 
transmission of Ebola virus to humans (Leroy et al., 2005). Isolation of a likely ancestor of Middle 
East Respiratory Syndrome (MERS) coronavirus from bats has not been successful to date, 
although related sequences have been detected in bat species  in Saudi Arabia and Africa (Memish 
et al., 2013, Ithete et al., 2013, Lu and Liu, 2012). The role of bats in the chain of transmission of 
MERS coronavirus to humans remains unclear. For many of these EIDs, an intermediate host acts 
as the main source of human infection. Through historical host-switching events it is thought that 
the evolutionary progenitors of extant human viruses such as measles, mumps, parainfluenza and 
hepatitis C may have originated in bats (Drexler et al., 2012, Quan et al., 2013, Epstein et al., 2010). 
Apart from the sixty-one viruses known to cause zoonotic disease (Luis et al., 2013), a multitude of 
viruses with unknown zoonotic potential have been detected or isolated from the excreta and/or 
tissues of bats using targeted molecular (Tong et al., 2012, He et al., 2013a) or more general 
metagenomic approaches (Li et al., 2010, He et al., 2013b, Baker et al., 2013a). These viruses 
belong to a wide-range of viral families including Orthomyxoviridae, Parvoviridae, Circoviridae, 
Picornaviridae, Hepadnaviridae, Adenoviridae, Poxviridae and Astroviridae (Tong et al., 2012, Li 
et al., 2010, He et al., 2013b). The identification of a diverse range of viruses from bats is partially 
due to the increased surveillance effort (Luis et al., 2013, Wang et al., 2011) and the large number 
of different bat species available for sampling worldwide – bats being the second most species-rich 
mammalian order (Wynne and Wang, 2013). However, there are indications that certain ecological 
and physiological characteristics inherent to bats make them particularly successful natural 
reservoir hosts.  
Bats, divided into two suborders: Yinpterochiroptera (containing family Pteropodidae) and 
Yangochiroptera, are evolutionary ancient mammals. They occupy a broad-range of ecological 
niches and are present on all continents except Antarctica (Calisher et al., 2006, Teeling et al., 
2005). Generally bats are nocturnal and live in dense congregations known as camps or colonies 
which may comprise multiple species (Tidemann, 1999). For bats of the family Pteropodidae 
particularly, these colonies are dynamic, where long-range migration afforded by the ability to fly 
allows bats to avoid adverse conditions and seek more favourable climatic and nutritional 
environments (Fleming and Eby, 2003). The interconnectedness of bat colonies maintains the chain 
of transmission of virus(es) from infected to susceptible individuals and thus contributes to the 
establishment of pathogen persistence in the metapopulation. Such dynamics satisfy one of the 
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important characteristics of natural reservoir hosts. In a study of rabies virus transmission dynamics 
in vampire bats, it was found that bat immigration between colonies was an important factor in 
maintaining virus transmission across the metapopulation (Blackwood et al., 2013). It was 
highlighted in this study that long term viral persistence in the metapopulation required spatially 
asynchronous transmission dynamics between networks of bat colonies (Blackwood et al., 2013). 
For their size, bats are generally long-lived animals and as stated by Calisher et al. (2006), this 
increases the number of transmission events that can occur over an individual’s life-time, 
particularly for the case of persistent viral infections. 
An explanation for the seemingly increased incidence of EIDs due to cross-species transmission of 
viruses directly or indirectly from bats to humans is through a heightened risk of exposure (Hayman 
et al., 2013). Encroachment of human settlement into native bat habitats and intensified farming 
practices have been linked to the emergence of Nipah virus in Malaysia (Pulliam et al., 2012). 
Sympatry of humans and bats through formation of bat colonies in urban areas is a probable driver 
of Hendra virus emergence in Australia (Plowright et al., 2011). Dense populations connected as a 
web over large geographical areas facilitates intra- and inter- species viral transmission. Given these 
characteristics and the tendency for these webs to overlap with those of humans and potential 
intermediate hosts, it is quite logical to consider bats as important sources of EIDs.  
The severe outcomes that often occur as a consequence of human infection with zoonotic viruses 
contrasted against the lack of observable clinical signs in naturally and experimentally infected bats 
has led many to conclude that as natural reservoir hosts, bats experience no or minimal disease 
(Towner et al., 2007, Watanabe et al., 2010, Williamson et al., 2000, Middleton et al., 2007, Davis 
et al., 2005). Caution should be used in applying this conclusion to all bat-virus interactions as there 
are examples where infection results in overt disease in the bat reservoir, such as infection with 
lyssaviruses (Hughes et al., 2006, Baer and Bales, 1967). Furthermore, pathological changes in the 
absence of overt disease were noted subsequent to experimental infection of fruit bats with Nipah 
virus (Middleton et al., 2007) and natural infection of a sheath-tailed bat with Belinga bat 
paramyxovirus (Maganga et al., 2014).  
Using phylogenetic analyses, evidence suggests that there is a long history of co-evolution between 
bats and the viruses they host as exampled by the coronaviruses (Wertheim et al., 2013), filoviruses 
(Taylor et al., 2010) and lyssaviruses (Badrane and Tordo, 2001, Wertheim et al., 2013, Cui et al., 
2007, Taylor et al., 2010). As a result of such co-evolution, purifying selection would most likely 
become the dominant selective force, reducing phenotypic variability of pathogen strains over time. 
Indeed, molecular epidemiological studies conducted on variants of Australian Bat Lyssavirus 
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(Guyatt et al., 2003), Hendra virus (Smith et al., 2011) and Lagos bat virus (Kuzmin et al., 2008) 
revealed a low rate of non-synonymous mutations in virus variants across space and time. 
Phylogenetically these variants cluster with and branch from viruses detected in bats of the same or 
different species – showing that bats provide a diverse ‘pool’ of viral genotypes belonging to a 
particular genus or family such as seen with SARS-like coronaviruses (Li et al., 2005) and 
paramyxoviruses (Drexler et al., 2012, Barr et al., 2014). 
As discussed in Mandl et al. (2015), bats may mount a different immune response to viral infection 
compared to spillover hosts and this may contribute to their success as natural reservoirs. Bat 
immune responses may result in tolerance and/or resistance to viral infection. Tolerance refers to 
the ability to maintain health at a given pathogen load (Schneider and Ayres, 2008). Resistance 
refers to the ability to limit pathogen burden and may or may not be associated with deterioration in 
health (Schneider and Ayres, 2008). Resistance and tolerance are not mutually exclusive (Mandl et 
al., 2015). To date, difficulties in establishing experimental models of infection have precluded a 
detailed analysis of the immune response of pteropid bats to henipavirus infection in vivo (Halpin et 
al., 2011; Plowright et al., 2015), however research in this area is increasing. Evidence to suggest 
immune resistance mechanisms was shown by Zhou et al. (2013), where in vitro immunological 
analysis of nine primary bat cell lines (Pteropus alecto) showed a high baseline level of interferon-α 
expression in the absence of virus infection. Two additional in vitro studies have identified the 
innate immune system of the bat as being important in mitigating virus infection (Janardhana et al., 
2012; Wynne et al., 2014). The findings of Zhang et al. (2013) perhaps describe a mechanism of 
immune tolerance whereby in evolutionary terms, genes that were selected to allow the evolution of 
flight were linked to the selection of innate immune genes. The authors concluded that flight-
induced adaptations may have indirectly affected bat immune function in a way that allows viral 
infection without significant pathology (Zhang et al., 2013).  
Modulation of the bat immune system by latent or endogenously incorporated viral elements is 
another hypothesized mechanism by which bats control viral infection. Latent herpesvirus 
infections (Barton et al., 2007) and endogenous genomic viral elements of RNA and DNA viruses 
(Katzourakis and Gifford, 2010) have been associated with modulation of the host immune system 
to create a continuously activated antiviral state. Herpesvirus infections and endogenous viral 
elements have been shown to exist in bats (Wibbelt et al., 2007, Katzourakis and Gifford, 2010, 
Hayward et al., 2013, Cui et al., 2012, Zhuo et al., 2013). In fact compared to other mammals, bats 
(in addition to rodents and primates) are overrepresented in terms of the endogenous viral elements 
they carry (Katzourakis and Gifford, 2010). The functions of these persistent virus and viral 
elements in anti-viral immunity are to-date unknown. An additional hypothesis used explain the 
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ability of bats to maintain transmission of a wide-range of viruses is the idea of multiple pathogen 
infection. The immune response generated against one particular virus may allow for immune 
tolerance or resistance towards future infection with related viruses (Wynne and Wang, 2013).  
The pathogen diversity identified in bat populations may also be related to bat ecology. A higher 
number of zoonotic viruses per host species (viral richness) occurs where multiple bat species 
occupy the same geographical location (sympatry) (Luis et al., 2013), presumably due to the 
opportunity for inter-species transmission. Sympatry was shown to be a major factor determining 
the higher viral richness observed in bats compared to rodents (Luis et al., 2013). The opportunity 
for interspecies viral transmission may be lower for rodents as rodent species typically do not share 
communal nesting sites compared to the multi-species aggregations often seen in bat colonies (Luis 
et al., 2013). In North American bats, rabies virus variants tend to be host-specific where the 
majority of successful transmission and infection events occur within the same species (Streicker et 
al., 2010). This phenomenon was also reflected in the phylogenetic analysis of coronaviruses from 
several bat species (Cui et al., 2007). It is likely that inter-species viral transmissions occur 
frequently but may rarely lead to successive infections. The likelihood of sustained transmission 
increases with the degree of genetic relatedness of the hosts (Streicker et al., 2010). Again it is often 
hard to tease apart the relative importance of host phylogeny and sympatry in successful cross-
species transmission events. A study by Lau et al. (2012) found inter-species transmission of a 
coronavirus between bat species from different suborders, likely due to sharing of the same roosting 
sites. It is likely that a combination of the two plays a role in ensuring exposure (sympatry) and 
successful infection post exposure (host relatedness).  
Whether bats are able to be infected and transmit a wide variety of viruses due to specific immune 
mechanisms requires further research. What is clear is that bats are an important and emerging 
source of novel viruses with proven or potential abilities to cause disease in humans and/or 
domestic animals. The remainder of this Chapter will concentrate on paramyxoviruses detected 
from bats of the family Pteropodidae. Bat paramyxoviruses have been relatively well studied and 
comprise important zoonotic pathogens.   
1.3 BAT PARAMYXOVIRUSES AND THEIR ROLE IN EMERGING INFECTIOUS 
DISEASE 
Paramyxoviruses are negative-sense single-stranded RNA viruses of the family Paramyxoviridae 
(Lamb and Parks, 2007). Paramyxoviruses are the causative agents of many important human and 
animal diseases including measles, mumps, Newcastle disease and canine distemper (Centers for 
Disease Control and Prevention, 2013). Paramyxoviruses are classified according to Figure 1.2. 
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Figure 1.2. Family Paramyxoviridae 
Paramyxovirus classification including important human and animal pathogens for each genus. This diagram 
includes a list of ‘Unclassified’ paramyxoviruses as a separate sub-family. Yuan et al. (2014) suggest they be 
included under a new genus Jeilongvirus. Viruses detected from bats occur in the genera highlighted by orange 
stars. This figure has been adapted from that of NPTEL (2015). 
 
Although detection of partial RNA sequences suggest paramyxoviruses of the sub-families 
Paramyxovirinae (genera Rubulavirus, Morbillivirus, Henipavirus and Jeilongvirus) and 
Pneumovirinae circulate in bat populations (Drexler et al., 2012, Yuan et al., 2014, Maganga et al., 
2014), successful virus isolation has only been achieved for paramyxoviruses of the genera 
Rubulavirus and Henipavirus. Geographically, serological evidence of paramyxovirus infection has 
been identified in bats sampled in West Africa (Hayman et al., 2008), Southeast Asia (Breed et al., 
2013, Breed et al., 2010), Australia (Marsh et al., 2012, Breed et al., 2011), India (Epstein et al., 
2008) and the islands of Madagascar (Iehlé et al., 2007) and Annobόn (Peel et al., 2012). Detection 
of viral RNA and/or virus isolation of paramyxoviruses have occurred for bats sampled in China 
(Yuan et al., 2014, Lau et al., 2010), Central and South America (Drexler et al., 2012, Hagmaier et 
al., 2007), West and Central Africa (Drexler et al., 2012, Baker et al., 2013c), Europe (Drexler et 
al., 2012), Southeast Asia (Breed et al., 2013, Chua et al., 2001, Chua et al., 2002) and Australia 
(Marsh et al., 2012, Barr et al., 2014, Halpin et al., 2000, Barr et al., 2012). The detection of 
genetically diverse paramyxoviruses from multiple bat species across space and time suggests that 
bats are natural reservoirs of paramyxoviruses.  
The ability of bat-borne paramyxoviruses to cross species barriers and cause disease in humans is 
well established for the henipaviruses Hendra virus and Nipah virus (Mackenzie et al., 2003). 
Menangle virus, a rubulavirus, has a probable link with human disease (Chant et al., 1998) while 
evidence suggests that human infection with other bat-borne rubulaviruses such as Achimota 2 virus 
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and Tioman virus is possible however the link to disease remains unclear (Baker et al., 2013c, Yaiw 
et al., 2007). Recent surveillance of human sera collected in Cameroon, Central Africa, detected 
Nipah virus cross-neutralising antibodies and revealed an epidemiological link to individuals 
involved in butchering bats for bushmeat. Often human infection with bat-borne paramyxoviruses 
involves contact with an intermediate host such as occurs with Hendra, Nipah (Malaysia) and 
Menangle viruses. Recent surveillance of cattle, goats and pigs in Bangladesh detected Nipah virus 
binding, non-neutralising antibodies (Chowdhury et al., 2014). These findings suggest infection of 
these animals with an antigenically related henipavirus, possibly originating in bats (Chowdhury et 
al., 2014). Cross-species transmission of paramyxoviruses from bats to humans and other animal 
species may not be a rare phenomenon. Drexler et al. (2012) showed using phylogenetic analyses 
that of bats, rodents, birds, carnivores, primates, and ungulates, the greatest number of cross-species 
transmission of paramyxoviruses occurred from bats to other animals. 
Bat populations are a source of a diverse assemblage of paramyxoviruses that have demonstrated 
the ability to cross species barriers and in some instances cause severe disease and death in humans 
and livestock over a wide geographical range. The discovery of further novel bat paramyxoviruses 
in the natural reservoir and infection of spillover hosts is certainly expected with increased 
surveillance effort. From a public health standpoint, for disease mitigation, prevention, and 
forecasting, it is not enough to simply add to a catalogue of bat-borne viruses. However 
challenging, research must now attempt to understand the dynamics of paramyxovirus infection in 
the reservoir host and identify factors associated with increased virus excretion and thus spillover 
risk to non-bat species. The following section will summarize the findings of experimental and 
observational studies of bat paramyxoviruses to give a current understanding of important 
epidemiological factors associated with infection and excretion. Emphasis will be placed on 
findings that suggest plausible routes of transmission (both from bat to bat and from bat to spillover 
host) as well as periods of increased susceptibility of bats to infection.  
1.3.1 Bat-borne zoonotic disease in Australia: The specific case of Hendra virus 
Hendra virus (HeV) was first identified in 1994 as the causative agent of an outbreak of 
predominantly respiratory disease that resulted in the deaths of 13 horses in the Brisbane suburb of 
Hendra (Field et al., 2012). The zoonotic potential of HeV was realized during this outbreak as two 
humans became infected with one dying from the disease (Field et al., 2012). Human infection is 
linked to exposure of virus from HeV infected horses (Field et al., 2012). Since this initial event, 
sporadic outbreaks have occurred annually since 2006 with increasing frequency (Department of 
Agriculture, Fisheries and Forestry, 2014, Plowright et al., 2015). Over 70 horses have died due to 
the disease, 1 dog showed serological evidence of infection, 7 people became infected and four 
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have died with the last human death in 2009 (Department of Agriculture, Fisheries and Forestry, 
2014). To date, Hendra virus cases in horses have been confined to Queensland and New South 
Wales (Department of Agriculture, Fisheries and Forestry, 2014) with their distribution as at 
December 2012 shown in Figure 1.3. 
 
Figure 1.3. Location of Hendra virus spillover events in horses (1994-2012) 
Map of eastern Australia showing the distribution of 40 HeV cases occurring from September 1994 to December 
2012. Hendra virus horse case locations are shown by the black circles. Locations where horses occur without 
detected Hendra virus spillover are shown by the open circles. The figure is included to show the absence of 
detected Hendra virus spillover events in Victoria. This figure is taken directly from Smith et al. (2014) 
 
Fruit bats of the genus Pteropus, commonly known as ‘flying foxes,’ are the reservoir hosts of HeV 
(Field, 2005). The distributions of the four species of mainland Australian flying fox are shown in 
Figure 1.4. Serological evidence of infection has been found in all four of these species however 
sampling efforts have been concentrated in the northern regions of the country where spillover 
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events occur (Field et al., 2001, Young et al., 1996). No evidence of direct bat to human 
transmission has been recorded. 
 
Figure 1.4. Distributions of the four Australian mainland Pteropus spp. Adapted from Weir et al. 
(2014). 
Map of Australia (excluding Tasmania) showing distributions of the four Australian mainland pteropid bat 
species: Black flying fox (P. alecto); Grey-headed flying fox (Pteropus poliocephalus); Spectacled flying fox (P. 
conspicillatus) and the Little red flying fox (P. scapulatus). 
 
Hendra virus spillover appears to cluster temporally with 45/51 (88%) horse cases prior to 
December 2014 occurring from May to October with the peak in July (Department of Agriculture, 
Fisheries and Forestry, 2014, Plowright et al., 2015). This period has been identified by McFarlane 
et al. (2011) as the ‘dry season’ for locations where spillover events have occurred: months of 
lowest temperature and rainfall. Furthermore this temporal pattern coincides with the period 6-9 
months after peak parturition for the black, grey-headed and spectacled flying foxes and the period 
directly following parturition for the little red flying fox (McFarlane et al., 2011). Prior to 2011, 
Hendra virus spillover events occurred near-simultaneously in disparate geographic locations (Field 
et al., 2012). The greatest number of Hendra virus spillover events to date occurred in 2011 with a 
large proportion in that year located in NSW (Field et al., 2012). The cases in 2011 clustered 
geographically with foci in southeast QLD and northern NSW (Field et al., 2012). Comparison of 
the genetic sequences of viruses from the 2011 outbreaks with viruses from previous years showed 
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no evidence for changes suggestive of heightened virulence (Field et al., 2012). Non-viral factors 
were considered the driving force between the increased incidence of Hendra virus spillover cases 
in 2011 (Field et al., 2012). 
The chain of infection from bats to horses is indeed complex and requires the overlap of virus 
excretion from the reservoir host with contact and infection of susceptible horses. No cases of HeV 
infection in horses or humans have been reported in the southern, temperate regions of Australia 
despite opportunistic and targeted testing of horses since 1995 (Department of Environment and 
Primary Industries, 2013). These findings suggest a difference in the epidemiology of HeV 
transmission from pteropid bats to horses between northern and southern locations. There is 
evidence to suggest that certain species, namely the black flying fox (Pteropus alecto) and the 
spectacled flying fox (P. conspicillatus) may play a more important role in the spillover of virus to 
horses compared to the grey-headed flying fox (P. poliocephalus) and the little red flying fox (P. 
scapulatus) (Field et al., 2011; Smith et al., 2014; Edson et al., 2015, Goldspink et al., 2015). 
Considering the restricted tropical and subtropical distribution of the black and spectacled flying 
foxes, this scenario aligns with the lack of HeV detection – and disease - in horses in southern, 
temperate regions. Figure 1.5 shows distributions modelled according to habitat suitability for the 
black and grey-headed flying fox along the east coast of Australia (Kerryne Graham, 2015). The 
maps are overlaid with locations of HeV spillover events in horses as at 2015. It can be seen from 
the maps that all HeV spillover cases occur within the distribution of the black flying fox whereas 
spillover events have occurred outside of the distribution of the grey-headed flying fox.  
HeV serological surveillance and urinary excretion prevalence data are only available from bats in 
regions where HeV spillover has occurred (Field 2011, Barr et al., 2014, Edson et al., 2015). In such 
regions, mixed-species colonies are common and make it difficult to tease apart species differences 
in HeV excretion dynamics, particularly given the common method of analyzing pooled urine 
samples for virus (Smith et al., 2011, Field et al., 2011). No measurements of HeV excretion 
prevalence exist for bats sampled in southern regions where spillover is not recorded and where 
single-species colonies are more common. Thus, given current available data, it cannot be 
determined whether a lack of HeV cases in southern locations is due to a lack of virus excretion by 
less competent host species, or due to differences in downstream steps of the transmission chain 
from the bats to horses (Plowright et al., 2015). 
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Figure 1.5. Habitat suitability for black and grey-headed flying foxes with locations of Hendra 
virus spillover events as at 2015 (Kerryne Graham, 2015). 
Maps of the distributions of the black flying fox (left map) and the grey-headed flying fox (right map) created 
using Maxent version 3.3. The predictor variables are the BioClim bioclimatic variables (Version 1.4), Australian 
Land Use and Management Classification Version 7 and the NVIS Major Vegetation Subgroups (Version 4.1). 
The locations of flying foxes were extracted from the National Flying Fox Monitoring Program using camp 
presence only. Suitability index is provided in the legend. Locations of Hendra virus spillover events are shown 
by the red circles.   
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1.3.2 Paramyxovirus infection dynamics in the reservoir host 
1.3.2.1 Route of virus excretion: Experimental infection of individual bats 
No virus was isolated from a range of tissues and excretions from male Pteropus poliocephalus bats 
experimentally inoculated with a 5.0 x 10
4
 Tissue Culture Infective Dose 50 (TCID50) of Hendra 
virus (Williamson et al., 1998). In a subsequent experiment using the same dose and route of 
inoculation in late pregnant female P. poliocephalus, virus was isolated from adult tissues as well as 
from apparently healthy foetal tissues (Williamson et al., 2000). Isolation of virus from foetal 
tissues demonstrates that transplacental (vertical) transmission of Hendra virus is possible. 
Horizontal transmission of Hendra virus may also occur through contact of other bats with infected 
birthing tissues and fluids. In the experiment by Williamson et al. (2000), virus isolation was only 
successful on one sampling date and the authors discuss that the window of virus excretion and 
opportunity for transmission may be narrow. The results of this study also suggest that the state of 
pregnancy may play a role in increasing the susceptibility of the host to virus infection, replication 
and excretion post-exposure. Experimental inoculation of male and female P. poliocephalus bats 
with Nipah virus resulted in the intermittent isolation of virus from the urine of one male bat, the 
kidney of another male, and the uterus of a female (Middleton et al., 2007). Similarly, Hendra virus 
was isolated on consecutive sampling days from the urine of a non-pregnant female P. alecto as 
well as from a rectal swab from the same animal (Halpin et al., 2011). The positive rectal swab was 
attributed to urine contamination of the sample. Importantly, the study by Halpin et al. (2011) found 
Hendra virus to be excreted in low quantities over a short period of time. These results again 
highlight the importance of the genito-urinary tract as a site of virus replication as well as the 
apparent narrow window of opportunity for henipavirus transmission.  
1.3.2.2 Route of virus excretion and transmission: Naturally infected bats 
Supporting the results of experimental studies, henipaviruses have been isolated from the same 
tissues as those collected from experimentally infected bats. Hendra virus was isolated in a low 
percentage (0.4%; 2/465) of pteropid bats sampled in a study by Halpin et al. (2000). When 
successful, virus was isolated from uterine fluid and foetal tissues of a P. poliocephalus female and 
foetal tissue of a P. alecto female. After successful isolation of Nipah virus from pooled urine 
samples collected using a novel technique described by Chua et al. (2002), this method has been 
commonly employed by a number of subsequent surveillance studies. Isolation of henipaviruses and 
rubulaviruses from wild pteropid bat urine samples has been achieved in a number of studies (Smith 
et al., 2011, Barr et al., 2014, Marsh et al., 2012, Baker et al., 2013c, Chua et al., 2001, Barr et al., 
2012). An additional specimen from which a paramyxovirus has been isolated from naturally 
infected pteropid bats is chewed and discarded fruit (‘spats’) (Chua et al., 2002), which could 
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represent virus excretion in saliva or urine contamination of the sample. Successful isolation of the 
majority of bat paramyxoviruses from urine samples collected from multiple bat species in multiple 
locations suggests contact with urine is an important route of horizontal transmission. Mists of urine 
are often observed in bat colonies as well as the use of urine by bats to aid grooming, making this a 
plausible hypothesis (Middleton et al., 2007).  
1.3.2.3 Henipavirus infection dynamics in pteropid bat reservoirs and risk factors for 
spillover 
Although the following discussion concentrates on infection dynamics of bat-borne henipaviruses, 
similar dynamics would be expected for other paramyxovirus genera considering they share 
common routes of excretion, i.e., in urine. A number of serological surveillance studies of 
henipavirus infection in pteropid bat populations have revealed risk factors such as age, pregnancy, 
lactation, and nutritional stress that are associated with an increased prevalence of neutralising 
antibody in the population (Breed et al., 2011, Plowright et al., 2008, Epstein et al., 2008, Rahman 
et al., 2013, Baker et al., 2013b) . Given that a specific time of infection cannot be deduced from 
antibody status, the following discussion will concentrate on the limited number of observational 
studies that directly measure the presence of current replicating virus.  
The two available serial cross-sectional studies of henipavirus excretion from wild pteropid bat 
populations used the same collection technique and revealed similar results (Field et al., 2011, 
Wacharapluesadee et al., 2010). It was found for both Hendra virus and Nipah virus that excretion 
in urine could be detected for most months of the calendar year and from the majority of the 
locations sampled. However, there was a suggestion of spatial and temporal determinants that 
increased the number of positive detections in certain months and in certain locations. As virus 
titres from individual bats were not determined for either study, an increase in the detection 
prevalence is assumed to be due to a greater number of bats excreting virus in urine. Additional 
evidence of temporal clustering of virus excretion was given by Barr et al. (2014) who found that 
for urine samples collected at certain times, the isolation of Hendra virus was accompanied by the 
isolation of numerous additional paramyxoviruses. This suggests certain factors are similarly 
influencing the transmission dynamics of multiple pathogens. It appears that the dynamics of 
henipavirus infection vary over time and space and are driven by an undetermined factor, or more 
likely, a combination of factors.  
Field et al. (2011) speculated that temporal clustering of the majority of Hendra virus cases in 
horses despite the detection of virus year-round from bat colonies suggests factors other than the 
presence of virus in the environment driving infection and disease in the spillover host. This may 
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well be true however the previously observed temporal clustering of an increased number of bats 
excreting virus and/or an increase in the amount of virus being excreted may increase the risk of 
exposure, cross-species transmission and infection in horses. Exposure dose may be important in 
facilitating infection and the development of disease in non-bat species. The unprecedented number 
of equine Hendra virus cases in 2011 coincided with substantially higher excretion prevalences in 
sampled colonies (Field et al., 2012). Field et al. (2011) detected a ‘peak’ period of Hendra virus 
detection which was not repeated in the same period of the preceding or following year. A high 
prevalence of Hendra virus excretion suggests a high number of susceptible individuals (Field et al., 
2011).  
An important paper by Plowright et al. (2011) used a model to identify epidemiological factors that 
influence virus infection and excretion in the reservoir host to best explain the sporadic temporal 
pattern and urban/peri-urban centric distribution of Hendra virus spillover events in horses. In 
Australia, the continuous food supply provided by cities and suburbs has driven a trend towards the 
establishment of pteropid bat colonies in urban areas (Williams et al., 2006). In addition to 
increasing the contact opportunity between bat and spillover host, it was stated that urbanisation of 
bat populations has likely changed virus infection dynamics at a meta-population level (Plowright et 
al., 2011). A simulation involving increased urbanisation and segregation of bat colonies and 
decreased migration/decreased connectedness resulted in decreased spatial transmission of Hendra 
virus and increased numbers of susceptible individuals/decreased herd immunity within local 
populations (Plowright et al., 2011). Introduction of the virus into a population with a large number 
of susceptible animals in the model resulted in explosive, short-term epidemics with a large number 
of animals infected and excreting virus (Plowright et al., 2011). Heterogenous herd immunity across 
a meta-population is likely in nature, giving rise to a combination of explosive epidemic ‘peaks’ and 
slow ‘smouldering’ epidemic dynamics (Plowright et al., 2011). Viral persistence over time in the 
model relied on a small number of these persistent ‘smouldering’ epidemics (Plowright et al., 
2011). Reflection of these dynamics were found in the spatial and temporal variability of Hendra 
virus detections made by Field et al. (2011), validating the hypotheses made by the model. The 
proportion of susceptible individuals within a population has been reported by a number of studies 
to be the main factor determining virus invasion and persistence (Plowright et al., 2011, Wang et 
al., 2013). It is thus important to determine the factors that influence susceptibility of bats to virus 
infection.  
Plowright et al. (2011) discussed the importance of co-ordinated seasonal birthing periods and the 
waning of maternal antibody in producing a temporally-clustered cohort of susceptible individuals 
for a given bat species. The incorporation of waning maternal immunity into the model better 
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reflected the seasonal period of Hendra virus cases in horses (Plowright et al., 2011). Waning 
maternal immunity to henipaviruses is a well-documented phenomenon for pteropid bats (Epstein et 
al., 2013, Baker et al., 2013b). Plowright et al. (2011) identified additional ecological factors such 
as pregnancy, lactation and nutritional stress that may superimpose upon and exacerbate the 
reduction of herd immunity, providing seasonal periods of large numbers of susceptible animals 
resulting in temporal trends in viral infection dynamics. The phenomenon of seasonal ‘peaks’ of 
virus infection and excretion that coincide with an increased incidence of spillover was shown by 
Amman et al. (2012) for Marburg virus. It was shown that the seasonal clustering of human 
infections coincided with identified seasonal peaks of active infection in older juvenile bats during 
the birthing period. Apart from the heightened periods of virus transmission in the colony around 
the birthing period, transmission occurred at a ‘baseline’ level for the remainder of the year. 
Identifying drivers of these ‘peaks’ of virus infection and excretion in the reservoir host is important 
for public health. If these drivers are repeatable and predictable, preventative measures may be 
employed to reduce the risk of spillover.  
Apart from introduction of virus from infected to susceptible bats via migration, recrudescent 
excretion of persistent viral infection has been discussed in the literature as an alternative 
mechanism of virus maintenance in reservoir populations (Wang et al., 2013). Virus recrudescence 
has been cited as the mechanism that allows the maintenance of virus transmission over time in 
isolated bat populations as observed by Peel et al. (2012). Henipavirus recrudescence has been 
shown for humans infected with Hendra virus (Field and Kung, 2011) as well as for Nipah virus in 
a closed captive colony of pteropid bats (Sohayati et al., 2011). Wang et al. (2013) used a model to 
simulate infection dynamics following recrudescence and virus excretion. Their assumption was 
that recrudescence occurred in pregnant/lactating bats. Due to the synchronised, seasonal 
reactivation of virus infection and excretion, simulated patterns of infection agreed with the 
seasonal clustering of equine cases of Hendra virus as well as infection dynamics measured in bats 
in the field (Wang et al., 2013). The authors discuss that the proposed mechanism of virus 
recrudescence is certainly not mutually exclusive to that proposed by Plowright et al. (2011); both 
transmission mechanisms may work in concert. For example, virus reactivation and excretion in 
pregnant females may infect a large number of susceptible pups born the year before to initiate a 
local epidemic, and with animal migration, introduce infection into another local population. It is 
difficult using field sampling to determine the more important mechanism of virus transmission, 
given that patterns of infection look similar for both (Wang et al., 2013). Wang et al. (2013) argue 
that the temporal clustering of Hendra virus cases in horses in geographically disparate locations 
agrees more with the virus recrudescence theory.  
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A lot still remains to be understood regarding the complex and multi-factorial dynamics of virus 
infection in bat populations on a local, meta-population and global scale. What seems to be 
important to understand are the factors that influence susceptibility of bats to infection as well as the 
circumstances under which the proportion of susceptible animals in a population exceeds the 
threshold for virus introduction and invasion within local bat populations. In the next section, stress 
will be discussed as a factor that may increase an animal’s susceptibility to virus infection.      
1.4 THE ROLE OF STRESS IN INCREASING SUSCEPTIBILTY TO INFECTION 
Not all exposures to infectious agents lead to disease (Chapman and Hill, 2012). An established 
principle of the pathogenesis of infectious disease is that there is an immune “threshold” separating 
the disease and non-disease state. The threshold level can be crossed with increasing infectious dose 
or pathogenicity of the agent. Host factors such as decreased immunity lower the threshold and 
make disease a more likely outcome of infection. Stress is recognised as having important immune 
modulating effects and in certain circumstances has been associated with an increased susceptibility 
to infectious disease (Godbout and Glaser, 2006, Marsland et al., 2002). “Stress” is a difficult term 
to delineate however a clear definition is given by Martin (2009): “a physiological and behavioural 
state (mediated by stress hormones) engaged to endure, avoid, or recover from an aversive stimulus 
or condition.” 
Stress and its association with disease has a long history of investigation in humans (Cohen et al., 
2007, Cohen and Williamson, 1991, Peterson et al., 1991), laboratory animals (Peterson et al., 
1991) and domestic livestock (Griffin, 1989, Blokhuis et al., 1998). The idea that being in a state of 
stress predisposes one to disease has its origins in Selye’s ‘General Adaptation Syndrome’ of the 
1930’s (Selye, 1946). While Selye’s work did not examine the role of stress in infectious disease 
outcomes, he did show strong evidence for the ability of glucocorticosteroid hormones to induce 
pathological change and ‘diseases of adaptation.’ Since this time, Selye’s concept has been used to 
explain infectious disease outcomes. Stated at its simplest, the concept is that stressors such as cold 
or hunger or psychological malaise result in the release of glucocorticoids such as cortisol, and 
these if sustained at high levels over a prolonged period, impact negatively on the stressed person or 
animal. In the specific case of infectious disease, the negative result is manifested by immune-
suppression, which leads to increased disease susceptibility. Disease might then result either by the 
recrudescence of a pathogen lying dormant in the body, by increased susceptibility upon exposure 
to a pathogen, or else by more severe pathology upon infection. Examples where there is strong 
evidence to support this concept include respiratory infections (Graham et al., 1986, Cohen et al., 
1991, Cohen et al., 1998) and herpesvirus reactivation (Strachan et al., 2011, Sainz et al., 2001, 
Padgett et al., 1998). Infectious disease where there is a suspicion that stress plays a role in disease 
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development include the progression of HIV infection to AIDS (Leserman et al., 1999, Clerici et al., 
1994). 
Given the evidence that stress has a role in predisposing humans to infectious disease it was not 
surprising that a similar connection was also presumed to occur in wildlife. Early studies of the 
1950’s and 1960’s attributed stress to the development of infectious and non-infectious disease in 
captive (Christian and Ratcliffe, 1952, Sauer and Fegley, 1960, Schmidt and Rehkemper, 1967, 
Noble, 1966) and free-ranging (Christian et al., 1960) animals. More recent examples where 
statements presuming without investigation that there is a strong relationship between stress and 
infectious disease in wildlife include: (Lucioli et al., 2008, Palmer and Whipple, 1999, Nolet et al., 
1997, Nandi and Kumar, 2010). The abstract of Lucioli et al. (2008) states “stress is an important 
risk factor for disease in all animals but especially in wild animals unaccustomed to human 
contact.”  
Stress-induced susceptibility to infection is thought to play a role in the increased rate of emergence 
of infectious disease from wildlife reservoirs (Plowright et al., 2008). The increased incidence of 
emergence is likely coincident with a greater anthropogenic change to the environment. Habitat 
destruction, population fragmentation and climatic change would be expected to cause stress and 
significantly affect the behaviour, physiology and health of wildlife populations. Despite stress 
being commonly cited as a driver of zoonotic disease emergence, very few studies have purposely 
sought to investigate this link. A study by Owen et al. (2012) is one of the few studies that directly 
investigate the relationship between stress and the risk of transmission of a zoonotic agent, West 
Nile virus, in a known reservoir host species, the Northern Cardinal. Birds receiving doses of 
exogenous corticosterone to mimic chronic stress conditions had higher mortality rates but no 
difference in serum virus titres compared to ‘non-stressed’ controls.  
For bat-borne zoonoses, stressors such as habitat destruction and poor nutrition have been 
implicated as potential triggers for virus transmission and excretion from the reservoir and thus the 
emergence of disease in humans (Hahn et al., 2014, Plowright et al., 2008). Here we are less 
concerned with the role stress plays in the manifestation of disease and more interested in the 
immunomodulating effects of stress that may promote excretion rather than clearing of virus post-
infection or post-recrudescence. Stress would play a plausible role in both of the simulated 
scenarios described by Plowright et al. (2011) and Wang et al. (2013). Firstly, a stressor or 
combination of stressors affecting bats at a regional scale would increase the proportion of animals 
susceptible to infection and excretion, thus allowing such ‘explosive’ epidemics upon introduction 
of virus and ‘peaks’ of virus excretion. Stress may also affect infection dynamics through changes 
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in behaviour. For example, extreme weather and food shortages may cause migration and mixing of 
bats en masse, favouring the introduction of virus to naïve populations. Secondly, similar to stress-
associated reactivation of persistent herpes simplex infection in humans (Sainz et al., 2001), stress 
has the potential to reactivate latent henipavirus infection in bats. If the stressor is seasonal, for 
example cold stress in temperate regions or stress associated with pregnancy, then stress-associated 
reactivation of virus infection would explain the seasonal trend of Hendra virus cases in horses.  
The most common method of assessing the degree of stress experienced by an animal is to measure 
concentrations of the end products of a stress reaction: the glucocorticosteroid hormones, namely 
cortisol and corticosterone (Romero, 2004). These hormones have been measured in a variety of bat 
species by researchers seeking to understand the fundamentals of stress physiology in bats. Cortisol 
is the major steroid released in bats as part of the stress response (Reeder et al., 2004b, Widmaier 
and Kunz, 1993, Widmaier et al., 1994, Reeder et al., 2006b) with their stress axis sharing similar 
characteristics to that of other mammals (Widmaier et al., 1994). McMichael et al. (2014) 
demonstrated a measureable increase in plasma and urine cortisol concentration in response to 
stress in wild-caught pteropid bat species. Furthermore these researchers developed a robust method 
for estimating stress at a population scale through the measurement of cortisol in pooled urine 
samples collected non-invasively from underneath colonies. This study has established population-
level urinary cortisol ranges for the four Australian species of pteropid bats.  
The only study to assess the association of stress with henipavirus infection was that of Plowright et 
al. (2008). Hendra virus neutralisation titres were used as a proxy for virus infection and it was 
found that the highest seroprevalences were recorded in animals showing evidence of nutritional 
stress: low body weight, poor body condition and abnormal diurnal feeding behaviour. It was 
hypothesized from these results that nutritional stress resulting from a loss of food supply due to 
such environmental processes as habitat loss and climate change may increase Hendra virus 
infection and transmission (Plowright et al., 2008). It is important to note however that this study 
did not include any endocrinological evidence of stress nor were specific indicators of current virus 
replication and excretion measured. The method described by McMichael et al. (2014) provides a 
scientifically robust means of assessing the degree of stress experienced by pteropid bats at a 
population scale. Combining this method with a measure of virus infection and excretion allows a 
direct assessment of the association of stress with an increased risk of spillover from a natural 
wildlife reservoir: such a study does not appear in the scientific literature to date.  
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1.5 ECOLOGY OF AUSTRALIAN PTEROPID BATS WITH SPECIFIC REFERENCE 
TO PTEROPUS POLIOCEPHALUS AND THE GEELONG COLONY 
Compared to those in Queensland, pteropid bat colonies in Victoria are smaller, less numerous, and 
have greater distances separating them (Department of Environment and Primary Industries, 2013, 
Tidemann, 1999). An illustration of this is shown in Figure 1.6. This figure is obtained from an 
Interactive Flying fox Web Viewer developed as part of the National Flying fox Monitoring 
Programme (Department of the Environment, 2014). Permanent locations of colonies in Victoria 
include Melbourne (Yarra Bend), Geelong, Bendigo, Numurkah and Bairnsdale (Department of the 
Environment, 2014). Temporary visits have been made by bats to locations in Karbethong, 
Wodonga, Warrnambool, Doveton and HMAS Cerberus on the Mornington Peninsula (Department 
of the Environment, 2014) 
 
Figure 1.6. Recorded locations of P. poliocephalus camps 
Map of Australia showing results of the National Flying fox Monitoring Programme (Department of the 
Environment, 2014). The yellow/orange circles show the locations and relative sizes of Pteropus poliocephalus 
colonies counted in November 2012. The image is taken directly from the Interactive Flying fox Web Viewer 
(Department of the Environment, 2014). 
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The Geelong colony is located beside the East Geelong Golf Club within Eastern Park, Geelong, 
Victoria, Australia. The central GPS coordinates for the colony are: S 38.148003°, E 144.384263°. 
The Geelong colony is thought to have formed as an offshoot of the colony present at the Royal 
Botanic Gardens in Melbourne. Intentional methods employed to relocate these bats from the Royal 
Botanic Gardens resulted in the formation of colonies at Yarra Bend and Geelong. The original 
colony at the Royal Botanic Gardens in Melbourne was occupied only in Summer months until 
1986, after which bats were present year-round (Van Der Ree et al., 2006). Generally pteropid bats 
occupy separate summer and winter camps/colonies, each providing seasonally available food 
supplies (Nelson, 1965b). It is thought that a year-round food supply provided by the planting of 
numerous native and non-native food trees in urban settings allow the winter occupation of southern 
locations (Parry-Jones and Augee, 2001, McDonald‐Madden et al., 2005). Furthermore, 
microclimate conditions provided by the city environment including warmer winter temperatures 
and fewer frost days may have initially attracted these subtropical species to the area (Van Der Ree 
et al., 2006).  
Pteropus poliocephalus are endemic to the east-coast of Australia from subtropical Queensland to 
temperate Geelong and across to Adelaide. The highest population densities of pteropid bats in 
Australia generally occur in the subtropics (Roberts et al., 2012a). In the northern parts of its range, 
P. poliocephalus co-roosts with P. alecto and even P. scapulatus (Tidemann and Nelson, 2011). 
These animals are able to tolerate a few degrees of frost at one extreme and roosting temperatures 
of up to 43°C at the other (Tidemann, 1999). There have been observations of little red flying foxes 
(P. scapulatus) in northern Victoria (Department of the Environment, 2014) as well as incursions of 
black flying foxes (P. alecto) as far south as the Geelong colony however these visits tend to be rare 
and sporadic (G. Baverstock, personal communication) and certainly were not observed over the 
study period. Over the study period and from subsequent observations (Department of the 
Environment, 2014), only the grey-headed flying fox (Pteropus policephalus) was observed 
roosting in the Geelong colony, and thus the colony is considered to be mono-specific. 
P. poliocephalus are protected under the Wildlife Act 1975 (VIC) and are classified as Vulnerable 
under the Environmental Protection and Biodiversity Conservation (EPBC) Act 1999 
(Commonwealth) (DEPI, 2014). The Geelong population varies seasonally with peak abundance 
occurring in late summer/autumn (up to 35,000 individuals) and the lowest abundance in 
winter/early spring (~800 individuals). This pattern is observed elsewhere in Australia (Eby, 1991, 
McDonald‐Madden et al., 2005). The number of bats visiting the Geelong colony has generally 
increased from 2003 with the highest recorded fly-out count of 35,000 individuals in April 2013 (G. 
Baverstock, unpublished data). In winter it is thought that a proportion of P. poliocephalus either 
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disperse into smaller groups in different locations or migrate large distances north (Roberts et al., 
2012b, Nelson, 1965b, Eby, 1991). Camp populations do not behave as a single unit (Eby, 1991), 
that is there is no total population movement north in winter and south in summer: some bats 
migrate, some bats remain (Tidemann and Nelson, 2004). The composition of the colony at the 
peaks and troughs of population size is generally unknown. Peak numbers are likely to be made up 
of year-round residents as well as seasonal southern migrants and those remaining through winter 
may be those born in the colony that become permanent residents (Van Der Ree et al., 2006). 
The social system of P. poliocephalus involves seasonal harems that consist of a single male with 
varied numbers of females (Welbergen, 2005). In December/January, the adult population of a 
colony is at its maximum. From February, males defend their territories with dominant males 
occupying more central locations of the colony (Welbergen, 2005). The mating season occurs from 
mid-March to mid-May where females mate repeatedly with the harem male (Welbergen, 2005). 
Gestation occurs for approximately 6 months with most females giving birth in late September to 
late October to one young that is weaned at approximately 4-6 months (Nelson, 1965b). After birth 
pups are dependent upon their mother for heat regulation and remain attached as the mother flies at 
night (Nelson, 1965b). At 3 weeks the pups are still unable to fly but are left in the colony while the 
mother leaves to feed. At 3 months the pups are able to fly and leave the colony at night to feed 
(Nelson, 1965b). The mass exit of these volant juveniles accounts for the increase in number of bats 
counted at fly-out during summer (Parry-Jones and Augee, 2001). After birthing, the sexes tend to 
be segregated within the colony (Nelson, 1965b).  For a permanent colony these reproductive events 
are generally repeated annually (Parry-Jones and Augee, 2001). 
Bats leave their daytime roosts to forage by night. P. poliocephalus are a generalist nectarivore and 
frugivore and are considered a sequential specialist in the way they consume a limited number of 
food sources in turn (Parry-Jones and Augee, 1991, Schmelitschek et al., 2009). P. poliocephalus 
may travel distances up to 30 km from their roost site to forage (McDonald‐Madden et al., 2005). It 
is common for these bats to shift roost sites frequently. Roberts et al. (2012b) found that the 
majority of individuals stayed for less than 5 days at a single roost although some bats did remain in 
the one location for several months. Combined with these short-range movements, long distance 
migrations driven by food availability have seen individual bats recorded with a north/south 
displacement of 1, 000 km over the study period (Roberts et al., 2012b). These long-range 
movements made by P. poliocephalus are essentially north-south, consistent with seasonal 
latitudinal migration (Roberts et al., 2012b, Tidemann and Nelson, 2011).  
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Despite these short and long-range movements, P. poliocephalus display site fidelity, returning 
seasonally to the same location, possibly their place of birth (Augee and Ford, 1999, Roberts et al., 
2012b, Welbergen, 2005). Movements of P. poliocephalus are highly variable between individuals 
and do not seem to be predicted by gender or age (Eby, 1991, Roberts et al., 2012b, Tidemann and 
Nelson, 2011). The causes for variation in individual bat movements are poorly understood 
(Roberts et al., 2012b). Tracking devices placed on P. poliocephalus bats caught in Bendigo in 
March 2012 (John Nelson 2012, unpublished data) revealed one female’s northern migration in 
winter through Albury, Cowra, Parramatta, to a location 70 km north of Sydney before her return 
south in October. Another bat remained in Bendigo for the length of observation (March to July). 
The study by Tidemann and Nelson (2004) similarly tracked the northern migration of a male P. 
poliocephalus trapped in Melbourne in April 2000 to central NSW. These tracking studies show the 
variability and unpredictability of movements at the level of the individual. They also show the 
connectedness between individual P. poliocephalus bats throughout Victoria and New South Wales. 
The movements of individuals in effect connect geographically distinct colonies into one 
interconnected population. 
1.6 OBJECTIVES 
The circulation of paramyxoviruses within pteropid bats of Australia poses a significant risk to the 
health of humans, livestock and domestic animals. This is particularly true given the trend towards 
urbanisation of many pteropid bat populations combined with the emergence of recent ecological 
drivers that increase the risk of spillover. Plowright et al. (2015) essentially identified three layers 
of enabling conditions required for spillover: the presence of the reservoir host and spillover host in 
the same location; infection of the reservoir host and excretion of virus; and susceptibility of the 
spillover host to infection and disease. This PhD project focuses on the second layer or ‘necessary 
cause’ for cross-species transmission of bat-borne viruses. Surveillance of pteropid bats frequenting 
locations in Victoria for Hendra virus is necessary to investigate whether differences in infection 
dynamics exist between populations sampled at lower and higher latitudes, given the available data 
pertains to northern bat populations. 
The pteropid bat colony present in Geelong was chosen for this surveillance for a number of 
reasons. Firstly, this colony has been a permanent and continuous one since 2003: bats are present 
for sampling at all times throughout the year. Secondly, this colony consists of a single species, thus 
allowing species-specific inferences of virus infection dynamics. Thirdly, natural productive 
infection with Hendra virus has been demonstrated for the pteropid species present in Geelong 
(Halpin et al., 2000). Fourthly, the Geelong colony is the most southern location of a permanent 
pteropid bat colony in the world. This makes a great opportunity to study the physiology of these 
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bats at such high latitudes. Lastly, the convenient location of this colony allows for regular, frequent 
sampling and rapid transport of samples to the laboratory. 
The project aims firstly to identify the diversity of paramyxoviruses that are present in pteropid bat 
populations (Chapters 2, 3 and 6). Secondly it aims to elucidate specific environmental and host 
factors that increase the susceptibility of pteropid bats to paramyxovirus infection with an emphasis 
on periods of heightened virus excretion (Chapters 2, 3, 4 and 5). Even for well-studied viruses such 
as Hendra virus, the major factors influencing infection in bats remain unclear. This is mainly due 
to the difficulties in determining causality through studying bats in their natural environment where 
confounding variables complicate the interpretation of results. However difficult, observational 
studies of wild bat populations are important and necessary for understanding virus infection 
dynamics and ‘real world’ risks for spillover. The difficulties in establishing productive henipavirus 
infections in experimental settings suggest ecological factors are important in driving transmission, 
the complexities of which are impossible to replicate in captivity.  
A unique feature of this project is the monitoring over time of multi-pathogen infection dynamics in 
a single bat reservoir host species. Surveillance for numerous pathogens is used not to examine 
pathogen interactions but to better tease apart the dominant mechanisms and drivers of virus 
circulation within bat populations. Despite opportunistic and targeted testing of horses, Hendra 
virus infection has never been identified in horses in Victoria (Department of Environment and 
Primary Industries, 2013). A specific aim embedded within this project is to determine whether the 
absence of reported Hendra virus cases in horses in Victoria is due to an absence of excretion of 
virus from the reservoir host. Are the dynamics of Hendra virus infection within the reservoir host 
influenced by location-specific factors?  
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CHAPTER 2 SEROLOGICAL SURVEILLANCE FOR HENIPAVIRUSES IN 
THE GEELONG FLYING FOX COLONY 
2.1 INTRODUCTION 
Serological evidence of infection with Hendra virus has been documented for all four species of 
mainland pteropid bat in Australia (Field, 2005). Although a lot still remains to be understood, the 
infection dynamics of Hendra virus have been relatively well studied in pteropid bats sampled in 
northern locations including Pteropus conspicillatus in northern Queensland (Breed et al., 2011) 
and P. scapulatus in the Northern Territory (Plowright et al., 2008) but are lacking for bats present 
in southern locations including Victoria. Using repeated cross-sectional sampling of individual bats 
over 27 months, the study described in this Chapter first seeks to find evidence of henipavirus, 
specifically Hendra virus and Cedar virus, infection in grey-headed flying foxes (P. poliocephalus) 
present in a southern location. The second aim is to determine bat-specific factors that may be 
associated with positive serology. Serological status will be determined using two different assays: 
one that measures antigen-specific antibody binding (ab-Luminex) and one that indirectly measures 
a functional biological activity – antibody neutralisation of virus.  
2.2 MATERIALS AND METHODS 
2.2.1 Animal ethics 
The following ethics statement applies to all Chapters where samples are collected from the 
Geelong colony. Approval for all work involving bats was given by AAHL’s animal ethics 
committee (AEC) prior to commencement of this project. For colony-based urine collections, 
approval was given under AEC 1412, and for the trapping events, AEC 1480. Furthermore, research 
permits under the Wildlife Act 1975 were granted by the Victorian Department of Sustainability 
and Environment for all work involving bats. Urine collection permit numbers were 10005406 and 
10006810. Trapping was covered under permit number 10005979. 
2.2.2 Sample collection 
On 12 separate occasions between November 2011 and February 2014, bats were caught before 
dawn using mist nets set up at a location within 500 m of the Geelong colony. Once caught, bats 
were kept in cotton pillowcases for a maximum of two hours before sampling. Handling of bats was 
performed only by trained and experienced individuals. A double layer of latex gloves were worn 
during trapping and sampling and gauntlets worn if directly handling the bats. For early sampling 
events, isoflurane was used to anaesthetize bats during sample collection however for later sampling 
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events no anaesthesia was used. It was found that maintenance of body temperature and recovery 
was better in bats that were not anaesthetized. An amendment to the animal ethics protocol was 
accepted by the AEC which allowed us to sample without anaesthetic agent. After sampling, bats 
were placed back into pillowcases to recover before release. Samples collected from individual bats 
included blood, faeces, and urine if available, rectal swabs, and oral swabs. Individual bat 
characteristics of sex, weight, forearm length, approximate age, and pregnancy or lactation status 
were recorded. Weight was measured to the nearest gram using a digital hanging scale and forearm 
length was measured to the nearest millimetre using a plastic ruler. For age, each bat was classified 
as either adult or juvenile. This distinction was made based on external characteristics of sexual 
maturity. If bats were deemed to be sexually mature they were classified as adult. For males, sexual 
maturity was based on testis and penis size as well as relative body size. For females, sexual 
maturity was based on nipple characteristics – if small and unworn the animal was classified as 
juvenile. Any signs of pregnancy or previous pregnancy such as enlarged and worn nipples, 
palpable foetus in the abdomen or milk expression from the nipples would classify the animal as an 
adult. For bats where a clear age division was not possible, the findings of Nelson (1965a) were 
referred to. Here, sexually mature males are considered those weighing between 540-650 g with a 
forearm length of 140-150 mm. Sexually mature females are considered those weighing 550-600 g 
with a forearm length of 138-152 mm. According to the study of Nelson (1965a), bats classified as 
juveniles for our purposes were under 18 months of age and adults above 18 months. A 
weight/forearm ratio was calculated for each bat to give an indication of body condition as 
described by Plowright et al. (2008). 
In total, 158 Pteropus poliocephalus were caught and sampled. Only blood and urine samples were 
further processed for serological and endocrinological (Chapter 4) testing respectively. Faeces, oral, 
and rectal swabs were stored at -80 °C and are planned for use in future virus detection and 
metabolomics studies. Urine was collected either from the bag used to temporarily hold individual 
bats or directly from the bat itself. Urine was collected into tubes containing 100 μL viral transport 
medium (VTM) (10 % BSA in PBSA + 10 x Gibco® Antibiotic-Antimycotic containing penicillin, 
streptomycin and amphotericin B). Urine samples were kept on ice after collection until arrival at 
the laboratory for processing approximately three hours later. Approximately 1 mL of blood was 
collected via venipuncture from the propatagial vein into either BD Vacutainer™ SST™ Serum 
Separation or EDTA tubes using 23 or 25 gauge needles and 3 mL syringes. Until processing in the 
laboratory, EDTA blood was kept on ice and Serum Separation samples were kept at environmental 
temperature. Identification of the recapture of any bat was not possible during this study.  
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2.2.3 Sample processing 
For blood samples collected in EDTA, tubes were spun at 1,000 g for 10 minutes. Plasma was then 
collected and stored at 4 °C. For blood samples collected into BD Vacutainer™ SST™ Serum 
Separation tubes, blood was allowed to clot for a minimum of 30 minutes at room temperature in a 
vertical position before spinning at 2,000 g for 10 minutes at 25 °C. Serum was collected and stored 
at -80 °C. Before serological analyses, plasma and serum samples were first heat-inactivated at 56 
°C for 30 minutes to destroy complement.  
2.2.4 Luminex assay 
Plasma and serum samples collected from the Geelong bats were analysed for antibodies capable of 
binding to Hendra virus soluble-G (attachment glycoprotein) and Cedar virus soluble-G protein. A 
Luminex multiplex bead-based assay was used (ab-Luminex), in which the antigenic proteins are 
coupled to magnetic beads, each set with their own spectral fingerprint Table 2.1. The binding assay 
for Hendra virus soluble-G is described in Bossart et al. (2007). The binding assay for Cedar virus 
soluble-G is in the process of being published by researchers at AAHL (Vicky Boyd and Jenn Barr, 
personal communication). 
Table 2.1. Bead sets and coupled antigens used in ab-Luminex binding assay 
Bead (xMAP) # Antigen 
29 Hendra virus soluble G 
39 Cedar virus soluble G 
 
Protocol was as follows. Previously coupled magnetic beads suspended in bead storage buffer (1% 
BSA in PBSA with 0.05% sodium azide, protease inhibitor, 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride, and N-hydroxysulfosuccinimide) at a ratio of 150 beads per μL of 
buffer were vortexed for 30-60 seconds then bath sonicated for 30-60 seconds. Beads were then 
diluted in 2 % skim milk in PBS-T to give 150 beads of each bead set per 100 μL. A volume of 100 
uL of diluted beads in skim milk were added to each well of a flat bottom plate – giving 150 beads 
per well. The plate was covered in foil to shield from light and placed on a plate shaker at room 
temperature for 30 minutes. After incubation, supernatant was removed and the beads washed twice 
with PBS-T using a magnetic Millipore plate vacuum apparatus and vacuum pump. Heat inactivated 
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bat serum/plasma diluted 1:50 in PBS-T was added at a volume of 100 μL to each well (one well 
per sample). The same volume of positive control sera was diluted 1:100 and added to the 
appropriate wells. Positive HeV controls were sera from horses naturally infected with HeV and 
bats experimentally infected with HeV. Positive CedPV controls were sera collected from ferrets 
experimentally infected with CedPV and rabbits inoculated with the soluble G antigen. Room 
temperature incubation with shaking and removal of supernatant and washing were repeated as 
above. To each well, 100 μL of biotinylated protein A/G (Thermo Fisher Scientific) diluted in PBS-
T (1:500 (protein A) and 1:250 (protein G)) was added. Incubation, supernatant removal and 
washing were repeated as above. Lastly, 100 μL of Streptavidin-phycoerythrin (Qiagen) diluted 
1:1000 in PBS-T was added to each well. The plate was incubated as above then antibodies bound 
to each of the bead-coupled antigens were quantified by fluorescence and read as the median 
fluorescence intensity (MFI) on the Bio-Plex Protein Array System integrated with Bio-Plex 
Manager Software (Bio-Rad Laboratories, Inc., CA, USA). The machine parameters were set for 
detection of 50 beads per bead set per well.  
The Cutoff Finder described in Budczies et al. (2012) was used to determine an MFI value that 
maximized √(sensitivity2 + specificity2) to virus neutralisation test (VNT) results. The Cutoff Finder 
is a free online-tool and the link is given in Budczies et al. (2012). The outcome variable was set as 
the VNT result at a 1:50 sample dilution (binary: positive or negative neutralisation) and the 
independent or biomarker variable was set as the MFI reading for each corresponding sample (also 
analysed at 1:50 sample dilution). For each virus, ninety-one samples had both a VNT and ab-
Luminex test result and thus contributed to the calculation of the cut-off. The method used 
determines a cutoff point by minimizing the distance on the receiver operating characteristic (ROC) 
curve to the left top edge of the diagram and minimizes the Euclidean distance between these two 
points. The output will report the calculated MFI cut-off value as well as the sensitivity and 
specificity of this cutoff in determining VNT result. 
2.2.5 Virus neutralisation test 
The virus neutralisation tests (VNT) using Hendra and Cedar viruses were performed at BSL-4. 
Serial two-fold dilutions of sera/plasma samples were prepared in a 96-well tissue culture plate in 
50 μL cell media (Minimal Essential Medium containing Earle’s salts and supplemented with 2 mM 
glutamine, antibiotic-antimycotic and 10% foetal calf serum). Starting serum/plasma dilution was 
1:12.5 and increased to a final dilution of 1:100. An equal volume containing 200 TCID50 of target 
virus (either Hendra virus or Cedar virus) was added and the virus-sera/plasma mix incubated for 30 
min at 37 °C in a humidified 5% CO2 incubator. A suspension of Vero cells (100 μL) containing 2 x 
10
5
 cells/mL was added to each well and the plate incubated at 37 °C in a humidified 5% CO2 
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incubator.  After 4 days the plate was examined for viral cytopathic effect (CPE). The highest 
serum/plasma dilution resulting in complete inhibition of CPE was defined as the final neutralising 
titre. In total, 91 samples (84 serum and 7 plasma) were tested for the presence of neutralising 
antibodies. Serum/plasma samples that had insufficient volume remaining after use in the ab-
Luminex assay could not be tested in the VNT. Samples tested for virus neutralisation are 
highlighted in grey according to individual bat in the table of Appendix 1. A serum/plasma sample 
was considered positive if it neutralised 200 TCID50 of virus at a dilution of 1:12.5 or greater in the 
VNT, since bat sera at lower dilutions often produce toxic or non-specific reactions in these tests.  
2.2.6 Interpretation of ab-Luminex and VNT results 
Anti-henipavirus antibodies in a given sample were assessed as to their reactivity in the ab-Luminex 
(reflected as an MFI reading) compared to their ability to neutralise virus. As serum/plasma samples 
were tested in the ab-Luminex at a dilution of 1:50, for the VNT, the presence or absence of virus 
neutralization by a sample at a dilution of 1:50 or greater will be used to categorise samples as 
either VNT positive or VNT negative, respectively. MFI values for VNT negative and VNT 
positive samples are displayed accordingly in a box-and-whisker plot for each virus. The sensitivity 
and specificity values given by the Cutoff Finder are discussed in relation to VNT results.  
2.2.7 Determination of potential correlates of anti-henipavirus antibody neutralizing activity 
For the following analysis, neutralisation of virus by a sample at a dilution of 1:12.5 or greater in 
the VNT will be regarded as a positive VNT result. To explore associations between collection 
month, age, sex, and lactation status on VNT result, bar graphs showing proportion VNT positive 
and confidence intervals for each proportion estimate will be presented. For the relationship 
between weight/forearm ratio and VNT result, a scatter plot will be presented. Statistical analysis 
will then be performed to assess bat-specific and temporal factors associated with the circulation of 
anti-henipavirus antibodies. Bat specific factors will include age, sex, weight, forearm length, 
weight/forearm ratio and lactation status. As no pregnant females were identified during this study, 
pregnancy could not be included as a factor. Temporal associations will be examined by including 
month of collection in the analyses. 
2.2.8 Statistical analyses 
Statistical analyses were performed using Stata (StataCorp) version 10.0. A two-sample Wilcoxon 
rank-sum test was used to test for any difference in the distributions of MFI values for VNT 
positive compared to VNT negative samples. For each virus, two-sample Wilcoxon rank-sum tests 
were also used to test for any differences in the distributions of weight, forearm length and 
weight/forearm ratios for VNT positive compared to VNT negative samples. A p value < 0.05 was 
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considered significant and the null hypothesis of equal distributions rejected. To assess the 
association between bat-specific and temporal factors (independent variables) with VNT result 
(dependent variable), a univariate logistic regression was performed. Individual bats were classified 
by sex (female or male), age (juvenile or adult), and lactation status (no lactation or lactation 
observed). For the univariate analysis only, samples were grouped according to collection month for 
analysis of any temporal association. Weight, forearm length and weight/forearm ratio were kept as 
continuous variables in the regression. Univariate analyses were followed by a mixed-effects 
logistic regression allowing for the intercept to vary randomly by collection date to account for the 
clustering of the sampling effort. Any association of an independent variable with VNT positivity 
yielding p < 0.25 in univariate analysis were incorporated into the mixed-effects model. A p value < 
0.05 was considered significant.  
2.3 RESULTS 
2.3.1 Samples from individual bats 
Appendix 1 lists the details for each trapping date including the number of bats caught and sampled 
with individual bat characteristics as mentioned above. Over 12 sampling dates, 158 bats were 
caught and sampled. One-hundred and nine (109) of these were female (69%), 48 male, and one bat 
with unclassified sex. No pregnant bats were detected, eight females were lactating. Seventy-eight 
(78) bats were classified as adults and 80 as juveniles.  
2.3.2 Serological findings from the ab-Luminex 
Of the 158 bats caught, 137 serum/plasma samples contained enough material for testing in the ab-
Luminex. The frequency distribution of MFI readings for antibody binding to HeV sG antigen is 
shown in Figure 2.1.  
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Figure 2.1. MFI histogram for HeV ab-Luminex 
 
 
There was a large range (57-27093) in MFI values obtained from the Geelong bats for the Hendra 
virus ab-Luminex. The Hendra virus ab-Luminex is specific for Hendra and Nipah virus (NiV) 
infection (Bossart et al., 2007) but it cannot be ruled out that infection with a Hendra-like 
henipavirus may cause cross-reaction (Hayman et al., 2008, Breed et al., 2013). Nipah virus 
infection of grey-headed flying foxes is unlikely given the current knowledge of the geographical 
distribution of Nipah virus (Breed et al., 2013). 
There are no published data available for the Cedar virus ab-Luminex. The range of MFI values for 
this assay was also very broad (46-29227) with a greater proportion of samples in the highest MFI 
bracket compared to the Hendra virus ab-Luminex (Figure 2.2). Again, this assay is designed to be 
specific for binding to Cedar virus sG antigen however cross-reactivity to similar henipaviruses 
cannot be discounted. Cross-reactivity between the HeV sG and CedPV sG antigens is unlikely due 
to the specificity seen in the positive controls and due to the fact that the G protein amino acid 
sequence identity between HeV and CedPV is low at only 29% (Marsh et al., 2012).  
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Figure 2.2. MFI histogram for CedPV ab-Luminex 
 
 
Plotting Hendra virus ab-Luminex MFI values against Cedar virus ab-Luminex MFI values gives 
Figure 2.3. There appears to be four groupings of samples: those that have low MFI readings for 
both viruses, those that are high for one virus and low for the other, and those that have high MFI 
readings for both viruses. Of 34 samples that had CedPV MFI value > 10, 000, only two also had 
high HeV MFI (> 10, 000) and these are obvious in the top right corner of Figure 2.3. 
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Figure 2.3. Two-way scatterplot of HeV MFI vs. CedPV MFI values 
 
 
Using the Cutoff Finder, the MFI cut-off for anti-Hendra virus binding was 16,710 (Figure 2.4). 
This gave a sensitivity of 100% and specificity of 97%. The MFI cut-off for anti-Cedar virus 
binding was 8,579 (Figure 2.5), giving a sensitivity of 90% and specificity of 90%. 
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Figure 2.4. Output of Cutoff Finder for anti-Hendra virus binding antibodies 
 
 
Figure 2.5. Output of Cutoff Finder for anti-Cedar virus binding antibodies 
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2.3.3 Findings from virus neutralisation test 
For Hendra virus, images showing positive virus neutralisation and positive virus CPE are shown in 
Figure 2.6. For Cedar virus, images showing positive virus neutralisation and positive virus CPE are 
shown in Figure 2.7. 
Figure 2.6. Hendra virus VNT: Positive neutralisation and positive CPE 
 
Appearance of Vero cells with the following: a: cell control; b: HeV control; c: positive neutralisation; and d: 
positive HeV CPE (absence of neutralisation) 
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Figure 2.7. Cedar virus VNT: Positive neutralisation and positive CPE 
 
Appearance of Vero cells with the following: a: cell control; b: CedPV control; c: positive neutralisation; and d: 
positive CedPV CPE (absence of neutralisation) 
 
A total of 24 of 91 (26%) samples showed positive neutralising titres to Hendra virus (≥ 1:12.5) and 
36/91 (40%) had positive neutralising titres to Cedar virus at a dilution of 1:12.5 or greater. For 
both viruses, the majority of samples were negative for virus neutralisation at a VNT titre of 12.5. 
Data showing the frequency distribution of neutralising titres are shown in Table 2.2. 
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Table 2.2. VNT results for each sample titre 
Hendra virus Cedar virus 
VNT Data VNT Data 
VNT titre Number of 
samples 
VNT titre Number of 
samples 
<12.5 67 <12.5 55 
12.5 6 12.5 9 
25 5 25 7 
50 4 50 9 
≥100 9 ≥100 11 
 
Only 12/91 (13%) of the samples tested had neutralising antibody against both viruses. Cross-
neutralisation of Hendra and Cedar viruses is unlikely due to the findings of Marsh et al. (2012) 
where CedPV-neutralising antibodies failed to neutralise either HeV or NiV and vice versa.  
2.3.4 Correlation of ab-Luminex and VNT results 
For a comparison of ab-Luminex MFI values according to VNT results for each of the 91 samples 
analysed in the VNT, readings for both assays at a sample dilution of 1:50 were analysed. In this 
analysis, the absence of CPE at a sample dilution of 1:50 was considered VNT positive.  
For Hendra virus, the ranges of MFI values for positive and negative VNT samples are shown in 
Figure 2.8. The median MFI value for VNT positive samples (n = 13) was 24,331, 95% CI (22,367-
26,376). The median MFI value for VNT negative samples (n = 78) is 201, 95% CI (156-255). The 
MFI distribution for VNT positive samples is significantly different to the MFI distribution for 
VNT positive samples (p<0.05). 
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Figure 2.8. MFI ranges for positive and negative HeV VNT samples at a 1:50 dilution 
 
Dotted line represents the MFI cutoff value determined by the Cutoff Finder (MFI = 16,710).  
 
For Cedar virus, the ranges of MFI values for the 91 samples tested in the VNT are shown in Figure 
2.9. The median MFI value for VNT positive samples (n = 20) is 27,578, 95% CI (24,351-28,874). 
The median MFI value for VNT negative samples (n = 71) is 163, 95% CI (131-243). The MFI 
distribution for VNT positive samples is significantly different to the MFI distribution for VNT 
positive samples (p<0.05). 
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Figure 2.9. MFI ranges for positive and negative CedPV VNT samples at a 1:50 dilution 
 
Dotted line represents the MFI cutoff value determined by the Cutoff Finder (MFI = 8,579).  
 
Comparing the ab-Luminex and VNT assays for both viruses, samples without neutralising 
antibody at a dilution of 1:50 displayed a wide range of binding activity to the soluble G proteins in 
the ab-Luminex assay as reflected in the range of MFI values that overlap with MFI values of 
samples with neutralising antibodies in Figure 2.8 and Figure 2.9. However, for both viruses, the 
presence of neutralising antibody was significantly associated with higher MFI readings in the ab-
Luminex, particularly in the Hendra virus assay. In summary, samples that have neutralising 
activity are more likely to correlate with high MFI values than samples that do not have neutralising 
antibody.  
Using the Cutoff Finder, the MFI value in the Hendra virus assay that maximized sensitivity and 
specificity to VNT result was 16,710. The resulting sensitivity was 100% and specificity 97%. The 
MFI value in the Cedar virus assay that maximized sensitivity and specificity to VNT result was 
8,579. The resulting sensitivity was 90% and specificity 90%. For Hendra virus, the cutoff value 
gives high sensitivity and specificity, resulting in no false negatives (where VNT positive samples 
are categorized as negative based on the ab-Luminex assay) and few false positives (where VNT 
negative samples are categorized as positive based on the ab-Luminex assay). For Cedar virus, the 
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cutoff value gives lower but still reasonable sensitivity and specificity with few false negatives and 
positives. Thus for either virus but especially Hendra virus, samples with low MFI values (below 
respective cutoffs) are unlikely to contain neutralizing antibodies to the same virus. However, 
samples with high MFI values (above respective cutoffs) may or may not contain neutralizing 
antibodies to the same virus. This difference is likely due to each assay measuring different classes 
of antibodies and will be discussed later. For Hendra virus, using the cutoff value to divide samples 
as ‘seronegative’ or ‘seropositive’ based on ab-Luminex MFI values, 121/137 (88%) bats were 
seronegative and 16/137 (12%) were seropositive. For Cedar virus, using the cutoff value to divide 
samples as ‘seronegative’ or ‘seropositive’ based on ab-Luminex MFI values, 88/137 (64%) were 
seronegative and 36/137 (26%) were seropositive.  
2.3.5 Biological and temporal correlates of anti-henipavirus antibody neutralizing activity 
For each virus, the proportion of samples VNT positive by collection month are shown in Figure 
2.10. The temporal pattern of serology appears to be different between the two viruses. For Hendra 
virus, seropositivity appears to increase and decrease over time while for Cedar virus, seropositivity 
appears to decrease over time. Determining significant differences in serology results between 
sampling months is difficult however due to the small samples sizes which are reflected in the wide 
confidence intervals. 
Figure 2.10. Proportion of samples VNT positive with confidence intervals by collection month 
for Hendra virus (left) and Cedar virus (right). Note the different scale on the y-axis for each 
virus. 
 
 
For each virus, the proportion of samples VNT positive by sex are shown in Figure 2.11. Initial 
observations show that for both viruses, seropositivity is greater in males however due to the 
overlapping confidence intervals, the difference is unlikely to be significant.  
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Figure 2.11. Proportion of samples VNT positive with confidence intervals by sex for Hendra 
virus (left) and Cedar virus (right). Note the different scale on the y-axis for each virus. 
 
 
For each virus, the proportion of samples VNT positive by age category are shown in Figure 2.12. 
Initial observations find different seropositivity profiles according to age category. For Hendra 
virus, seropositivity appears to be greater in juveniles compared to adults. For Cedar virus, there 
does not appear to be a large difference in seropositivity between juveniles and adults. 
Figure 2.12. Proportion of samples VNT positive with confidence intervals by age for Hendra 
virus (left) and Cedar virus (right). Note the different scale on the y-axis for each virus. 
  
 
For each virus, the proportion of samples VNT positive by lactation status are shown in Figure 2.13. 
Due to the very few number of animals observed lactating, the wide confidence intervals preclude 
any comment regarding the influence of lactation on seropositivity. 
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Figure 2.13. Proportion of samples VNT positive with confidence intervals by lactation status for 
Hendra virus (left) and Cedar virus (right).  
  
 
For each virus, the distributions of weight measurements according to VNT result are shown in 
Figure 2.14. Using a Wilcoxon rank-sum test, the distributions of weight by VNT result are 
significantly different for Hendra virus (p<0.05) but not significantly different for Cedar virus 
(p=0.41).  
Figure 2.14. Box plots of weight measurements by VNT result for Hendra virus (left) and Cedar 
virus (right) 
 
 
For each virus, the distributions of forearm measurements according to VNT result are shown in 
Figure 2.15. Using a Wilcoxon rank-sum test, the distributions of forearm measurements by VNT 
result are significantly different for Hendra virus (p<0.05) but not significantly different for Cedar 
virus (p=0.87).  
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Figure 2.15. Box plots of forearm measurements by VNT result for Hendra virus (left) and Cedar 
virus (right) 
  
 
For each virus, the distributions of weight/forearm ratios according to VNT result are shown in 
Figure 2.16. Using a Wilcoxon rank-sum test, the distributions of weight/forearm ratios by VNT 
result are significantly different for Hendra virus (p<0.05) but not significantly different for Cedar 
virus (p=0.30).  
Figure 2.16. Box plots of weight/forearm ratios by VNT result for Hendra virus (left) and Cedar 
virus (right) 
  
 
The results of the regression analyses used to determine bat-specific and temporal factors associated 
with the presence of neutralising antibodies to henipaviruses are shown in Table 2.3 and Table 2.4. 
The sex of one individual bat trapped in August 2012 was not recorded, thus this bat is not included 
in the analysis of association with sex. The dependent variable was the absence or presence of 
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neutralizing antibody at a sample dilution of 1:12.5 or greater. Odds ratios are presented alongside p 
values and 95% confidence intervals. 
Table 2.3. Results of logistic regression of bat-specific and temporal factors on HeV VNT result 
HENDRA VIRUS 
Variable Odds Ratio P value 95 % Confidence Interval 
Univariate analysis 
Sex (male vs. female) 1.64 0.31 0.62 4.32 
Age (adult vs. juvenile) 0.30 0.03* 0.11 0.86 
Lactation (lactation vs. no lactation) 0.53 0.57 0.06 4.79 
Collection month 0.85 0.37 0.60 1.22 
Weight 1.00 0.03* 0.99 1.00 
Forearm length 0.96 0.07* 0.92 1.00 
Weight to forearm ratio 0.53 0.03* 0.30 0.95 
*p<0.25 and variable included in the multivariable analysis 
Mixed effects logistic regression 
Age 0.15 0.08 0.02 1.28 
Weight 1.13 0.02* 1.02 1.26 
Forearm length 0.63 0.02* 0.43 0.93 
Weight to forearm ratio 6.39e
-09
 0.02* 8.83e
-16
 0.05 
 
In the univariate analysis, age was significantly associated with a positive VNT result (p<0.05). The 
odds of a bat having positive neutralizing antibodies to Hendra virus were 70% less in adults 
compared to juveniles, thus higher odds of seropositivity in juveniles. Although weight showed a p 
value < 0.05, the odds ratio was 1 and the confidence interval contained 1 thus the association was 
not strong. Weight to forearm ratio was significantly associated with a positive VNT result 
(p<0.05). Bats with lower weight to forearm ratios had greater odds of a positive VNT result. 
Although not statistically significant, the p value for forearm length was < 0.25 and was thus 
included in the multivariate analysis.  
In the mixed effects logistic regression which accounts for the clustered sampling, weight, forearm 
length and weight/forearm ratio were each significantly associated with a positive VNT result 
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(p<0.05). These results remain significant even after accounting for age. In the univariate model, 
perhaps one or all of weight, forearm length, and weight/forearm ratio were confounding the 
association between age and VNT positivity. A mixed effects logistic regression was repeated as 
above with the addition of sex into the model. In this model, age and sex were not significantly 
associated with the outcome whereas weight, forearm length, and weight/forearm ratio were (data 
not shown). It appears that for Hendra virus, even after accounting for age and sex, weight, forearm 
length, and weight/forearm ratio were significantly associated with the presence of neutralizing 
antibody. It is difficult to distinguish which of the three variables have the greatest effect on VNT 
result due to collinearity. 
Table 2.4. Results of logistic regression of bat-specific and temporal factors on CedPV VNT result 
CEDAR VIRUS 
Variable Odds Ratio P value 95 % Confidence Interval 
Univariate analysis 
Sex (male vs. female) 1.32 0.51 0.54 3.23 
Age (adult vs. juvenile) 1.16 0.74 0.50 2.69 
Collection month 0.42 0.00* 0.27 0.65 
Lactation (lactation vs. no lactation) 0.29 0.27 0.03 2.63 
Weight 1.00 0.66 1.00 1.00 
Forearm length 0.99 0.67 0.95 1.03 
Weight to forearm ratio 1.17 0.55 0.70 1.94 
 *p<0.05 and therefore considered significant 
 
For Cedar virus, in the univariate analysis, only collection month was significantly associated with 
the presence of neutralising antibodies. The univariate regression was repeated for collection month 
with p values and confidence intervals determined for each month separately. April and August 
2012 predicted success perfectly in the model and were dropped from the regression. When 
adjusting for the other months of collections (March 2013, April 2013, and February 2014), there 
was no significant association between any month of collection and CedPV seropositivity. A 
multivariable regression was not performed. For Cedar virus, infection appears to be independent of 
age, sex, weight, forearm length, and weight/forearm ratio. 
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2.4 DISCUSSION 
2.4.1 Prevalence of henipavirus neutralising antibodies 
In this study, 26% of samples were positive for neutralising antibodies to Hendra virus and 40% of 
samples were positive for neutralising antibodies to Cedar virus. For Hendra virus this value falls 
within the range of neutralising antibody prevalence (23-56%) determined from previous 
surveillance studies of Australian pteropid bat populations (Breed et al., 2011, Plowright et al., 
2008, Marsh et al., 2012). In the only report on sero-surveillance for Cedar virus infection, Marsh et 
al. (2012) reported that 23% of samples collected from pteropid bats caught in Queensland showed 
neutralising antibodies to Cedar virus. A higher proportion of bats sampled in the current study 
were positive for neutralising antibodies to Cedar virus (40% vs. 23%). For the Queensland data, it 
is unknown what species were sampled and over what time frame, which makes comparison 
difficult.  
The neutralising titres measured in the samples of this study are consistent with titres measured in 
pteropid bats infected naturally and experimentally with henipaviruses (Williamson et al., 1998, 
Sohayati et al., 2011, Halpin et al., 2000, Middleton et al., 2007). For wild-caught bats, henipavirus 
neutralising titres ranged from 1:8 to 1:128 (Halpin et al., 2000, Sohayati et al., 2011). For bats 
experimentally inoculated with Hendra virus, Williamson et al. (2000) found neutralising titres 
between 1:40 and 1:80 three weeks post-inoculation. For bats experimentally inoculated with Nipah 
virus, Middleton et al. (2007) found neutralising titres of >640 in one bat fourteen to fifteen days 
post-inoculation.  
An important question asked of this project is whether Hendra virus replicates and circulates in 
pteropid bats found at the southern-most region of their geographic range. Such a question has an 
implication for local human and domestic animal health. Positive neutralising antibody titres to 
Hendra virus in samples collected from bats in Geelong strongly suggests that these bats have 
previously been infected with this virus. It is unclear however at what time and thus at what location 
infection occurred (i.e. where the infectious virus is present). Furthermore previous infection with a 
closely related henipavirus cannot be ruled out if induced antibodies are capable of neutralising both 
Hendra and Hendra-like viruses, similar to the cross-neutralisation of Hendra and Nipah viruses 
(Zhu et al., 2008). Detection of or isolation of infectious virus from samples collected from this 
colony is required to definitively answer this question.  
2.4.2 Biological and temporal associations with henipavirus antibody neutralizing activity 
Bat demographic and temporal factors were investigated for their association with Hendra virus- 
and Cedar virus-specific antibody neutralizing activity. It should be noted that the interpretation of 
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these results must be treated with caution, given inconsistencies in the frequency of sampling, the 
variability in the number of bats caught, and the inability of this study to sample from the same 
individual over time. General conclusions will instead be made with reference to the body of 
literature which exists in relation to henipavirus serological surveys.  
There was no significant association of sex with neutralising antibody presence for either Hendra or 
Cedar virus. This is in agreement with two studies (Breed et al., 2011, Plowright et al., 2008) that 
investigated Hendra virus serum neutralisation in wild-caught pteropid bats and found that apart 
from times of pregnancy, birthing and lactation, serostatus of female bats did not differ significantly 
to that of male bats.  
The repeated cross-sectional surveillance studies of Breed et al. (2011) and Plowright et al. (2008) 
divided bats into various age categories. Breed et al. (2011) categorized bats as adults, sub-adults or 
juveniles, while Plowright et al. (2008) divided bats into four age classes: <1 month, 3 months, 6 
months, 1-2 years, and >2 years. Both studies found that after maternal antibodies had waned, 
Hendra virus seroprevalence increased with age. The results of the current study are not in 
agreement with these studies as for both viruses, regression analysis showed no significant 
association between age and the presence of neutralizing antibody. In this study, age does not 
appear to be a risk factor for henipavirus infection. Juvenile and sub-adult bats in this study were 
categorized together whereas in the above-mentioned studies these categories were divided. In the 
current study, it was considered that the distinction between these age groups was too subjective. 
Perhaps the lack of age resolution influenced the results of this study.  
The paper by Plowright et al. (2008) found that Hendra virus seroprevalence and body condition 
shared an inverse relationship. In the bat research community the results of this study have led to an 
acceptance of the idea that bats under energy stress are more susceptible to viral infection and pose 
a greater risk of Hendra virus transmission. For Hendra virus but not Cedar virus, the results of the 
current study support those of Plowright et al. (2008). Accounting for age, a significant inverse 
association was found between weight, forearm length, and weight to forearm ratio (a measure of 
body condition) with the detection of HeV neutralizing antibodies. Compared to Cedar virus, it 
appears that regardless of age, a distinct sub-population of bats are at a greater risk of infection with 
Hendra virus: those that are smaller with relatively poorer body conditions. In studies of other 
wildlife populations, Beldomenico at al. (2009) found that field voles in poorer conditions were at a 
greater risk of infection with cowpox virus. Alternatively, perhaps these bats are those that have 
travelled large and energetically costly distances from northern Australia to Geelong. If Hendra 
virus transmission occurs mainly from bat to bat in northern regions of the country, this may 
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explain the lack of Hendra virus detection from the Geelong colony over the sampling period 
(Chapter 3). Further work is required to establish the role of poor nutrition in susceptibility to 
henipavirus infection. Cross-sectional serology may not be the best tool to address this question due 
to the inability to pinpoint the time of infection and does not necessarily correlate with immediate 
spillover risk. Instead, re-capture and sampling of the same animals over time with the aid of collars 
would enable an investigation of bat-specific and temporal factors associated with seroconversion.  
A number of studies (Epstein et al., 2008, Breed et al., 2011, Rahman et al., 2013, Plowright et al., 
2008, Baker et al., 2013b) investigating the influence of bat demographic factors on henipavirus 
serology found an increased risk for infection in pregnant and lactating adult females compared to 
non-reproductive females and adult males. Although no pregnant females were observed during this 
study, anti-HeV and anti-CedPV neutralising antibodies were measured for eight (8) lactating 
females. No significant association of lactation with previous infection with either virus was found 
in this study which is more in agreement with the results of Epstein et al. (2013) who also found no 
significant difference in Nipah virus seroprevalence between lactating and non-lactating female 
bats. However, the majority of evidence including that gained from monitoring the same animals 
over time does agree with higher henipavirus seroprevalence in reproductive females (pregnant or 
lactating). Inconsistencies of the results of the current study with those of others are most likely due 
to the fact that fewer reproductive females were included or because there are different henipavirus 
transmission dynamics in the bats sampled in Geelong compared to those sampled in more northern 
locations.  
In the current study, 13% of animals had neutralising antibodies to both Hendra and Cedar viruses. 
Marsh et al. (2012) reported in their study of Queensland pteropid bats that 8% of sera neutralised 
both viruses and thus reflected ‘co-infection.’ It is preferred here to instead deduce from such 
findings that previous infection of a single animal with both viruses has occurred, not necessarily at 
the same time. Of the 12 animals in the present study with neutralising antibodies to both viruses, 
50% were male, 50% female, 67% juvenile and 33% adults. Furthermore the scatterplot of HeV vs. 
CedPV ab-Luminex MFI values in Figure 2.3 revealed two bats that had high readings for both 
viruses. Both of these animals were juveniles. Juveniles caught were 18 months old or less and had 
been weaned from their mothers (no pups still attached to their mothers were caught). Antibodies 
detected in these juveniles may have been those obtained through maternal transfer where maternal 
antibodies have been detected in pups anywhere between 6 and 12 months after birth (Epstein et al., 
2013, Baker et al., 2013b). However, due to the subjective observation that caught juveniles were 
developed and independent, a more likely possibility may be that the period after waning of 
protective maternal immunity induces a susceptible state in juveniles where the incidence of viral 
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infection is increased in this demographic of animals as postulated by Plowright et al. (2011). This 
may explain the higher proportion of juvenile animals with evidence of previous infection with 
multiple viruses. 
There was no significant association of collection month on HeV seropositivity. For Cedar virus, 
the significant association found between collection month and seropositivity was explained by 
100% positivity of samples collected in April 2012 and August 2012. The 100% seropositivity was 
not repeated in April 2013. Samples collected during these times were from a mixture of males, 
females, juveniles, and adults. Perhaps this represents a sporadic period of active virus introduction 
and circulation within the colony. Surveillance for viral RNA (Chapter 3) continued to July 2012 
however no Cedar virus RNA was detected around the March-April 2012 period.  
2.4.3 The importance and difficulty in determining MFI cut-off values 
The ab-Luminex is becoming a common method to measure the presence of antigen-specific 
antibody reactivity in bat serum/plasma samples (Baker et al., 2013b, Epstein et al., 2013, Breed et 
al., 2013, Peel et al., 2012). The output of this assay is an MFI reading and there are issues in 
inferring the biological relevance of these values as well as dividing such a continuous variable into 
‘high’ and ‘low’ categories and thus ‘seropositive’ and ‘seronegative’ samples for comparison with 
other studies. This study revealed a positive association between MFI value and the presence of  
neutralising antibody, which was also found by Peel et al. (2013) who showed as MFI values for 
antibody binding to Nipah virus soluble-G protein increased, the proportion of the same samples 
able to neutralise Hendra and Nipah viruses also increased. Epstein et al. (2013) found that juvenile 
P. alecto with anti-HeV maternal antibodies with serum neutralising ability had MFI values of 
greater than 25,000. However, not all instances where MFI values exceeded 25,000 resulted in such 
properties. There does not seem to be a clear MFI ‘cut-off’ for neutralising/non-neutralising 
properties.  
A common method to divide MFI readings into ‘seropositive’ and ‘seronegative’ is to use the value 
which is three times the mean MFI reading of negative bat sera as a cut-off (Hayman et al., 2008, 
Epstein et al., 2013). For the assay used in this project, this cut off for HeV s-G is an MFI of 243 
and for CedPV 315. The main issue with this technique is the use of sera from wild-caught animals 
as a negative control, because the infection status of the animal is usually unknown and thus cannot 
confidently be said to be seronegative (Peel et al., 2013). In the current study, a novel method to 
divide bat serum/plasma samples into positive and negative categories based on MFI values was 
used. This involved the use of a statistical Cutoff Finder and the output values maximized 
sensitivity and specificity in combination against VNT results. The cutoff values for each virus 
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proved to be a conservative method to divide the samples, with higher cutoff values than calculated 
using the common method above (MFI values of 16,710 and 8,579 for Hendra and Cedar, 
respectively).  
The usefulness of the cut-off values determined in this study in deducing neutralising properties of 
the antibodies in a sample was assessed using the sensitivity and specificity values produced by the 
model. Dividing samples as positive and negative based on MFI readings proved a sensitive and 
specific way of detecting neutralising antibodies in that sample for both Hendra virus and Cedar 
virus. Samples with neutralizing antibodies were generally positive based on the MFI cutoff for 
each virus (sensitivity). However, for both Hendra virus and Cedar virus, there were a number of 
samples without neutralizing antibodies that were positive based on ab-Luminex MFI values. As the 
glycoprotein is composed of multiple epitopes, this finding is likely explained by the presence of 
antibodies in the sample that bind to the soluble-G protein but do not play a role in virus 
neutralization. For the validation of the ab-Luminex, it will be necessary to determine the 
characteristics of the antibodies that bind and are detected by the ab-Luminex but which do not 
show neutralising abilities in the VNT. If the analytes that bind to the G antigen in the ab-Luminex 
do not play any role in anti-viral immunity, this would have implications for the validation of the 
ab-Luminex. In this case, higher cutoff values may be needed to increase specificity but at the cost 
of sensitivity. It must be kept in mind that MFI values and their correlation to neutralising abilities 
are not linear and the relationship still remains unclear as these two assays measure different 
populations of antibodies. 
The role of neutralising antibodies in an immune response and their role in protecting the host 
against infection and disease is relatively well characterized compared to the actions of non-
neutralising antibodies that bind in the ab-Luminex assay. Both types of antibodies are produced 
during an immune response to infection (Giannelli et al., 1994). It has been suggested that in 
addition to neutralising antibodies, bats produce low-affinity but broadly-reactive antibodies (Baker 
et al., 2013b). Although such antibodies may not directly impede cell entry of a virus, they may 
play a role in activating and enhancing certain components of the immune system such as activation 
of complement, enhancement of phagocytosis through opsonization or induction of antibody-
dependent cell-mediated cytotoxicity. 
2.4.4 Serostatus and spillover risk 
When considering the risk of cross-species transmission of zoonotic viruses, it is important to make 
a distinction between a risk based on serology results and results based on the detection of virus. 
The presence of circulating antibody is not equivalent to the presence of replicating virus within 
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that animal or in the population of animals from which it was sampled. As it stands, the current 
understanding of humoral immunity in bats does not allow an assessment of likely time of virus 
exposure given a particular MFI value or VNT titre. It is common for studies to assume life-long 
immunity post henipavirus infection in bats (Plowright et al., 2008, Sohayati et al., 2011, Plowright 
et al., 2011). The longest documented maintenance of neutralising titres was 11 months in a study 
of captive bats naturally infected with Nipah virus (Sohayati et al., 2011). Thus the detection of 
neutralising titres may indicate that virus infection and replication occurred days/weeks or years 
ago. Neutralising antibody has been associated both with the presence of replicating virus (Halpin et 
al., 2000, Middleton et al., 2007, Williamson et al., 2000) and the absence of detectable virus 
(Sohayati et al., 2011, Middleton et al., 2007, Williamson et al., 2000). This Chapter has revealed 
that bats present in the Geelong colony show evidence of previous infection with the henipaviruses 
Hendra virus and Cedar virus. To determine whether this population of bats may act as a source of 
infection for humans and other animals, targeted virus detection will be the focus of the following 
Chapters. 
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CHAPTER 3 SURVEILLANCE OF PARAMYXOVIRUS EXCRETION 
FROM A COLONY OF PTEROPUS POLIOCEPHALUS  
3.1 INTRODUCTION 
Surveillance studies of paramyxovirus infection in pteropid bat populations have thus far been 
concentrated in the northern states of Australia: Northern Territory, Queensland and northern New 
South Wales. Furthermore these studies have taken place over relatively short time frames with 
long periods between sampling events. Repeated, cross-sectional, longitudinal surveillance studies 
have significantly contributed to an understanding of the transmission dynamics of zoonotic viruses 
in wildlife reservoir populations (Amengual et al., 2007, Smith et al., 2009, Begon et al., 1999). As 
there appears to be a seasonal pattern to Hendra virus infection in horses (Field et al., 2012), this 
surveillance project was designed to identify any temporal pattern to paramyxovirus infection and 
excretion in a colony of Pteropus poliocephalus (grey-headed flying foxes, GHFF). A cross-
sectional study using frequent repeated sampling was conducted. The aim was to determine if there 
are particular risk periods for virus excretion from bats, which may lead to higher risk of cross-
species transmission of these viruses to humans and other animals.  
The study used a multiplex assay which allows the simultaneous detection of several bat-
paramyxoviruses in addition to Hendra virus. The field sampling procedure involved non-invasive 
collections of pooled urine samples, a technique which has been successfully used by other groups 
to detect a variety of viruses including paramyxoviruses from bat colonies (Chua, 2003, Baker et 
al., 2012, Field et al., 2011, Vidgen et al., 2015). Paired with the serological analyses from the 
trappings of individual bats determined in Chapter 2, an overall picture of multi-pathogen dynamics 
in a single flying fox colony will be determined. 
3.2 MATERIALS AND METHODS 
3.2.1 Animal ethics 
Please refer to Chapter 2 for Animal ethics. 
3.2.2 Repeated cross-sectional collection of urine samples 
For virological analyses, urine collections were performed one morning per week where possible 
from June 2010 until July 2012 (109 weeks; 26 months). The collection procedure most commonly 
involved placing four plastic sheets (2.6 m x 3.6 m) in four separate locations underneath trees 
containing bats. The inaugural positioning of sheets was not done at random – sheets were placed in 
disparate locations to sample from subgroups of the colony in areas of high densities of bats. 
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Locations of the sheets were kept approximately constant from week to week. Sheet placements 
were completed before dusk and urine collection performed one to two hours after dawn the next 
morning. If rain occurred during the night before collection, sampling did not go ahead. Personal 
protective gear was worn during sheet placement and sample collection. This included disposable 
overalls, eye goggles, disposable face masks, enclosed shoes and disposable shoe covers.  
For a given sheet, neat (undiluted) urine was collected using disposable pipettes and pooled into 2 
mL Sarstead tubes containing 100 μL VTM (10 % BSA in PBSA + 10 x Gibco® Antibiotic-
Antimycotic containing penicillin, streptomycin and amphotericin B). Approximately 4-15 droplets 
of urine were collected into each tube. A new pipette was used for each tube. For each sheet, two to 
three tubes of pooled urine were collected and most commonly, ten tubes of pooled urine were 
collected in total from all sheets at each sampling event. Care was taken not to contaminate urine 
samples with faeces or saliva which were also present on the sheet however the possibility of such 
contamination cannot be excluded in all cases. It is important to note that it was not possible to 
determine how many bats contributed urine to each pooled sample. One pooled sample may contain 
urine from one to any number of bats. Furthermore, one bat may contribute urine to more than one 
different pooled sample. After the collection, samples were taken directly to the laboratory for 
storage at 4 °C before processing 
3.2.3 Sample processing 
3.2.3.1 RNA extraction and storage 
Volumes of up to 500 μL of urine were taken from each sample of pooled urine and added to 
MagMax™ lysis buffer (Applied Biosystems®) in a 1:2 ratio. For every 1 mL of lysis buffer used, 
15.4 μL of carrier RNA (Applied Biosystems®) was added to increase the yield of viral RNA. RNA 
was extracted from the samples using the MagMax™ Viral RNA Isolation Kit. The extraction 
platform used for the longitudinal samples was the MagMax™ Express 96 automated extraction 
unit (Applied Biosystems
®
). The platform used for the targeted collections was the KingFisher™ 
Flex Magnetic Particle Processor (Thermo Scientific). After extraction, RNA was stored at -80 °C. 
Any remaining urine was also stored at -80 °C.   
3.2.4 Luminex nucleic acid assay (nc-Luminex) 
For an efficient and reliable assessment of the longitudinal excretion of multiple paramyxoviruses 
in a large number of samples, a Luminex nucleic acid assay (nc-Luminex) was chosen as the 
screening tool (Boyd et al., 2015). Such assays allow the sensitive and specific detection of multiple 
nucleic acid sequences in a single sample (theoretically up to 500 in the Luminex system), unlike 
quantitative PCR assays that have limited multiplexing capacity (Boyd et al., 2015). Sensitivities of 
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these assays have shown to be on par or even to exceed that of quantitative PCR assays designed to 
detect henipaviruses (Foord et al., 2013; Boyd et al., 2015). Luminex nucleic acid assays utilize 
multiple bead sets; each with their own distinct spectral fingerprints which are distinguished by 
lasers in a detector. In addition, each bead set contains a unique 24 base DNA “anti-TAG” sequence 
covalently coupled to its surface. It is this anti-TAG sequence that hybridizes to complementary 
“TAG” sequences which are incorporated into specifically amplified target nucleic acid sequences. 
The nc-Luminex used in this study follows the methodology of bat virus panel assay 1 (BVPA-1) in 
Boyd et al. (2015). This panel assay used in this study contains the same viral targets as BVPA-1 
except for Nipah virus Bangladesh/Malaysia (NiV-BD, NiV-MY) and Tioman virus (TioV) which 
were not included. Described below are details of the viruses chosen for screening, a list of the anti-
TAG and TAG sequences specific for each virus/bead set and the assay procedure.  
3.2.5 Target viruses 
Table 3.1 shows the nine bat paramyxoviruses chosen for addition in the 9-plex nc-Luminex used in 
this project. These viruses were chosen as they constitute all reported paramyxovirus isolates 
obtained from pteropid bat colonies in Australia. Early in this project I detected a novel 
paramyxovirus partial L gene sequence using a paramyxovirus-family based PCR adapted from the 
method described by Tong et al. (2008) from urine collected from the Geelong colony on 22
nd
 
December 2010. This viral sequence has been named Geelong paramyxovirus (GeePV) but it has 
not yet been isolated. Using the same PCR methods a member of my laboratory group, Cecilia 
Sanchez, detected another novel paramyxovirus partial L gene sequence from urine collected from 
bats of the Yarra Bend colony of Melbourne in May 2012. This viral sequence has been named 
Yarra Bend paramyxovirus (YarPV), but it has also not yet been isolated. Both GeePV and YarPV 
were included in this assay. Figure 3.1 shows a phylogenetic tree of selected members of the family 
Paramyxoviridae including those used in this assay.  
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Table 3.1. List of viruses chosen for longitudinal analysis of Geelong bat urine 
Virus Name Genus 
Original bat isolate obtained from 
samples collected from following 
locations 
Virus isolated/detected from 
following bat species (wild-living) 
Zoonotic 
potential 
(Y/N) 
Hendra 
(HeV) 
Henipavirus 
Brisbane, Queensland 
(Halpin et al., 2000) 
P. poliocephalus, P. alecto, P. 
conspicillatus (Halpin et al., 2000, Field 
et al., 2011) 
Y (Murray et 
al., 1995) 
Cedar 
(CedPV) 
Cedar Grove, Queensland 
(Marsh et al., 2012) 
P. poliocephalus, P. alecto (Marsh et 
al., 2012) 
NK (Marsh et 
al., 2012) 
Menangle 
(MenPV) 
Rubulavirus 
Cedar Grove, Queensland 
(Barr et al., 2012)  
P. alecto, P. poliocephalus (Barr et al., 
2012) 
Y (Chant et 
al., 1998) 
Yeppoon 
(YepPV) 
Yeppoon, Queeensland  
(Barr et al., 2014) 
P. alecto, P. poliocephalus 
(Barr et al., 2014) 
NK 
Grove 
(GroPV) 
Cedar Grove, Queensland 
(Barr et al., 2014) 
P. alecto, P. poliocephalus 
(Barr et al., 2014) 
NK 
Teviot 
(TevPV) 
Cedar Grove, Queensland 
(Barr et al., 2014) 
P. alecto, P. poliocephalus 
(Barr et al., 2014) 
NK 
Hervey 
(HerPV) 
Hervey Bay, Queensland 
(Barr et al., 2014) 
P. alecto, P. poliocephalus 
(Barr et al., 2014) 
NK 
Geelong 
(GeePV) 
No isolate. Detection of nucleic acid 
from Geelong colony, Geelong, Victoria 
(Unpublished) 
P. poliocephalus 
NK 
Yarra Bend 
(YarPV) 
Unclassified 
No isolate. Detection of nucleic acid 
from Yarra Bend colony, Melbourne, 
Victoria (Unpublished) 
P. poliocephalus 
NK 
*NK, not known 
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Figure 3.1. Phylogenetic tree of selected members of family Paramyxoviridae 
 
Figure 3.1. Phylogenetic analysis of amino acid sequences derived from partial L-gene fragments.  
Neighbour-joining phylogeny reconstructed from 108 amino acids coded by the L-gene corresponding to positions 855-
962 in Hendra virus L protein (Genbank NP047113). Representative viruses from subfamily Paramyxovirinae in the 
genera: Avulavirus (Newcastle  disease virus B1 – no shading), Rubulavirus (yellow shading), Respirovirus (blue 
shading), Morbillivirus (Measles virus – no shading), Henipavirus (pink shading) and the subfamily Pnemovirinae 
(genera Pneumovirus and Metapneumovirus - brown shading) included. Paramyxoviruses that have not yet been 
officially classified are shown by red branches. Virus sequences detected from Victorian bat colonies before application 
of the nt-Luminex are written in blue text. Viruses incorporated in the 9-plex nt-Luminex are demarcated by a star. 
Genbank accession numbers for each virus are included in Appendix 3. The bootstrap values obtained after 1000 
replicates are indicated at each branch. Scale bar indicates amino acid substitutions per site. Phylogenic tree constructed 
using MEGA 6 with a p-distance model. 
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3.2.6 Details of primers used in this study  
The anti-TAG and TAG sequences are a function of the individual bead sets Table 3.2 and are 
provided by the manufacturer. 
Table 3.2. Anti-TAG and TAG sequences for the bead sets used in this assay 
Bead # Virus Target Sequence on bead (Anti-TAG) 5’ to 3’ complement (TAG) appended to TSPE primer 
53 HeV L gene GTTTGTGTTTGTATAAGTTGTTAA TTAACAACTTATACAAACACAAAC 
51 CedPV L gene GATAAGAAAGTGAAATGTAAATTG CAATTTACATTTCACTTTCTTATC 
55 MenV L gene GAAGATATTGAAAGAATTTGATGT ACATCAAATTCTTTCAATATCTTC 
45 YepPV L gene GTTAGTTATGATGAATATTGTGTA TACACAATATTCATCATAACTAAC 
47 GroPV L gene TATTGTTGAATGTGTTTAAAGAGA TCTCTTTAAACACATTCAACAATA 
43 TevPV L gene AAATAAGAATAGAGAGAGAAAGTT AACTTTCTCTCTCTATTCTTATTT 
12 HerPV L gene AGTAGAAAGTTGAAATTGATTATG CATAATCAATTTCAACTTTCTACT 
72 GeePV L gene AATTGAGAAAGAGATAAATGATAG CTATCATTTATCTCTTTCTCAATT 
15 YarPV L gene GTTGTAAATTGTAGTAAAGAAGTA TACTTCTTTACTACAATTTACAAC 
 
The first round of amplification involved the use of degenerate primers designed to detect all known 
paramyxoviruses by targeting the conserved polymerase (L) gene. The primers and protocol used 
are a modification of that published by Tong et al. (2008). The design of the TSPE sequences 
involved aligning the L gene sequences of all nine viruses and selecting sequences 22-28 
nucleotides in length specific for each virus within the L gene region amplified in the first round. 
These sequences are coupled to the anti-tag. TSPE primer designs for all viruses except for GeePV 
and YarPV were performed by Vicky Boyd. Design of the sequences for GeePV and YarPV were 
performed with the advice of Vicky Boyd. Primer sequences for the first round and specific PCRs 
are detailed in Table 3.3.  
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Table 3.3. Virus-specific primers for amplification stages of the nc-Luminex 
First round amplification 
Primer Sequence 5’ to 3’ Target 
PAR-F1 GAAGGITATTGTCAIAARNTNTGGAC L-gene 
PAR-R *CAGGAAACAGCTATGACGCTGAAGTTACIGGITCICCDATRTTNC L-gene 
TSPE target sequence 5' to 3' with TAGs (bold) 
HeV ttaacaacttatacaaacacaaac-ttatattttgacaggctcagaatgaatc 
CedPV caatttacatttcactttcttatc-caaggttacggcacaacatgaa 
MenV acatcaaattctttcaatatcttc-ccattgcgtaccaaaatagtatgga 
YepPV tacacaatattcatcataactaac-caggtctctggaccataagctc 
GroPV tctctttaaacacattcaacaata-agttccaagatcattgagccaccagt 
TevPV aactttctctctctattcttattt-caaccatggttccgcgcagtcta 
HerPV cataatcaatttcaactttctact-attctctctgcaaccgaggcaaactc 
GeePV ctatcatttatctctttctcaatt-ctcaatcgtcctgttcaaatctgg 
YarPV tacttctttactacaatttacaac-tgcttgtagcaatatatctactaccctg 
* Italics capital M13 sequence 
 
3.2.7 Assay procedure 
3.2.7.1 First round amplification 
A one step RT-PCR was performed using the Superscript III One-Step with Platinum Taq kit 
(Invitrogen) with the following conditions: 12.5 μL reaction volume, 100 μM forward and reverse 
primers (Table 3.3), 5.0 mM MgSO4 and 3 μL template RNA. Thermal cycling conditions: 60 °C 
for 1 min, 48 °C for 30 min (RT reaction), 94 °C for 2 min (Taq activation), 40 cycles of 94 °C for 
15 s, 49 °C for 30 s and 68 °C for 1 min, followed by 68 °C for 5 min in a 96 well PCR plate. 
Unincorporated dNTPs and primers at the end of this reaction were removed by treating with 
ExoSAP-IT (Affymetrix) according to the manufacturer’s instructions.  
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3.2.7.2 Target-specific primer extension (TSPE) 
The TSPE reaction involves linear amplification of specific paramyxovirus sequences. This TSPE 
reaction serves two purposes: first to incorporate the TAG sequence into the PCR products and 
second to incorporate biotin-labeled cytosine into the products for reaction with streptavidin R-
phycoerythrin which is detected on the Bioplex Array System. Each 20 μL TSPE reaction contained 
5 μL of Exo-SAP treated RT-PCR product, 5 U/μL Tsp DNA polymerase (Invitrogen), 1 μM of 
each TSPE primer (Geneworks) (Table 3.3), 0.2 mM dATP, dTTP and dGTP (Invitrogen), 400 μM 
biotin-dCTP (Invitrogen), 10 x PCR buffer (Qiagen), 50 mM MgCl2 and water. Thermocycling was 
performed at 94 °C for 2 min, followed by 40 cycles of 94 °C for 30 s, 55 °C for 30 s, and 72 °C for 
40 s. 
3.2.7.3 Microsphere hybridisation 
TAGs of the TSPE reaction were hybridized with the corresponding anti-TAG sequence coupled to 
the beads under the following conditions: 10 μL of TSPE products was added to 40 μL of 
microsphere mix in 1 x hybridization buffer (0.2 M NaCl/0.1 M Tris/0.08% Triton X-100, pH 8.0) 
with 1500 each (microspheres/microsphere set/well) of the appropriate MagPlex-TAG microspheres 
(Table 3.2). The reaction was incubated at 96 °C for 90 s followed by 37 °C for 30 min. The plate 
was then placed on a magnetic separator, supernatant removed and two washes performed using 1 x 
hybridisation buffer.  
3.2.7.4 Microsphere identification and fluorescence detection 
Seventy-five microliters of 1 x hybridization buffer containing 2 mg/L streptavidin-R-phycoerythrin 
(Invitrogen) was added to each well and the plate incubated in the dark at 37 °C for 15 min on a 
plate shaker. Hybridised microspheres contained in 50 μL of reaction mixture at 37 °C were then 
analysed on the Bio-Plex Array System integrated with Bio-Plex Manager software (v 6.0) (Bio-
Rad Laboratories, Inc., CA, USA). Each assay plate was analysed at a high reporter target channel 
(RP1) setting with 100 beads of each bead set analysed per well. Fluorescence was measured as 
units of Median Fluorescence Intensity (MFI). A positive result was defined as an MFI greater than 
three times the average MFI of known negative controls (Foord et al., 2013, Foord et al., 2014).  
3.2.8 Assay specificity and analytical sensitivity 
The specificities of multiplex assays containing the virus targets used in this assay have been 
validated previously by Boyd et al. (2015). Specificity will also be reflected in an absence of false 
positive results in the virus controls. An RNA positive control (B06) which had been extracted from 
a urine sample previously determined to contain 4 viruses of the panel (TevPV, GroPV, MenPV and 
HerPV) was included in each nc-Luminex run. The analytical sensitivity of this assay will be 
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evaluated by comparing the limit of detection of the nc-Luminex to that of the quantitative PCR 
(qRT-PCR) ‘gold standard’ for a subset of the viruses of this assay – Hendra and Cedar viruses. The 
qRT-PCR assays chosen were those previously validated to be the most sensitive for Hendra and 
Cedar viruses, despite targeting different genes to nc-Luminex. The qRT-PCR for Hendra virus 
targets the M gene and for Cedar virus the P gene. Primer and probe sequences for the Hendra virus 
and Cedar virus qRT-PCR assays are shown in Table 3.4. The limit of detection was determined for 
each assay platform using tenfold serially diluted RNA control templates testing in duplicate. Assay 
conditions for the nc-Luminex were as above however for each virus two reaction conditions were 
set up – one where all TSPE primers were added into the mix (multiplex) and one where only the 
one virus specific TSPE primer was added to compare sensitivities. For the qRT-PCR, the 
Superscript III Platinum Taq One-Step qRT-PCR system was used with 5 pmol/μL of probe and 10 
pmol/μL of forward and reverse primers Table 3.4. Thermal cycling was 50 °C for 5 min, 95 °C for 
2 min followed by 40 cycles of 95 °C for 3 s and 60 °C for 30 s.  For the qRT-PCR assays, cycle 
threshold (CT) values ≤ 39 were considered positive and > 39 negative. Positive results for the 
multiplex assay were determined as above. 
Table 3.4. Primers and probes for qRT-PCR 
Primers and Probe Sequence 
HeVM-F CTTCGACAAAGACGGAACCAA 
HeVM-R CCAGCTCGTCGGACAAAATT 
HenVM-Probe (FAM) TGGCATCTTTCATGCTCCATCTCGG (TAMRA) 
CedPV-F 
TGCATTGAGCGAACCCATATAC 
CedPV-R 
GCACGCTTCTTGACAGAGTTGT 
CedPV-Probe (FAM) TCCCGAGAAACCCTCTGTGTTTGA (MGB) 
 
3.2.9 Statistical analyses 
To assess temporal associations with paramyxovirus excretion, univariate logistic regression 
analyses were performed in Stata version 10.0. The outcome variable was RNA detection (yes/no) 
and the explanatory variables were year of collection (2010, 2011, 2012), season of collection 
(summer, autumn, winter, spring) and season by year of collection (winter 2010, spring 2010, 
summer 2010/2011, autumn 2011, winter 2011, spring 2011, summer 2011/2012, autumn 2012, 
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winter 2012). If seasonality to paramyxovirus excretion was occurring then the same season for 
each year (e.g. winter 2010, winter 2011 and winter 2012) should be significantly associated with 
the outcome. A multivariate logistic regression will be performed that includes the explanatory 
variables year and season to account for confounding. Odds ratios are presented with 95% 
confidence intervals and p-values. P<0.05 is considered statistically significant. A calculation of 
minimal detectable prevalence with 95% sensitivity was made using an online calculator (AusVet, 
2015). 
3.3 RESULTS 
3.3.1 Weekly pooled urine samples 
Appendix 2 lists the dates of urine collection by month, the number of pooled samples collected per 
week, the number of sheets used for each collection and the monthly and overall number of pooled 
urine samples collected. Collections were conducted 2 to 5 times per month, from June 2010 to July 
2012, with no months missing from the dataset. The number of pooled urine samples collected per 
month ranged from 20 to 50. Over 88 sampling dates, 872 pooled urine samples were collected.  
3.3.2 Detection of paramyxovirus RNA in pooled urine samples 
Of the 88 sampling events and 872 pooled urine samples collected and analysed, 18/88 (20%) and 
29/872 (3.3%) respectively yielded at least one positive detection of one of the nine 
paramyxoviruses included in the nc-Luminex. Only one sample was concurrently positive for two 
viruses (YarPV & CedPV), giving an overall total of 30 paramyxovirus RNA detections. Positive 
detections were made for YarPV (17), GeePV (7), TevPV (4) and CedPV (2). No detections were 
made for HeV, MenV, YepPV, GroPV or HerPV.  
Detections of the same paramyxovirus in more than one urine sample on a particular collection date 
occurred on six occasions: 12/8/2011 (YarPV), 13/9/2011 (YarPV), 11/11/2011 (YarPV), 
21/11/2011 (YarPV), and 6/7/2012 (YarPV & GeePV). For example, on 11
th
 November 2011, 
YarPV RNA was detected in four different pooled urine samples. Two different paramyxoviruses 
were detected in different pooled urine samples of the same collection date on 4 sampling 
occasions: 21/9/2011 (TevPV & YarPV), 11/11/2011 (CedPV & YarPV), 21/11/2011 (TevPV & 
YarPV), & 6/7/2012 (GeePV & YarPV). Two different paramyxoviruses were detected in the same 
pooled urine sample on one occasion: 11/11/2011 (CedPV & YarPV).  
A plot of the 30 positive paramyxovirus RNA detections by virus type and collection month is 
shown in Figure 3.2. YarPV was the predominant virus detected over the sampling period. 
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Figure 3.2. Paramyxovirus RNA detections by virus type 
 
 
A plot of the proportion of samples per month of collection that tested positive for at least one 
paramyxovirus is depicted in Figure 3.3. Proportions are shown with 95% confidence intervals. The 
highest proportion of samples positive occurred in July 2012 (40%, 95% CI (12.16 – 73.76)). 
Combining results by month for all years, the highest number of detections was made in November 
(9/30).  
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Figure 3.3. Longitudinal detection of paramyxovirus RNA in pooled urine samples over 26 
months 
 
 
Over the sampling period, 20/30 (67%) paramyxovirus detections occurred in 2011 compared with 
4 (13%) in 2010 and 6 (20%) in 2012. It is important to consider however that sampling only 
occurred for half of 2010 and 2012. To assess patterns of virus excretion by year, a plot of the 
proportion of samples per year of collection that tested positive for at least one paramyxovirus is 
depicted in Figure 3.4. Proportions are shown with 95% confidence intervals. From the graph it 
appears that a higher proportion of samples for paramyxovirus RNA occurred in 2011 compared to 
2010 and 2012. The overlapping 95% confidence intervals preclude an assessment of the 
significance of this association from the graph alone.  
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Figure 3.4. Proportion of paramyxovirus RNA positive samples by year of collection 
 
 
Detection patterns for 2011 and 2012 suggest that RNA detection occurs predominantly in the 
second half of the year. To examine seasonality of excretion, seasons will be classified as follows: 
Summer (Dec, Jan, Feb); Autumn (Mar, Apr, May); Winter (Jun, Jul, Aug); and Spring (Sep, Oct, 
Nov). The proportion of samples positive for at least one paramyxovirus per season within each 
year is shown in Figure 3.5. Proportions are shown with 95% confidence intervals. 
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Figure 3.5. Proportion of paramyxovirus RNA positive samples by season within each year of 
collection 
 
 
It is difficult to compare trends over the three collection years as unfortunately sampling began 
halfway through 2010 and stopped halfway through 2012. It cannot be determined for 2010 but for 
2011 and potentially 2012, the greatest proportions of samples appear to occur in the winter and 
spring months compared to summer and autumn. The high proportion sample positive in spring 
2011 is mainly driven by the large number of samples positive in November 2011 but also a number 
of samples positive in September 2011. The high proportion sample positive in winter 2012 is 
driven mainly by the large proportion of samples positive in July 2012. Ideally sampling would 
have continued through winter and spring 2012 to gather further evidence to support the hypothesis 
of seasonality. Unfortunately testing data were only generated after sampling had ceased. Grouping 
proportion of samples positive by season overall gives Figure 3.6. Proportions are shown with 95% 
confidence intervals. The majority of paramyxovirus RNA detections occurred in winter/spring 
(27/30) compared to summer/autumn (3/30).  
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Figure 3.6. Proportion of paramyxovirus RNA positive samples by season  
 
 
The results of a univariate analysis of temporal variables associated with paramyxovirus detection 
will be summarized below. Year of collection (2010, 2011, and 2012) was not significantly 
associated with paramyxovirus detection (p=0.41). For season, (summer, autumn, winter, spring), 
spring was significantly associated with paramyxovirus detection (Odds Ratio (OR) 6.59, 95% CI 
(1.49-29.79), (p<0.05)). The odds of paramyxovirus detection were 6.59 times higher in spring 
compared to summer. Season by year by category (winter 2010, spring 2010, summer 2010/2011, 
autumn 2011, winter 2011, spring 2011, summer 2011/2012, autumn 2012, winter 2012) showed 
that spring 2011 (OR 13.00, 95% CI (1.67-101.14), p<0.05) and winter 2012 (OR 15.00, 95% CI 
(1.73-135.32), p<0.05) were significantly associated with paramyxovirus detection. The reference 
category was winter 2010. In the multivariate logistic regression that included season and year, 
adjusting for year, winter (OR 7.03, 95% CI (1.48-33.33), p<0.05) and spring (OR 14.92, 95% CI 
(2.84-78.25), p<0.05) were significantly associated with paramyxovirus detection compared to 
summer. Adjusting for season, 2011 (OR 4.51, 95% CI (1.50-13.53), p<0.05) and 2012 (OR 9.59, 
95% CI (2.24-41.11), p<0.05) were significantly associated with paramyxovirus detection 
compared to 2010.  
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A range of MFI values for each positive detection of a given paramyxovirus is depicted in Figure 
3.7. 
Figure 3.7. Box-and-whisker plot of median fluorescence intensity (MFI) results for the positive 
detections of YarPV, GeePV, TevPV and CedPV RNA 
 
 
3.3.3 Determination of specificity and analytical sensitivity of the nc-Luminex  
As mentioned above, much of the specificity testing for this nc-Luminex had been previously 
performed by Boyd et al. (2015). In the assays performed for this project, all positive control RNAs 
tested positive to their corresponding virus target and negative to the other virus targets. All four 
viruses of the RNA positive control B06 were detected in each nc-Luminex run.  
For analytical sensitivity, limits of detection for serially diluted HeV and CedPV RNA controls 
were compared between quantitative PCR (qRT-PCR) and the nc-Luminex performed as both 
single (Hendra virus or Cedar virus) and multiplex (9 viruses) assays. Results are shown in Table 
3.5. For the qRT-PCR, CT values values ≤ 39 were considered positive. For the nc-Luminex, values 
above 3 x the average MFI of the negative controls were considered positive. For this assay, the cut-
off MFI was 850. CT and MFI values reported are the average values of duplicate testing. Two sets 
of MFI values are given for the nc-Luminex assay. The first, nc-Luminex MIX, are the values 
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where all TSPE primers were added to the reaction (multiplex) and the second, nc-Luminex IND, 
are the values when only the Hendra or Cedar virus specific TSPEs were added.  
Table 3.5. Sensitivity testing. Positive results are shaded blue. 
H
EN
D
R
A
 V
IR
U
S 
RNA dilution qRT-PCR (CT)  
nc-Luminex MIX 
(MFI) 
nc-Luminex IND 
(MFI) 
10-1 23.19 19,057 19,742 
10-2 27.39 18,437 18,473 
10-3 30.89 13,846 13,816 
10-4 33.90 4,761 4,209 
10-5 NA 733 651 
10-6 NA 161 219 
 
C
ED
A
R
 V
IR
U
S 
RNA dilution qRT-PCR (CT)  
nc-Luminex MIX 
(MFI) 
nc-Luminex IND 
(MFI) 
10-1 25.10 19,204 18,585 
10-2 29.65 3,820 3,603 
10-3 33.08 162 255 
10-4 37.13 191 246 
10-5 NA 178 245 
10-6 NA 209 241 
*NA, out of range of assay  
 
For Hendra virus, nc-Luminex MIX had the same limit of detection and thus the same analytical 
sensitivity as the HeV M gene qRT-PCR and the Hendra-specific nc-Luminex. For Cedar virus, the 
nc-Luminex MIX and the Cedar-specific nc-Luminex assays were 100 fold less sensitive than the 
CedPV P-gene qRT-PCR.  
3.4 DISCUSSION 
This Chapter reports the findings derived from repeated (2-5 times per month), cross-sectional 
sampling of a single bat colony over a two-year period. The sampling regime was designed to be 
frequent enough and of adequate duration to detect temporal variations in paramyxovirus excretion 
patterns. Such resolution to excretion patterns would allow pairing to dynamic ecological and 
environmental factors (Chapters 4 & 5). Expectations were that a large number and a diverse array 
of paramyxoviruses would be detected over the sampling period and that the pattern of excretion 
would vary from week to week. What was found at the end of this study was an overall low 
prevalence of RNA detection. Large periods of sampling contained an absence of RNA detection. 
There was diversity in the types of paramyxoviruses detected; however the majority of detections 
were of one particular viral sequence, Yarra Bend paramyxovirus.  
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Surveillance for the excretion of paramyxoviruses was achieved with the use of a multiplex nc-
Luminex assay designed to detect nine specific viral RNA sequences in pooled urine samples. This 
assay proved to be both a sensitive and specific method and allowed the detection of multiple 
viruses within a single sample. These results demonstrated that this assay is certainly a useful 
method to use in surveillance studies where a large number of samples are involved.  
RNA sequence from at least one of nine bat paramyxoviruses was detected in 3.3% of 821 pooled 
urine samples collected over the 2-year period. This detection rate is lower than the prevalence of 
paramyxovirus excretion reported in some studies (Baker, et al. 2012, Vidgen et al., 2015), but is 
similar to others (Field et al., 2011). However, such comparisons are difficult to make because of 
differences in sampling regimes and detection methods. It may be relatively uncommon for bats of 
this colony to be infected with and excreting these paramyxoviruses. Alternatively, it is possible 
that the sampling and testing regime of this project was too specific or not sensitive enough to 
detect all positive events. For this project, broadly-reactive paramyxovirus family-based RT-PCR 
was only applied to a small number of samples before the nc-Luminex was used for surveillance. If 
all urine samples were investigated broadly, it would be expected that an even greater diversity of 
paramyxovirus sequences would be revealed as found by Vidgen et al. (2015).  
The urine samples were collected from plastic sheeting placed under the bat colony roosting site, 
with an unknown number of bats contributing to each pooled urine sample. Thus, on the six 
sampling dates when the same paramyxovirus was detected in more than one urine sample, it was 
not possible to determine whether the positive detections resulted from one individual contributing 
to multiple urine samples or from a number of bats each contributing to separate urine samples. 
However, as only 2-3 urine samples were collected per sheet and the sheets were placed in disparate 
locations, it seems likely that multiple detections of viral sequence on one sampling occasion result 
from multiple bats excreting virus. Similarly, when different paramyxoviruses were detected in 
different urine samples on the same sampling date or in the same pooled urine sample, it cannot be 
determined whether co-infection of a single bat with more than one paramyxovirus occurred or 
whether multiple bats were excreting different paramyxovirus RNA at the same time. Despite these 
limitations, the study provides the most comprehensive longitudinal data on paramyxovirus 
excretion reported to date. 
3.4.1 Seasonality of paramyxovirus excretion from bats in the Geelong colony? 
The pattern of sample positivity and negativity observed over the study period paired with the 
significant association of winter and spring with RNA detection suggests a temporal association 
with paramyxovirus transmission dynamics. The likelihood of virus detection was higher in the 
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second half compared to the first half of the year. Not enough evidence was available to confirm 
seasonality of virus excretion however seasonality is a common phenomenon of virus transmission 
and detection from various populations, including wildlife reservoirs and zoonotic viruses (Altizer 
et al., 2006).  
The observed pattern of virus detection could be explained in three ways, which are not mutually 
exclusive. Firstly, RNA degradation during the hot and dry conditions of summer and autumn may 
limit the ability to detect viral nucleic acid in the urine (Fogarty et al., 2008). Limited virus survival 
during these climatic conditions may also impede virus transmission from animal to animal thus 
reducing the number of infected animals excreting virus. As detections were made during the 
months of December, January and March (months with known high temperatures in the morning, 
when urine collection sheets were exposed), it is unlikely that an inability to detect was the main 
reason behind the seasonal pattern observed. A second explanation is that the temporal pattern in 
virus detection resulted from inherent biological and/or ecological changes in the bats that influence 
virus excretion and occur in the second rather than the first half of the year. Such events may 
include gestation, birthing, lactation, and weaning of juveniles. These influences will be evaluated 
and discussed in more detail in Chapter 5 with regards to their roles in driving transmission, 
infection, excretion and detection of paramyxoviruses. As a last explanation, perhaps all bats are 
equally likely to excrete virus whatever time of the year. In this case, periods where there are 
increased numbers of bats present in the colony would coincide with a higher rate of virus 
detection. If there are more bats present in winter/spring and less bats in summer/autumn, this 
would explain the results seen in this Chapter. The influence of colony numbers on paramyxovirus 
detection is discussed in more detail in Chapter 5.   
Of the 109 weeks spanning the period of pooled urine collections in this study, 88 weeks contained 
a sampling event and 21 weeks did not (missed sampling weeks due to poor weather conditions). If 
more of these missed sampling weeks occurred in summer/autumn, perhaps this would explain the 
lower amount of overall virus RNA detected in these seasons. In summer/autumn, 13 weeks (non- 
consecutive) did not contain a sampling event and in winter/spring there were 8 weeks (non-
consecutive) when sampling did not occur. Due to the sporadic occurrence of these missed 
sampling weeks throughout the seasons, it is unlikely that such a small difference in sample 
intensity between winter/spring and summer/autumn would explain the temporal pattern to RNA 
detection. 
A major caveat to interpreting seasonality from the data presented here is the truncated period of 
sampling. Only 2011 contained a full calendar year of sampling (Jan-Dec) thus the pattern of RNA 
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detection in this year cannot be compared to any other year. If seasonality existed, it was thought 
that in the logistic regression, the same season across years would be significantly associated with 
RNA excretion. Overall spring was significantly associated with detection, however when analysed 
by year, only spring 2011 and not spring 2010 was associated with the outcome. Similarly, winter 
2012 was significantly associated with RNA detection however winter 2011 and winter 2010 were 
not. A more acceptable conclusion from the data available is that sporadic peaks or increases in 
paramyxovirus excretion and RNA detection occurred in November 2011 and July 2012 which 
combined with other data generated the temporal associations with detection. Although significant 
associations were not found, support to the idea of seasonality may be provided by the low 
proportion of positive samples in the summer and autumn months. Perhaps these periods are 
‘protective’ against virus excretion. In retrospect, sampling ideally would have continued for at 
least another full calendar year.  
3.4.2 Large diversity of paramyxoviruses circulating in pteropid bats  
Of the nine bat paramyxoviruses selected for detection by the nc-Luminex, seven had been 
previously isolated and/or detected from samples collected from pteropid bat colonies in QLD and 
NSW. The detection of Cedar virus RNA from P. poliocephalus in the Geelong colony represents 
the lowest latitude at which any henipavirus has been identified. This project is the first to describe 
paramyxovirus sequences obtained from samples collected from pteropid bats in Victoria (GeePV 
& YarPV). Furthermore, it is obvious from Figure 3.1 that these sequences are unique to any 
previously identified paramyxovirus from pteropid bats sampled in Australia. There is a substantial 
diversity in the four paramyxovirus sequences detected from the Geelong colony where sequences 
occupy three genera (rubula, henipa and unclassified). 
Currently, GeePV is most closely related to parainfluenza virus 5 with 78% nucleic acid identity 
using NCBI BLAST. This parainfluenza virus was isolated from a canid. Attention here should be 
drawn to an orthoreovirus and an adenovirus isolated from European bat species which were also 
found to have their nearest relative a canine orthoreovirus and adenovirus respectively (Kohl et al., 
2012a, Kohl et al., 2012b), perhaps suggesting cross-species transmission from bats to canids is not 
uncommon. The virus detected most frequently during this study, YarPV, is most closely related 
(81% nucleic acid identity using NCBI BLAST) to Paramyxovirus IFBPV01/2010, a partial L-gene 
viral sequence derived from splenic tissue collected from a Pteropus vampyrus bat caught in the 
Panjalu district of Indonesia (Sasaki et al., 2012).  
79 
 
It could be argued whether these two novel RNA sequences indicate the presence of true infectious 
viruses. Ideally these viruses would be isolated and full-genome sequencing performed in order to 
comprehensively calculate sequence similarities and phylogenetic groupings.  
In conclusion, the diversity of paramyxoviruses detected from samples collected from the Geelong 
colony reflect similar findings of surveillance of bat colonies for paramyxoviruses around the world 
(Vidgen et al., 2015, Baker et al., 2012, Sasaki et al., 2012, Yuan et al., 2014, Drexler et al., 2012, 
Lau et al., 2010). These findings also support the theory that bats, particularly those of the family 
Pteropodidae, (Drexler et al., 2012, Zeller et al., 1989) have a long co-evolutionary history with 
paramyxoviruses (Drexler et al., 2012, Vidgen et al, 2015). 
3.4.3 Difference in infection dynamics of the Geelong colony from those occupying more 
northern locations 
An interesting finding from this study is the absence of detection of Hendra virus excretion, despite 
convincing evidence that bats present in this colony have been infected with the virus sometime in 
the past. Such a finding is in stark contrast to what would be expected if a surveillance study of 
similar frequency was conducted using a QLD colony. It is certainly not unusual on a sampling date 
not to detect Hendra virus, as found by (Field et al., 2011) where Hendra virus was not present in all 
flying fox colonies all of the time. However it is the repeated sampling over time conducted in this 
study which is important. Taken from Field et al. (2011), if each of the sheets placed down under 
the Geelong colony could hold urine from 5-20 individuals, given a sample size of 20-80 
individuals from four sheets, this gives a minimum detectible infection prevalence between 3.9 and 
15% (for 95% sensitivity). On average, Field et al. (2011) found a 2.5% prevalence of Hendra virus 
excretion with prevalences ranging from 3 to 33%. Although the average prevalence falls outside 
the minimum detectable by this study, sampling frequently over time would be expected to yield a 
positive result given the large degree of fluctuation seen in excretion of Hendra virus from colonies 
(Field et al., 2011). As another example, results generated in our group from monthly pooled urine 
samples collected from a colony in Boonah, Queensland are shown in Table 3.6 (Ina Smith, 
personal communication). The sampling period overlaps that of the sampling period of the Geelong 
colony. Results reported are number of Hendra virus detections made using the above-detailed 
qPCR assay with a cut-off value of 39 CT. 
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Table 3.6. Hendra virus surveillance data of Boonah flying fox colony 
Month Year No. Samples Collected No. Positives % Positive Species Present 
October 2011 30 2 7 P. alecto, P. poliocephalus 
November 2011 30 7 23 P. alecto, P. poliocephalus 
December 2011 29 3 10 P. alecto, P. poliocephalus 
January 2012 23 7 30 P. alecto, P. poliocephalus 
February 2012 30 1 3 P. alecto, P. poliocephalus 
March 2012 30 2 7 P. alecto, P. poliocephalus 
April 2012 30 5 17 P. alecto, P. poliocephalus 
May 2012 30 3 10 P. alecto, P. poliocephalus 
June 2012 30 0 0 P. alecto, P. poliocephalus 
 
Considering that a larger number of samples were collected each month from the Geelong colony 
than from the Boonah colony, if the prevalence of Hendra virus excretion was similar between the 
two colonies, at least one detection of Hendra virus would have been made. Many differences exist 
between the Geelong and Boonah colonies, one of which is the species present in the colony. At the 
time of the above sampling in Boonah, the colony consisted of different proportions of grey-headed 
and black flying foxes. Results of an investigation conducted by Smith et al. (2014) highlighted the 
possibility that black and spectacled flying foxes play a more important role in HeV cross-species 
transmission than grey-headed and little-red flying foxes. It is interesting to note here that black and 
spectacled flying foxes are similar genetically (Fox, 2006). Perhaps certain species are more 
‘competent’ in HeV infection, replication and excretion and thus pose a greater risk for transmission 
both within and from bat populations. A lack of detection of HeV in the Geelong grey-headed 
flying fox colony is consistent with a lack of reported HeV infections of horses or humans in 
Victoria.   
It has been shown that P. poliocephalus are capable of being naturally infected with Hendra virus. 
Hendra virus was isolated from uterine fluid and foetal tissues collected from a female P. 
poliocephalus (Halpin et al., 2000). This bat was found in South-East QLD and euthanased while in 
a wildlife care facility due to extensive injuries. This bat showed positive serum-neutralisation titres 
to Hendra virus (1:40) (Halpin et al., 2000). Trapping of individual P. poliocephalus bats in QLD 
by a team from QCEID has revealed positive detections in urine samples (Dan Edson, personal 
communication). It may be however that GHFF are not as competent a host for HeV as the black 
(BFF) and spectacled flying foxes and infection may mostly occur when GHFF co-habit with one or 
both of these other species. As BFF are rarely found in Victoria, infection may mostly be occurring 
when GHFF co-habit with these animals in NSW or QLD where the other species most commonly 
occur. By the time a GHFF reaches Geelong, an immune response may have been mounted so that 
infection is cleared and excretion does not occur or occurs at a low level which is undetectable 
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given the sensitivity of the sampling regime employed in this study. Work performed by our group 
detected YarPV and GeePV in urine from local colonies of GHFF in Melbourne. YarPV and GeePV 
were the most commonly detected virus sequences in this study. Cedar virus and Teviot 
paramyxovirus were isolated from mixed GHFF and BFF colonies. Conversely, YarPV and GeePV 
have been detected in urine collected from a colony in QLD (Vicky Boyd, personal 
communication).  
The findings of this study support the hypothesis presented by Vidgen et al. (2015) of host-species 
specific paramyxoviruses. This phenomenon of host species specific viruses is very common in the 
animal world (Mills and Childs, 1998, Streicker et al., 2010, Velasco-Villa et al., 2006). Cross-
species transmission of these viruses into different hosts may result in non-patent infections or 
infections with too low an intensity to maintain the virus within the new host population without 
significant adaptations made by the virus. Another theory proposed is that pteropid bat colonies 
found in Victoria are less numerous and thus possibly less connected (Tidemann, 1999). Decreased 
mixing of bats may result in ‘dying’ out of virus transmission cycles where transmission cannot be 
maintained once it moves through a relatively isolated population. Another explanation for the lack 
of detection of Hendra virus is that a Hendra-like virus may be circulating in bats found in Geelong 
- a virus genetically different enough that the nc-Luminex assay could not detect it but similar 
enough that cross-reactive antibodies prevent infection with classical Hendra virus. A virus sharing 
90% similarity to Hendra virus based on a short sequence of the M gene has been recently detected 
in tissue collected from a GHFF (Jianning Wang, personal communication).  
3.4.4 Public health risk of viruses present in the Geelong colony 
If it can be said that the virus sequences detected correspond to circulating infectious virus, then it is 
important to comment upon the potential public health risks. The Geelong colony is situated within 
Eastern Gardens and next to the East Geelong Golf Course, which are both heavily frequented by 
people. It could not be definitively determined whether seasonality to virus excretion and thus 
periods of increased risk of spillover occurs. Perhaps the risk of zoonotic transmission is highest 
during the months of winter and spring and lowest during summer and autumn however it would be 
prudent to assume that virus excretion could occur at any time. The zoonotic risk of the most 
commonly detected paramyxovirus, Yarra Bend paramyxovirus is unknown. Its closest known 
relative, Paramyxovirus IFBPV01/2010, had no association with disease in humans. However, due 
to its grouping with other unclassified paramyxoviruses which share similarity to the Henipaviruses, 
it is important that this virus is isolated and its pathogenicity determined in other animals to provide 
an indication of its zoonotic potential. Geelong paramyxovirus, a rubulavirus, is most similar to 
parainfluenza virus 5 isolated from a canine. Parainfluenza virus 5 is often referred to as canine 
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parainfluenza virus and is thought to play a role in the development of kennel cough, a respiratory 
syndrome in dogs, but is not known to be zoonotic (Weese and Stull, 2013). Cedar virus has been 
used in infection trials of ferrets, guinea pigs and mice however no overt clinical disease was noted 
(Marsh et al., 2012).  Teviot paramyxovirus is related most closely with the known Tioman virus, a 
rubulavirus isolated from Pteropus hypomelanus bats of Malaysia (Chua et al., 2001). Sero-surveys 
have identified possible human infection with Tioman virus however its association with disease is 
unknown (Yaiw et al., 2007). With regard to Hendra virus, if BFF are the main species involved in 
transmission of the virus, the observed trend (Roberts et al., 2012a) of a southern movement of 
these animals with time necessitates increased surveillance of Victorian flying fox colonies, 
vigilance of veterinarians dealing with sick horses as well as people sharing environments with 
these animals.  
3.4.5 Biases present in sampling regime 
With all surveys of wild animals where a subpopulation is selected for sampling, there will always 
be bias associated with the chosen study regime. There is a selection bias inherent in the position of 
the plastic sheets used in the urine collections. As flying foxes have a distinct social-spatial 
organization of their colonies, particularly during mating (Welbergen, 2006, Nelson, 1965b), 
positioning sheets without knowledge of the age/sex structure will introduce bias. Perhaps where 
the sheets were placed during this study unintentionally selected for animals more/less likely to 
excrete virus due to age/sex differences. The sheets were intentionally placed both close to the 
centre and on the outer perimeter of the colony to reduce such a bias. The structure of the colony 
certainly changes seasonally while the positions of the sheets were kept relatively constant. Thus it 
is highly unlikely that samples were being collected from the same animals over time, rather 
sampling was a snapshot of the colony at that one point in time with an aim of obtaining a cross-
section of the age/sex distribution of the population. 
3.4.6 Future research needs 
Even from a small number of samples tested broadly for paramyxovirus presence, it is clear that 
there is a great diversity of paramyxovirus species circulating in bats present in Geelong, and 
perhaps there is a host-specificity to these viruses. To characterize further the idea of species-
specific paramyxoviruses, broad surveillance for paramyxovirus species and variants need to be 
performed using samples from all species of flying fox found on the Australian mainland, similar to 
that of Vidgen et al. (2015). In terms of determining the zoonotic risk of these viruses, isolation 
attempts need to be performed and cell culture or animal infection trials carried out. Surveillance of 
urine from Victorian flying fox populations should certainly occur with evidence of BFF 
colonization.   
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It is still unclear from the results of this study the dynamics with which paramyxoviruses are 
introduced and circulate within flying fox colonies. The sampling period included only one 
complete calendar year and two half-years. This combined with the small number of 
paramyxoviruses detected over the study period did not allow a robust assessment of seasonality 
although there may be an indication that excretion is higher in winter and spring months and lower 
in summer and autumn. Apart from seasonal factors, what are other important factors which drive 
infection? Is bat-bat horizontal transmission the main mechanism or do paramyxoviruses lie 
dormant within tissues and reactivate upon a certain trigger (Wang et al., 2013)? There is evidence 
from this study that multiple viral species circulate and are excreted at the same time in a bat 
population. Does this fit more with horizontal transmission or reactivation of dormant viruses? It is 
still unclear what constitutes a susceptible, infected and recovered/resistant (SIR) bat in terms of 
paramyxovirus transmission. The SIR model is fundamental to the field of epidemiology and is 
used in modeling studies of virus transmission dynamics (Amengual et al., 2007, Smith et al., 2009, 
Begon et al., 1999). The results of modeling studies would have a greater external validity if factors 
such as duration of immunity and age-related susceptibility to infection are known. In a natural 
setting, to address these questions, capture-mark-recapture studies of pteropid bats would enable the 
study of temporal, virological, immunological, and bat-demographic factors that influence infection. 
Unfortunately it is difficult to recapture pteropid bats due to the inability to trap at a single colony 
entry/exit. Perhaps novel technologies such as remote sampling devices could be used to remove the 
need for continual trapping. Experimental infections using captive pteropid bats are also useful to 
examine factors such as duration of infection and immunity (Baker et al., 2013b). These studies 
however tend to remove dynamic external influences such as natural bat-bat interactions and 
nutrition that may play important roles in driving pathogen transmission dynamics.  
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CHAPTER 4 INVESTIGATING STRESS IN A FLYING FOX 
POPULATION AT A COLONY-LEVEL SCALE 
4.1 INTRODUCTION 
Stress may be considered an altered physiological state where metabolic changes allow an animal to 
respond to and ultimately survive adverse changes in their environment. It is generally agreed that 
prolonged alterations to animal physiology as occurs in chronic states of stress are detrimental to 
host health, particularly to the reproductive and immune systems (Dantzer et al., 2014, Martin et al., 
2010). Due to such immune alterations it is thought that animals under stress are more susceptible 
to infectious disease and thus may be more likely to be involved in the transmission of pathogens 
including zoonotic agents (Plowright et al., 2015, Owen et al., 2012).  
The overall aim of this project is to first develop a method to quantify periods of stress in the 
Geelong flying fox population and then to assess whether periods of stress may be associated with 
heightened viral excretion and thus increased risk of cross-species transmission of zoonotic viruses. 
If an association exists, identifying periods of stress may be useful in heralding or predicting 
spillover events. Most commonly stress is measured in individual animals. This Chapter describes 
the assessment of stress at a population-level. If found to be a useful predictor of viral excretion, 
pooled urine samples collected from bat colonies - as is common for virological studies - may be 
tested in parallel for indices of stress. Furthermore, non-invasive collection of urine for stress 
hormone analysis minimizes the bias that is often associated with capture and handling studies. The 
method of quantifying stress involved the measurement of cortisol metabolites in pooled urine 
samples using a commercial cortisol-specific ELISA. This ELISA has been validated for use with 
urine samples collected from the four species of Australian-mainland flying fox (McMichael et al., 
2014)  
4.2 MATERIALS AND METHODS 
4.2.1 Animal ethics 
Please refer to section 2.2.1 of Chapter 2 for AEC and Victorian Department of Sustainability and 
Environment approvals that permit all work conducted with bats that pertain to this Chapter.  
Urine collection from bats housed in the Large Animal Facility was covered under AEC 1474. 
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4.2.2 Repeated cross-sectional collection of urine samples  
The weekly pooled urine samples (i.e. 4-15 urine droplets collected into one tube) that were used 
for virological analyses (collection described in section 2.2.2 of Chapter 2 and Appendix 2) were 
also subjected to endocrinological assessment for the purposes of this Chapter.  
A second method of pooled urine collection was added to the sampling regime. This regime 
involved a greater number of urine droplets collected from a greater number of sheets but on a 
monthly rather than weekly basis. This sampling consisted of the collection of individual urine 
droplets (each ~ 60 μL) into a 96-well plate (one droplet/well) from 10 plastic sheets. These urine 
collections occurred approximately monthly beginning in August 2012 and ending in October 2013. 
Dates of monthly urine collections are provided in Appendix 4. Individual urine droplets were then 
pooled as described in section 4.2.4. 
4.2.3 Monthly colony counts 
On a monthly basis collaboration was made with staff of the Geelong Botanic Gardens and City of 
Greater Geelong, namely Grant Baverstock and Phil Mulroyan, to conduct monthly counts at fly-
out of the Geelong colony. Such monthly counts were part of a greater Australia-wide project to 
monitor the dynamics and numbers of flying fox populations. Counts were conducted at dusk with 
3-4 people each standing at different vantage points surrounding the colony. The sky was divided 
into sectors and each person counted the bats they saw flying over-head and recorded approximately 
every 10 bats. The individual counts were tallied into a final overall number at the end of the 
counting session. For dates where I was not involved in the counting, Grant Baverstock provided 
the count data. Over the three years of colony count data used in this project, four counts (four 
months) were not conducted due to bad weather, and these occurred in August 2010, March 2011, 
August 2011 and February 2012. To smooth over these missing data points in the following graphs, 
the average values of the counts taken in the months directly before and after the missing month 
were used.  
4.2.4 Inactivation, processing, and storage 
Following OIE guidelines for the inactivation of Hendra virus in biological samples, all pooled 
urine samples were inactivated by diluting 1:5 in inactivation buffer (PBS containing 0.5 % Tween-
20 & 0.5 % Tritox-X100) and heating at 56 °C for 30 minutes prior to hormone analysis. This 
allowed work with the samples to occur outside the biosafety cabinet.  
In order to use the monthly urine collections, individual urine droplets were pooled to approximate 
the amount of urine collected from each sheet during the weekly pooled urine collections. For each 
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96-well plate, the individual urine droplets in the first four rows of each column from columns 3 to 
12 were pooled and this pooling repeated for the last four rows. As each column corresponded to 
one collection sheet, this resulted in two pooled urine samples each containing urine from ~4 bats 
analysed for each collection sheet (10 sheets). Therefore for the monthly pooled urine collections, 
results from 20 pooled urine samples are reported rather than 10 as in the weekly pooled urine 
collections. 
Following inactivation and processing, samples were stored at -20 °C. 
4.2.5 Cortisol ELISA 
The ELISA selected for use was the Cayman Chemical Company Cortisol Express Enzyme 
Immunoassay Kit (Item number 500370). This is a competitive ELISA which uses a cortisol-
specific mouse monoclonal antibody to bind either cortisol or its metabolites in the sample or to 
cortisol conjugated to the enzyme acetylcholinesterase (the competitor). The assay has been 
validated for use with human urine and plasma and the manufacturer has described its use with 
samples from other mammalian species with good success (Brooke Kilyanek, Technical Support 
Representative, Caymen Chemical, personal communication). The assay was selected due to low 
cross-reactivity of the monoclonal antibody to other related hormones or compounds. The 
specificity of the monoclonal antibody is stated by the manufacturers with 100% reactivity to 
cortisol and 4% or less to the other listed compounds (prednisolone 4.0%, cortexolone 1.6%, 11-
deoxycorticosterone 0.23%, 17-hydroxyprogesterone 0.23%, cortisol glucuronide 0.15%, 
corticosterone 0.14%, cortisone 0.13%, and <0.1% for androstenedione, enterolactone, estrone, 17-
hydroxypregnenolone, pregnenolone and testosterone). The assay has a minimum detectable 
cortisol concentration of 0.1 ng/mL.  
As the most accurate estimates of cortisol concentration are obtained from the linear range of the 
standard curve, it was necessary to dilute each urine sample by a factor that placed its reading 
within this range – a range delineated by sample and standard values which fell between 20 and 
80% maximum competitive binding. An example standard curve which uses 5-parameter logistics 
to fit % maximum competitive binding values to standard cortisol concentrations is shown in Figure 
4.1.  
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Figure 4.1. Sample standard curve using a 5-parameter logistic fit 
 
 
After trial and error with several pooled urine samples, it was determined that the majority fell 
within this range at a dilution of 1:100 in kit assay buffer. When measurements fell outside this 
range at a 1:100 dilution, samples were re-assayed at higher dilutions until the desired measurement 
was obtained. With samples that contained cortisol metabolite concentrations too low to be detected 
in a given assay, the lowest detectable cortisol concentration for that assay (reading at 80% 
maximum binding) was used and reported as x ng/mL. Cases where such extrapolation was required 
will be reported below. Assay procedures followed that described in the kit manual. Briefly, 50 μL 
of sample was added to each well followed by equal volumes of tracer and monoclonal antibody. 
Incubation occurred at room temperature for 2 hours after which the plate was washed five times 
and then developed for 30 minutes after the addition of 200 μL of Ellman’s reagent. Absorbances 
were read at 405 nm with a Thermo Fisher Scientific Multiskan Ascent microplate reader using 
Ascent software (Version 2.6).  
Cortisol metabolite concentrations in the each pooled urine sample were calculated first by 
constructing the standard curve using a 5-parameter logistic fit (Readerfit, 2015) for each plate. The 
5-parameter logistic fit was chosen as it contains an asymmetric function which makes it a better 
model for immunoassay data compared to the 4-parameter logistic model. Sample cortisol 
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metabolite concentrations were interpolated from this standard curve and then multiplied by the 
dilution used for each individual sample (taking into account the initial 1:5 inactivation dilution). 
All cortisol metabolite concentrations are reported as ng/mL.  
4.2.6 Assay validation - Analytical 
Subsequent to the start of this project, an almost identical immunoassay (Cayman Chemical 
Company Cortisol Enzyme Immunoassay Kit, Item number 500360) was analytically and 
biologically validated by Lee McMichael for use with urine collected from the four pteropid bat 
species of Australia (McMichael et al., 2014). The only difference between the two kits is the 
express nature of the one used in this project – a two hour incubation at room temperature versus 
overnight at 4°C and differing development times (30 minutes versus 90-120 minutes). All reagents 
are the same. Despite this previous validation, the validation process used for this project will still 
be reported below.  
4.2.6.1 Effect of heat treatment 
In order to evaluate whether heating of a urine sample affects the downstream UCMC measurement 
in the ELISA, a cortisol standard (provided in the Kit described below) was serially diluted 1:2 to 
give eight different cortisol concentrations. An aliquot of each was incubated at 37 °C for one hour. 
Samples (heat treated and non-heat treated) were ran in duplicate on the ELISA.  
4.2.6.2 Parallelism 
The parallelism between the standard curve and a serially diluted pooled urine sample was assessed. 
The standard sample provided in the kit was analysed using a seven-step, four-fold dilution series 
(run in duplicate) and the pooled urine sample in a five-step, four-fold dilution series (run in 
triplicate). Averages of replicate values for the standard and sample values were made. Natural 
logarithmic transformations were made of the % maximum binding values and dilution factors and 
plotted against each other. A linear regression was performed to assess whether the slopes for each 
sample differed significantly.  
4.2.6.3 Intra- and Inter- assay coefficients of variation 
The variability of the assay was assessed as follows. Intra-assay variability was determined using 
the calculated cortisol metabolite concentrations of 68 pooled urine samples run in duplicate on the 
same plate and replicated over 11 plates. Inter-assay variability was evaluated using the calculated 
cortisol metabolite concentrations of 50 pooled urine samples that were run on at least two different 
plates across eight plates.  
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4.2.7 Assay validation - Biological 
Biological validation of the assay was necessary to ensure that the assay was able to measure an 
increase in analyte concentration with stress. This would give confidence in the assay’s ability to 
detect biological relevant increases in cortisol concentrations in the urine samples and also to give 
support to the assay measuring products of the stress reaction, specifically cortisol.  
4.2.7.1 Caught bats from the Geelong colony 
During the trapping events described in Chapter 2 (section 2.2.2), a measurable increase in cortisol 
production in the trapped bats compared to roosting bats would be expected due to the stress of 
handling and confinement for up to two hours within pillowcases before processing. A subset of 
urine samples collected from individual bats were analysed for cortisol metabolite concentrations.  
4.2.7.2 Captive bats 
In August 2011, 13 pregnant adult Pteropus alecto flying foxes were captured in Queensland, 
transported to Victoria and housed in the Large Animal Facility (LAF) of AAHL for experimental 
purposes (unrelated to this PhD project). After one week of acclimatization, individual bats were 
sampled for blood and urine on a monthly basis and pooled urine samples were collected weekly 
from the bottom of their cages. The process of capture, transport and captivity of wild animals 
would be expected to be highly stressful and result in an increase in cortisol production. Urine 
samples collected from individual bats as well as pooled urine samples were analysed for cortisol 
metabolite concentrations. Samples analysed included those collected at the beginning of captivity 
and for up to three months thereafter to determine whether acclimatization to the captive 
environment and decrease in stress had occurred. Data from samples collected approximately one 
year after the start of captivity were also included.  
During the 5
th
 month of captivity, a pup born from one of the above-mentioned females (pup 
WY54) became entangled in netting on the afternoon of the 24
th
 April 2012 and was found 
deceased the next day. This allowed the opportunity to collect urine samples from an individual bat 
pre- and post- a stressful event in captivity. Urine had been collected from this bat once a month for 
four months before this incident as well as from the bladder at post-mortem. Cortisol metabolite 
concentrations were analysed for each of these samples.  
4.2.7.3 Pooled urine collections from the Geelong colony during potentially stressful periods  
To evaluate the effect of extreme temperature on cortisol production, targeted pooled urine 
collections were made during a period of extreme heat and during a period of low overnight 
temperatures. These collections were made to evaluate whether collecting pooled urine from a 
90 
 
cross-section of the colony was sensitive enough to detect responses to stressful situations. Pooled 
urine collections were performed on the mornings of the following dates shown Table 4.1. 
Additionally, urine specific gravity (USG) measurements were recorded with a refractometer for all 
54 pooled urine samples collected during the extreme heat and cold period.  
Table 4.1. Targeted collection dates 
Month/Year Date No. Pooled samples No. Sheets Target Period 
Collection on 
Figure 4.2 
June 2013 20
th
 10 4 cold  
 
21
st
 10 4 cold  
January 2014 17
th
 10 4 heat 1 
 
21
st
 10 4 heat 2 
 
29
th
 4 3 heat 3 
February 2014 13
th
 10 4 heat 4 
 
According to the Bureau of Meteorology website (Bureau of Meteorology, 2015) the minimum 
overnight temperature preceding the collections on the 20
th
 and 21
st
 of June 2013 was 1.0°C and 
0.1°C respectively as measured from the Breakwater (Geelong racecourse) weather station 087184 
(approximately 3.2 km from colony). The highest minimum temperature for June 2013 was 11.9°C, 
the lowest minimum -0.2°C and the mean minimum temperature was 6.1°C. During a heat wave 
which occurred in January 2014, collections were made after days of extreme heat (collections 1, 2 
& 3: Figure 4.2) and two weeks afterwards (collection 4: Figure 4.2) to monitor cortisol production. 
Data for Figure 4.2 was obtained from the Bureau of Meteorology. 
91 
 
Figure 4.2. Daily maximum temperatures and targeted collection dates in January and February 
2014 
 
 
4.2.8 Analysis and presentation of colony-level urine cortisol metabolites 
All weekly pooled urine UCMCs measured over the 109 weeks will be combined and presented as a 
histogram to give an idea of the range and distribution of the data.  
Cortisol concentration will be analysed as a continuous variable throughout this study as there is not 
enough information in the literature to guide the categorization of samples as ‘low’ and ‘high’ or 
‘not stressed’ and ‘stressed.’ UCMCs from all samples (weekly and monthly collections) will be 
included in analyses. For ease of visualization, UCMC measurements will be grouped according to 
month of sample collection and mean values presented along with +/- one standard deviation (SD). 
Means rather than medians will be used as the influence of outliers should be incorporated into 
summary estimates. As the majority of collections were made on a weekly basis, it may appear that 
resolution is lost when grouping results by month. However, including weekly data into a monthly 
estimate gives more data points and thus the estimate is more reflective of the range of cortisol 
concentrations that may occur within a month compared to if a single monthly collection was 
performed.  
For each year of collection, sample data will then be grouped according to season of sample 
collection. Summer is considered the calendar months: December, January, February; Autumn: 
March, April, May; Winter: June, July, August; Spring: September, October and November. 
Sample data will then be condensed further by grouping by season of collection (amalgamating all 
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collection years). Lastly, sample data will be grouped by year of collection. For each graph, means 
will be presented with +/- one standard deviation. 
To investigate the association of month, season by year, season, and year on colony-level UCMC, 
linear regression analyses will be performed in Stata (StataCorp) version 10.0. The dependent 
variable will be sample UCMC (continuous variable) and the independent variable either month, 
season by year, season, or year (categorical variables). P<0.05 will be considered a significant 
association of a variable with UCMC. The regression will be run to obtain robust standard errors by 
clustering by sampling event.  
Lastly, colony numbers and bat life-history stages will be investigated as to their association with 
measured urinary cortisol. For the grey-headed flying fox the life-history stages will be considered 
to occur during the following non-overlapping calendar months: mating (Mar, Apr); gestation (May, 
Jun, Jul, Aug); birthing (Sep, Oct) and lactation (Nov, Dec, Jan, Feb) (Nelson, 1965b). Colony 
count data was that obtained through the methods of section 4.2.3. A linear regression will be 
performed with Stata (StataCorp) version 10.0 to examine the effect of the independent variable 
colony count (continuous) on UCMC. Univariate linear regression analyses will also be performed 
to examine the association of mating, gestation, birthing, or lactation (binary variables) on UCMC. 
Robust standard errors will be generated through clustering by sampling event. P<0.05 will be 
considered statistically significant.  
4.3 RESULTS 
4.3.1 Establishment and validation of cortisol ELISA method 
For the experiment that examined the effect of heat on downstream UCMC measurement, the 
coefficient of variation between UCMCs of the treatment groups (heat treated versus non-heat 
treated) was 1.99% and UCMCs for the heat-treated samples were neither higher nor lower than the 
non-treated samples (an equal number were higher and lower). Thus, heat does not seem to have a 
significant effect (in either direction) on downstream UCMCs. 
Parallelism of the sample curve with the standard curve is demonstrated in Figure 4.3. No 
significant difference was found between regression slopes of the two curves (P = 0.22; standard 
slope = -0.58; sample slope = -0.70).  
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Figure 4.3. Assessment of parallelism 
 
 
An intra-assay coefficient of variation of 7% and an inter-assay coefficient of variation of 12% were 
calculated for the assay as it was used in this project. 
Considering the raw data, urinary cortisol metabolite concentrations (UCMCs) of urine samples 
collected from 37 individual bats after 1-2 hours of being caught, handled and confined revealed an 
extreme range of values. Values ranged from 78 to 53,943 ng/mL. UCMCs were thus log10 
transformed before depiction in Figure 4.4. Figure 4.4 shows each log10 transformed UCMC of the 
37 samples with the mean (=8,928 ng/mL) and standard error of measurement (SEM) = 2,485 
ng/mL. 
 
94 
 
Figure 4.4. UCMC of urine samples collected post-trapping 
 
Figure 4.4. Mean UCMC of the urine samples collected from individual caught bats is depicted as the longer line 
transecting the standard error of measurement.  
 
The first urine collection for the P. alecto bats entering the captive environment of the LAF 
occurred on the 19
th
 of August 2011 after an initial acclimatization period of 1 week. From then on, 
urine was collected from individual bats where possible on a monthly basis. These collections were 
supplemented with weekly sampling of urine pools at the bottom of the 3 cages they were divided 
into. In Figure 4.5, UCMC are shown by collection date to get a sense of whether acclimatization to 
the captive environment occurred. Results are shown for individual bat urine collections (19
th
 Aug, 
7
th
 Sept, 16
th
 Nov) and pooled urine collections (24
th
 Aug, 25
th
 Aug, 8
th
 Sep, 26
th
 Sep). All results 
generated for each collection date are shown with the mean UCMC included. Despite the small 
number of samples analysed, there does appear to be a trend towards a decrease in the overall 
production of cortisol in the captive environment.  
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Figure 4.5. UCMC of samples collected post-entry of P. alecto bats into the LAF 
 
Figure 4.5. UCMC of each sample tested per date of collection are shown. Mean UCMC for each date of 
collection is shown as a horizontal line. Collections made after the vertical dotted line show UCMCs after a 
significant period (~ 12 months) in captivity.   
 
The average UCMC for urine collected monthly for four months preceding the traumatic death of 
LAF Pup WY54 are shown in Figure 4.6. Seven replicates of each sample were run on the ELISA 
and the mean value calculated for depiction in the graph. The UCMC calculated for urine collected 
from the pup’s bladder post-death on 24th April 2012 are also shown (average of sample run in 
duplicate). There is an obvious increase in cortisol production, most likely explained by the stress of 
entanglement. 
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Figure 4.6. Urine collections made pre- and post- mortem (LAF Pup WY54) 
 
 
To assess the ability of pooled urine samples to detect responses to stress at a colony-level scale, the 
results of the targeted urine collections during extreme overnight cold and extreme heat events are 
presented in Figure 4.7. 
Figure 4.7. UCMCs of pooled urine samples collected during extreme heat and cold periods 
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Figure 4.7. Raw UCMC values are presented for each sample collected per collection date. The left graph shows 
results of the collections made during the extreme heat event and the right graph shows results of the collections 
made during the extreme cold period. The horizontal dotted line on the left graph (extreme heat) represents the 
average UCMC for all samples collected in January and February of 2011, 2012 and 2013 (=53.8 ng/mL). The 
horizontal dotted line on the right graph (extreme cold) represents the average UCMC for all samples collected 
in June of 2010, 2011 and 2012 (=183.3 ng/mL).  
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During the heat-wave period, measured cortisol concentrations in the pooled urine samples 
increased with time. The first collection (17
th
 Jan) was taken after four days of consecutive 
maximum daily temperatures exceeding 40°C. The second collection (21
st
 Jan) was taken after four 
days of maximum temperatures below 24°C. The third collection (29
th
 Jan) was taken immediately 
after two days of daily maximum temperatures exceeding 37°C. The last collection (13
th
 Feb) was 
taken approximately two weeks after the third collection during which time the highest temperature 
recorded was 38.8°C. It appears that the physiological effects of heat stress at the colony-level are 
cumulative, that is even after the initial high temperatures subsided, periods with intermittent high 
temperatures resulted in higher and higher measurements of cortisol in the pooled urine samples. 
During the heat wave event, hundreds of bats from the Geelong colony died, particularly juveniles. 
Although speculative, perhaps in addition to the detrimental physiological effects of heat stress 
which may be acute and/or chronic, there may be other behavioural or social stressors that persist 
after a large proportion of the colony are lost. Collections made the mornings after two nights of 
low temperatures (1.0 °C and 0.1 °C respectively) show increasing UCMCs, the majority of values 
exceeding baseline (dotted line) after a second night of low overnight temperature.  
It can be concluded that the cortisol EIA chosen is able to demonstrate biologically relevant 
increases in cortisol production and metabolite excretion in urine samples pre- and post- stressful 
events both the individual and colony-level scale. 
4.3.2 Analysis of colony-level urine cortisol metabolites 
For the 100 collection dates occurring from June 2010 to October 2013, 1,100 pooled urine samples 
were analysed in the ELISA. Of these, nine samples did not contain enough urine to be used in the 
ELISA, leaving 1,091 urine samples available for analysis. A % antibody binding value between 
20-80% was obtained for 1,041 samples allowing the calculation of sample UCMC directly from 
the standard curve. For 50 urine samples, the % antibody binding value fell above 80% antibody 
binding (low concentration) and thus to determine the UCMC for these samples the concentration at 
80% binding for that plate was used so as not to bias results towards higher UCMC values. For one 
sample the UCMC was not determined, giving 1,090 UCMC values. Figure 4.8 shows a histogram 
of the 1,090 UCMC values. The minimum value was 6.6 ng/mL and the maximum 1310 ng/mL. 
The histogram is positively skewed with the mass of distribution concentrated with the low UCMC 
values.  
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Figure 4.8. Histogram of all urine sample UCMCs 
 
 
Figure 4.9 plots the mean UCMC (+/- SD) of all sample readings per month of sample collection. 
Where monthly mean UCMCs appear to be elevated, the standard deviation is also increased.  
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Figure 4.9. Monthly mean cortisol metabolite measurements (+/- SD) of pooled urine samples  
 
 
Figure 4.10 groups all readings by month of collection (all years amalgamated into one) and gives a 
value of the monthly mean UCMC +/- SD. Peaks in month mean UCMC values appear to occur in 
the winter months (June, July, August) and in March.  
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Figure 4.10. Monthly mean cortisol metabolite measurements (+/- SD) of pooled urine samples 
 
 
To investigate seasonality to cortisol production, Figure 4.11 categorises samples by season and by 
year and presents mean UCMC values +/- SD. Within each year, summer and spring appear to have 
lower UCMC values compared to autumn and winter months within that same year.  
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Figure 4.11. Mean UCMC by season and year 
 
 
To investigate seasonality further, Figure 4.12 categorises samples by season (all years combined) 
and presents mean UCMC values +/- SD. Again, samples collected in autumn and winter appear to 
have higher cortisol concentrations than samples collected in summer and spring. 
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Figure 4.12. Mean UCMC by season 
 
 
Lastly, Figure 4.13 categorises samples by year of collection and presents yearly mean UCMC +/- 
SD. There does not appear to be a significant difference in cortisol production at the colony-level 
from year to year.  
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Figure 4.13. Mean UCMC by year of collection 
 
 
The results of the linear regression analyses of temporal variables on UCMC are shown below in 
Table 4.2. Coefficients are presented with p values and 95% confidence intervals. 
Table 4.2. Results of linear regression of UCMC on temporal variables 
Variable Coefficient p-value 95% Confidence Interval 
Month of collection 
January Reference 
February 7.71 0.34 -8.34 23.77 
March 96.02 0.00* 56.61 135.44 
April 30.19 0.02* 5.44 54.94 
May 14.08 0.28 -11.87 40.02 
June 124.40 0.00* 41.31 207.48 
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July 100.70 0.02* 16.20 185.19 
August 46.01 0.07 -4.22 96.25 
September 13.83 0.28 -11.51 39.16 
October 31.64 0.09 -5.23 68.52 
November -1.52 0.08 -15.86 12.80 
December -7.88 0.31 -23.07 7.31 
Season by year 
Winter 2010 Reference 
Spring 2010 -47.29 0.09 -102.79 8.21 
Summer 2010/2011 -58.92 0.04* -113.48 -4.35 
Autumn 2011 -20.75 0.48 -78.44 36.93 
Winter 2011 57.37 0.22 -35.74 150.48 
Spring 2011 -63.28 0.02* -117.39 -9.16 
Summer 2011/2012 -70.70 0.01* -124.68 -16.71 
Autumn 2012 -31.83 0.40 -106.56 42.91 
Winter 2012 26.30 0.73 -125.88 178.48 
Spring 2012 -2.26 0.97 -127.05 122.52 
Summer 2012/2013 -76.89 0.01* -131.20 -22.58 
Autumn 2013 -15.37 0.71 -97.78 67.03 
Winter 2013 -30.22 0.42 -104.91 44.47 
Spring 2013 -74.76 0.01* -127.79 -21.74 
Season  
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Summer Reference 
Autumn 44.93 0.00* 19.01 70.86 
Winter 89.57 0.00* 44.33 134.81 
Spring 18.42 0.09 -3.20 40.03 
Year 
2010 Reference 
2011 4.95 0.79 -31.78 41.67 
2012 -1.68 0.95 -49.41 46.06 
2013 -10.21 0.64 -53.05 32.63 
*p<0.05 and denotes a significant association between variable (bold) and UCMC 
 
There was no significant association of year with colony-level UCMC measurements. This indicates 
that drivers of cortisol production exist similarly within years. The months of March, April, June 
and July are all significantly associated with increased UCMC measurements. For season by year, 
summer of every year was significantly associated with decreased UCMC measurements. This 
suggests a seasonality to low cortisol production and perhaps low levels of stress. Spring of 2011 
and 2013 were significantly associated with low UCMC measurements. For season overall, autumn 
and winter were significantly associated with increased UCMC measurements.  
To examine the influence of colony size on cortisol production, Figure 4.14 is presented to visualize 
the dynamic nature of the Geelong colony. Within each year there are a maximum number of bats 
present in the colony during the early period of the year in February, March and April. From 
April/May, there is a trend for colony numbers decrease until October/November however not all 
years show this trend. After November, numbers generally increase. Figure 4.15 presents a 
scatterplot of colony size with sample UCMCs to visualize the direction of any association.  
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Figure 4.14. Geelong colony size by month and year of collection 
 
 
Figure 4.15. Scatterplot of colony count and UCMC 
 
 
107 
 
The relationship between the number of bats in the colony and the amount of cortisol measured 
does not appear to be linear. When the largest number of bats were observed in the colony (> 
30,000 animals), samples collected from the colony contained relatively low amounts of cortisol. 
The highest measured concentrations of UCMC correlated with relatively few bats in the colony. 
Linear regression showed no significant association between colony size and UCMC (p=0.85, 95% 
CI -0.00-0.00).  
Linear regression analyses were used to investigate bat-life history stages which may be important 
drivers of cortisol production. Table 4.3 presents the results of these analyses. Coefficients are 
presented with p values and 95% confidence intervals.  
Table 4.3. Results of linear regression of UCMC on bat life-history stages 
Variable Coefficient p-value 95% Confidence Interval 
Life-history stage 
Mating 31.68 0.09 -4.63 67.99 
Gestation 47.01 0.02* 9.39 84.63 
Birthing -19.68 0.23 -51.71 12.36 
Lactation -57.64 0.00* -79.80 -35.48 
*p<0.05 and denotes a significant association between variable (bold) and UCMC 
 
Gestation was significantly associated with increased UCMC measurements while lactation was 
significantly associated with decreased UCMC measurements. It is important to remember that the 
bat life-history stages were classified according to calendar month. Gestation was considered to 
occur in May, June, July and August and lactation during November, December, January and 
February.  
Combining UCMC values measured from urine samples collected under various conditions or 
‘stressors’ are shown on a scale in Figure 4.16. The right-hand side of the scale shows selected 
values of UCMC from pooled urine samples collected non-invasively from under the Geelong P. 
poliocephalus colony (lowest, highest, mean) as well as the mean UCMC from urine samples 
collected from individual bats post trapping and handling in Geelong. The left-hand side of the scale 
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shows selected values of UCMC from pooled urine samples collected in the cage as well as from 
individual P. alecto bats throughout a year spent in captivity in the LAF.  
Figure 4.16. Relative urine UCMC for different 'stressors' 
 
 
4.4 DISCUSSION 
4.4.1 Estimating stress at a colony-level scale 
This Chapter describes a method of estimating stress at a population level using pooled urine 
samples collected from a cross-section of a flying fox colony. Stress is a complicated phenomenon 
with many physiological changes made in such a state. A variety of stress markers have been 
utilized by animal researchers, however cortisol remains the most studied and best validated method 
to quantify a stress response in bats, hence its inclusion in this study. The method of sample 
collection used in the study was non-invasive and thus avoided the common problem of undesirably 
inducing a stress response during the process of sample collection. Sample collection occurred 
frequently over a long period of time which enabled the detection of natural fluctuations in cortisol 
production within and between sampling occasions. Identifying periods of increased and decreased 
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cortisol production allowed an investigation into potential drivers of stress including population size 
and important bat life-history stages.  
The large standard errors of measurement (Figure 4.9) that occurred during peaks of cortisol 
detection suggest that only a few individuals contributing urine to the samples were significantly 
“stressed” and influencing the overall increased mean. The relative stress scale shown in Figure 
4.16 shows the large range in measured UCMCs from urine collected from bats in different 
environments. It also shows that a large range in UCMC is also measured for samples collected 
from bats in a single environment (e.g. captivity, roosting). This supports the above statement that 
under a given situation, only a proportion of bats may be stressed and producing increased cortisol. 
It is interesting to question the characteristics of such bats, i.e. are certain bats more susceptible to 
stress at different times of the year (e.g. female bats during gestation, males during mating, 
juveniles during periods of poor nutrition)? To answer this question, it would be necessary to 
serially collect urine (or serum) from known individuals over time and perhaps pair the 
measurement of cortisol with reproductive hormones.  
The months of March and April were significantly associated with increased cortisol production as 
was the season of autumn (Feb, Mar, Apr). Mating as a variable however was not significantly 
associated with UCMC. This is puzzling as ‘mating’ was classified as occurring during the months 
of March and April. Despite this, there is good evidence to suggest that a significant change in bat 
ecology that occurs around this time may be a driver of increased cortisol production. This period 
coincides with the time of mating where colony size remains fairly constant but the density of bats 
increases from the outer edge to the centre where territories are formed (Nelson, 1965b). As colony 
size alone was not significantly associated with increased UCMC, perhaps density and the change 
in social organisation is a more important driver of stress. Mating has been shown to be stressful to 
bats, particularly males (Reeder et al., 2004b), and results in increased cortisol production (Reeder 
et al., 2006a), making this theory plausible. Further support to this conclusion would be given if 
testosterone levels were measured in the urine samples and were also found to increase during this 
period. Another important overlapping life-history stage that occurs around this time is the weaning 
of juveniles (Welbergen, 2006). Although speculative, perhaps this period is one that is stressful for 
both mothers and pups and may explain on its own or in combination with the stress of mating the 
increased UCMC measurements in autumn.   
The months of June and July and the season winter were significantly associated with increased 
UCMC. During July 2011, the maximum value of raw UCMC was measured in one of the pooled 
samples: 1310 ng/mL. This value is higher than any other reported value of urinary cortisol 
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concentration in the literature for any animal, including bats, and well exceeds the maximum pooled 
urine UCMC of 311.3 ng/mL reported by McMichael et al. (2014). Repeated testing of this sample 
was not performed but would be required using an ELISA or a gold standard technique such as 
mass spectrometry to confirm this value. Perhaps low temperatures of the winter season are 
associated with increased cortisol production. The impact of winter could either result from 
prolonged exposure to low temperatures over several months or from short periods of extreme cold 
over several days causing hypothermia in some bats. Sophisticated statistical models such as time-
series analyses would need to be performed to relate fluctuations in temperature with cortisol 
production. Such analyses are outside the scope of this study. It is also likely that other 
environmental and bat-specific factors were occurring in concert during these winter months such 
as a change in nutrition and gestational pressures. It has been shown that poor nutrition and certain 
stages of pregnancy are associated with higher glucocorticsteroid production (Manary et al., 2006, 
Lanctot et al., 2003, Jung et al., 2011, Reeder et al., 2004a). The period of gestation (May, Jun, Jul, 
Aug) was significantly associated with increased cortisol production. It is difficult in this study to 
differentiate bat life-history events from environmental factors as life-history stages were classified 
according to month rather than any visual or biological indicator. It was not possible during this 
project to tease apart the importance of each of these factors on cortisol production however it 
would be useful in future studies to measure reproductive hormones alongside cortisol 
measurements and/or sample from individual bats where visual inspection may distinguish the stage 
of reproduction. Wherever handling of individual bats occurs, it would be important to consider the 
stress of capture on interpretation of results.  
Interestingly, the summer months of each study year were significantly associated with decreased 
UCMC, suggesting seasonality to reduced cortisol production or lowered stress. Perhaps a life-
history stage that also occurs in summer may downregulate cortisol production. Lactation 
(classified by the months of Nov, Dec, Jan, Feb) was significantly associated with decreased 
UCMC. Being in a state of lactation has been shown to downregulate cortisol production in females 
as a mechanism to protect the young from high cortisol exposure (Reeder et al., 2004b). If the 
majority of the Geelong colony at this time is comprised of lactating females, then this may explain 
the results. 
4.4.2 Sampling bias, lack of resolution and confounding 
The same biases inherent in the sampling technique as described in Chapter 3 also apply to this 
Chapter. Additionally, as bat numbers and life-history stages were available on a monthly basis; 
UCMCs were also compared on a monthly basis, thus limiting the resolution of the data. Using data 
from pooled urine samples allows trends in the population to be detected; however changes in 
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individual animals cannot be determined. Thus, this study was unable to determine the 
characteristics of individual bats that were more susceptible to stress during periods of peak UCMC 
measurement. Further analyses could include a measure of sex steroids such as testosterone or 
pregnancy hormones in the urine to correlate life-history stages and increased cortisol. 
From the paper by McMichael et al. (2014) it was suggested that urine concentration may have a 
significant effect on the measured UCMC and that concentration must be corrected for before raw 
UCMC values are reported. A validated method to measure concentration is by using a 
refractometer to record the urine specific gravity (USG). It may be questioned that the peaks in 
cortisol detection during the winter months may be because the urine was more concentrated and 
low summer UCMC occurred due to the presence of more dilute urine. Intuitively this does not 
seem logical, as you would expect more concentrated urine to be produced in hot summer months. 
Although urine concentration measurements were not performed for all samples, the USGs of the 
samples collected during the extreme heat and cold events revealed as expected that urine 
collections in winter/cooler conditions had generally lower USGs: range 1.007-1.022, mean 1.015, 
median 1.015, mode 1.015 compared to USGs of samples collected in warmer conditions: range: 
1.011-1.031, mean 1.019, median 1.017, mode 1.015. If USG measurements were used to correct 
raw cortisol measurements, the lower USG readings of winter collections would inflate cortisol 
measurements further. Thus measurements made during winter are likely to be underestimates of 
the true UCMC. Another explanation for the low cortisol measured in the hot summer months may 
be explained by heat/solar degradation. However, the experiment described in this Chapter that 
evaluated the effect of heat treatment on urine samples demonstrated that heat does not seem to 
have a significant effect (in either direction) on UCMCs.  
The data on colony numbers were collected by fly-out counts. The accuracy and precision of fly out 
counts has been investigated (Forsyth et al., 2006) and is considered an estimate which may 
underestimate or overestimate numbers depending on the dynamics of the colony at that time as 
well as observer experience. Despite no information on the precision and accuracy of this method, 
monthly colony count data were included to look at general trends in the population and the impact 
of population size on cortisol excretion. The count supervisor, Grant Baverstock, has a lot of 
experience in bat ecology and can confidently distinguish when there is significantly increased or 
decreased numbers in the colony. 
4.5 CONCLUSION 
This study identified periods of increased cortisol excretion in a colony of flying foxes in Geelong. 
The increased cortisol excretion that occurred in March and April (autumn) is possibly associated 
112 
 
with mating activities that occur at that time. The increased cortisol excretion during winter months 
may be associated with stress resulting from low temperatures, or nutritional or gestational stress. 
The decreased cortisol excretion during summer months may be associated with lactation-mediated 
down-regulation of cortisol production. The association (causative or otherwise) between stress and 
virus excretion will now be examined by combining the paramyxovirus excretion data from Chapter 
3 with the cortisol data from this Chapter. 
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CHAPTER 5 RISK FACTORS FOR PARAMYXOVIRUS EXCRETION 
5.1 INTRODUCTION 
This study has identified periods of virus excretion from a colony of pteropid bats. Although the 
zoonotic potential of these identified viruses are unknown, from the examples of Hendra and 
Menangle viruses it is clear that the circulation of paramyxoviruses within pteropid bats of Australia 
has the potential to pose a significant threat to the health of humans, livestock and domestic animals 
(Ng and Baker, 2013, Croser and Marsh, 2013). To establish the ability to predict future outbreak 
events and employ preventative measures, it is essential to understand the major factors that 
influence virus excretion and transmission dynamics at the level of the reservoir host. Even for 
well-studied viruses such as Hendra and Nipah viruses, the main drivers of virus infection and thus 
increased risk of cross-species transmission remain unclear. Stress is considered amongst the key 
drivers of disease emergence due to its immune modulating effects and in certain circumstances its 
association with an increased susceptibility to infectious disease (Godbout and Glaser, 2006). 
Stressors such as habitat destruction, poor nutrition and reproductive demands are implicated as 
potential triggers for virus transmission and excretion from the bat reservoir and thus the emergence 
of disease in humans (Plowright et al., 2008, Hahn et al., 2014). Despite these claims, studies where 
stress in bat populations is quantified and assessed in relation to virus infection and excretion are 
lacking. This Chapter takes a specific look at the role of stress (quantified using cortisol metabolite 
concentrations) in influencing virus transmission in addition to other potential bat-specific and 
broader ecological drivers such as reproductive events and colony size. 
5.2 MATERIALS AND METHODS 
5.2.1 Analysis of risk factors from paramyxovirus detection in urine 
From Chapter 3 there were periods of increased risk of paramyxovirus RNA detection, with the 
majority of detections occurring in the winter/spring months. In this Chapter, further environmental 
and bat-specific factors will be examined for their association with virus excretion.  
5.2.1.1 Life-history stage 
Each month of urine collection will be classified as to whether at least one virus detection was made 
during that period (yes/no) and as to where this month falls with respect to the four major 
mammalian reproductive stages: mating, gestation, birthing and lactation. For the grey-headed 
flying fox these stages will be considered to occur during the following non-overlapping calendar 
months: mating (Mar, Apr); gestation (May, Jun, Jul, Aug); birthing (Sep, Oct) and lactation (Nov, 
Dec, Jan, Feb) (Nelson, 1965b). A logistic regression will be performed to assess the association 
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between detection of at least one paramyxovirus sequence and mating, gestation, birthing or 
lactation. All statistical analyses in this Chapter were performed using Stata (StatCorp) version 
10.0. Odds ratios will be presented alongside p-values and 95% confidence intervals. A p value < 
0.05 will be considered statistically significant.  
5.2.1.2 Colony numbers 
A logistic regression analysis will be performed to assess the association between a month 
containing at least one paramyxovirus detection (yes/no) and colony size for that month. Odds 
ratios will be presented alongside p-values and 95% confidence intervals. A p value < 0.05 will be 
considered statistically significant. This analysis is to determine whether all bats are equally likely 
to excrete paramyxoviruses at any given time. If this were the case then as colony numbers peak, 
more bats would be excreting virus and contributing to the pooled urine samples – thus an 
expectation that there would be more virus detections during high colony counts and less detections 
when bat numbers are low.  
5.2.1.3 Stress 
The main focus of this chapter is to investigate the association between stress and the risk of 
paramyxovirus excretion from a flying fox colony. This will be assessed by looking at whether 
monthly mean UCMC is associated with the detection of at least one paramyxovirus sequence 
within that month. A logistic regression will be performed to investigate this association. The above 
analysis assesses the relationship between UCMC and paramyxovirus detection in the same month. 
To allow for a potential lag-time between increased cortisol production and physiological changes 
that increase susceptibility to viral infection and thus excretion, a logistic regression will be 
performed that assesses the association between the detection of at least one paramyxovirus 
sequence and the mean UCMC of the preceding month. A third logistic regression will allow for a 
lag time of two months. Odds ratios will be presented alongside p-values and 95% confidence 
intervals. A p value < 0.05 will be considered statistically significant. 
Targeted urine collections made during an extreme heat event in January/February 2014 (method 
described in Chapter 4; section 4.2.7.3) were performed to investigate the link between the stress of 
extreme heat, the effects of extreme heat on cortisol production and the influence of heat stress on 
paramyxovirus excretion in a flying fox colony. In addition to UCMC analysis, the pooled urine 
samples collected during this time were also analysed using the 9-plex nc-Luminex as described in 
Chapter 3 (section 3.2.4). UCMC results will be taken from Chapter 4 (Figure 4.7) and compared to 
the virology data.  
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5.3 RESULTS 
5.3.1 Risk factors for paramyxovirus detection in urine 
5.3.1.1 Life-history stage 
The number of paramyxoviruses detected per sampling month are shown in relation to the four 
major bat life-history stages in Figure 5.1. 
Figure 5.1. Paramyxovirus detections with bat life-history stages 
 
 
The results of the logistic regression analyses are shown in Table 5.1. 
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Table 5.1. Regression analyses of paramyxovirus detections on bat life-history stages 
Variable Odds-Ratio p-value 95% Confidence Interval 
Life-history stage 
Mating 0.23 0.24 0.02 2.59 
Gestation 1.50 0.62 0.30 7.43 
Birthing 3.0 0.37 0.27 33.49 
Lactation 0.80 0.79 0.15 4.24 
 
No significant association between any bat life-history stage and paramyxovirus detection was 
found.  
5.3.1.2 Colony numbers 
The number of paramyxovirus RNA detections per month of collection are shown in Figure 5.2 in 
relation to monthly colony counts. 
Figure 5.2. Paramyxovirus detection in relation to colony size 
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It is apparent from this graph that the majority of virus detections do not occur with peaks in colony 
size, in fact there is an opposite trend: low rates of paramyxovirus RNA detection occur when bat 
numbers are high and high rates of paramyxovirus RNA detection occur when bat numbers are low. 
The logistic regression showed no association between monthly colony size and the odds of 
paramyxovirus RNA detection within that month (OR 1.00, 95% CI 1.00-1.00).  
5.3.1.3 Stress 
Figure 5.3 shows monthly mean UCMC in relation to monthly paramyxovirus RNA detection. 
Figure 5.3. Monthly mean UCMC and paramyxovirus RNA detections 
 
 
Figure 5.3 was prepared to broadly assess by visual inspection any obvious associations between 
peaks of cortisol measurement and virus excretion. Paramyxovirus detections occurred in the same 
months of both peaks and troughs of cortisol production. UCMC peaks in March 2011, June 2011, 
July 2011 and June 2012 coincided with virus detection in those same months. However, the peaks 
in UCMC in August 2010 and March 2012 are not associated with virus detection in the same 
month. The majority of RNA detections within each year appeared to occur in the months during or 
following the winter peaks in UCMC. None of the regression analyses revealed a significant 
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association between monthly mean cortisol and the odds of paramyxovirus detection within the 
same month (p=0.52), the following month (p=0.13), and two months later (p=0.21).  
Cortisol metabolite concentrations measured in 34 urine samples collected during and after the heat 
wave of January/February 2014 were depicted in Chapter 4 (Figure 4.7). There was evidence to 
suggest a cumulative increase in cortisol production within the colony which may reflect a stress 
response to the extreme heat. However, despite plausible evidence of a stress response at the 
colony-level, the same 34 pooled urine samples analysed in the 9-plex microsphere suspension 
array assay revealed no detection of paramyxoviruses. 
5.4 DISCUSSION 
This Chapter brings together the results of Chapters 3 and 4 to assess how bat-specific and 
environmental factors may influence paramyxovirus transmission dynamics within flying fox 
populations. An emphasis will be placed on the effects of physiological stress as measured by 
cortisol production on viral infection, replication and excretion. 
5.4.1 Risk factors for paramyxovirus detection in urine 
Compared to serological testing, detection of viral RNA in urine samples is a more likely indicator 
of the presence of current viral infection and replication in host tissues. Apart from isolating virus, 
it is the best technique to indicate the likely occurrence of infectious virus particles in the 
environment and thus times of increased risk of transmission from bat to bat and also importantly 
from bats to other animal species including humans. The following bat-specific and environmental 
factors will be investigated as to their likely influence on virus excretion as measured by nucleic 
acid and thus risk of cross-species transmission.  
5.4.1.1 Life-history stage 
Following from the serological findings of a number of studies which suggest a period of enhanced 
virus transmission and host susceptibility to infection during important reproductive events in the 
bat life-cycle (Epstein et al., 2008, Breed et al., 2011, Rahman et al., 2013, Plowright et al., 2008, 
Baker et al., 2013b), the same reproductive episodes were investigated for their association with 
paramyxovirus excretion. There are very few publications available that attempt to correlate virus 
detection with bat ecological factors. Those that do are in support of enhanced transmission and 
infection of Nipah virus, coronaviruses and astroviruses during female reproductive events, 
particularly during lactation (Wacharapluesadee et al., 2010, Drexler et al., 2011, Gloza-Rausch et 
al., 2008).  
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Explanations given for enhanced virus transmission during pregnancy, birthing and lactation 
include reduced maternal immunity during pregnancy (Baker et al., 2013b, Breed et al., 2011, 
Pourrut et al., 2007), vertical transmission of virus from mother to pup (Breed et al., 2011, Drexler 
et al., 2011, Williamson et al., 2000, Halpin et al., 2000), environmental excretion of virus in 
birthing tissues/fluids (Pourrut et al., 2007, Williamson et al., 2000, Halpin et al., 2000a), persistent 
infections in newborns (Baker et al., 2013b) and waning maternal antibodies concurrent with a 
naive cohort of weaned pups (Plowright et al., 2011, McFarlane et al., 2011, Epstein et al., 2013, 
Drexler et al., 2011, Gloza-Rausch et al., 2008). Although no significant associations were found 
between any bat life-history stage and paramyxovirus RNA detection at a colony-scale, this does 
not preclude such associations at an individual level. Due to the unexpected low number of 
paramyxovirus RNA detections, detection data were grouped by month, and bat life-history stages 
were also categorized by month. In reality, reproductive events are not mutually exclusive, they 
cannot be defined by calendar month and the timing of onset and duration may vary between 
individuals and between years. This study was not designed to assess associations at the individual 
level, rather on a colony scale. At this level, no association could be found between life-history 
stage and RNA detection. If an association does exist but the study was unable to detect it, this may 
be due to the pooled urine samples not being a representative sample of the population. Perhaps 
those bats which were more likely to excrete virus due to reproductive influences were not sampled.  
It is interesting that very few paramyxovirus detections were made during the mating period 
(March, April). Mating is associated with increased, often aggressive, contact between males (Klose 
et al., 2009) and between males and females where exchanges of potentially infectious body fluids 
would occur. In the Geelong colony during these times perhaps active virus introduction and 
circulation within the colony was not occurring or perhaps population susceptibility to infection was 
not high enough for infection, replication and excretion to occur.  
5.4.1.2 Colony numbers 
A longitudinal study of Nipah virus excretion found a positive correlation between colony size and 
number of positive paramyxovirus detections (Wacharapluesadee et al., 2010). That study 
concluded that colony size increased with mating and continued to increase throughout the 
reproductive season. Drexler et al. (2011) also found a positive association between colony size and 
virus detection where a peak in coronavirus and astrovirus prevalence was found on seasonal 
formation of a maternal colony. For the Geelong colony it would be intuitive to think that increased 
detection of paramyxoviruses would occur during and directly after peak bat numbers when animals 
are entering the colony having travelled from other locations with the potential of introducing 
viruses to susceptible animals. For closed populations, an important epidemiological concept often 
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referred to in the literature is the idea of a threshold population size above which a population is 
able to maintain continued viral replication (Deredec and Courchamp, 2003). As the Geelong 
colony is a contiguous population, such thresholds should not apply here and additionally low 
colony numbers have been shown to support paramyxovirus transmission (Peel et al., 2012).  
For the Geelong colony, no association between colony size and paramyxovirus detection was 
found. Generally, higher rates of paramyxovirus detection occurred when colony size was at its 
lowest and vice versa. Peak colony numbers occurred during the mating period which has already 
been established as a period of very low virus detection. The colony profile when numbers are at 
their lowest would be interesting to determine but was outside the scope of this project. It is 
interesting to note that colony size was not a predictor of cortisol production. The highest measured 
concentrations of UCMC occurred when colony size was relatively small. This is not a suggestion 
that higher cortisol causes viruses excretion, more that secondary or tertiary factors that occur when 
the colony is small play an important role in influencing virus excretion. Presumably bats leave the 
area due to poor conditions/poor food availability, thus the types of bats which remain may be more 
susceptible to virus infection for some reason. It cannot be concluded that a large colony size is 
unimportant in the transmission dynamics of paramyxoviruses in the Geelong colony, it can just be 
said that in this study there appear to be more important factors which may be driving increased 
virus infection, replication and excretion. 
5.4.1.3 Stress 
Motivated generally by the wide-held belief that stress increases susceptibility to disease and more 
specifically by the observations of Plowright et al. (2008) that reproductive and nutritional stress are 
risk factors (“causes”) of Hendra virus infection in flying foxes, this study sought to determine 
whether stress as measured by increased cortisol production is associated with or in fact is a causal 
factor of paramyxovirus infection, replication (including recrudescence) and excretion in the 
Geelong colony. The study by Plowright et al. (2008) did not include a typical physiological marker 
of stress. The current study addressed the issue of quantifying stress by determining urinary cortisol 
metabolite concentrations in pooled urine samples collected non-invasively from the colony. In 
Chapter 4 it was found that increased cortisol occurred during the months of March and April 
(coinciding with the mating period) and also during the winter months of June and July. Edson et al. 
(2015) also found significantly increased pooled urine cortisol measurements in winter for bats 
sampled in more northern colonies. For paramyxovirus excretion it was found that the majority of 
detections occurred in the winter/spring period which coincided with pregnancy/lactation with 
minimal detection occurring during the mating period. Considering that cortisol increases during 
mating but paramyxovirus detection rate is low at this time, there does not seem to be a strong 
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association between stress and virus excretion. However, it is possible the winter increase in cortisol 
production exerts its biological effect over a few months (lag-time) resulting in higher virus 
excretion in the late winter/spring period.  
However, with the approach taken in this study, no significant association was found between stress 
as measured by increased cortisol production and paramyxovirus excretion. This suggests that the 
quantification of cortisol is not a useful tool for virus spillover prediction. In the Geelong colony 
there are certainly peaks of cortisol production and periods of increased virus excretion. At some 
times these peaks overlap however the association is not consistent and unlikely to be causal. This 
indicates that different ecological and/or physiological drivers (perhaps those that have already been 
discussed above) for cortisol production and virus transmission are operating. In the beginning of 
this study this result would have been surprising considering the strength of belief in the paradigm 
of stress-glucocorticosteroid release-immunosuppression-disease which permeates scientific 
literature. However a thorough and critical review of literature pertaining to stress and infectious 
disease found very few studies that convincingly demonstrated this positive association. Where 
results were convincing they tended to be for specific viruses such as herpes virus and rhinovirus in 
human disease rather than wildlife (Strachan et al., 2011, Sainz et al., 2001, Cohen et al., 1998). 
Only one phenomenon in the wildlife health realm showed a strong causal relationship between 
stress, increased cortisol production and infectious disease. This scenario was the total post-mating 
mortality of antechinus marsupials and involved the combination of multiple stressors (metabolic, 
social), multiple hormonal changes and increased contact rates between animals (Bradley et al., 
1980).  
The peaks of cortisol production appeared to be acute rather than chronic, that is peak UCMC 
values appeared to occur for only one (or two) months at a time. Glucocorticosteroid (GC) 
metabolite concentrations in urine are not a measure of steroid production at a single point in time 
as in serum: they are a cumulative measure of steroid production (Mostl and Palme, 2002; Sheriff et 
al., 2011; Sheriff et al., 2010; Whitten et al., 1998). Minor short-term fluctuations and diurnal 
variations in GC secretion are levelled out to give a cumulative measure of HPA axis activity 
(Palme et al., 2005). In this way, urinary measurements give a better indication of the degree to 
which detrimental GC actions are influencing the physiology of individual or populations of 
animals. After release of GCs from the adrenals, metabolites appear almost immediately in urine 
and can usually be measured in the first sample voided post-stressor. Concentrations of GC 
metabolites reach their peak in urine after 4-8 hours (Mostl and Palme, 2002; Palme et al., 2005; 
Whitten et al., 1998). Pooled urine collections are thus an appropriate measurement of acute or 
recent stressors occurring in the colony. However, chronic stress is thought to have a greater 
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association with disease than acute stressors (Goymann and Wingfield, 2004, Dhabhar and 
McEwen, 1997). It has been shown that animals experiencing chronic stress show attenuated GC 
responses to acute stressors (Rich and Romero, 2005). Thus, if chronic rather than acute stress plays 
a more important role in immune modulation and susceptibility to infection, increased cortisol 
concentrations in pooled urine samples may not be reflective of the physiological state at greater 
risk of virus infection and excretion. Hair provides a means to measure the long-term retrospective 
exposure of an animal to GCs however this method would not be useful in forecasting spillover 
risk.  
The lack of association found may also be due to the type of viruses investigated. Herpesvirus 
infections are classically associated with stress (Sainz et al., 2001, Strachan et al., 2011) because of 
the characteristic latent period of infection with these viruses. Herpesviruses have been detected in 
bats of the genus Pteropus (Razafindratsimandresy et al., 2009) and may be better used in 
assessments of the link between stress and virus infection. 
As mentioned before, the biological effects of different cortisol concentrations in bats are unknown. 
Previous research has found levels of circulating total glucocorticoids in pteropid bats that are the 
highest known values for mammals (Widmaier and Kunz, 1993, Widmaier et al., 1994, Reeder et 
al., 2004b). Perhaps bats have evolved mechanisms to avoid the detrimental tissue effects of high 
circulating glucocorticoid levels, for example through production of high levels of corticosteroid 
binding proteins (Widmaier and Kunz, 1993, Widmaier et al., 1994) or decreased binding affinity of 
glucocorticoid receptor as seen in certain New World monkeys (Chrousos et al., 1982). The 
downstream effects of cortisol may differ in bats compared to other mammals. This study assumes 
stress is occurring in the Geelong bats when peaks of cortisol detection occur. Figure 4.16 of 
Chapter 4 depicted a scale of UCMCs measured from urine samples collected from bats under 
captive and free-living environments. From this scale, the relative level of stress experienced by 
bats under these conditions may be made. The highest UCMC recorded from pooled urine samples 
collected from roosting bats in Geelong was significantly lower than the mean UCMC measured in 
urine collected from individual bats caught in Geelong after a period of known stress (capture, 
restraint, and handling). It is possible that during the periods where peak cortisol detection occurred 
in pooled urine samples, the roosting Geelong bats were not in fact “stressed” and measured cortisol 
excretion (low and high) fell within a range driven by undisturbed daily variation (Chung et al., 
2011). Thus, this study may not have been able to investigate the association between stress, 
cortisol production and virus excretion as the bats in the colony were not stressed. It would be 
useful then to address this hypothesis by sampling from a different colony – one which may be 
more likely to experience stress. The study by Edson et al. (2015) investigated the effect of roost 
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disturbance on cortisol production and the rate of HeV detection. It was found that cortisol 
measurements did not significantly change before, during, or after roost disturbance. The rate of 
HeV detection also did not significantly change pre-, during, or post-, disturbance. The authors state 
a small positive association between samples positive for HeV RNA and cortisol concentration of 
the same sample. The authors conclude that such an association is not unexpected due to the large 
number of samples. The authors also stress the importance of not assuming an association implies 
causation. In the current study, although a large number of samples were collected, there was an 
overall low rate of paramyxovirus RNA detection, precluding robust statistical analyses. 
The absence of a strong association between cortisol production and susceptibility to paramyxovirus 
infection sheds some light on the importance of different modes of virus transmission for the 
Geelong colony. Recrudescence of tissue-latent paramyxovirus infection has been cited as a 
possible mode of transmission in bat populations (Sohayati et al., 2011, Wang et al., 2013, 
Plowright et al., 2011, Peel et al., 2012, Baker et al., 2013b) as evidence of this phenomenon has 
occurred in bats infected with Nipah virus (Sohayati et al., 2011, Rahman et al., 2010) and in 
humans infected with Nipah virus (Tan et al., 2002) and Hendra virus (O'Sullivan et al., 1997). 
Stress is commonly cited as a trigger for viral recrudescence as exampled by herpes viruses: 
Epstein-Barr virus (Mehta et al., 2000) and herpes simplex viruses (Sainz et al., 2001). The lack of 
association between stress and virus excretion found in this study implies that such a phenomenon 
and mode of transmission is not an important component of virus infection dynamics for the 
Geelong colony.  
It may be asked whether the ‘chain of causation’ is directed in the opposite direction: is infection 
with paramyxoviruses causing stress and thus increased cortisol production? Infection-induced 
stress is a well characterised phenomenon (Torpy and Ho, 2007, Christeff et al., 1997). This idea 
may be plausible where peaks of cortisol detection occur simultaneously with paramyxovirus 
detection. Generally however the majority of virus detection in this study occurred after cortisol 
peaks. One way to answer this would be to compare UCMCs of pooled urine samples that were 
positive for paramyxovirus RNA with samples that were negative. Of the 29 pooled urine samples 
positive for virus RNA, the mean UCMC was 114.64 ng/mL. Of the 833 urine samples negative for 
virus RNA and with a corresponding UCMC measurement, the mean UCMC was 92.90 ng/mL. The 
difference was not significantly different (p=0.09) using a two-sample Wilcoxon rank-sum test. The 
pooled urine sample that was positive for two different paramyxoviruses (possibly representing a 
single bat infected with multiple viruses) had a UCMC of only 40 ng/mL (below the mean roosting 
UCMC = 94 ng/mL). Increased UCMC above roosting average in samples positive for 
paramyxovirus RNA occurred only for those urine samples collected during winter months and thus 
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increased cortisol production here is more likely to be a result of seasonal drivers rather than virus 
infection.  
The heat wave of January/February 2014 appeared to be the perfect situation to measure increased 
cortisol production and its association with virus excretion. During this time, bats were showing 
obvious signs of heat stress including wing fanning, panting and a large number of heat-related 
deaths (over 400 from the Geelong colony). In the literature, heat stress has been shown to increase 
cortisol production in humans (Follenius et al., 1982, Collins et al., 1969) and other mammals 
(Assia et al., 1989, Nazifi et al., 2003). Cortisol production during this time was observed to 
increase with time over the heat stress period (Chapter 4, Figure 4.7). Paramyxovirus RNA was not 
detected during the heat wave period, which was not unexpected given the already described low 
prevalence of detection during summer months. This gives more support to the idea that there are 
other more important seasonal drivers of virus infection and excretion. With climate change and the 
occurrence of more extreme heat events (Hanna et al., 2011), there are likely to be more mass flying 
fox mortalities due to heat stress. There is public concern over whether these heat events present an 
increased risk of spillover of zoonotic viruses. The results of this study suggest that these periods do 
not present a significant increase in risk however further studies are needed to confirm these results. 
Perhaps bats change their behavior in a way that reduces the power to detect viral RNA in pooled 
urine samples. For example, dehydrated bats may not urinate as frequently throughout the day and 
sampling during the morning may not give the same chance at detecting virus compared to if 
sampling occurred at a different time of the day. The public should not be complacent however as 
such die-offs increase the risk of human contact with moribund bats and thus an increased risk of 
infection with Australian Bat Lyssavirus. 
5.4.1.4 General comments regarding sampling bias 
Cross-sectional sampling of a population using pooled urine samples results in inferences being 
made about what is happening at an individual bat level based on population level results. Such 
population based sampling may not be appropriate to address certain research questions. For this 
study however the sampling regime was appropriate as its aim was to investigate trends over time at 
a colony scale. Continued sampling over multiple years allowed an assessment of such trends and if 
patterns were repeated they were likely to be significant. This study was not longitudinal in nature 
as it did not specifically monitor the same animals over time. Addressing the effects of increased 
cortisol at a given time on paramyxovirus excretion one- and two- months later assumes the 
population is stable and made up of the same animals. The Geelong colony is not a stable 
population as colony numbers fluctuate regularly. If there was a positive association between 
increased cortisol production and virus excretion at the individual bat level, perhaps animals 
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measured as having increased UCMC at a particular time point migrated to another location where 
virus was excreted and not detected in the Geelong colony. This is not important for the question of 
this study however: the question was whether for a bat population, were periods of increased stress 
at a colony-scale associated with periods of increased virus excretion? This study has been able to 
answer this question. To address stress physiology, immune changes and infection susceptibility in 
individual bats, experimental studies or individual bat trapping over time would need to be 
performed. It must be considered however that in these situations, cortisol would most likely be 
artificially elevated due to the captive environment, trapping and handling.   
One question which would be possible in the scope of this study but which was not performed is an 
investigation into the characteristics of the individual bats that were excreting virus. From a urine 
sample, molecular tests are available which can distinguish the sex of the bat from which the 
sample came. The test is based on a sequence in the Y chromosome and thus in a pooled urine 
sample would only detect male contributions to the sample. Work is currently underway to develop 
a molecular test which is able to determine the approximate age of a bat from a urine sample. 
Hormonal tests may be able to distinguish pregnant female bats and also possibly male bats in the 
mating period. Once such tests are developed and validated, they would be invaluable to apply to 
cross-sectional urine samples collected from a colony. In this case it would be important to avoid 
pooled samples and aim to collect urine from individual bats. 
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CHAPTER 6 ISOLATION OF TWO PARAMYXOVIRUSES FROM 
PTEROPUS POLIOCEPHALUS AND A COMPARISON TO RELATED 
VIRUSES  
6.1 INTRODUCTION 
Evidence of infection with paramyxoviruses in the Geelong colony of flying foxes was 
demonstrated through the detection of viral RNA in pooled urine samples collected from the colony 
(Chapter 3). Isolation of infectious virus from similarly collected colony-level pooled urine samples 
has been successful in a number of studies (Barr et al., 2014, Smith et al., 2011, Chua et al., 2002, 
Baker et al., 2013c), including those that use both Vero and primary bat-derived cell lines (Baker et 
al., 2013c, Smith et al., 2011, Barr et al., 2014). In this part of the PhD project, an attempt is made 
to isolate virus from samples collected from the Geelong colony. This will allow for novel virus 
discovery which was not possible using the specific nc-Luminex-in Chapter 3. Targeting isolation 
attempts to collections containing samples positive for viral RNA may increase the likelihood of 
isolating that particular virus or other novel viruses. This reasoning is based upon the observations 
of Chapter 3 but also those of Barr et al. (2014) where isolation and/or detection of one virus 
coincides with the isolation and/or detection of multiple other viruses during ‘peaks’ of viral 
excretion. Obtaining an isolate will allow for whole genome sequencing, comparison of the isolated 
virus to related viruses, and pathogenesis studies in animal models, leading to a better assessment of 
zoonotic risk. If successful this will be the first isolation of virus from samples collected from 
pteropid bats, specifically Pteropus poliocephalus, at the southern-most extreme of their geographic 
range.  
6.2 MATERIALS AND METHODS 
6.2.1 Urine samples 
Isolation attempts were performed on a selection of pooled urine samples collected as per Chapter 3 
(section 3.2.2). Pooled urine sample number 3 of the 10 samples collected on 26/10/2010 was 
positive for Cedar virus RNA using the Luminex platform. Isolation of Cedar virus was attempted 
from this sample in order to investigate a correlation between Luminex positive results and the 
presence of infectious virus particles. The remaining 9 pooled samples from that week were also 
selected for novel virus discovery. Pooled urine samples from two additional collection dates were 
chosen for a combination of reasons. Firstly, as Yarra Bend paramyxovirus was the most frequently 
detected virus from the Geelong colony, an isolate would enable further genomic sequencing and 
virus characterization. Attempts to isolate YarPV were made by selecting pooled urine samples with 
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high mean fluorescence intensity (MFI) values for YarPV. For this reason, all ten pooled urine 
samples from the 11/11/2011 collection and all ten pooled urine samples from the 21/11/2011 
collection were used. Secondly, based on the phenomenon of multiple paramyxovirus infection, 
excretion and detection from bat colonies at a single time period it was hypothesized that the 
highest chance of isolating novel viruses would occur with samples collected on these two dates (in 
addition to YarPV, Cedar virus RNA was detected in sample 4 of 11/11/2011 and Teviot 
paramyxovirus RNA in sample 7 of 21/11/2011. In total, virus isolation was attempted on 30 pooled 
urine samples.  
6.2.2 Cell culture 
All isolations were performed in duplicate using two different cell lines: Vero cells and Pteropus 
alecto kidney (PaKi) cells as established in Crameri et al. (2009). Cells were grown in Nunclon 
Delta Surface six-well tissue culture plates (Thermo Scientific) at 37 °C in 5% CO2. Growth media 
for Vero cells was Minimal Essential Media (MEM) (Gibco ®) supplemented with 10 mM Hepes 
(Gibco®), double-strength Gibco® Antibiotic-Antimycotic containing penicillin, streptomycin and 
amphotericin B and 10% foetal calf serum (FCS). Growth media for PaKi cells was Dulbecco’s 
Modified Eagle’s Medium supplemented with F12-Ham (Gibco®), 10% FCS and double-strength 
Antibiotic-Antimycotic as described above. 
6.2.3 Virus isolation 
Virus isolation was performed at Biosecurity Level 3 (BSL-3) with the use of biosafety cabinets. 
Urine samples were thawed and centrifuged at 13,000 rpm for ten minutes to sediment large 
contaminants such as bacteria. Supernatant was diluted 1:10 in each of the above media for both 
cell types. To confluent cell monolayers, 500 μL of inoculum was added followed by gentle rocking 
for five minutes every 15 minutes for one hour with incubation at 37 °C in between. After the final 
rocking, 2 mL of the appropriate media was added to the wells and cells were examined every 24 
hours for the presence of cytopathic effect (CPE). At seven days post-inoculation, 500 μL of 
supernatant was passaged onto a new cell monolayer (repeated to give up to three passages). Where 
CPE was confirmed, supernatant was harvested and stored at -80 °C. 
6.2.4 Molecular characterisation 
RNA was extracted from supernatant harvested from wells showing obvious CPE using the 
QIAamp Viral RNA Mini Kit (QIAGEN) according to manufacturer’s instructions. To detect 
whether cell infection was due to a paramyxovirus, a paramyxovirus-family based hemi-nested PCR 
adapted from the method described by Tong et al. (2008) was used. The first-round RT-PCR was 
performed using the Superscript III One-Step with Platinum Taq kit (Invitrogen) with the following 
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conditions: 25 μL reaction volume, 10 μM forward and reverse primers (PAR-F1 & PAR-R, Table 
6.1), 5.0 mM MgSO4 and 2 μL template RNA. Thermal cycling conditions: 60°C for 1 min, 48°C 
for 30 min (RT reaction), 94°C for 2 min (Taq activation), 40 cycles of 94 for 15 s, 49°C for 30 s 
and 68°C for 1 min, followed by 68°C for 5 min. The second amplification round was performed 
using the Expand High Fidelity PCR System (Roche) with the following conditions: 25 μL reaction 
volume, 10 μM forward and reverse primers (PAR-F2 & PAR-R, Table 6.1), 10 mM dNTPs, 5.0 
mM MgCl2 and 1 μL template RNA. Thermal cycling conditions: 94°C for 2 min, 40 cycles of 
94°C for 15 s, 49°C for 30 s and 72°C for 1 min, followed by 72°C for 5 min. 
Table 6.1. Primers used in hemi-nested paramyxovirus RT-PCR 
Hemi-nested Paramyxovirus RT-PCR 
Primer Sequence 5’ to 3’ Target 
PAR-F1 GAAGGITATTGTCAIAARNTNTGGAC L-gene 
PAR-F2 GTTGCTTCAATGGTTCARGGNGAYAA L-gene 
PAR-R *CAGGAAACAGCTATGACGCTGAAGTTACIGGITCICCDATRTTNC L-gene 
* Italics capital M13 sequence 
 
Products were run on a 1% agarose gel at 100 V for 30 minutes. Bands of the appropriate size were 
excised and DNA purified using the QIAquick Gel Extraction Kit (QIAGEN) according to 
manufacturer’s instructions. Sequencing reactions were performed using the BigDye® Terminator 
v3.1 Cycle Sequencing Kit (Applied Biosystems ®) with the following conditions: 20 μL reaction, 
1 μL BDT 3.1 Ready Reaction Premix, 2 μM primer (M13F – complement to M13 sequence on 
PAR-R primer, Table 1) and 1 μL purified DNA eluted from gel band. Reaction conditions: 96°C 
for 1 min, 25 cycles of 96°C for 10 s, 50°C for 5 s and 60°C for 4 min. Products were sent to the 
sequencing laboratory within AAHL for capillary electrophoresis on the 3130xL Genetic Analyzer. 
With the knowledge of sequencing results, qRT-PCR reactions to detect Cedar and Teviot 
paramyxovirus RNA (Cedar virus: P gene; Teviot paramyxovirus: N gene) were performed on 
extracted RNA from virus pellets (section 6.2.5.1) as well as RNA extracted from supernatant 
collected from wells containing CPE at different passages. These PCRs were performed as 
confirmation of virus type and also to monitor virus titres over different passages. The primers and 
probe sequences for the Cedar qRT-PCR were shown in Chapter 3 (section 3.2.8). The primers and 
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probe sequences for Teviot paramyxovirus are shown below in Table 6.2. For both viruses these 
primers and probes were designed using sequences of the Queensland Cedar and Teviot isolates. 
For the qRT-PCR, the Superscript III Platinum Taq One-Step qRT-PCR system was used with 5 
pmol/μL of probe and 10 pmol/μL of forward and reverse primers. Thermal cycling was 50°C for 5 
min, 95°C for 2 min followed by 40 cycles of 95°C for 3 s and 60°C for 30 s.  For the qRT-PCR 
assays, cycle threshold (CT) values ≤ 39 were considered positive and > 39 negative.  
Table 6.2. Primer and probe sequences for Teviot paramyxovirus qRT-PCR 
Primers and Probe Sequence (5’-3’) 
TevPV F ACC TGC TAA CTA CCC GCT GT 
TevPV R TCG GTT TGC TGT CTC AAC TC 
TevPV Probe (FAM) TC CTG AAC GCT TCC GAT ACC CA (TAMRA) 
 
6.2.5 Whole genome characterization using next-generation sequencing 
6.2.5.1 RNA purification 
To minimize virus sequence changes due to cell adaptation, supernatant collected from the earliest 
time point where CPE was identified was used. For both viruses this was passage 1, day 10. As 
these supernatants were collected from PaKi cells, PaKi cells were also used in this growth step. 
Confluent 25 cm
2
 PaKi monolayers were infected with 500 μL of supernatant harvested and diluted 
1:10 in media from CPE-positive isolation wells. When CPE was observed in ~50 % of cells, 10 
mL of supernatant was harvested and spun at 2,000 rpm for 10 minutes at 4°C to remove cellular 
debris. Virus particles were semi-purified through a discontinuous sucrose gradient. Briefly, 10 mL 
of supernatant was added to the top of a discontinuous sucrose gradient composed of 2 mL 50 % 
sucrose solution and 4 mL 20 % sucrose solution (top layer). Samples were ultracentrifuged at 
36,000 rpm for 1.5 hours at 4°C. The virus pellet was harvested from the 50%/20% sucrose 
interface, resuspended in 560 μL AVL buffer and extracted with the QIAamp Viral RNA Mini Kit 
(QIAGEN) according to manufacturer’s instructions. 
6.2.5.2 Random PCR 
Randomly-amplified DNA was prepared for deep sequencing from viral genomic RNA as follows. 
Firstly, 11 μL of genomic viral RNA was reverse transcribed (Invitrogen, Superscript III) using a 
random-octamer-conjugated primer (cDNA primer, Table 6.3). Complementary-strand DNA was 
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synthesized by Klenow reaction: DNA polymerase buffer, 20 μL first strand inactivated cDNA, 15 
U DNA polymerase I enzyme large fragment (Promega) with reaction conditions: incubation at 
37°C for 30 min followed by inactivation at 70°C for 15 min. Secondly, the random PCR utilized a 
thiol-modified 454 complementary primer lacking the Muliplex Identifier (MID) tag (20 μM) with 
5 μL cDNA in a 50 μL reaction (Expand High Fidelity, Roche) under the following conditions: 
95°C for 5 min, 35 cycles of 94°C for 1 min, 50°C for 1 min and 72°C for 1min followed by 72°C 
for 7 min. Three reactions were set up and products pooled for Cedar virus and two reactions set up 
and pooled for Teviot paramyxovirus. Products were visualised using a 1 % agarose gel to ensure a 
size distribution of products > 300 bp (essential for efficient DNA fragmentation and adapter 
incorporation). Random PCR products for each virus were then diluted 1:6 in Buffer PB (Qiagen) 
for removal from BSL-3. Mary Tachedjian continued the process of sample preparation for deep 
sequencing briefly outlined below.  
Table 6.3. Primers for random PCR 
Primer Sequence 
cDNA GTTTCCCAGTAGGTCTCNNNNNNNN 
454 Amp Primer no 
MID 
C*G*C*C*GTTTCCCAGTAGGTCTC 
*denotes phosphorothioates linkages 
 
6.2.5.3 DNA purification and quantification 
DNA was purified using the MinElute PCR Purification Kit (QIAGEN) according to 
manufacturer’s instructions. DNA was eluted in 20 μL EB buffer. 
A NanoDrop ND-1000 (Thermo Scientific) was used according to manufacturer’s instructions for 
an initial assessment of DNA quality (acceptable quality was deemed a 260/280 nm reading > 1.8) 
and quantity. A more accurate determination of DNA concentration was made using a Qubit
TM
 
dsDNA HS Assay Kit and Qubit
®
 2.0 Fluorometer (Life Technologies) according to manufacturer’s 
instructions.  
6.2.5.4 Size distribution 
An Agilent High Sensitivity DNA Kit (Agilent Technologies) with an input of 5 ng/μL of DNA was 
used according to manufacturer’s instructions to assess the size distribution of the randomly 
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amplified DNA products. Successful library preparation relies on the majority of fragments having 
greater than 300-500 bp.  
6.2.5.5 Library preparation 
Library preparation was achieved using the Nextera
®
 XT DNA Sample Preparation Kit (Illumina
®
, 
Cat. # FC-131-1096) and the Nextera
®
 XT Index Kit (Illumina
®
, Cat. # FC-131-1002) according to 
the Nextera
®
 XT DNA Sample Preparation Guide (Illumina
®
, Part# 15031942 Rev. C, Oct. 2012) 
with an input of 2 ng of total DNA. Each DNA fragment was dual indexed with 5’ and 3’ barcode 
combinations unique to each sample. Library DNA concentration was measured using the Qubit
TM
 
dsDNA HS Assay Kit and Qubit
®
 2.0 Fluorometer (Invitrogen
TM
 by Life Technologies) according 
to manufacturer’s instructions. Average fragment size of the library was performed using the 
Agilent High Sensitivity DNA Kit (Agilent Technologies). Library DNA concentration and average 
fragment size was used to determine the quantity of product to load into the MiSeq
®
 system. 
6.2.5.6 Sequencing using the MiSeq® platform 
Libraries were prepared for sequencing using the MiSeq
®
 Reagent Kit v2 (300 cycle) (Illumina
®
, 
Cat. # MS-102-2002) according to the Preparing Libraries for Sequencing on the MiSeq
®
 guide 
(Illumina
®
, Part# 15039740 Rev. D, Oct. 2013). For each sample, 10 pM of library was loaded and 
run on the Illumina
®
 MiSeq System (Illumina
®
) using the Illumina
®
 Experiment Manager software 
v1.8 with a read-length of 2 x 150 bp (paired-ends).  
6.2.6 Bioinformatical analysis 
After an initial quality control step performed by the Illumina
®
 Experiment Manager software, the 
raw data was exported as a FASTQ format into CLC Genomics Workbench v7.5 (CLC bio) where 
all bioinformatic analyses occurred, unless otherwise specified. Mary Tachedjian performed all 
bioinformatical analyses to achieve a full genome sequence. Raw data was filtered and trimmed 
using CLC “Trim Sequences” module. Ambiguous nucleotides were trimmed with maximum 
number of ambiguities set at two. Adapter sequences from library preparation and primer sequences 
from the random PCR reaction were removed via adapter trimming. Low quality reads were 
trimmed, with limit (p) set at 0.01, corresponding to a Phred score (Q) of 20. Finally read lengths 
below 180 bp and above 1000 bp were discarded via length trimming.  Output reads from trimming 
were then used for assembly. 
The trimmed reads for each sample were first mapped to their respective reference genomes: Cedar 
virus isolate CG1a, complete genome (Genbank accession: JQ001776) (CedPV-Ref) and Teviot 
paramyxovirus isolate 454 sequence assembly 2012 (Mary Tachedjian and Linfa Wang, 
unpublished) (TevPV-Ref). Next, a subtraction was performed to remove reads that mapped to host-
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cell genome (in this case Pteropus alecto genome from cell culture). The input was the P. alecto 
reference genome (Genbank accession number: ASM32557v1). All reads that mapped to this 
reference were discarded. As read-mapping of raw reads assumes similarity between the reference 
genome and the virus in question, an unbiased approach was also taken by performing a de novo 
assembly of the P. alecto subtracted data set for both samples. De novo assembly would allow the 
construction of contigs containing significant genetic differences compared to the reference 
sequence. Contigs formed from the de novo assembly were then mapped back to the Cedar virus 
and Teviot paramyxovirus reference sequences and the result compared to the result of mapping 
raw reads to the reference sequences as a means of validating each assembly method. A consensus 
viral genomic sequence for each sample was then assembled and made available for further 
analysis. The isolate of Cedar virus obtained from the Geelong P. poliocephalus colony is referred 
to as CedPV-Pp and the isolated of Teviot paramyxovirus obtained from the Geelong colony is 
referred to as TevPV-Pp.  
6.2.6.1 Initial analysis of contiguous sequences: Gap identification and gap filling by Sanger 
sequencing 
As the consensus sequence for Cedar virus isolated from the Geelong colony contained significant 
gaps, a second MiSeq
®
 run was performed as per section 6.2.5.6 with a higher concentration of 
input library DNA: 12 pM. The same bioinformatic workflow was performed on this sample as per 
6.2.6 and the results of both runs combined into one initial consensus sequence. Each read-mapped 
consensus sequence (one for Cedar virus and one for Teviot paramyxovirus) was assessed in 
relation to the reference sequences for regions of low coverage (< 10 x coverage) and each de novo 
assembled consensus sequence was assessed for regions of no coverage. The low/no coverage 
regions identified for filling-in with Sanger sequencing are shown in Table 6.4. These regions will 
be referred to as ‘gaps’: 
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Table 6.4. Gaps in consensus sequences of CedPV-Pp & TevPV-Pp 
Cedar virus 
Gap Number Genome location (nucleotide 1 to 18,162) Size (nucleotides) 
1 5’ end: 1-340 340 
2 4,023-4,171 149 
3 6,312-8,065 1,754 
4 8,722-9,171 450 
5 11,449-11,952 504 
6 13,979-14,067 89 
7 15,602-16,208 607 
8 17,446-17,623 178 
9 3’ end: 17,968-18,162 195 
Teviot paramyxovirus 
Gap Number Genome location (nucleotide 1 to 15,522) Size (nucleotides) 
1 3’ end: 15,425-15,457 33  
2 3’ end: 15,475-15,522 48 
 
Primers were designed to cover each of these gaps using CLC Genomics Workbench v7.5 (CLC 
bio). Where bordering sequence was unavailable (3’ and 5’ ends), the reference viral sequences 
were used for primer design. For Cedar virus, one set of primers were designed to bridge gaps 8 and 
9. For Teviot paramyxovirus, one set of primers were designed to bridge gaps 1 and 2. Primer 
sequences (GeneWorks) are given in Table 6.5.  
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Table 6.5. Primer sequences for CedPV-Pp & TevPV-Pp consensus gap filling 
Cedar virus 
Gap Number Forward Primer Sequence Reverse Primer Sequence Coverage (bp) Positions 
1 TCC GGA TTA AAT CAT ATT CG CTT TCA TAG ACT CTG CGG AG 329 23-351 
2 ACC ATT ACC CTG ATA AAG GC GTT CTA GTA TGG ACA GTA GC 285 3,970-4,254 
3 
TTG AAG GGC TAG AAG TCA GG ATG TCT TCG GGG AAG GTC CG 1,984 6,174-8,157 
GCA GTC ATC GCG TCA CAC TC AGG ATC ACT TAG AGG GAT AC 701 7,500-8,200 
4 AGC CAC TTC TGT TAC TCT CC CTC GTC TGA CGA GTA ATC TG 598 8,678-9,275 
5 GGC TAG ACT CAG AGG ATT TG TCT CAT CTT CCG GGT AGT TC 759 11,281-12,039 
6 AGA CAA ACA CCC GGA TAG CG CTG CAT GCT GCT CTA GTT TC 325 13,792-14,116 
7 AGA GTA TCG CGG CAT GTA AC TGC CTT GCA TGA GTG ATG TC 911 15,426-16,336 
8 & 9 CTG AAT TTT ACC TGA TTT GC ACC TAA AAA AGG GAA TTA TAA G 795 17,368-18,162 
Teviot paramyxovirus 
Gap Number Forward Primer Sequence Reverse Primer Sequence Coverage (bp) Positions 
1 & 2 TCA GAC TGA GCC AAT TAG GC CAA GGG GAA AAT CCA TAT AG 661 14,862-15,522 
 
Amplification of the gap regions was achieved by adding the RNA extracted from tissue culture 
supernatant as described in section 6.2.4 into the first round paramyxovirus-family based RT-PCR 
using the Superscript III One-Step with Platinum Taq kit (Invitrogen) also described in section 
6.2.4. The hemi-nested round of amplification was not performed. For gap 3 of Cedar virus, in 
addition to the primer pairs listed in Table 6.5, an additional forward and reverse primer (unpaired) 
were incorporated to ensure good coverage of this large region. The additional forward primer 
sequence was CV9 (ATG GGT GGG ATA GCA ATA GG) which bound to genome positions 
6744-6763 and the additional reverse sequence was CV8 (GAC CCA ACT ACT AGC GCC CA) 
that bound to genome positions 6718-6737. Extension time was extended from 1 min to 3 min for 
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expected products > 1000 bp. Products were ran on a gel, bands excised, DNA purified and 
sequenced in-house as per section 6.2.4 by capillary/Sanger sequencing. For each gap, two 
sequencing reactions were performed – one including the respective forward primer and the other 
the respective reverse primer as detailed in Table 6.5 to allow for sequencing overlap and sequence 
validation.  
Sanger sequences were imported into CLC Genomics Workbench v7.5, added to the existing 
trimmed next generation sequencing (NGS) paired-end reads and read mapped to the reference viral 
genomes using default parameters of CLC Genomics Genome Finishing Module “Add Reads to 
Contigs” algorithm to assess remaining regions of low and no coverage. Nucleotide differences 
between Sanger and NGS sequences were assessed individually. Nucleotide differences were 
ignored if they existed at the ends of NGS reads or in regions of poor quality according to the 
original Sanger trace files. Nucleotide differences that occurred in overlapping forward and reverse 
Sanger sequences were classified as real changes. A de novo assembly of the Sanger sequences and 
the read mapping consensus alignments was then performed using the “Align Contigs” algorithm of 
the CLC Genomics Workbench Genome Finishing Module. Completion of gap filling and de novo 
assembly resulted in the output of a final consensus sequence for each virus.    
6.2.6.2 Final analysis of contiguous sequences: Variant detection 
As the libraries were generated by using numerous PCR reactions, duplicate reads from read 
mapping were first removed before variant detection using the “Remove Duplicate Mapped Reads” 
function in CLC Genomics Workbench. A basic variant detection analysis was then performed on 
the read mapped reads using the “Basic Variant Detection” function in CLC Genomics Workbench. 
Minimum coverage was set at 10, minimum frequency of the variant set at two and minimum 
frequency set at 35%. All SNPs generated from basic variant detection were then manually 
confirmed as the algorithm does not include SNPs occurring in Sanger sequences. Manual 
confirmation involved the comparison of the reference genome with the subject virus read mapping 
consensus sequence and the de novo assembled contigs.    
Final consensus sequences were compared to their respective reference sequences with  regard to 
genome lengths, adherence to the Rule-of-Six observed for all known members of the subfamily 
Paramyxovirinae (Lamb and Parks, 2007), positions of open reading frames (ORFs), protein 
lengths and presence or absence of RNA editing sites within the P (phosphoprotein) gene. Once 
ORFs were determined, SNPs were classified as occurring in either coding or non-coding regions. 
Translated protein sequences were compared to respective reference sequences and SNPs occurring 
in coding regions were classified as to whether or not the mutation resulted in an amino acid 
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change. Each amino acid change was classified as being a conserved or non-conserved change. A 
conserved amino acid change is classified as one where a SNP results in translation of the same 
amino acid or an amino acid from the same group compared to the reference protein sequence. 
Groupings of amino acids were considered as per the table sourced at The University of Manchester 
(2013) and shown in Appendix 7. All such analyses were performed using Clone Manager v9 (Sci-
Ed Software).  
6.2.7 Phylogenetical analysis 
A phylogenetic tree was constructed to compare the full length genome sequence of TevPV-Pp to a 
selection of 16 other rubulaviruses. The tree was constructed using CLC Genomics Workbench v7. 
Whole genome sequences were downloaded from GenBank (National Center for Biotechnology 
Information, 2014). Accession numbers are given in Appendix 8. Selected viruses and their 
abbreviations include: Human parainfluenza virus 2 (hPIV2), human parainfluenza virus 4 (hPIV4), 
Mapuera virus, Mumps virus, parainfluenza virus 5 (PIV5), porcine rubulavirus (pRV), simian 
parainfluenza virus 41 (sPIV41), Achimota virus 1, Achimota virus 2, Menangle virus, Sosuga 
virus, Tioman virus, Tuhoko virus 1, Tuhoko virus 2, Tuhoko virus 3, Pp TevPV, and the reference 
Teviot paramyxovirus (rTeviot virus). An alignment was performed followed by a Neighbour-
Joining phylogenetic analysis using a Jukes Cantor nucleotide distance measure and showing the 
results of 1000 bootstrap replicates. A second phylogenetic tree was constructed using the same 
method to compare the full length genome sequence of CedPV-Pp to CedPV-Ref as well as to all 
available whole genome sequences of the other members of the henipavirus genus. Additional 
sequences included Nipah virus Malaysia (NiV-M), Nipah virus Bangladesh (NiV-B), Mojiang 
virus, Hendra virus, and Hendra virus strain HeV/Australia/Bat/2009/Cedar Grove 11c. GenBank 
references are included in Appendix 8. A third phylogenetic tree was constructed also using the 
same method. This tree included the same rubulaviruses from the first tree in addition to selected 
whole genome sequences of viruses from the Avulavirus, Respirovirus, Morbillivirus and 
Henipavirus genera of sub-family Paramyxovirinae. Additional viruses included: Newcastle disease 
virus (NDV), bovine parainfluenza virus 3 (bPIV3), human parainfluenza virus 3 (hPIV3), porcine 
parainfluenza virus 1 (pPIV1), Sendai virus, canine distemper virus, measles virus, rinderpest virus, 
Nipah virus Malaysia (Nipah virus M), Nipah virus Bangladesh (Nipah virus B), Hendra virus, 
Cedar virus and CedPV-Pp. GenBank references are included in Appendix 8. This tree enabled the 
assessment of where TevPV-Pp and CedPV-Pp are placed phylogenetically within the subfamily 
Paramyxovirinae.  
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6.3 RESULTS 
6.3.1 Virus isolation 
Of the ten pooled urine samples collected on 26/10/2010, cells inoculated with urine from pool 
number 3 showed evidence of CPE from day 7 of the first pass in PaKi cells (P1D7). The initial 
signs of CPE were of cell death. On day 3 of the second pass (P2D3) in PaKi cells there were 
obvious signs of syncytial CPE which progressed with time (Figure 6.1). Syncytial CPE was 
observed also on P3D6 in PaKi cells. The only signs of CPE in Vero cells for urine pool number 3 
occurred two days after passage of supernatant from infected P2D7 PaKi cells to Vero cells.  
 
Figure 6.1. P2D4 PaKi cells. a: infected cells showing syncytial CPE. b: control cells 
 
 
Over 3 passages, no evidence of CPE was observed for cells inoculated with the ten pooled urine 
samples collected on 11/11/2011. For the ten pooled urine samples collected on 21/11/2011, cells 
inoculated with urine from pool number 7 showed evidence of syncytial CPE from day 6 of the first 
pass in PaKi cells (P1D6) (Figure 6.2). Syncytial CPE was observed on day 3 of the second pass 
(P2D3) in PaKi cells. The only sign of CPE in Vero cells for urine pool number 7 occurred three 
days after supernatant was passed from infected P1D7 PaKi supernatant to Vero cells 
 
b a 
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Figure 6.2. P1D6 PaKi cells. a: infected cells showing syncytial CPE. b: control cells 
 
 
In summary, of the 30 pooled urine samples used to isolate virus, two samples resulted in positive 
signs of CPE characterized by syncytia formation.  
6.3.2 Preliminary characterization by PCR and limited sequencing 
A BLAST search of sequence data from the RNA extracted from cells infected with pooled urine 
sample 3 of the 26/10/2010 collection revealed the closest match as Cedar virus isolate CG1a 
(accession number JQ001776) with 83% query coverage and 99% identity. A BLAST search of 
sequence data from the RNA extracted from cells infected with pooled urine sample 7 of the 
21/11/2011 collection revealed the closest match as Teviot virus strain 3c (accession number 
KJ716814) with 84% query coverage and 98% identity. The attempt to isolate Yarra Bend 
paramyxovirus in cell culture was unsuccessful.  
Cedar virus- and Teviot paramyxovirus- specific qRT-PCRs performed on RNA extracted from 
virus pellets prepared in section 6.2.5.1 were positive for the respective viruses. Both samples gave 
a CT value of 30. The Cedar virus- specific qRT-PCR performed on RNA extracted from 
supernatant from P1D10, P2D7 and P3D9 infected PaKi cells and P3D9 infected Vero cells (for 
urine sample 3 of 26/10/10) was positive for all samples (CT < 39). CT values varied depending on 
passage number and cell type. CT values are given in brackets after each passage number and cell 
type: P1D10 PaKi (21), P2D7 PaKi (24), P3D9 PaKi (23) and P3D9 Vero (18). The Teviot 
paramyxovirus qRT-PCR was not applied to RNA extracted from infected-cell supernatant. 
a b 
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6.3.3 Characterisation of the new Cedar virus isolate from Pteropus poliocephalus 
6.3.3.1 Genome assembly 
The total number of trimmed paired-end reads combined from both MiSeq
®
 runs for Geelong 
Pteropus poliocephalus Cedar virus (CedPV-Pp) was 32.96 x 10
6
 reads. From the first run, 13,098 
reads mapped to the CedPV reference genome and for the second run there were 150,347 mapped 
reads. For the second run, 0.46% of reads mapped to the reference genome. The results of both runs 
revealed gaps in the genome (22% of genome missing), the most significant of which occurred in 
the region of the F (fusion) gene (Table 6.4). Of the total number of trimmed pair-end reads, 88% 
mapped to the P. alecto host genome sequence and were subtracted from further analysis. After the 
de novo assembly, nine of 2,914 contigs aligned to the CedPV reference genome. The consensus 
sequence created from the read-mapping and the de novo assembly showed gaps in the same 
regions. As both assembly methods revealed similar gaps, missing data are unlikely due to 
significant differences between the reference and subject genomes and more likely due to missing 
data that requires further sequencing.  
Gaps in the CedPV-Pp genome are shown in Table 6.4. Sanger sequences generated from the 
methods of 6.2.6.1 filled all gaps except for the first 22 bases of the genome (5’ end of messenger 
sequence). Due to the high level of sequence homology between CedPV-Pp and the reference 
genome, the first 22 bases of the reference genome were extrapolated onto the CedPV-Pp final 
sequence. For the final read mapping, the highest read coverage was 10690 reads (within the G 
gene) with an average coverage of 951 reads. In the final de novo assembly, six overlapping contigs 
mapped to the reference genome. The complete CedPV-Pp genome is deposited in GenBank with 
the accession number KP271122 All descriptions given of the CedPV-Pp genome are described in 
the 5’ to 3’ coding (antigenome/messenger) frame.  
6.3.3.2 Comparison with the original Cedar virus isolate from bats in Queensland 
The genome of CedPV-Pp is 18,162 nucleotides in length and is a multiple of six, thus conforming 
to the Rule-of-Six for viruses of the subfamily Paramyxovirinae (Lamb and Parks, 2007, 
Kolakofsky et al., 2005). CedPV-Pp is the same length as the reference genome (Marsh et al., 
2012). Open reading frames were located with ATG start codons and TGA/TAA stop codons, 
compared to the reference sequence and extrapolated for CedPV-Pp. The location of the protein 
coding genes, names and lengths of the translation products are shown in Table 6.6. The location, 
order and relative sizes of the seven protein coding regions are depicted graphically in Figure 6.3. 
The N gene encodes the nucleocapsid protein (N), the P gene encodes the phosphoprotein (P) and 
the smaller non-structural C protein (C), the M gene encodes the matrix protein (M), the F gene 
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encodes the fusion glycoprotein (F), the G gene encodes the attachment glycoprotein (G) and the L 
gene encodes the RNA polymerase protein (L).  
Table 6.6. Location of coding regions in CedPV-Pp genome with encoded protein identification 
and lengths 
Gene ORF Start ORF End Protein Translation Product (AA) 
N 144 1676 Nucleocapsid 510 
P 2112 4325 Phosphoprotein 737 
C 2137 2670 Non-structural 177 
M 4635 5717 Matrix 360 
F 6405 8078 Fusion glycoprotein 557 
G 8268 10136 Attachment glycoprotein 622 
L 10572 18077 RNA polymerase 2501 
 
 
Figure 6.3. Location and order of protein coding regions for CedPV-Pp 
CedPV-Pp genome schematic showing coding regions in yellow. Upper numbers denote nucleotide positions. 
Letters are gene abbreviations (see text). The smaller coding region of the P gene (also denoted P) is the non-
structural C protein.  
 
Compared to the reference genome, a manual confirmation of the basic variant detection revealed 
27 SNPs representing 0.15% nucleotide variation across the entire genome. The CedPV-Pp full 
genome sequence aligned with the reference sequence showing all SNPs is given in Appendix 5. 
Appendix 9 shows the position of each SNP, whether it occurs in a coding (with corresponding 
gene) or non-coding region of the genome, the nucleotide change and whether this change results in 
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no amino acid change, a conserved amino acid change or a non-conserved amino acid change. 
Table 6.7 shows protein similarities between CedPV-Pp and the reference virus.  
Table 6.7. CedPV-Pp amino acid changes per protein compared to reference virus proteins 
Protein 
Length 
(aa) 
No. SNPs in 
coding region 
No. amino 
acid changes 
% similarity to 
reference protein 
sequence 
Conserved:Non-
conserved 
N 510 4 3 99.4 1:2 
P 737 1 0 100 NA 
C 177 0 0 100 NA 
M 360 3 3 99.2 1:2 
F 557 1 1 99.8 0:1 
G 622 3 2 99.7 1:1 
L 2501 11 3 99.9 1:2 
 
Of the 27 SNPs, the majority (23; 85%) occur in coding regions of the genome while the remainder 
(4; 15%) occur in non-coding regions. Of the 23 SNPs that occur in coding regions, 11 (48%) are 
synonymous mutations (do not result in an amino acid change) and 12 (52%) are non-synonymous 
mutations (do result in an amino acid change). Of the 12 non-synonymous mutations, 4 (33%) result 
in a conserved amino acid change while 8 (67%) result in a non-conserved amino acid change. 
Thus, there is a high degree of protein conservation between CedPV-Pp and those of the reference 
virus. All CedPV-Pp protein sequences exceed 99% similarity to those of the reference virus.  
As found by Marsh et al. (2012), the reference Cedar virus lacks the RNA editing site in the P gene 
necessary for production of mRNAs with different ORFs encoding for multiple proteins. This is in 
contrast to the other members of the genus Henipavirus. Furthermore, Marsh et al. (2012) did not 
find the highly conserved, cysteine-rich ORF that codes for the V protein which is present in most 
other paramyxoviruses. No conserved P gene RNA editing site was evident in the NGS dataset for 
CedPV-Pp, matching that of the reference virus.  
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6.3.4 Characterisation of the new Teviot paramyxovirus isolate from Pteropus poliocephalus 
6.3.4.1 Genome assembly 
The total number of trimmed paired-end reads for Geelong Pteropus poliocephalus Teviot 
paramyxovirus (TevPV-Pp) was 5.28 x 10
6
 reads. In total, 249,416 reads (4.72%) mapped to the 
TevPV reference genome. In general there was excellent coverage of the genome. Of the total 
number of trimmed pair-end reads, 84% mapped to the P. alecto host genome sequence and were 
subtracted from further analysis. The consensus sequence created from the read-mapping and the de 
novo assembly showed gaps in the same regions. Low coverage occurred at the 3’ end (Table 6.4). 
NGS reads missing at the 5’ end of the genome (positions 1 to 7) were inferred from the Menangle 
virus genome (GenBank accession number AF326114) as leader sequences are conserved across the 
rubulavirus genus (Lamb and Parks, 2007). 
The region of low or no coverage at the 3’ end of the genome (Table 6.4) was determined by Sanger 
sequencing. For the final read mapping, the highest read coverage was 12614 reads (within the L 
gene) with an average coverage of 1894 reads. The complete TevPV-Pp genome is deposited in 
GenBank with the accession number KP271123 All descriptions given of the TevPV-Pp genome 
are described in the 5’ to 3’ coding (antigenome/messenger) frame. 
6.3.4.2 Comparison with the original Teviot paramyxovirus isolate from bats in Queensland 
The genome of TevPV-Pp is 15,522 nucleotides in length and is a multiple of six, thus conforming 
to the Rule-of-Six for viruses of the subfamily Paramyxovirinae (Lamb and Parks, 2007, 
Kolakofsky et al., 2005). TevPV-Pp is the same length as the reference genome (Mary Tachedjian 
and Linfa Wang, unpublished). Open reading frames were located with ATG start codons and 
TGA/TAA/TAG stop codons, compared to those of Tioman virus (GenBank ref. AF298895) and 
the reference sequence, and extrapolated to TevPV-Pp. The gene boundary information was not 
available for the reference genome and thus was determined initially for TevPV-Pp. The location of 
the gene regions, open reading frames, and names and lengths of the translation products are shown 
in Table 6.8. The location, order and relative sizes of the seven protein coding regions are depicted 
graphically in Figure 6.4. The N gene encodes the nucleoprotein (N), the P gene encodes the 
phosphoprotein (P) and the smaller V protein (V), the M gene encodes the matrix protein (M), the F 
gene encodes the fusion glycoprotein (F), the HN gene encodes the haemagglutinin-neuraminidase 
protein (HN) and the L gene encodes the RNA polymerase protein (L). Both TevPV-Pp and the 
reference virus have 5’ leader sequences of 55 nucleotides in length. The first 14 nucleotides of 
each virus are the reverse complement of the final 14 nucleotides of the trailer sequence as occurs 
for rubulaviruses. Genes are bound by conserved transcriptional start and stop signals and separated 
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by intergenic regions (IGRs) that varied in length and sequence composition (Table 6.9). Gene 
boundaries and IGRs are compared between TevPV-Pp and Tioman virus (Lau et al., 2010). 
TevPV-Pp and the reference virus have an AG couplet at positions 5 and 6 of the antigenome, 
similar to most rubulaviruses except for Sosuga virus, Tuhoko viruses 1, 2 & 3 and Achimota 
viruses 1 & 2 which have a GA couplet at this position (Albariño et al., 2014, Lau et al., 2010, 
Baker et al., 2013c). 
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Table 6.8. Location of coding regions in TevPV-Pp genome with encoded protein identification 
and lengths 
Gene Feature Start End Protein 
Translation Product 
(AA) 
 3’ Leader 1 55   
N Gene 56 1843   
 ORF 165 1724 Nucleocapsid 519 
P Gene 1885 3345   
 P ORF 2033 3188 Phosphoprotein 
385 
 
 V ORF 2033 2713 V protein 226 
 mRNA editing 
site 
2474 2475   
M Gene 3354 4769   
 ORF 3389 4516 Matrix 375 
F Gene 4772 6548   
 ORF 4846 6462 Fusion glycoprotein 538 
HN Gene 6589 8551   
 ORF 6644 8431 
Haemagglutinin-neuraminidase 
(attachment) 
595 
L Gene 8634 15499   
 ORF 8642 15457 RNA polymerase 2271 
 5’ Trailer 15500 15522   
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Figure 6.4. Location and order of protein coding regions for TevPV-Pp 
TevPV-Pp genome schematic showing coding regions in yellow. Upper numbers denote nucleotide positions. 
Letters are gene abbreviations (see text). The P protein is coded from the P and P’ coding regions combined. The 
smaller coding region of the P gene encodes the V protein.  
 
Table 6.9. Nucleotide sequences of intergenic regions (IGRs) and transcriptional start and stops 
signals of TevPV-Pp compared to the reference genome 
Gene Virus Start Stop 
IGR 
Sequence Size 
N 
TevPV-Pp GAGCCCAGAAGT ATTTAAGAAAAAA CAAGTATCAG…AAACTGAAACT 41 
Tioman virus GAGCCCAGAACT TTTTAAGAAAAAA CAGAAATTAA…CAAAAGCCGGT 41 
P/V 
TevPV-Pp GAGCCCGAAC TTTTAATAAAAAA TCAAAAAT 8 
Tioman virus GAGCCCGAAT TTTAAGAAAAAA CTTAAAAT 8 
M 
TevPV-Pp GGGTCCGAAC ATTTAAGAAAAAA TT 2 
Tioman virus GGGTCCGAAC TTTTAATAAAAAA CTAAGGGGTA…CCATGGCTA 35 
F 
TevPV-Pp GAGCCCGGAA TTTAAAGAAAAAA TTAGTGATTG…AGCTAAAACGT 40 
Tioman virus GAGCCCGAAC TTTAAGGAAAA CTAGGCATAT…AACAGCGCTTG 55 
HN 
TevPV-Pp GGGCCCGAAC TTTAAGAAAAAA TTGACTCCAT…GCAATATAACT 82 
Tioman virus GAGCCCGACT TTTAAGAAAAAA CTAAAGGGGA…CAAGTCCAAGT 70 
L 
TevPV-Pp GGGCCAGA 
TTTAATAAAAAAA 
 
CCTATATGGATTTTCCCCTTGGT 
(5’ trailer sequence) 
23 
Tioman virus GGGCCAGAAT TTTAAGAAAAAAA 
CCTATATTGATTTTCCCCTTGGT 
(5’ Trailer sequence) 
23 
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Compared to the reference genome, a manual confirmation of the basic variant detection revealed 
101 SNPs representing 0.65% nucleotide variation across the entire genome. The TevPV-Pp full 
genome sequence aligned with the reference sequence showing all SNPs is given in Appendix 6. 
Appendix 10 shows the position of each SNP, whether it occurs in a coding (with corresponding 
gene) or non-coding region of the genome, the nucleotide change and whether this change results in 
no amino acid change, a conserved amino acid change or a non-conserved amino acid change. 
Table 6.10 shows protein similarities between TevPV-Pp and the reference virus 
Table 6.10. TevPV-Pp amino acid changes per protein compared to reference virus proteins 
Protein 
Length 
(aa) 
No. SNPs in 
coding region 
No. amino 
acid changes 
% similarity to 
reference protein 
sequence 
Conserved:Non-
conserved 
N 519 9 0 100 NA 
V 226 4 1 99.6 0:1 
P 385 10 4 99 1:3 
M 375 2 0 100 NA 
F 538 9 0 100 NA 
HN 595 9 3 99.5 2:1 
L 2271 40 6 99.7 2:4 
 
Of the 101 SNPs, the majority (79; 78%) occur in coding regions of the genome while the 
remainder (22; 22%) occur in non-coding regions. Of the 79 SNPs that occur in coding regions, 65 
(82%) are synonymous mutations (do not result in an amino acid change) and 14 (18%) are non-
synonymous mutations (do result in an amino acid change). Of the 14 non-synonymous mutations, 
5 (36%) result in a conserved amino acid change while 9 (64%) result in a non-conserved amino 
acid change. There is a high degree of protein conservation between TevPV-Pp and those of the 
reference virus. All TevPV-Pp protein sequences are at least 99% similar to those of the reference 
virus.  
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As per the closely related Tioman virus (Chua et al., 2001), the P gene of TevPV-Pp contains an 
RNA editing site between nucleotide positions 2474 and 2475 of the genome: 
TTTAAGA*GGGGGGATT. The sequence TTTAAGA preceding the 6-G residues is identical to 
the putative transcriptional termination signal in a number of rubulaviruses including Tioman virus 
(Chua et al., 2001). In addition to viral genome sequence data, MiSeq
®
 analysis enabled the 
assessment of mRNA modifications through the read mapping results. In most cases there were 
either no or 2-G non-templated insertions in the P gene mRNA. No reads contained single G 
insertions (coding for the W protein in Tioman virus) and only 1 read contained a 3-G insertion 
(unreliable data).  
Production of the P protein involves the addition of 2-G residues at the editing site during 
transcription. The P gene mRNA is 1,158 nucleotides long and includes the 2-G residue insertion 
(Figure 6.5). The P gene mRNA encodes for the P protein 385 amino acids in length (Figure 6.6).  
Figure 6.5. TevPV-Pp edited partial mRNA sequence encoding for P protein. Red G residues show 
the 2-G insertion at the editing site 
AAGAGGGGGGGGATTCCTCCGCCACATGGCCCCGCCGCCACAGACAAGGGGGCCACAGGAGGGAGA
TTGCAATCAGCTGGGCAACAGGGGTCCCACGAGTCACAGAATGGTG 
 
Figure 6.6. TevPV-Pp P protein amino acid sequence 
MDASPSDAEISAWIDKGLDTVEHFLSVATPPVRSLGKSSIKPGNTGELISAAEKLVSNMEGITASS
PTMKGPDPAVRPKERTKPPQDNAQNQEQNDIYEEVIPSESTALIPKSAPKKPSRNKEKVMSMMALS
PPEDNSAKEKPSVFK|RGGIPPPHGPAATDKGATGGRLQSAGQQGSHESQNGATQYVTQYLNPRTE
DPVGADSAQMSALCVREIMHYLQTLETRITNLDWKVDKLLSQQSTITQIKNDQHTIKASLATIEGL
ITTIKIMDPGVGPGATAAQAKKIFKEVPVVISGPILGENQVIHADTIQLDELARPSPAKGKQAKTA
SPNPNAVIGYRSTLQSLVKECITNPGLRQKFDVAINSVKTEQDFKQVRRDIIRSAT* 
The red arginine (R) residue highlights the first translated amino acid at the insertion site 
 
Production of the V protein arises from translation of unedited mRNA (no G insertions) (Figure 
6.7). The V protein mRNA is 681 nucleotides and encodes for a protein 226 amino acids in length 
(Figure 6.8). In summary, the P gene of TevPV-Pp has the potential to code for at least two 
different proteins (P and V) with a common N-terminal 147 amino acid region, the same as for 
Tioman virus (Chua et al., 2001). As no mRNA sequences displaying a single G insertion were 
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found with this NGS dataset, there is no evidence that TevPV-Pp produces a W protein as Tioman 
virus (Chua et al., 2001). The addition of 3-G residues has not been described for Tioman virus nor 
for the related Menangle virus and is likely a spurious result of NGS. Further sequencing targeting 
transcription products of this region is required to make more informed conclusions as to the coding 
capacity of TevPV-Pp P gene. The unpublished reference Teviot paramyxovirus isolate sequence 
(Mary Tachedjian and Linfa Wang, unpublished) was constructed using 454 sequencing. Such 
sequencing did not allow the assessment of edited mRNA. Using the data from TevPV-Pp, the P 
gene editing site for this reference virus was identified and allowed comparisons between the P and 
V protein sequences of both viruses.  
 
Figure 6.7. TevPV-Pp unedited partial mRNA sequence encoding for V protein 
AAGAGGGGGGATTCCTCCGCCACATGGCCCCGCCGCCACAGACAAGGGGGCCACAGGAGGGAGATT
GCAATCAGCTGGGCAACAGGGGTCCCACGAGTCACAGAATGGTG 
 
Figure 6.8. TevPV-Pp V protein amino acid sequence 
MDASPSDAEISAWIDKGLDTVEHFLSVATPPVRSLGKSSIKPGNTGELISAAEKLVSNMEGITASS
PTMKGPDPAVRPKERTKPPQDNAQNQEQNDIYEEVIPSESTALIPKSAPKKPSRNKEKVMSMMALS
PPEDNSAKEKPSVFK|RGDSSATWPRRHRQGGHRREIAISWATGVPRVTEWCNPICHPISQSTYRG
SCRCGFCPDVCSLCEGDYALLTDIRDSDY* 
The red arginine (R) residue highlights the first translated amino acid at the insertion site. No mRNA editing 
occurs for production of the V protein. 
6.3.5 Phylogenetics 
The results of the phylogenetic analysis of 17 full-length rubulavirus genome sequences are shown 
in Figure 6.9. The results of the phylogenetic analysis of 7 full-length henipavirus genomes are 
presented in Figure 6.10. The results of the phylogenetic analysis expanded to include selected 
members of the Avulavirus, Respirovirus, and Morbillivirus genera in addition to the Rubulaviruses 
and Henipaviruses are shown in Figure 6.11.  
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Figure 6.9. Phylogenetic tree based on 17 whole genome sequences of selected rubulaviruses 
 
Figure 6.9. Phylogenetic analysis of whole genome sequences of 17 viruses of the genus Rubulavirus. See text for 
complete virus names. The bat image highlights those viruses detected and/or isolated from a chiropteran host. 
Only bootstrap values of 100% are shown at nodes. Unclassified rubulaviruses include: Achimota viruses 1 & 2, 
Menangle virus, pPIV, Sosuga virus, Tioman virus, TevPV-Ref, TevPV-Pp, and Tuhoko viruses 1, 2 & 3. The 
remaining viruses are classified rubulaviruses according to the ICTV. Genbank accession numbers for each 
virus are given in Appendix 8. 
 
150 
 
Figure 6.10. Phylogenetic tree based on 7 whole genome sequences that comprise the genus 
henipavirus 
 
Figure 6.10. Phylogenetic analysis of whole genome sequences of 7 henipaviruses. See text for complete virus 
names. Mojiang virus was detected in a rodent as denoted by the image (Zhiqiang et al., 2014). The remaining 
henipaviruses have all been detected and/or isolated from a chiropteran host. Only bootstrap values of 100% are 
shown at nodes. Root is imputed. GenBank accession numbers for each virus are given in Appendix 8. 
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Figure 6.11. Phylogenetic tree based on whole genome sequences of selected members of sub-
family Paramyxovirinae 
 
Figure 6.11. Phylogenetic analysis of whole genome sequences of selected paramyxoviruses. Viruses are shown 
grouping in their respective genus (Rubulavirus, Avulavirus, Respirovirus, Morbillivirus and Henipavirus). See 
text for complete virus names. Only bootstrap values of 100% are shown at nodes. Genbank accession numbers 
for each virus are given in Appendix 8.  
 
TevPV-Pp and CedPV-Pp share a very close phylogenetic relationship with their particular 
reference viruses within the rubulavirus and henipavirus genera respectively. TevPV-Pp is a variant 
of Teviot paramyxovirus and CedPV-Pp is a variant of Cedar virus. The next closest relatives to 
Teviot paramyxovirus are Tioman and Menangle viruses. The closest relatives to Cedar virus are 
Hendra and Nipah viruses. 
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6.4 DISCUSSION 
6.4.1 Genetic comparison of Geelong isolates to the reference viruses 
Teviot paramyxovirus was first isolated from pooled urine samples collected from a mixed species 
pteropid bat colony in Cedar Grove, Queensland in 2009 (Barr et al., 2014). This virus was 
subsequently re-isolated from urine collected from colonies in Boonah, Queensland and Nambucca 
Heads, New South Wales in 2011 (Barr et al., 2014). The Cedar Grove isolate of Teviot 
paramyxovirus was sequenced using 454 technology and the consensus sequence used as the 
reference genome. Cedar virus was also first isolated from the same collection of pooled urine 
samples collected from the Cedar Grove colony in 2009 (Marsh et al., 2012). The Geelong isolates 
of Teviot and Cedar viruses described here are separated from the original isolates temporally by 
two and one year(s) respectively and spatially by over 1, 800 kilometres. The isolation of the same 
virus from such geographically disparate locations is not surprising given the interconnectedness of 
pteropid bat populations. 
Based on the error rates measured for RNA polymerases in vitro (Steinhauer et al., 1992), it is 
commonly thought that RNA viruses mutate relatively rapidly with time. However, Rima (2014) 
identified a paradox between the stability and sequence conservation of paramyxoviruses in the 
field versus the high error rates measured in vitro. A high degree of genetic stability has been 
observed for Hendra virus isolated from bats and horses alike (Smith et al., 2011, Marsh et al., 
2010). Rima (2014) suggests this conservation is attributable to constraints imposed that limit 
variability in important promoter regions, protein functionality, the interaction of the RNA genome 
with the nucleocapsid protein, RNA secondary structures, and codon usage pattern. It is thus very 
difficult to predict on the basis of in vitro data the variance that would be expected in nature.  
With the above in mind, considering virus evolution through time and space, the expected amount 
of variation between the isolates is difficult to estimate. Although the Geelong isolates are > 99% 
similar to their respective reference viruses at both the genome and protein levels, for both viruses 
the majority of SNPs occurred in ORFs and when a base change resulted in an amino acid change, 
the majority were substituted for a non-conserved amino acid. The significance that these altered 
proteins have in affecting viral transmissibility and virulence in both the reservoir and spillover 
hosts is unknown and requires further protein modeling and experimental testing. For TevPV-Pp, 
the majority of nucleotide changes did not result in amino acid changes. For CedPV-Pp, the 
majority of nucleotide changes did result in amino acid change. This may reflect different stages of 
virus adaptation to their hosts. There are not enough data available to make an assessment of the 
degree of co-evolution of these viruses with their host species. Similar to the method employed by 
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Switzer et al. (2005), this would require genetic information from multiple Cedar virus isolates, 
preferably from multiple host species as well as a genetic marker of bat phylogeny from multiple 
bat species. These would be informative analyses however, particularly in identifying the natural 
reservoir host species of a virus, or at least the host species that has shared the longest evolutionary 
relationship with a virus. Alternatively, co-infection of Cedar virus with another virus may result in 
complementation, where selection pressure against deleterious mutations are weakened (Gao and 
Feldman, 2009). Indeed one pooled urine sample was positive for both CedPV and YarPV sequence 
(Chapter 3, Section 3.3.2), possibly representing co-infection.  
If it is concluded that the Geelong isolates are more similar than expected to the reference viruses, 
bias in the isolation and sequencing technique may select for certain viral variants that 
overestimates the degree of paramyxovirus sequence conservation. Barr et al. (2014) discussed the 
possibility that certain viral variants may outperform others in cell culture conditions. A study by 
Allison et al. (2014) showed that parvoviruses passaged in vitro developed specific mutations 
depending on the host cells in which they were grown. Furthermore, constructing a consensus 
sequence from NGS and Sanger sequencing data are biased towards the most abundant sequences 
and does not allow the identification of viral variants. However, sequencing directly from biological 
samples was performed as part of a molecular epidemiology study of Hendra virus and a high 
degree of sequence homology was still observed (Ina Smith, personal communication).  
It may be argued that the viruses isolated as part of these projects could be laboratory contaminants 
of the reference viruses. For Cedar virus this is highly unlikely as all work done on the original 
2010 isolate was performed at BSL-4 whereas the work for this project was performed at BSL-3 in 
a completely separate and contained area. Furthermore, isolation was only successful from samples 
that were previously tested positive for viral RNA in the nc-Luminex assay from Chapter 3. The 
SNPs detected for the Geelong isolates of CedPV and TevPV does support that these viruses are 
unique variants of the reference viruses.  
6.4.2 Bat rubulaviruses 
A large proportion of known rubulaviruses have been detected from bats, particularly fruit bats. 
Although a genome sequence does not exist, the first rubulavirus to be isolated from a bat was bat 
parainfluenza virus which was isolated using cell culture from a Rousettus leschenaultia bat in India 
(Hollinger and Pavri, 1971). Mapuera virus was isolated from the salivary glands of Sturnira lilium 
in Brazil (Hagmaier et al., 2007). Tioman virus was isolated in cell culture from pooled urine 
samples of Pteropus hypomelanus in Malaysia (Chua et al., 2001). Tuhoko viruses 1, 2 & 3 were 
sequenced directly from tissue samples collected from Rousettus leschenaultia bats of China (Lau et 
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al., 2010). Achimota viruses 1 & 2 were isolated in cell culture from pooled urine samples collected 
from Eidolon helvum bats of Africa (Baker et al., 2013c). Menangle virus, Hervey virus, Grove 
virus, Teviot virus and Yeppoon virus were all isolated in cell culture from pooled urine samples 
collected from Pteropus sp. bats of Australia (Barr et al., 2014).Sosuga virus, while detected and 
characterised from deep sequencing of blood samples from a human patient with an acute febrile 
illness, has been linked to the patient’s contact with bats of multiple possible species in Africa 
(Albariño et al., 2014). Thus of the 16 viruses in the rubulavirus genus, over a half (56%) have 
come from bats. 
Of the other Paramyxovirinae genera, bat virus isolates have only been obtained for the 
Henipavirus genus (Hendra virus, Cedar virus and Nipah virus). A number of studies obtained 
partial viral sequence data to suggest bats harbor viruses that belong to the genus Morbillivirus and 
the Unclassified or ‘Jeilongvirus’ genus however no viral isolates were obtained (Drexler et al., 
2012, Yuan et al., 2014, Maganga et al., 2014). While isolation methods may favour the isolation of 
rubulaviruses from bats, it is clear that these animals harbor a wide variety of rubulaviruses over a 
large proportion of the globe. Undoubtedly more viruses from the rubulavirus genus (and other 
Paramyxovirinae genera for that matter) will be discovered with increased surveillance effort such 
as evidence of rubulavirus infection in European bat species (Kurth et al., 2012) and Indonesian 
fruit bats (Sasaki et al., 2012). The zoonotic potential of the bat henipaviruses is clear however that 
of the rubulaviruses is largely unknown. Neutralising antibodies were found in two piggery workers 
associated with the Menangle virus outbreak. These people had a history of severe flu-like illness 
(Chant et al., 1998). Neutralising antibodies against Tioman virus was detected during surveillance 
in three asymptomatic people (Yaiw et al., 2007). Neutralising antibodies to Achimota 2 virus was 
found in two healthy people and one febrile paediatric patient (Baker et al., 2013c). Sosuga virus 
has already been discussed above. Thus, evidence suggests that rubulavirus are capable of crossing 
species barriers to infect humans however their potential to cause disease remains uncertain.  
6.4.3 Purification process 
Bioinformatic analysis revealed significant contamination of both virus preparations with Pteropus 
alecto genome from the cell culture process. Such contamination reduces the depth of NGS 
coverage and likely contributed to the significant gaps in the genome of CedPV-Pp. The virus 
purification procedure used was suboptimal and would require refining for future experiments. The 
use of filtering and DNAse treatment as used in Djikeng et al. (2008) should be considered in 
combination with growing viruses in cell culture to higher titres and using longer ultracentrifugation 
times.  
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6.4.4 Detection of viral RNA versus isolation of infectious virus 
Both CedPV-Pp and TevPV-Pp were isolated from pooled urine samples previously determined in 
the nc-Luminex to be positive for specific viral RNA. The MFI value of urine pool number 3 of the 
26/10/2010 collection from which CedPV-Pp was isolated was 1,066. CedPV-Pp RNA at an MFI of 
2,414 was also detected in urine pool number 4 of the 11/11/2011 collection but virus was not 
isolated in cell culture from this sample. A positive correlation does not seem to exist between MFI 
values (semi-quantitative) and isolation success. A lack of correlation was also seen for Smith et al. 
(2011) between low Ct values in a quantitative TaqMan PCR assay and isolation success of Hendra 
virus. Attempts to isolate Yarra Bend paramyxovirus from RNA-positive pooled urine samples in 
this study was also unsuccessful. Although not described in this Chapter, inoculation of the same 
urine samples into embryonated eggs and suckling mice brains was also performed in an attempt to 
isolate infectious virus but were also unsuccessful. The partial sequence of Yarra Bend 
paramyxovirus suggests it is not a rubulavirus and thus may not be as successful at propagating in 
cell culture conditions. Without a virus isolate there is debate as to whether detection of partial or 
even full virus sequences signify the existence of a real virus. Detection of viral RNA certainly does 
not indicate that infectious viral particles are present in a sample and may be a reflection of residual 
viral genomic material left from a prior infection. A second interpretation is that infectious virus 
was excreted in the urine with viral RNA detected in the nc-Luminex, but through handling and 
processing the virus was inactivated and unable to grow in cell culture. 
Viruria is the presence of infectious virus in a urine sample and the route of entry of virus into urine 
may be varied. Virus may directly infect, replicate and be released by cells of the urogenital tract as 
part of the infection process (Nickeleit et al., 1999). Viruses such as polyomaviruses may even 
remain latent in cells of the urogenital tract with the ability to recrudesce and produce viruria 
(Nickeleit et al., 1999). Alternatively virus may be filtered from blood vessels supplying the genito-
urinary tract where viraemia occurs as part of a systemic infection (Schultz and Neva, 1965). 
Schultz and Neva (1965) demonstrated in their study that the sites of viral access into the urine are 
not confined to the kidney and may occur at more distal sites of the genitor-urinary tract such as the 
bladder. Viruria was an outcome of experimental inoculation of Pteropus poliocephalus bats with 
Nipah virus (Middleton et al., 2007). However, in a bat where virus was isolated from the kidney, 
no viruria was detected. In a different bat where viruria was detected, no virus was isolated from the 
kidney at the conclusion of the experiment. Thus, it cannot be assumed that the kidney is the site of 
viral entry into the urine. Isolation of Hendra virus in reproductive tissues (foetal tissues and 
placental) has been demonstrated in wild-caught pteropid bats (Halpin et al., 2000) and in the study 
by Middleton et al. (2007), Nipah virus was isolated from the uterus of experimentally inoculated 
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bats. Successful virus isolation from pooled urine samples collected from pteropid bat colonies 
around the time of birthing may indicate a reproductive tissue origin for viruria.  
In conclusion, detection of viral RNA in urine indicates a current or prior infectious process in an 
animal. Viruria indicates the presence of a current systemic infection resulting in a degree of 
viraemia exceeding a ‘threshold’ for filtration in the urine (Schultz and Neva, 1965) and/or the 
presence of a virus with a predilection for replication in the tissues of the urogenital tract. Human 
viruses where viruria is a common feature of infection include coxsackie viruses (Pasch and Frey, 
2006), mumps virus (Utz et al., 1964), measles virus (Ihara et al., 1995), adenoviruses (Gutekunst 
and Heggie, 1961), rubella virus (Utz, 1967, Menser et al., 1971), and polyomaviruses (Leung et al., 
2002). Paramyxoviruses appear in this list, including the rubulavirus mumps.  Mumps has been 
shown to result in renal complications with evidence of prolonged viral infection of the urinary tract 
and replication in the kidneys (Helin and Carstensen, 1983). Isolation of viruses from urine samples 
may bias towards detecting those with an affinity towards infection of and replication in cells of the 
urogenital tract, such as the paramyxoviruses including rubulaviruses. This being said, the excretion 
of virus in urine is a plausible route by which humans and domestic animals may come into contact 
with bat viruses. With an increased surveillance of bat pathogens, more and more viruses are bound 
to be discovered. While interesting from a phylogenetic and evolutionary standpoint, extrapolating 
virus sequence data to inform zoonotic and thus public health risk may have limited validity. 
Isolation of live virus is essential for characterization and further in vitro and in vivo assessment of 
transmission and disease risk in humans. Isolation of viruses from biological samples likely to come 
in contact with humans and domestic animals (e.g. spats, urine, and faeces) will be informative in 
terms of ‘real-world’ risk. 
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CHAPTER 7 GENERAL DISCUSSION 
The role and reputation of bats as important reservoirs of zoonotic viruses were well established at 
commencement of this PhD. Since then, such importance was demonstrated further given the 
purported bat-origin of the viruses responsible for the emergence of MERS in 2012 and Ebola 
disease in West Africa in 2013-2014. Research akin to ‘virus hunting’ was being performed 
worldwide in an attempt to identify the next pandemic threat originating in bats. However, the 
dynamics by which these viruses are transmitted within and across bat populations were less well 
characterised. Few studies attempted to understand how bat ecology influences virus transmission 
and the risk of spillover to other species. At the time this PhD research commenced, several studies 
suggested that species, population size, seasonal reproductive events, nutritional stress and changes 
in population distribution and behaviours influenced henipavirus infection dynamics (Field, 2005, 
Plowright et al., 2008, Plowright et al., 2011, Wacharapluesadee et al., 2010, Breed et al., 2011).  
Concurrent but separate to my PhD project, pooled urine samples collected approximately monthly 
from various flying fox colonies in Queensland by QCEID and tested for paramyxovirus RNA at 
AAHL revealed ‘peaks’ of virus excretion where multiple paramyxoviruses including Hendra virus 
were detected for some collection dates. These ‘peaks’ of excretion occurred before and after 
periods of minimal or no paramyxovirus detection. The frequency and duration of these sample 
collections did not allow an assessment of the repeatability or seasonality of these periods of 
increased virus excretion nor a robust correlation to any ecological factor(s). This PhD project 
involved targeted surveillance of a single colony using frequent cross-sectional sampling over 
multiple years to determine whether paramyxovirus excretion associates with any bat ecological 
factors. If such factors are seasonal (e.g. pregnancy) and the association is repeatable, periods of 
heightened virus excretion and thus spillover risk may be predicted and thus mitigated.  
7.1 SUMMARY, SIGNIFICANCE AND IMPLICATIONS OF FINDINGS 
7.1.1 Chapter 2: Serological surveillance for henipaviruses in the Geelong flying fox colony  
Serosurveillance of P. poliocephalus caught from the Geelong colony was performed to obtain 
henipavirus seroprevalence data. Although flying foxes present in Victoria are thought to be 
extensions of NSW populations (Field, 2005), no seroprevalence data were available for bats 
sampled at these southern latitudes. As colonies established in Victoria tend to be smaller, less 
numerous, spaced further apart, and consist of a single species, infection dynamics may differ to 
those in more northern locations. The first step in assessing the risk of transmission of Hendra virus 
to horses present in Victoria was to establish if infection occurs in bats present in this region. 
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Antibodies capable of binding and neutralising Hendra virus and Cedar virus antigens respectively 
were detected in bats sampled in Geelong. These results imply previous infection with these or 
antigenetically related viruses. Twenty-six (26%) and forty (40%) percent of sampled bats 
contained antibodies capable of neutralising Hendra virus and Cedar virus respectively – levels in 
agreement to those obtained from surveillance studies of northern flying fox populations. Given the 
proportion of seropositive animals, transmission of both viruses appears to be efficient within the 
local and greater population of flying foxes (Halpin et al., 2000). Assuming the traditional 
Susceptible-Infected-Recovered (SIR) model applies to P. poliocephalus, the Geelong colony 
comprises animals that are susceptible and animals that are resistant to infection with these two 
viruses. The colony exceeds the threshold proportion of susceptible animals required for disease 
invasion according to two studies that simulate Hendra virus infection dynamics in hypothetical 
flying fox populations (Wang et al., 2013, Plowright et al., 2011). These data alone suggest that 
Hendra virus incursion within this colony would result in successful replication and transmission, 
posing a potential risk to local horse populations as well as to the public. Interpreting spillover risk 
from serological data however is not ideal as it is only a proxy for the presence of infectious virus. 
Furthermore, infection is a necessary but not a sufficient cause of virus excretion. Direct evidence 
of virus excretion must be measured in order to inform spillover potential.  
7.1.2 Chapter 3: Surveillance of paramyxovirus excretion from a colony of Pteropus 
poliocephalus 
As identified in the review by Hayman et al. (2013) the number of studies that consider multi-
pathogen dynamics in bat populations are limited (Baker et al., 2012, Drexler et al., 2011, Gloza-
Rausch et al., 2008, Kemenesi et al., 2014). As exampled by Telfer et al. (2010), studies of 
pathogen communities in small mammals show the strong influence of prior infection on 
susceptibility to subsequent infections with different pathogen species. Often, infection with other 
parasite species accounted for greater infection risk than factors related to risk of exposure and host 
demographic factors (Telfer et al., 2010). Such an approach applied to bat populations would 
improve our understanding of the ecology of bat pathogens and perhaps identify the more dominant 
mechanisms of pathogen maintenance and transmission. This study employed a multiplex assay 
designed to simultaneously detect nucleic acid of nine specific bat paramyxoviruses in a single 
sample. This enabled the assessment of multi-pathogen dynamics in a population consisting of a 
single species of flying fox. Pooled urine samples collected from the Geelong colony measured 
virus excretion over 25 months. Paramyxovirus excretion was detected in 20% of the sampling 
events and in 3.3% of the samples collected, similar to prevalence data of other studies of single 
pathogen dynamics in bat populations (Field, 2005). Four of the nine viruses surveyed were 
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detected from bats sampled in the Geelong colony; Yarra Bend paramyxovirus (YarPV), Geelong 
paramyxovirus (GeePV), Teviot paramyxovirus (TevPV), and Cedar virus (CedPV). The most 
frequent detections were made for viruses that were first identified during this project from samples 
collected from a local P. poliocephalus colony in Melbourne. These two viruses, YarPV and GeePV 
were detected in each sampling year, unlike CedPV and TevPV which were detected only in 
2010/2011 and 2011 respectively. This may indicate local sustained transmission of the former two 
viruses with sporadic introduction of CedPV and TevPV after return of bats from distant locations.  
Three findings emerged from this work. Although sampling started and finished mid-way through 
2010 and 2012 respectively, there appeared to be an increased likelihood of paramyxovirus 
excretion in the second half of 2011 and 2012. This may be driven by bat-specific or environmental 
factors that occur in the second half but not the first half of the year. Sampling of other bat colonies 
in the region would need to occur to investigate whether this dynamic is repeatable for a more 
robust assessment of seasonality. The second finding was the detection of more than one 
paramyxovirus type on a given sampling date, and on one occasion the detection of two different 
paramyxovirus sequences in the one pooled urine sample. This possibly reflects co-infection of 
individuals with multiple paramyxoviruses or at the least the circulation of multiple 
paramyxoviruses within the colony at the one time. Certain bat-specific or ecological drivers may 
be similarly influencing the transmission dynamics of multiple viruses. Or, as per Telfer at al. 
(2010), prior infection with one virus may have a significant impact on the risk of infection with 
subsequent viruses. 
The third and major finding was the absence of detection of Hendra virus despite the power of the 
sampling being adequate to detect Hendra virus excretion based on virus prevalence data from 
Queensland colonies. Considering that serology data of bats sampled in Queensland and Geelong 
were comparable, this difference in virus detection suggests a difference in drivers for Hendra virus 
excretion between bats in the two locations. Possible explanations include differences in colony 
connectedness in southern and northern locations as well as the relative conduciveness of different 
pteropid species to Hendra virus excretion post infection. Recent studies have supported the 
hypothesis that grey-headed and little red flying foxes are less efficient hosts of Hendra virus 
compared to black and/or spectacled flying foxes (Edson et al., Goldspink et al., 2015). The 
excretion of Hendra virus in urine may only occur as part of a disease process within the bat – 
perhaps precipitated by co-infection or other physiological states that rarely occur in Geelong. It is 
understood that the detection of viral RNA does not necessarily indicate the presence of infectious 
virus in a sample. It is however a better indicator of current or recent virus replication within an 
animal and thus a more appropriate indicator of spillover risk compared to serology data. 
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Considering the significant complications of live virus isolation at BSL-4 the presence of nucleic 
acid has been used as a substitute. 
7.1.3 Chapter 4: Estimating stress at a colony-level scale 
Stress is commonly cited as a potential driver of zoonotic disease emergence from wildlife 
populations. Given historical work on stress and stress related disease in human medicine, wildlife 
researchers have adopted this dogma and have accepted the idea that stress increases susceptibility 
of an animal to infectious disease in the absence of empirical data. In the specific case of disease 
emergence from bat reservoirs, Plowright et al. (2008) was the first study to associate evidence of 
infection, albeit previous infection via detection of antibody, with indicators of stress – poor body 
condition and abnormal feeding behaviour. It must be noted that in this study exposure to the virus 
may have been prior to the onset of stress. Studies of stress physiology typically quantify the stress 
response by measuring corticosteroid concentrations in various samples including urine. Concurrent 
to this study, McMichael et al. (2014) published a validated method to quantify stress in Australian 
pteropid species using non-invasively collected pooled urine samples from underneath colonies. 
This PhD project applied the same method to quantify stress over time for the Geelong colony and 
identified periods of low and high cortisol production. This represents the first longitudinal 
population assessment of cortisol production for a bat colony. The months of March and April, and 
the season autumn were significantly associated with increased cortisol measurement. Bat-life 
history events such as mating and the weaning of juveniles was discussed as potential stressors. The 
months of June and July, the season winter, and gestation were significantly associated with 
increased cortisol measurement. The bat-life history event of gestation was discussed as a potential 
stressor. The summer months of each year of sampling were significantly associated with decreased 
cortisol measurements. Lactation-mediated downregulation of cortisol production was discussed as 
a potential explanation. It would be important to replicate this study using other bat colonies in the 
region to investigate the repeatability of these results and thus determine whether the significance of 
the same bat-life history stages is generalizable to other populations. The impact of increased 
cortisol production on virus replication and excretion was investigated in Chapter 5.  
7.1.4 Chapter 5: Risk factors for paramyxovirus infection and excretion 
A common goal of emerging disease research is to determine the factors or ‘drivers’ that increase 
the risk of cross-species transmission of zoonotic viruses. As mentioned above, stress is a 
commonly assumed driver. This PhD study is unique in emerging disease research in that it 
quantifies both stress and virus excretion and measures an association between the two. No 
significant association was found between the periods of heightened cortisol production and virus 
detection. This implies that stress as defined by this project was not a cause of virus excretion for 
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the paramyxoviruses detected. Such a negative finding was not unexpected given the lack of 
conclusive evidence in the literature linking stress in wildlife with virus infection and excretion, as 
well as the difficulties found by researchers in detecting virus excretion from experimentally 
infected bats kept in highly stressful captive environments. One would assume that bats kept in 
captivity for experimental purposes would be under a considerable amount of stress. It does 
however raise the question: what factors are driving virus excretion? This study did not find a 
significant association between any measured bat-life history stage and virus excretion. Colony size 
was not associated with the detection of paramyxovirus sequence. 
It is important to consider that the drivers of virus infection may differ from the drivers of virus 
excretion. Excretion in urine likely results from virus replication in the tissues and/or vessels of the 
urogenital tract. Previous immunity may neutralise virus upon infection and prevent such 
localization and replication. In the study by Plowright et al. (2008) nutritional stress was considered 
a risk factor for Hendra virus infection as nutritionally stressed animals were more likely to have 
neutralising antibody titres to the virus. Logically however these seropositive animals would be less 
susceptible to current virus infection. The conclusions made by Plowright et al. (2008) were based 
on the assumption that infection occurred at a time when the animal was stressed and susceptible to 
infection. For flying foxes the duration of protective immunity or even what constitutes protective 
immunity or susceptibility to virus infection and excretion are unclear. Using serology to inform 
risk factors for spillover is not ideal and rather should be addressed through direct evidence of 
pathogen excretion. Viral factors such as dose, exposure route, pathogenicity, and tissue tropism 
may also play important roles in determining excretion in urine post-infection. If only certain viral 
variants are capable of replication in urogenital tissues this would explain the lack of genetic 
diversity in Hendra virus isolates from urine samples collected over different locations and years. 
This also creates a type of ‘bottleneck’ that restricts the diversity of viruses available for cross-
species transmission.  
7.1.5 Chapter 6: Isolation of two paramyxoviruses from Pteropus poliocephalus and a 
comparison to related viruses 
The isolation of a rubulavirus (TevPV-Pp) and a henipavirus (CedPV-Pp) from urine samples that 
were also positive for corresponding viral RNA in the Luminex platform implies that the periods of 
heightened viral RNA detection represent periods of current virus replication in the bats sampled. 
Infectious virus in the Geelong environment is presumably capable of being presented to potential 
spillover hosts. It is interesting to consider why Hendra virus was not detected or isolated from the 
Geelong colony given it has been found to circulate in the same Queensland populations as CedPV 
and TevPV. Why have these other viruses been able to find their way down to Geelong and be 
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excreted while Hendra virus has not? Again, this may be explained by certain bat species being 
more likely to excrete particular viruses post-infection. Or, compared to CedPV and TevPV, the 
excretion of Hendra virus requires certain physiological and/or viral co-factors that do not occur in 
Geelong. Alternatively, perhaps for the duration of sampling Hendra virus was not actively 
circulating in local bat populations and was confined to northern aggregations. Lastly, a related 
henipavirus not detected or isolated in this study but reflected in anti-henipavirus serology may 
circulate locally and confer cross-protective immunity to Hendra virus, thereby limiting infection 
and excretion. 
7.2 CONCLUSIONS  
Since commencing this PhD study there has been a noted shift in emerging disease research away 
from cataloging viruses and towards an understanding of the dynamics of how these viruses 
circulate in wildlife populations. A notable recent example is that by Dietrich et al. (2015) who 
investigated co-excretion dynamics of Leptospira bacteria and paramyxoviruses in urine samples 
collected longitudinally from a free-tailed bat colony. This study sought to address similar questions 
to this PhD project, namely the influence of certain seasonal life-history events on the infection 
dynamics of multiple pathogens. Considering the current body of literature, the results of this PhD 
project support the findings of related studies yet contraindicate the dogma that stress contributes to 
an increased risk of disease emergence. The growing amount of evidence suggests that the 
epidemiology of virus transmission in bat populations is intimately linked to ecology and 
population structure rather than to stress per se. Any assessment of periods of heightened spillover 
risk from bat populations must be attuned to bat ecological factors with an emphasis on changes 
that are occurring to these dynamics brought about by human involvement. 
7.3 LIMITATIONS OF STUDY 
The major limitations of this study are inherent to research conducted on subjects in a natural 
setting where uncontrolled confounding variables may bias results. Studying bats in the wild is a 
difficult task. Gaining a sample size large enough and random enough to be representative of the 
whole population is logistically impossible. In this PhD project, normally four collection sheets 
were placed non-randomly underneath the colony in order to sample from demographic subsets of 
the population. If given the chance to repeat this study, a larger number of collection sheets would 
be used to increase virus detection sensitivity and each pooled urine sample would be labeled with 
which sheet it was collected from. This way, virus detections from samples collected from the same 
sheet could be assumed to be from the same bat but if from distant sheets then it could be concluded 
that two separate virus detections were made. PCR assays that detect the sex, species and number of 
individuals contributing to a pooled sample are currently in development by researchers at AAHL 
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and QCEID. Such assays would be useful to apply to the samples collected in this study to enable 
the association of bat-specific factors to virus excretion. An unexpected outcome and limitation of 
this study was the low number of paramyxovirus sequence detections. This reduced the power to 
investigate associations between excretion and bat-specific and ecological factors. In future, broader 
virus family based PCRs may result in a higher number of detections and more valid results.  
Ideally the study of bat-specific factors that influence virus excretion would involve tracking 
devices placed on a large number of individual bats with monitoring and sampling of these bats 
over time. This is also currently being performed by CSIRO researchers. For the cortisol study this 
would be invaluable as stressed individuals may have been driven to migrate with excretion 
occurring in a different location and thus undetected. Unfortunately due to the frequent and often 
long distance movements of bats, particularly pteropid bats, longitudinal sampling of the same 
animal over time is very difficult despite advances in tracking technologies. Bats of the former 
suborder Microchiroptera tend to display higher site fidelity which would make recaptures more 
likely. Longitudinal studies of infection dynamics in individual bats may be more achievable in 
such populations. Captive studies are useful for longitudinal sampling of individual bats however 
such environments remove many influencing factors that may be important in the wild.  
Results found at a population scale do not necessarily represent that which occurs at an individual 
animal level. For example, just because increased cortisol production was not found to correlate 
with virus excretion at a colony level, this is not to say that cortisol doesn’t influence susceptibility 
to infection in individuals. Experimental studies are needed here to characterize the effects of 
cortisol on various components of the bat immune system. In general there is lack of basic 
immunological understanding regarding what constitutes the susceptible, infected and recovered 
states in bats. A number of modeling studies of Hendra virus transmission dynamics identify the 
susceptible state as the most important factor influencing virus invasion and transmission within a 
population. Research is currently being performed in this area but is difficult due to a lack of bat-
specific reagents and the challenges associated with establishing models of infection using captive 
bats. Furthermore, cortisol is just one, albeit a major, product of the stress axis of animals. 
Additional studies that incorporate monitoring of other hormones or immune markers in addition to 
cortisol would give a more comprehensive understanding of the state of stress in bats.  
7.4 BROADER PERSPECTIVES ON DISEASE EMERGENCE FROM WILDLIFE 
RESERVOIRS 
Greater surveillance combined with the application of metagenomic analyses to samples collected 
from bats will no doubt uncover greater pathogen diversity. It would not be unexpected to find 
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similar diversity once intense surveillance is applied to other animal species including humans. 
Whether or not bats are unique in the number of pathogens they host and the mechanisms by which 
they maintain infections is irrelevant in terms of public health risk. Either way they are important 
sources of pathogens where the 3 layers identified by Plowright et al. (2015) as necessary for 
spillover have aligned in many parts of the world, resulting in serious emerging disease in humans, 
domestic animals, and livestock. The incidence of such disease appears to be increasing. High 
species diversity, interconnected populations, dense aggregations of local populations, and high 
pathogen diversity combined with sympatry with humans contribute to the success (for lack of a 
better word) of bats as reservoirs of zoonotic pathogens. It is important to note that some or all of 
these characteristics also apply to other wildlife populations such as rodents and birds. Surveillance 
efforts should continue to concentrate on such animal populations to assess emerging disease risk.  
Surveillance that focuses on pathogen discovery from animal species does have merit in aiding the 
identification of the likely source of infection in the event of an outbreak of novel disease. Research 
that aims to understand pathogen infection dynamics in wildlife reservoirs is essential to identify 
periods of increased risk of spillover. Such research is challenging, expensive, requires the input of 
multiple disciplines, and rarely results in definitive answers to research questions. Supportive 
evidence accumulates over time from different research groups and different sample populations. It 
is promising to note then that research into the ecology of wildlife pathogens is finding similar 
drivers for infection across multiple animal species (Peel et al., 2014, Altizer et al., 2006). In 
addition, a growing amount of evidence suggests anthropogenic-mediated effects on wildlife 
ecological systems is a major cause of changed pathogen infection dynamics within these 
populations leading to outbreaks of severe disease both in the reservoir host as well as in spillover 
hosts (Gay et al., 2014, Daszak et al., 2001). A recent example whose results may apply to bat 
populations is that of Satterfield et al. (2015). It was found that a decrease in the migratory 
behaviour of North American monarch butterflies correlated with increased parasite infection 
prevalence. The decrease in migratory behaviour is in response to deforestation and artificial 
planting of host plants. Outbreaks of infectious disease in threatened wildlife populations 
significantly challenge species survival as exampled by chytridiomycosis, ranavirus, and protozoal 
infections in amphibians (Cunningham and Daszak, 1998, Daszak et al., 1999, Schloegel et al., 
2006) and white-nose syndrome in bats (Blehert et al., 2009). Human influences on wildlife ecology 
will increase in the future and this change in how animals interact with themselves as well as with 
humans appears to be an important factor for disease emergence. We must be considerate of 
changes that occur to wildlife populations and monitor pathogen dynamics accordingly. For 
example, a southward extension of the distribution of Pteropus alecto is being observed. If this 
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species is more likely to excrete Hendra virus upon infection then surveillance of bats in more 
southern locations should be intensified and veterinarians and the public be made aware 
accordingly. Studies of infection dynamics in the reservoir host should be paired with surveillance 
for pathogens in likely spillover hosts including humans - both targeted (sentinel herds and at risk 
populations) and opportunistically in response to disease. Such studies are demonstrated by 
Chowdhury et al. (2014) and Maged et al. (2015). In this way a number of necessary steps for cross-
species transmission have already occurred and risk factors for infection of the spillover host can be 
monitored and addressed.  
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Appendices 
Appendix 1. Details of individual bats caught and sampled from the Geelong colony 
Month Date batID sex preg lac age weight (g) forearm (mm) w/f 
Nov-11 2 G021111(1) F N N J 632 151 4.19 
 2 G021111(2) M N N A 672 160 4.20 
 2 G021111(3) F N N A 643 152 4.23 
 2 G021111(4) M N N A 757 160 4.73 
 2 G021111(5) F N N A 517 148 3.49 
 2 G021111(6) F N N A 629 155 4.06 
 2 G021111(7) F N N J 528 148 3.57 
 2 G021111(8) F N N J 566 149 3.80 
 2 G021111(9) F N N J 528 150 3.52 
 2 G021111(10) M N N A 744 165 4.51 
 2 G021111(11) F N N A 630 152 4.14 
 3 G031111(12) M N N J 630 150 4.20 
 3 G031111(13) F N N J 675 155 4.35 
 3 G031111(14) F N N J 581 155 3.75 
 3 G031111(15) F N N J 563 150 3.75 
 3 G031111(17) M N N J 592 145 4.08 
 3 G031111(18) M N N A 873 170 5.14 
 3 G031111(19) F N N A 644 155 4.15 
 3 G031111(20) M N N J 587 157 3.74 
Feb-12 7 G070212(1) F N N A 608 162 3.75 
 7 G070212(2) F N N A 625 150 4.17 
 7 G070212(3) F N N A 542 152 3.57 
 7 G070212(4) F N N J 434 145 2.99 
 7 G070212(5) F N N A 651 154 4.23 
 7 G070212(6) M N N A 617 154 4.01 
 7 G070212(7) F N N A 633 157 4.03 
 7 G070212(8) F N N A 645 160 4.03 
 7 G070212(9) F N N J 683 163 4.19 
 7 G070212(10) M N N J 736 167 4.41 
 7 G070212(11) M N N J 714 164 4.35 
 7 G070212(12) F N N J 601 164 3.66 
 7 G070212(13) F N N J 669 158 4.23 
 7 G070212(14) F N N J 605 156 3.88 
 7 G070212(15) F N N A 703 162 4.34 
 8 G080212(16) M N N J 657 158 4.16 
 8 G080212(17) F N Y A 760 165 4.61 
 8 G080212(18) F N N A 727 165 4.41 
 8 G080212(19) M N N A 768 162 4.74 
 8 G080212(20) F N N A 665 165 4.03 
 8 G080212(21) M N N A 713 170 4.19 
 8 G080212(22) F N N J 604 161 3.75 
 8 G080212(23) F N N A 708 162 4.37 
 8 G080212(24) F N N A 701 165 4.25 
 8 G080212(25) F N N J 545 156 3.49 
 8 G080212(26) F N N A 678 158 4.29 
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 8 G080212(27) F N Y A 570 157 3.63 
 8 G080212(28) F N N A 634 159 3.99 
Apr-12 26 G260412(1) F N N J 645 150 4.30 
 26 G260412(2) F N N A 750 158 4.75 
 26 G260412(3) M N N J 495 140 3.54 
 26 G260412(4) F N N J 615 155 3.97 
 26 G260412(5) F N N J 560 145 3.86 
 26 G260412(6) M N N J 575 154 3.73 
 26 G260412(7) F N N J 575 145 3.97 
 26 G260412(8) F N N J 590 150 3.93 
 26 G260412(9) F N N A 750 170 4.41 
 26 G260412(10) F N N J 595 153 3.89 
 26 G260412(11) M N N A 660 154 4.29 
 26 G260412(12) F N N J 660 160 4.13 
 27 G270412(13) F NA NA A 695 150 4.63 
 27 G270412(14) M N N A 740 162 4.57 
 27 G270412(15) F N N A 770 162 4.75 
 27 G270412(16) F N N A 710 160 4.44 
 27 G270412(17) F N N J 705 157 4.49 
 27 G270412(18) F N N J 625 145 4.31 
 27 G270412(19) F N N A 760 170 4.47 
 27 G270412(20) M N N J 585 164 3.57 
 27 G270412(21) M N N A 860 170 5.06 
Jul-12 17 G170712(1) F N N J 580 150 3.87 
 17 G170712(2) F N N A 770 160 4.81 
 17 G170712(3) F N N A 635 155 4.10 
 17 G170712(4) M N N A 605 150 4.03 
Aug-12 21 G210812(1) M N N A 860 165 5.21 
 21 G210812(2) M N N A 750 167 4.49 
 21 G210812(3) NA NA NA A 730 160 4.56 
 21 G210812(4) F N N J 430 150 2.87 
 21 G210812(5) M N N A 770 165 4.67 
 21 G210812(6) M N N J 475 145 3.28 
 21 G210812(7) M N N A 830 160 5.19 
Mar-13 20 G200313(1) F N N J 410 140 2.93 
 20 G200313(2) F N N J 685 160 4.28 
 20 G200313(3) M N N J 545 155 3.52 
 20 G200313(4) F N N J 505 150 3.37 
 20 G200313(5) F N N J 520 150 3.47 
 20 G200313(6) F N N J 590 160 3.69 
 20 G200313(7) F N N J 440 150 2.93 
 20 G200313(8) F N N J 500 155 3.23 
Apr-13 18 G180413(1) F N N J 495 147 3.37 
 18 G180413(2) F N N A 680 160 4.25 
 18 G180413(3) F N N J 575 155 3.71 
 18 G180413(4) F N N J 490 150 3.27 
 18 G180413(5) F N Y A 665 152 4.38 
 18 G180413(6) F N N J 530 150 3.53 
 18 G180413(7) F N Y A 720 155 4.65 
 18 G180413(8) F N N J 475 138 3.44 
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 18 G180413(9) F N Y A 745 162 4.60 
 18 G180413(10) M N N J 505 140 3.61 
 18 G180413(11) F N N J 655 155 4.23 
 18 G180413(12) F N N J 410 135 3.04 
 18 G180413(13) M N N J 565 146 3.87 
 18 G180413(14) F N N A 750 153 4.90 
 18 G180413(15) F N N A 755 160 4.72 
 18 G180413(16) F N N A 790 162 4.88 
Feb-14 27 G270214(1) F N N J 395 145 2.72 
 27 G270214(2) F N N J 770 165 4.67 
 27 G270214(3) F N N J 680 160 4.25 
 27 G270214(4) M N N J 805 155 5.19 
 27 G270214(5) F N N A 750 170 4.41 
 27 G270214(6) F N N A 790 170 4.65 
 27 G270214(7) M N N A 745 157 4.75 
 27 G270214(8) M N N J 455 145 3.14 
 27 G270214(9) M N N J 655 155 4.23 
 27 G270214(10) M N N J 725 155 4.68 
 27 G270214(11) F N N J 435 145 3.00 
 27 G270214(12) F N N J 345 140 2.46 
 27 G270214(13) M N N J 445 150 2.97 
 27 G270214(14) M N N A 800 165 4.85 
 27 G270214(15) F N N J 635 155 4.10 
 27 G270214(16) F N N A 745 163 4.57 
 27 G270214(17) F N N J 325 135 2.41 
 27 G270214(18) F N N J 365 130 2.81 
 27 G270214(19) F N N J 330 135 2.44 
 27 G270214(20) M N N A 845 168 5.03 
 27 G270214(21) M N N J 365 140 2.61 
 27 G270214(22) F N N J 340 142 2.39 
 27 G270214(23) F N N A 715 158 4.53 
 27 G270214(24) F N N A 690 158 4.37 
 27 G270214(25) F N N J 620 153 4.05 
 27 G270214(26) F N N J 350 135 2.59 
 27 G270214(27) M N N A 710 161 4.41 
 27 G270214(28) F N N A 575 162 3.55 
 27 G270214(29) M N N A 750 160 4.69 
 27 G270214(30) F N N A 620 159 3.90 
 27 G270214(31) F N N A 610 152 4.01 
 27 G270214(32) M N N A 940 160 5.88 
 27 G270214(33) F N Y A 630 156 4.04 
 27 G270214(34) F N N A 635 155 4.10 
 27 G270214(35) F N N A 610 160 3.81 
 28 G280214(1) M N N J 380 140 2.71 
 28 G280214(2) M N N A 655 160 4.09 
 28 G280214(3) F N N J 670 160 4.19 
 28 G280214(4) F N N J 410 145 2.83 
 28 G280214(5) F N N J 635 155 4.10 
 28 G280214(6) F N N J 420 150 2.80 
 28 G280214(7) M N N A 875 165 5.30 
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 28 G280214(8) F N Y A 740 160 4.63 
 28 G280214(9) M N N A 905 160 5.66 
 28 G280214(10) F N N J 620 155 4.00 
 28 G280214(11) M N N J 410 147 2.79 
 28 G280214(12) F N N A 730 165 4.42 
 28 G280214(13) M N N A 705 157 4.49 
 28 G280214(14) F N N A 735 159 4.62 
 28 G280214(15) F N N J 390 140 2.79 
 28 G280214(16) F N N A 700 160 4.38 
 28 G280214(17) M N N A 775 155 5.00 
 28 G280214(18) F N Y A 630 153 4.12 
 28 G280214(19) F N N J 435 104 4.18 
 28 G280214(20) M N N J 395 145 2.72 
Samples from individuals highlighted in grey were tested in VNT 
M, male; F, female; N, no; Y, yes; A, adult; J, juvenile 
 
Appendix 2. Table of weekly pooled urine collections from Geelong colony 
Month/Year Date # Samples* # Sheets Samples/Month 
Jun-10 9 12 3   
  16 11 2   
  23 14 6 37 
Jul-10 6 11 6   
  13 10 6   
  22 10 6   
  28 10 6 41 
Aug-10 4 10 6   
  18 10 6   
  31 10 6 30 
Sep-10 8 9 6   
  14 10 6   
  24 10 6 29 
Oct-10 1 10 6   
  6 10 6   
  12 10 6   
  22 10 4   
  26 10 4 50 
Nov-10 4 10 4   
  10 10 6   
  17 10 4 30 
Dec-10 14 10 4   
  22 10 4 20 
Jan-11 20 10 4   
  25 10 4 20 
Feb-11 2 10 4   
  9 10 4   
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  18 10 4   
  24 10 4 40 
Mar-11 2 10 4   
  11 3 4   
  16 10 4   
  25 9 4   
  29 10 4 42 
Apr-11 7 10 4   
  15 10 4   
  19 10 4   
  28 10 4 40 
May-11 3 10 4   
  10 10 4   
  17 10 4 30 
Jun-11 1 10 4   
  7 10 4   
  15 10 4   
  29 10 4 40 
Jul-11 13 10 4   
  21 10 4   
  28 10 4 30 
Aug-11 3 10 4   
  12 10 4   
  23 10 4   
  30 10 4 40 
Sep-11 6 10 4   
  13 10 4   
  21 10 4   
  27 10 4 40 
Oct-11 4 10 4   
  14 10 4   
  18 10 4   
  26 10 4 40 
Nov-11 1 10 4   
  11 10 4   
  15 10 4   
  21 10 4 40 
Dec-11 2 10 4   
  14 10 4   
  22 10 10 30 
Jan-12 6 10 4   
  12 10 4   
  20 10 10   
  24 10 4 40 
Feb-12 3 10 4   
  10 10 3   
  23 10 10   
  29 10 4 40 
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Mar-12 9 10 3   
  21 5 4   
  29 10 10 25 
Apr-12 5 10 4   
  18 10 4 20 
May-12 9 10 10   
  17 10 4   
  22 8 5   
  30 10 10 38 
Jun-12 13 10 4   
  20 10 4   
  28 10 10 30 
Jul-12 6 10 4 10 
TOTAL NUMBER OF SAMPLES 872 
*a sample = collection of multiple urine droplets into one tube 
 
Appendix 3. GenBank accession numbers for selected paramyxoviruses 
Virus name Genbank Accession Number 
Menangle virus AFY09794 
Tioman virus NP665871 
Achimota virus 2 AFX75118 
Sosuga virus AHH02041 
Tuhoko virus 1 ADI80715 
Mumps virus NP054714 
Parainfluenza virus 5 YP138518 
Newcastle disease virus B1 NP071471 
Measles virus NP056924 
Bat Paramyxovirus Eid_hel/GH-M74a/GHA/2009 AET43339 
Cedar virus AFP87280 
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Hendra virus NP047113 
Nipah virus NP112028 
Human metapneumovirus YP012613 
Human respiratory syncytial virus NP056866 
Sendai virus AAB06283 
Human parainfluenza virus 1 AAL89409 
Human parainfluenza virus 3 AAA46854 
Mapuera virus YP001249278 
J-virus YP338085 
Beilong virus YP512254 
Henipavirus YN12069/CHN/2012 KC599257 
Bat Paramyxovirus Epo_spe/AR1/DRC/2009 AET43305 
Eidolon helvum paramyxovirus U71C AEY68869 
Eidolon helvum paramyxovirus U68E AEY68863 
Eidolon helvum paramyxovirus U66A AEY68860 
Paramyxovirus IFBPV01/2010 BAM63371 
Bat paramyxovirus Pteropus_polio/Geelong/26102010(2) KM391916 
Yarra Bend paramyxovirus 
KM359176 
Geelong paramyxovirus KM359175 
Teviot paramyxovirus KJ716814 
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Yeppoon paramyxovirus KJ716815 
Grove paramyxovirus KJ716812 
Hervey paramyxovirus KJ716813 
Tupaia paramyxovirus AAF63393 
Mojiang virus AHM23778 
 
Appendix 4. Dates of monthly pooled urine collections 
Month/Year Date 
August 2012 28
th
  
October 2012 
3
rd
  
31
st
  
December 2012 11
th
  
January 2013 24
th
  
February 2013 22
nd
  
March 2013 20
th
  
May 2013 
1
st
  
29
th
  
June 2013 27
th
  
August 2013 1
st
  
October 2013 30
th
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Appendix 5. Whole genome sequence of CedPV-Pp compared to reference sequence. SNPs highlighted in red 
 
Pa Cedar_Virus_J      1 accagacaaaggaagtctagtctccggattaaatcatattcgtatgattaatcttaggatcccggtatctagaatctggatctggattcggtttaattgaattgcgatcgtttataaattagaaaggaga 
Pp CedPV FINAL_3      1 accagacaaaggaagtctagtctccggattaaatcatattcgtatgattaatcttaggatcccggtatctagaatctggatctggattcggtttaattgaattgcgatcgtttataaattagaaaggaga 
 
Pa Cedar_Virus_J    131 tttactactcaaaatgtctgacattttcaatgagactcaatcatttagaaactatcagtccaacttaggcagagatggcagggccagtgcagcaacgactactttgacaactaaagtgaggatctttgtt 
Pp CedPV FINAL_3    131 tttactactcaaaatgtctgacattttcaatgagactcaatcatttagaaactatcagtccaacttaggcagagatggcagggccagtgcagcaacgactactttgacaactaaagtgaggatctttgtt 
 
Pa Cedar_Virus_J    261 ccagcgaataataatccaaacctcagatggcgtttaacactattcttgatggatgtcgtgaggtcacctgcctccgcagagtctatgaaagtgggtgctgggatatccttggtatctatgtatgctgaaa 
Pp CedPV FINAL_3    261 ccagcgaataataatccaaacctcagatggcgtttaacactattcttgatggatgtcgtgaggtcacctgcctccgcagagtctatgaaagtgggtgctgggatatccttggtatctatgtatgctgaaa 
 
Pa Cedar_Virus_J    391 aacccggggctcttgtgagagcattattgaatgacccagatgttgaagcgataatcatagatgtttatggctttgatgaaggtattcctataatggaacgaagaggtgataaagctacagatgacatgga 
Pp CedPV FINAL_3    391 aacccggggctcttgtgagagcattattgaatgacccagatgttgaagcgataatcatagatgtttatggctttgatgaaggtattcctataatggaacgaagaggtgataaagctacagatgacatgga 
 
Pa Cedar_Virus_J    521 ttccctaagaaagattgttaaagctgcacatgatttcagcagaggaaggagtttatttgttgatcaaagggtccaggatattgttatgtcagatatggggtcatttgtgaatgctattacttccatagag 
Pp CedPV FINAL_3    521 ttccctaagaaagattgttaaagctgcacatgatttcagcagaggaaggagtttatttgttgatcaaagggtccaggatattgttatgtcagatatggggtcatttgtgaatgctattacctccatagag 
 
Pa Cedar_Virus_J    651 acgcagatatggattttgatcgcaaaggctgtaactgccccagatacagcagaagagagcgaaggaagaagatgggcaaaatatgttcagcaaaagagggttaatcctttgttcttgatttctccacaat 
Pp CedPV FINAL_3    651 acgcagatatggattttgatcgcaaaggctgtaactgccccagatacagcagaagagagcgaaggaagaagatgggcaaaatatgttcagcaaaagagggttaatcctttgttcttgatttctccacaat 
 
Pa Cedar_Virus_J    781 ggatcaatgacatgagatccctgattgcggcaagtctttcgcttcgtaaattcatggttgaactactgatggaagctaagaaaggacgggggacaaaaggaagaataatggagattgtatccgatatcgg 
Pp CedPV FINAL_3    781 ggatcaatgacatgagatccctgattgcggcaagtctttcgcttcgtaaattcatggttgaactactgatggaagctaagaaaggacgggggacaaaaggaagaataatggagattgtatccgatatcgg 
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Pa Cedar_Virus_J    911 aaattacgttgaagagacaggaatggcagggttcttcgctacaataaagttcggtcttgagaccaaattccctgctttggcacttaatgagctccagagtgacttgaacacaatgaaaagtctcatgata 
Pp CedPV FINAL_3    911 aaattacgttgaagagacaggaatggcagggttcttcgctacaataaagttcagtcttgagaccaaattccctgctttggcacttaatgagctccagagtgacttgaacacaatgaaaagtctcatgata 
 
Pa Cedar_Virus_J   1041 ctgtacagaagcataggaccaaaggccccctttatggtgttgttggaagattcaattcagaccaaatttgctccaggaagctatccacttctttggagttttgcgatgggtgtaggcacaactattgaca 
Pp CedPV FINAL_3   1041 ctgtacagaagcataggaccaaaggccccctttatggtgttgttggaagattcaattcagaccaaatttgctccaggaagctatccacttctttggagttttgcgatgggtgtaggcacaactattgaca 
 
Pa Cedar_Virus_J   1171 gagctatgggtgccttgaacattaacagaagttatcttgaacctgtctattttaggctagggcaacaatcagctaaacatcaagcaggaaatgttgacaaagaaatggcagaaaagttaggattgacaga 
Pp CedPV FINAL_3   1171 gagctatgggtgccttgaacattaacagaagttatcttgaacctgtctattttaggctagggcaacaatcagctaaacatcaagcaggaaatgttgacaaagaaatggcagaaaagttaggattgacaga 
 
Pa Cedar_Virus_J   1301 agaccagatcgtgcacctatcagctaatgtgaaggatgcaagtcaaggtagagatgacaatcaaatcaacatccgagaagggaagttcacaaatgttgttgatgacatccaggatcatgcccagagttcc 
Pp CedPV FINAL_3   1301 agaccagatcatgcacctatcagctaatgtgaaggatgcaagtcaaggtagagatgacaatcaaatcaacatccgagaagggaagttcacaaatgttgttgatgacatccaggatcatgcccagagttcc 
 
Pa Cedar_Virus_J   1431 tctgaggattacaatcctagtaaaaagagtttctcaatattgacgagcatcacatccaccgtagatagtgctgacagtaggtctgcaatgaatgagtcaatgacaacaacatccttgctgaaattgagac 
Pp CedPV FINAL_3   1431 tctgaggattacaatcctagtaaaaagagtttctcaagattgacgagcatcacatccaccgtagatagtgctgacagtaggtctgcaatgaatgagtcaatgacaacaacatccttgctgaaattgagac 
 
Pa Cedar_Virus_J   1561 agaggctggcagagaagaaaggagactccaagaacagtcaagacacacctccaaaaccacccagagcaaaagatcaacccactgatgaggtctccttcatggattccaatatatgatcagaatgatggtt 
Pp CedPV FINAL_3   1561 agaggctggcagagaagaaaggagactccaagaacagtcaagacacacctccaaaaccacccagagcaaaagatcaacccactgatgaggtctccttcatggattccaatatatgatcagaatgatggtt 
 
Pa Cedar_Virus_J   1691 aaaatcaaccaactaagggcgcgtagagtaccttcagatagaacactacattaatcgggtgaaacaatagatttatgggtttggtgcttaatttttatttaatcttacttgcaaaacaggcagctgctac 
Pp CedPV FINAL_3   1691 aaaatcaaccaactaagggcgcgtagagtaccttcagatagaacactacattaatcgggtgaaacaatagatttatgggtttggtgcttaatttttatttaatcttacttgcaaaacaggcagctgctac 
 
Pa Cedar_Virus_J   1821 actcgtaaccactcctcacagtaagggcaacacgggtcatagaacttatgcctatagattacctctatctgtatatctagctatgattaaaatgtatacttctgctgaccggttttctagcaacagtcca 
Pp CedPV FINAL_3   1821 actcgtaaccactcctcacagtaagggcaacacgggtcatagaacttatgcctatagattacctctatctgtatatctagctatgattaaaatgtatatttctgctgaccggttttctagcaacagtcca 
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Pa Cedar_Virus_J   1951 cattattactttatgggtattttttaatcaaccttttataatcaaatatattacaaaaaacttaggatccaagtggtccaaactttttttgatcaagagtcatattggctactttaggaggacactttaa 
Pp CedPV FINAL_3   1951 cattattactttatgggtattttttaatcaaccttttataatcaaatatattacaaaaaacttaggatccaagtggtccaaactttttttgatcaagagtcatattggctactttaggaggacactttaa 
 
Pa Cedar_Virus_J   2081 acacaaattgttacaagaggatattcatcagatggacaaactacaattgattgaagatggcctctctactatcaattttatacaggaaaataaggaaaaattacagcattcttacggaagatcctccatc 
Pp CedPV FINAL_3   2081 acacaaattgttacaagaggatattcatcagatggacaaactacaattgattgaagatggcctctctactatcaattttatacaggaaaataaggaaaaattacagcattcttacggaagatcctccatc 
 
Pa Cedar_Virus_J   2211 agagagccacccacaagtgtcagggttgaagagtgggagaaatttattcgaaagatcgcttctggacctgaacaagttcaagggggaggatctgagactgagatcacaggcgataatggagatagaggca 
Pp CedPV FINAL_3   2211 agagagccacccacaagtgtcagggttgaagagtgggagaaatttattcgaaagatcgcttctggacctgaacaagttcaagggggaggatctgagactgagatcacaggcgataatggagatagaggca 
 
Pa Cedar_Virus_J   2341 attttaccaatcctgatcagggaggcggagtcacaggacaattcgaagaaaggtatcaaaaatgggggtcacaagattcagaattacaactggacccaatggttgtacacgatttcttctatgacgagag 
Pp CedPV FINAL_3   2341 attttaccaatcctgatcagggaggcggagtcacaggacaattcgaagaaaggtatcaaaaatgggggtcacaagattcagaattacaactggacccaatggttgtacacgatttcttctatgacgagag 
 
Pa Cedar_Virus_J   2471 aagggagaatcccgacaatggaaaatatgaccgcagctctaaaaaacgggataatatcagagaaggaacacgacaggataagtacaataatcagtctactgatgaattactgtcctgcctacaaccatct 
Pp CedPV FINAL_3   2471 aagggagaatcccgacaatggaaaatatgaccgcagctctaaaaaacgggataatatcagagaaggaacacgacaggataagtacaataatcagtctactgatgaattactgtcctgcctacaaccatct 
 
Pa Cedar_Virus_J   2601 tctaagaacgatgtcatcaagaatgaaagtacatcagtgtcaaatttgcatgttacaggaaataaactgaatcctgacgcaaaaccctttgaacccacctcccagtcgaaagagcacccaaccaccacac 
Pp CedPV FINAL_3   2601 tctaagaacgatgtcatcaagaatgaaagtacatcagtgtcaaatttgcatgttacaggaaataaactgaatcctgacgcaaaaccctttgaacccacctcccagtcgaaagagcacccaaccaccacac 
 
Pa Cedar_Virus_J   2731 agcacaacaaaaatgaccatcagaccgatgatgattataagaatagaagatccagtgaaaacaatgtgatctctgatcatgccaccacaatggaagacaacaacaattttatcccggcgaccaaaagaaa 
Pp CedPV FINAL_3   2731 agcacaacaaaaatgaccatcagaccgatgatgattataagaatagaagatccagtgaaaacaatgtgatctctgatcatgccaccacaatggaagacaacaacaattttatcccggcgaccaaaagaaa 
 
Pa Cedar_Virus_J   2861 gaatgcattgagcgaacccatatacgtccaggtattgccctcaaacacagagggtttctcgggaaaagattatccactcctcaaggacaactctgtcaagaagcgtgcagagccagtcatcctagaaact 
Pp CedPV FINAL_3   2861 gaatgcattgagcgaacccatatacgtccaggtattgccctcaaacacagagggtttctcgggaaaagattatccactcctcaaggacaactctgtcaagaagcgtgcagagccagtcatcctagaaact 
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Pa Cedar_Virus_J   2991 gccaaccaccctgcaggctctgccgaccaagacacaaatcagattgaagaaaacatgcagttcaaccttccaaaactgctcacagaagatacagacgatgaaccagaggataacaatgattccatgcctc 
Pp CedPV FINAL_3   2991 gccaaccaccctgcaggctctgccgaccaagacacaaatcagattgaagaaaacatgcagttcaaccttccaaaactgctcacagaagatacagacgatgaaccagaagataacaatgattccatgcctc 
 
Pa Cedar_Virus_J   3121 ttgaggaagacattagagagatcggttccatgctaaaagatggaaccaaagatatcaagacaaggatgaatgagatagatgacgcaatcaagaagataaataagaaatcaaaaaatagaagtctggatct 
Pp CedPV FINAL_3   3121 ttgaggaagacattagagagatcggttccatgctaaaagatggaaccaaagatatcaagacaaggatgaatgagatagatgacgcaatcaagaagataaataagaaatcaaaaaatagaagtctggatct 
 
Pa Cedar_Virus_J   3251 agaatcagacggtaaagatcaggggagaagagatccatcagtagacctcgggattaaaaaaagaaaggaagggctaaaggccgcaatgcaaaagacaaaagagcaattgtctataaaagtggagagagag 
Pp CedPV FINAL_3   3251 agaatcagacggtaaagatcaggggagaagagatccatcagtagacctcgggattaaaaaaagaaaggaagggctaaaggccgcaatgcaaaagacaaaagagcaattgtctataaaagtggagagagag 
 
Pa Cedar_Virus_J   3381 attggattgaacgacaggatatgtcaaaattcgaagatgagtacagaaaagaaattgatatatgctgggatggaaatggagtatggacaaacgagtactgggtcaggaggtccacaaggatcaaaggatg 
Pp CedPV FINAL_3   3381 attggattgaacgacaggatatgtcaaaattcgaagatgagtacagaaaagaaattgatatatgctgggatggaaatggagtatggacaaacgagtactgggtcaggaggtccacaaggatcaaaggatg 
 
Pa Cedar_Virus_J   3511 ggacttctgatgatgtccaggtagacgaagactacgatgaaggggaagactatgaggctatgccgtcagataggttttatacaacattatcaggtgaacaaaaggatagatttgatctagatgctaacca 
Pp CedPV FINAL_3   3511 ggacttctgatgatgtccaggtagacgaagactacgatgaaggggaagactatgaggctatgccgtcagataggttttatacaacattatcaggtgaacaaaaggatagatttgatctagatgctaacca 
 
Pa Cedar_Virus_J   3641 aatgtctcagtatgacctcgaggcccaggtggatgaattaaccagaatgaatctcatactctattctagattagaaactactaataagttgcttattgacatattagatctagctaaagaaatgccaaag 
Pp CedPV FINAL_3   3641 aatgtctcagtatgacctcgaggcccaggtggatgaattaaccagaatgaatctcatactctattctagattagaaactactaataagttgcttattgacatattagatctagctaaagaaatgccaaag 
 
Pa Cedar_Virus_J   3771 ttagttagaaaagtggataatcttgagagacagatgggtaacttgaatatgttaacctctacccttgagggtcacctatcttctgtaatgattatgatacccggtaaggataagagcgaaaaggaaatcc 
Pp CedPV FINAL_3   3771 ttagttagaaaagtggataatcttgagagacagatgggtaacttgaatatgttaacctctacccttgagggtcacctatcttctgtaatgattatgatacccggtaaggataagagcgaaaaggaaatcc 
 
Pa Cedar_Virus_J   3901 ctaaaaatccggacctgagaccaatactggggagaagcaacacgtcgttaactgatgttatcgacctagaccattaccctgataaaggctccaaaggtatcaaaccaagtggatctggagacagacagta 
Pp CedPV FINAL_3   3901 ctaaaaatccggacctgagaccaatactggggagaagcaacacgtcgttaactgatgttatcgacctagaccattaccctgataaaggctccaaaggtatcaaaccaagtggatctggagacagacagta 
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Pa Cedar_Virus_J   4031 catcggctctctagagagcaaattttctataaatgatgagtacaattttgctccataccctatcagggacgaactcctattgccaggtttaagagatgacaaaaccaatgcttcatcgttcatcccagat 
Pp CedPV FINAL_3   4031 catcggctctctagagagcaaattttctataaatgatgagtacaattttgctccataccctatcagggacgaactcctattgccaggtttaagagatgacaaaaccaatgcttcatcgttcatcccagat 
 
Pa Cedar_Virus_J   4161 gacacggacaggtctccaatggtgctcaaaataataattcgacagaacatccatgatgaagaagtgaaggatgagctactgtccatactagaacaacataacactgtggaggaattgaatgaaatatgga 
Pp CedPV FINAL_3   4161 gacacggacaggtctccaatggtgctcaaaataataattcgacagaacatccatgatgaagaagtgaaggatgagctactgtccatactagaacaacataacactgtggaggaattgaatgaaatatgga 
 
Pa Cedar_Virus_J   4291 atactgtgaatgattacctcgatggcaacatctgattaacagatattgagattgatcctattctaaacaagtaatctctgataatgatagtatggaataagaatactaatcacactattgtactcttgta 
Pp CedPV FINAL_3   4291 atactgtgaatgattacctcgatggcaacatctgattaacagatattgagattgatcctattctaaacaagtaatctctgataatgatagtatggaataagaatactaatcacactattgtactcttgta 
 
Pa Cedar_Virus_J   4421 gaatcttaacgagtgtctaatgtcagattttagcaacacatactaataacttgtaatccatttctccttattccatttaatctcacattagaaaaaacttaggatcccagatttgcaaagtcaaaacggg 
Pp CedPV FINAL_3   4421 gaatcttaacgagtgtctaatgtcagattttagcaacacatactaataacttgtaatccatttctccttattccatttaatctcacattagaaaaaacttaggatcccagatttgcaaagtcaaaacggg 
 
Pa Cedar_Virus_J   4551 atctactatcaggtgttggagctaacaatagcggagtctgcataacaaatagcgttcaaagaagtttgaaaaccatcatagaatatggatccgtcagatttgaggaggattataatggaggatgataaga 
Pp CedPV FINAL_3   4551 atctactatcaggtgttggagctaacaatagcggagtctgcataacaaatagcgttcaaagaagtttgaaaaccatcatagaatatggatccgtcagatttgaggaggattataatggaggatgataaga 
 
Pa Cedar_Virus_J   4681 gtctggtcaacaatgatgatagtacagaaactgattttctcgagaaaacttggagagaagggagtaagattgacaagatcacaccagaggttgatgaaaacgggaatatggtccccaagtacgttgtctt 
Pp CedPV FINAL_3   4681 gtctggtcaacaatgatgatagtacagaaactgattttctcgagaaaacttggagagaagggagtaagattgacaagatcacaccagaggttgatgaaaacgggaatatggtccccaagtacgttgtctt 
 
Pa Cedar_Virus_J   4811 caacccggggaaaaatgagaggaaaacatccggatatcaatatatgatttgttatggtttcattgaggatggacctatcaatggctcaccaagagtcaaaggtaatatcagaaccaccgcttcttttcct 
Pp CedPV FINAL_3   4811 caacccggggaaaaatgagaggaaaacatccggatatcaatatatgatttgttatggtttcattgaggatggacctatcaatggctcaccaagagtcaaaggtaatatcagaaccaccgcttcttttcct 
 
Pa Cedar_Virus_J   4941 ttgggtgttggaaaaacttactcgtctccagaagagatcttacaagagctgacaacactcaagatcactgtcagaaggacagccggatcaaatgagaagttggtgtatggaataacagggcctttaaatc 
Pp CedPV FINAL_3   4941 ttgggtgttggaaaaacttactcgtctccagaagagatcttacaagagctgacaacactcaagatcactgtcagaaggacagccggatcaaatgagaagttggtgtatggaacaacagggcctttaaatc 
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Pa Cedar_Virus_J   5071 acctttacccgtggtataaagttttgacaggtggctccatttttagtgcggtgaaggtctgtaggaatgtggatcaaatactattagacagaccccaaatacttagagtattctttctaagtataactaa 
Pp CedPV FINAL_3   5071 acctttacccgtggtataaagttttgacaggtggctccatttttagtgcggtgaaggtctgtaggaatgtggatcaaatactattagacagaccccaaatacttagaatattctttctaagtataactaa 
 
Pa Cedar_Virus_J   5201 attaacagataaaggtgtgtatatgatacccaaaagtgttctcgacttcagatcggataattcgatggccttcaatctgcttgtgtatctcaagatagacactgacatcaccaaagcaggcatcagaggg 
Pp CedPV FINAL_3   5201 attaacagataaaggtgtgtatatgatacccaaaagtgttctcgacttcagatcggataattcgatggccttcaatctgcttgtgtatctcaagatagacactgacatcaccaaagcaggcatcagaggg 
 
Pa Cedar_Virus_J   5331 attgtcaacaaagaaggggagaggataacgtcattcatgttacacatcggtaactttacaagaagaggaggaaaacattactcagtggagtattgcaaaaggaaaattgacaaaatgaagctcacattcg 
Pp CedPV FINAL_3   5331 attgtcaacaaagaaggggagaggataacgtcattcatgttacacatcggtaactttacaagaagaggaggaaaacattactcagtggagtattgcaaaaggaaaattgacaaaatgaagctcacattcg 
 
Pa Cedar_Virus_J   5461 ccttaggcactataggcggtctaagcttacatatcaggatcgatggaaggataagtaaaaggctccaagcacaagttggctttcagagaaacatttgctactcactaatggacacaaacccatggttgaa 
Pp CedPV FINAL_3   5461 ccttaggcactataggcggtctaagcttacatatcaggatcgatggaaggataagtaaaaggctccaagcacaagttggctttcagagaaacatttgctactcactaatggacataaacccatggttgaa 
 
Pa Cedar_Virus_J   5591 taaattaacgtggaacaatagttgtgaaatacacaaagtcaccgctgtcattcagccatctgtgccaaaggacttcatgttgtatgaggacatcttaatagataatacaggcaagatcttaaaataaagt 
Pp CedPV FINAL_3   5591 taaattaacgtggaacaatagttgtgaaatacacaaagtcaccgctgtcattcagccatctgtgccaaaggacttcatgttgtatgaggacatcttaatagataatacaggcaagatcttaaaataaagt 
 
Pa Cedar_Virus_J   5721 aggagagtcagtcattacccagtatattgaatactaatgacaactttattaatccaattctatctccagttactagaatttctaaaacaattctactgctcagcaacgcatctcaaacattgtgatcttc 
Pp CedPV FINAL_3   5721 aggagagtcagtcattacccagtatattgaatactaatgacaactttattaatccaattctatctccagttactagaatttctaaaacaattctactgctcagcaacgcatctcaaacattgtgatcttc 
 
Pa Cedar_Virus_J   5851 aattatgatcgacgcattgtaatctatatagcttttagttcatgaaatactaaaaagggcttaatcttgtaagttctcagcaaatactccaatgcaaaagagcgcctcaacatctcaagcagcaccaaaa 
Pp CedPV FINAL_3   5851 aattatgatcgacgcattgtaatctatatagattttagttcatgaaatactaaaaagggcttaatcttgtaagttctcagcaaatactccaatgcaaaagagcgcctcaacatctcaagcagcaccaaaa 
 
Pa Cedar_Virus_J   5981 taaaccacaatcaatgtgcaacaagagcaatcgtctaaagtgtgaaaaccaaaatcacagatcagaaagggcacatatttcagtcctgtaaaaataccaagtgggattaataaaagaggatcaatcctta 
Pp CedPV FINAL_3   5981 taaaccacaatcaatgtgcaacaagagcaatcgtctaaagtgtgaaaaccaaaatcacagatcagaaagggcacatatttcagtcctgtaaaaataccaagtgggattaataaaagaggatcaatcctta 
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Pa Cedar_Virus_J   6111 tcattttaagaaaaacttaggatcccagagatcctaaagagccaattcctttatattttgatcttgaagggctagaagtcaggctgaaacacagaggtggaggaacacaggaactaaaattgatgaaatc 
Pp CedPV FINAL_3   6111 tcattttaagaaaaacttaggatcccagagatcctaaagagccaattcctttatattttgatcttgaagggctagaagtcaggctgaaacacagaggtggaggaacacaggaagtaaaattgatgaaatc 
 
Pa Cedar_Virus_J   6241 aaccttagctcaacatctaatcaatcaagcttaagtcatcctaatactgtatacaaccagcagcgtagagagtggatttgatttcggcacccttgcgaagtgaaggctattactgcctgtcctttcaatc 
Pp CedPV FINAL_3   6241 aaccttagctcaacatctaatcaatcaagcttaagtcatcctaatactgtatacaaccagcagcgtagagagtggatttgatttcggcacccttgcgaagtgaaggctattactgcctgtcctttcaatc 
 
Pa Cedar_Virus_J   6371 agaaaattacatttacccataaagtaatctcaacatgtctaacaagaggacaacagtattgatcataataagctatacgttattttatttgaataatgcagcaattgtagggtttgattttgataaattg 
Pp CedPV FINAL_3   6371 agaaaattacatttacccataaagtaatctcaacatgtctaacaagaggacaacagtattgatcataataagctatacgttattttatttgaataatgcagcaattgtagggtttgattttgataaattg 
 
Pa Cedar_Virus_J   6501 aataaaataggtgtggtgcaagggagagtcctaaattataaaattaaaggagatccaatgacaaaagaccttgtcttgaaatttatccctaacatagtgaatatcactgaatgtgtgagagagcccttga 
Pp CedPV FINAL_3   6501 aataaaataggtgtggtgcaagggagagtcctaaattataaaattaaaggagatccaatgacaaaagaccttgtcttgaaatttatccctaacatagtgaatatcactgaatgtgtgagagagcccttga 
 
Pa Cedar_Virus_J   6631 gtaggtacaatgagaccgtgaggagattgcttttacctatacacaacatgcttgggttatacttgaataacacaaatgctaaaatgactgggttgatgatcgcgggtgtgatcatgggtgggatagcaat 
Pp CedPV FINAL_3   6631 gtaggtacaatgagaccgtgaggagattgcttttacctatacacaacatgcttgggttatacttgaataacacaaatgctaaaatgactgggttgatgatcgcgggtgtgatcatgggtgggatagcaat 
 
Pa Cedar_Virus_J   6761 aggtatagccacagcagctcagatcacagcaggttttgctctttatgaggcaaaaaagaacacagaaaatattcagaaattaacagacagcatcatgaaaacacaggactcgattgataaacttactgac 
Pp CedPV FINAL_3   6761 aggtatagccacagcagctcagatcacagcaggttttgctctttatgaggcaaaaaagaacacagaaaatattcagaaattaacagacagcatcatgaaaacacaggactcgattgataaacttactgac 
 
Pa Cedar_Virus_J   6891 agtgtggggacaagcatacttatattgaataagctacagacatacatcaacaatcaactggtaccaaatctagagcttctatcctgccgacaaaacaaaattgagtttgatctaatgttaaccaagtatt 
Pp CedPV FINAL_3   6891 agtgtggggacaagcatacttatattgaataagctacagacatacatcaacaatcaactggtaccaaatctagagcttctatcctgccgacaaaacaaaattgagtttgatctaatgttaaccaagtatt 
 
Pa Cedar_Virus_J   7021 tggtggatcttatgactgttattggtcctaatatcaataatcctgttaataaagatatgactattcaatctttgtcacttctttttgatggcaattatgatataatgatgtcagaacttggttatacacc 
Pp CedPV FINAL_3   7021 tggtggatcttatgactgttattggtcctaatatcaataatcctgttaataaagatatgactattcaatctttgtcacttctttttgatggcaattatgatataatgatgtcagaacttggttatacacc 
 
213 
 
Pa Cedar_Virus_J   7151 tcaggatttcttagatttgatagagagtaagagtataacagggcaaataatttatgttgatatggaaaacttgtacgttgtgatcaggacatatctacctaccctaattgaagtacctgatgcccaaata 
Pp CedPV FINAL_3   7151 tcaggatttcttagatttgatagagagtaagagtataacagggcaaataatttatgttgatatggaaaacttgtacgttgtgatcaggacatatctacctaccctaattgaagtacctgatgcccaaata 
 
Pa Cedar_Virus_J   7281 tatgagttcaacaaaataactatgagtagcaatggaggagaatacttgtcaaccatacctaatttcatattaataagaggtaattatatgtctaatatagatgttgcaacatgttatatgaccaaagcaa 
Pp CedPV FINAL_3   7281 tatgagttcaacaaaataactatgagtagcaatggaggagaatacttgtcaaccatacctaatttcatattaataagaggtaattatatgtctaatatagatgttgcaacatgttatatgaccaaagcaa 
 
Pa Cedar_Virus_J   7411 gcgtaatttgtaatcaagattattcactcccgatgagccaaaacttaagaagctgttatcaaggtgagacagaatactgtcctgttgaggcagtcatcgcgtcacactctccaagatttgctcttacaaa 
Pp CedPV FINAL_3   7411 gcgtaatttgtaatcaagattattcactcccgatgagccaaaacttaagaagctgttatcaaggtgagacagaatactgtcctgttgaggcagtcatcgcgtcacactctccaagatttgctcttacaaa 
 
Pa Cedar_Virus_J   7541 tggagttattttcgccaattgtataaatacaatttgtaggtgtcaagacaatggtaagactatcactcaaaacataaaccaattcgtaagcatgatcgacaacagtacttgtaatgatgtcatggtagat 
Pp CedPV FINAL_3   7541 tggagttattttcgccaattgtataaatacaatttgtaggtgtcaagacaatggtaagactatcactcaaaacataaaccaattcgtaagcatgatcgacaacagtacttgtaatgatgtcatggtagat 
 
Pa Cedar_Virus_J   7671 aagtttactatcaaggtaggaaaatatatggggagaaaagatatcaataatattaatatccagataggaccgcagatcataattgataaggttgacttgtctaatgaaataaacaagatgaatcaatctt 
Pp CedPV FINAL_3   7671 aagtttactatcaaggtaggaaaatatatggggagaaaagatatcaataatattaatatccagataggaccgcagatcataattgataaggttgacttgtctaatgaaataaacaagatgaatcaatctt 
 
Pa Cedar_Virus_J   7801 taaaagatagtattttctacctgagagaagccaagagaattttagactcagtaaatatcagtcttatatctccaagcgttcaattgtttctaataataatatcagtcctctcatttattatattattgat 
Pp CedPV FINAL_3   7801 taaaagatagtattttctacctgagagaagccaagagaattttagactcagtaaatatcagtcttatatctccaagcgttcaattgtttctaataataatatcagtcctctcatttattatattattgat 
 
Pa Cedar_Virus_J   7931 tatcatagtatacttgtactgtaaatcaaaacattcatataaatataacaaatttatagatgatcctgattattacaatgattacaaaagagaacgtattaatggcaaagccagtaagagtaacaatata 
Pp CedPV FINAL_3   7931 tatcatagtatacttgtactgtaaatcaaaacattcatataaatataacaaatttacagatgatcctgattattacaatgattacaaaagagaacgtattaatggcaaagccagtaagagtaacaatata 
 
Pa Cedar_Virus_J   8061 tattatgtaggtgattaacaatcgataatctaaaggattacctcactatcactaccaaggtaacttccatgtaagatcggaccttccccgaagacattaaataaaacttaggatcccagagtatccctct 
Pp CedPV FINAL_3   8061 tattatgtaggtgattaacaatcgataatctaaaggattacctcactatcactaccaaggtaacttccatgtaagatcggaccttccccgaagacattaaataaaacttaggatcccagagtatccctct 
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Pa Cedar_Virus_J   8191 aagtgatccttctagattggttactgatatatatacatatttatcctctttccgtcgttgtttattgatcattaataatgctttctcagctccaaaaaaattacttagacaactcaaaccaacaaggtga 
Pp CedPV FINAL_3   8191 aagtgatccttctagattggttactgatatatatacatatttatcctctttccgtcgttgtttattgatcattaataatgctttctcagctccaaaaaaattacttagacaactcaaaccaacaaggtga 
 
Pa Cedar_Virus_J   8321 taaaatgaacaacccagataagaaattaagtgtcaacttcaaccctttagaattagataaaggtcaaaaagatctcaataagtcttattatgttaaaaacaagaattataacgtttcaaatctattaaat 
Pp CedPV FINAL_3   8321 taaaatgaacaacccagataagaaattaagtgtcaacttcaaccctttagaattagataaaggtcaaaaagatctcaataagtcttattatgttaaaaacaagaattataacatttcaaatctattaaat 
 
Pa Cedar_Virus_J   8451 gaaagtctgcacgatatcaagttttgtatttattgtatattctcactgctaattatcattacaataatcaatataatcacaatatcaattgttataactcgtctgaaagtacatgaagagaataatggca 
Pp CedPV FINAL_3   8451 gaaagtctgcacgatatcaagttttgtatttattgtatattctcactgctaattatcattacaataatcaatataatcacaatatcaattgttataactcgtctgaaagtacatgaagagaataatggca 
 
Pa Cedar_Virus_J   8581 tggaatctcctaatttacaatctattcaagatagtctctcatctcttactaacatgatcaatacagagataactcctagaatagggattttagttacagccacttctgttactctctcttcatctatcaa 
Pp CedPV FINAL_3   8581 tggaatctcctaatttacaatctattcaagatagtctctcatctcttactaacatgatcaatacagagataactcctagaatagggattttagttacagccacttctgttactctcccttcatctatcaa 
 
Pa Cedar_Virus_J   8711 ttatgtcgggactaagacaaatcaactggtcaatgaattaaaagattatataaccaaaagttgtggctttaaggtccctgaattaaagttacatgaatgcaacataagttgtgctgatccaaaaattagc 
Pp CedPV FINAL_3   8711 ttatgtcgggactaagacaaatcaactggtcaatgaattaaaagattatataaccaaaagttgtggctttaaggtccctgaattaaagttacatgaatgcaacataagttgtgctgatccaaaaattagc 
 
Pa Cedar_Virus_J   8841 aaatctgcaatgtacagcaccaatgcctatgccgagcttgctggtccacctaagatattttgtaaaagtgtatccaaagaccccgactttagactgaagcagatagattatgtaataccagtgcagcaag 
Pp CedPV FINAL_3   8841 aaatctgcaatgtacagcaccaatgcctatgccgagcttgctggtccacctaagatattttgtaaaagtgtatccaaagaccccgactttagactgaagcagatagattatgtaataccagtgcagcaag 
 
Pa Cedar_Virus_J   8971 atcggtctatttgtatgaacaaccctttattggatatttctgatgggttttttacctacatacattatgaaggaataaatagctgtaaaaaatcagattcatttaaagtgctgctgtcacatggtgaaat 
Pp CedPV FINAL_3   8971 atcggtctatttgtatgaacaaccctttattggatatttctgatgggttttttacctacatacattatgaaggaataaatagctgtaaaaaatcagattcatttaaagtgctgctgtcacatggtgaaat 
 
Pa Cedar_Virus_J   9101 agttgacaggggtgattatcgaccatcattatatctattatcaagtcattaccatccttattcaatgcaggtaataaactgtgtacctgtgacttgtaaccagtcatcctttgtattctgtcatatctcc 
Pp CedPV FINAL_3   9101 agttgacaggggtgattatcgaccatcattatatctattatcaagtcattaccatccttattcaatgcaggtaataaactgtgtacctgtgacttgtaaccagtcatcctttgtattttgtcatatctcc 
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Pa Cedar_Virus_J   9231 aacaacactaaaacattggacaattcagattactcgtcagacgagtactacataacatatttcaatggcatagatcgtcccaaaaccaagaagattcccattaacaatatgacagcagacaatcgttata 
Pp CedPV FINAL_3   9231 aacaacactaaaacattggacaattcagattactcgtcagacgagtactacataacatatttcaatggcatagatcgtcccaaaaccaagaagattcccattaacaatatgacagcagacaatcgttata 
 
Pa Cedar_Virus_J   9361 tccattttacattctcaggtgggggaggtgtatgtttaggtgaagaatttattattcctgttaccacagtcatcaatactgatgtattcacgcatgattattgtgagagtttcaactgttcagtccaaac 
Pp CedPV FINAL_3   9361 tccattttacattctcaggtgggggaggtgtatgtttaggtgaagaatttattattcctgttaccacagtcatcaatactgatgtattcacgcatgattattgtgagagtttcaactgttcagtccaaac 
 
Pa Cedar_Virus_J   9491 cggtaaaagtctaaaggagatatgctctgagtcattaagatctccaacgaactcatcgcgatacaatttaaacggaatcatgattataagtcaaaacaacatgacagattttaagattcagttgaatggt 
Pp CedPV FINAL_3   9491 cggtaaaagtctaaaggagatatgctctgagtcattaagatctccaacgaactcatcgcgatacaatttaaacggaatcatgattataagtcaaaacaacatgacagattttaagattcagttgaatggt 
 
Pa Cedar_Virus_J   9621 ataacttataacaaactgtcattcggaagtcctggaagactgagcaagacactgggccaggtcctttattaccaatcttcaatgagttgggatacttatctaaaggcaggatttgtcgagaaatggaaac 
Pp CedPV FINAL_3   9621 ataacttataacaaactgtcattcggaagtcctggaagactgagcaagacactgggccaggtcctttattaccaatcttcaatgagttgggatacttatctaaaggcaggatttgtcgagaaatggaaac 
 
Pa Cedar_Virus_J   9751 cctttaccccgaattggatgaacaatactgtgatatccagacctaaccaaggtaattgtccaaggtatcataaatgccccgagatatgttatggagggacatacaatgatattgctcctttagatctagg 
Pp CedPV FINAL_3   9751 cctttaccccgaattggatgaacaatactgtgatatccagacctaaccaaggtaattgtccaaggtatcataaatgccccgagatatgttatggagggacatacaatgatattgctcctttagatctagg 
 
Pa Cedar_Virus_J   9881 aaaagacatgtatgttagcgttattctagattcagatcagcttgcagagaatccagagattacagtatttaactctactactatactttataaggagagagtatccaaagatgaactaaacacaagaagt 
Pp CedPV FINAL_3   9881 aaaagacatgtatgttagcgttattctagattcagatcagcttgcagagaatccagagattacagtatttaactctactactatactttataaggagagagtatccaaagatgaactaaacacaagaagt 
 
Pa Cedar_Virus_J  10011 actacaacgagctgttttcttttcctagatgaaccttggtgtatatcagtattagaaacaaacagatttaacggcaaatctattaggcccgagatttattcatacaaaattcctaagtattgttaatttg 
Pp CedPV FINAL_3  10011 actacaacgagctgttttcttttcctagatgaaccttggtgtatatcagtattagaaacaaacagatttaacggcaaatctattaggcccgagatttattcatacaaaattcctaagtattgttaatttg 
 
Pa Cedar_Virus_J  10141 atgagcttattcctcatacttcaatcaaatttaatataactaatatcaaattgttgcactcagctattattaaaactggatcatcagacaataaagatgtatacaaagatatatcgaagagggtattaaa 
Pp CedPV FINAL_3  10141 atgagcttattcctcatacttcaatcaaatttaatataactaatatcaaattgttgcactcagctattattaaaactggatcatcagacaataaagatgtatacaaagatatatcgaagagggtattaaa 
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Pa Cedar_Virus_J  10271 gaaaacttaggatcccagatccttcaataaggcagagccttgattgtatcagcgtcatttacaattgaatctcaattaacaacactgattaataacttaagcagaatactcctattacagtgtttaattg 
Pp CedPV FINAL_3  10271 gaaaacttaggatcccagatccttcaataaggcagagccttgattgtatcagcgtcatttacaattgaatctcaattaacaacactgattaataacttaagcagaatactcctattacagtgtttaatta 
 
Pa Cedar_Virus_J  10401 acttaattttaattgaggattttataatcctataattggagcagatctaaactctcaccgattcagttctaatcctttattaactaaagaacaaattctaaataattggatgacgtcacaggagacaagc 
Pp CedPV FINAL_3  10401 acttaattttaattgaggattttataatcctataattggagcagatctaaactctcaccgattcagttctaatcctttattaactaaagaacaaattctaaataattggatgacgtcacaggagacaagc 
 
Pa Cedar_Virus_J  10531 tggaaacaatttagttagaaggaagaaaccttttaccagatatggaaagtgactttgatatatctgttagcgacgtactgtacccagaatgtcatttggacagtcctatagtcggcggtaagctcattac 
Pp CedPV FINAL_3  10531 tggaaacaatttagttagaaggaagaaaccttttaccagatatggaaagtgactttgatatatctgttagcgacgtactgtacccagaatgtcatttggacagtcctatagtcggcggtaagctcattac 
 
Pa Cedar_Virus_J  10661 ttctcttgagtatgcgaatttgactcataaccaacctcatgaagatcagacattgctgactaatataaatgtcaataaaaagaagaagataaaaagtcctctaatatcccaacaatctttatttggaaat 
Pp CedPV FINAL_3  10661 ttctcttgagtatgcgaatttgactcataaccaacctcatgaagatcagacattgctgactaatataaatgtcaataaaaagaagaagataaaaagtcctctaatatcccaacaatctttatttggaaat 
 
Pa Cedar_Virus_J  10791 gaggttaataaggagattttcgatcttaaaaattattaccatgtcccctatccagaatgtaacagagatttattcttaatctctgatgacaaaatagcattcaaactcagtaaaatcatggataattcta 
Pp CedPV FINAL_3  10791 gaggttaataaggagattttcgatcttaaaaattattaccatgtcccctatccagaatgtaacagagatttattcttaatctctgatgacaaaatagcattcaaactcagtaaaatcatggataattcta 
 
Pa Cedar_Virus_J  10921 ataaactgtttgatggtttagagaggaaactgagtcgcttaatttcgaatgtagataatcaactattaaatgcaacctctcttcataataattctgagatggatcggaagggaaaagaacatccttgctt 
Pp CedPV FINAL_3  10921 ataaactgtttgatggtttagagaggaagctgagtcgcttaatttcgaatgtagataatcaattattaaatgcaacctctcttcataataattctgagatggatcggaagggaaaagaacatccttgctt 
 
Pa Cedar_Virus_J  11051 cccagaaaagagcacaattgatgatgtaagacagcagagacagacacgagattttccaaagaattcaactagagagggaagatctccaaaacaccctgatgccggtcctacacctgaaaacagtgccaaa 
Pp CedPV FINAL_3  11051 cccagaaaagagcacaattgatgatgtaagacagcagagacagacacgagattttccaaagaattcaactagagagggaagatctccaaaacaccctgatgccggtcctacacctgaaaacagtgccaaa 
 
Pa Cedar_Virus_J  11181 aacgatttgcatagagacaacacagacaatatgccaacaggccatagttcgacatctatgaaaaaacctaaaatatctggagaagaatatcttagtatgtggctagactcagaggatttgggttctaaac 
Pp CedPV FINAL_3  11181 aacgatttgcatagagacaacacagacaatatgccaacaggccatagttcgacatctatgaaaaaacctaaaatatctggagaagaatatcttagtatgtggctagactcagaggatttgggttctaaac 
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Pa Cedar_Virus_J  11311 gaatttctgcacaattagggaaggatgtatcatgtaaaggccatctgcacacgacagaagacaaaccgataatagttcctgacactcgatatatccaaaatcatgaatctaataacgatattttccccaa 
Pp CedPV FINAL_3  11311 gaatttctgcacaattagggaaggatgtatcatgtaaaggccatctgcacacgacagaagacaaaccgataatagttcctgacactcgatatatccaaaatcatgaatctaataacgatattttccccaa 
 
Pa Cedar_Virus_J  11441 aaaagagaaaaaattctgcaaacttccaccgtcatcggataatttaaccaaaatcatggtgaattcaaaatggtacaatcctttccttttttggtttactgtcaagactgaacttagagcctgccagaag 
Pp CedPV FINAL_3  11441 aaaagagaaaaaattctgcaaacttccaccgtcatcggataatttaaccaaaatcatggtgaattcaaaatggtacaatcctttccttttttggtttactgtcaagactgaacttagagcctgccagaag 
 
Pa Cedar_Virus_J  11571 gagaactacaaaaggaaaaacagaaaattgggaattatcacatcgattaaaggttcatgctataagttgatactcaaccagaatctagtagcaatattcgaggaagacagcagtggatactcagatcata 
Pp CedPV FINAL_3  11571 gagaactacaaaaggaaaaacagaaaattgggaattatcacatcgattaaaggttcatgctataagttgatactcaaccagaatctagtagcaatattcgaggaagacagcagtggatactcagatcata 
 
Pa Cedar_Virus_J  11701 aaaaaagaaaaaaacgatgctactatctaactcccgaaatggtccttatgttctccgatgtaactgaaggaagattgatgattgatgttgcaatgagatttgacaaaaagtacaaaactctagagaaaaa 
Pp CedPV FINAL_3  11701 aaaaaagaaaaaaacgatgctactatctaactcccgaaatggtccttatgttctccgatgtaactgaaggaagattgatgattgatgttgcaatgagatttgacaaaaagtacaaaactctagagaaaaa 
 
Pa Cedar_Virus_J  11831 ggctttgaaattatggtttcttatagacgagttatttccttctatgggaaatagagtgtataatattatatccatgcttgagcctttgactctcgcgatattacaggttaaggatgagtcaaggttgttg 
Pp CedPV FINAL_3  11831 ggctttgaaattatggtttcttatagacgagttatttccttctatgggaaatagagtgtataatattatatccatgcttgagcctttgactctcgcgatattacaggttaaggatgagtcaaggttgttg 
 
Pa Cedar_Virus_J  11961 agaggtgcattcatgcatcattgtttaggtgacctcttcgaagaacttcgagagtccaagaactacccggaagatgagatcaagagatttgccaacgacctaataaatgtcatgacctgtcgggacattc 
Pp CedPV FINAL_3  11961 agaggtgcattcatgcatcattgtttaggtgacctcttcgaagaacttcgagagtccaagaactacccggaagatgagatcaagagatttgccaacgacctaataaatgtcatgacctgtcgggacattc 
 
Pa Cedar_Virus_J  12091 atttagtagcagaattcttctcattctttaggactttcggacatccaatattgaacgctcaaactgcagccaggaaagttagagagtacatgttagcagataaaatccttgagtacgaacctatcatgaa 
Pp CedPV FINAL_3  12091 atttagtagcagaattcttctcattctttaggactttcggacatccaatattgaacgctcaaactgcagccaggaaagttagagagtacatgttagcagataaaatccttgagtacgaacctatcatgaa 
 
Pa Cedar_Virus_J  12221 aggtcatgcgattttctgtgctataatcataaatggatttagagatagacatggaggagtttggcctcctcttgatcttccaaaacattgttcaaagaacataatatctctcaaaaatacaggtgaaggg 
Pp CedPV FINAL_3  12221 aggtcatgcgattttctgtgctataatcataaatggatttagagatagacatggaggagtttggcctcctcttgatcttccaaaacattgttcaaagaacataatatctctcaaaaatacaggtgagggg 
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Pa Cedar_Virus_J  12351 gtaacttatgaagtagcaataaacaattggagatcatttgtcgggttaaagttcaaatgttttatgggtctcaatttagacaatgatctcagcatgtacatgaaagataaagcattatcacctttaaggg 
Pp CedPV FINAL_3  12351 gtaacttatgaagtagcaataaacaattggagatcatttgtcgggttaaagttcaaatgttttatgggtctcaatttagacaatgatctcagcatgtacatgaaagataaagcattatcacctttaaggg 
 
Pa Cedar_Virus_J  12481 atctttgggattcaatctattcacgtgaagtaatgtcctaccaaccacctagaaacaaaaaatcaagaagattggttgaggttttcgttgatgatcaggactttgatcccgttgatatgataaattatgt 
Pp CedPV FINAL_3  12481 atctttgggattcaatctattcacgtgaagtaatgtcctaccaaccacctagaaacaaaaaatcaagaagattggttgaggttttcgttgatgatcaggactttgatcccgttgatatgataaattatgt 
 
Pa Cedar_Virus_J  12611 tctgaccggagaatatctcagagatgatgatttcaatgcttcttatagtttaaaagagaaagagaccaaacaagttggcaggttgtttgctaagatgacttataaaatgagggcctgtcaagttattgct 
Pp CedPV FINAL_3  12611 tctgaccggagaatatctcagagatgatgatttcaatgcttcttatagtttaaaagagaaagagaccaaacaagttggcaggttgtttgctaagatgacttataaaatgagggcctgtcaagttattgct 
 
Pa Cedar_Virus_J  12741 gagaatttaattgcacatgggattgggagatatttccatgaaaacgggatggttaaggatgagcatgagctcagcaaatcactgtttcaattgtctatatcaggaataccaagagggaacaaaaacaaca 
Pp CedPV FINAL_3  12741 gagaatttaattgcacatgggattgggagatatttccatgaaaacgggatggttaaggatgagcatgagctcagcaaatcattgtttcaattgtctatatcaggaataccaagagggaacaaaaacaaca 
 
Pa Cedar_Virus_J  12871 aatcgacgaacgacacaatccacgaaagcaagatcgagaataaccattcctttaaaaacatccagaatcgatcatttcgaaagacggataacccatacaatagatttaacattgataacccaactttctt 
Pp CedPV FINAL_3  12871 aatcgacgaacgacacaatccacgaaagcaagatcgagaataaccattcctttaaaaacatccagaatcgatcatttcgaaagacggataacccatacaatagatttaacattgataacccaactttctt 
 
Pa Cedar_Virus_J  13001 atccccaaactgtaaccccaagtataaccgtaagaattcagagacaataggtatattctctcgtgcagaaaccaaaagcatgattagagaacagaaaagtcacagagaagtcaaaataaataagctagat 
Pp CedPV FINAL_3  13001 atccccaaactgtaaccccaagtataaccgtaagaattcagagacaataggtatattctctcgtgcagaaaccaaaagcatgattagagaacagaaaagtcacagagaagtcaaaataaataagctagat 
 
Pa Cedar_Virus_J  13131 atcggcagtgataatgaagagcaaggaaaagagatagatgccgccaagtacaaaatcacggacaacccaaatccacacataaatcctcaagatcaacccggaatctgtcaagaagacaaaggcaaagaag 
Pp CedPV FINAL_3  13131 atcggcagtgataatgaagagcaaggaaaagagatagatgccgccaagtacaaaatcacggacaacccaaatccacacataaatcctcaagatcaacccggaatctgtcaagaagacaaaggcaaagaag 
 
Pa Cedar_Virus_J  13261 gagcaaagtcagatctcacagaaggcatgagttttctggagatgcacacactctttaacccgagtaagagcgatatcagaacaaatctcgaattggaaaagagttcactttcaaaccctggatttatatc 
Pp CedPV FINAL_3  13261 gagcaaagtcagatctcacagaaggcatgagttttctggagatgcacacactctttaacccgagtaagagcgatatcagaacaaatctcgaattggaaaagagttcactttcaaaccctggatttatatc 
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Pa Cedar_Virus_J  13391 acaaaaagagaaaagaggcaaaacttataatgaatcccattcactgggaaagttctctaaagaggatgaagaaagatacgatgtcatcagtgcattcctgacaacagatttacgaaaattctgcttaaat 
Pp CedPV FINAL_3  13391 acaaaaagagaaaagaggcaaaacttataatgaatcccattcactgggaaagttctctaaagaggatgaagaaagatacgatgtcatcagtgcattcctgacaacagatttacgaaaattctgcttaaat 
 
Pa Cedar_Virus_J  13521 tggagacatgaatcaatcggcatttttgcaagaaggatggacgaaatctatggtttgcctggtttctttaattggatgcacagaagactagagcgatctgtgttatatgttgcggaccctcattgcccgc 
Pp CedPV FINAL_3  13521 tggagacatgaatcaatcggcatttttgcaagaaggatggacgaaatctatggtttgcctggtttctttaattggatgcacagaagactagagcgatctgtgttatatgttgcggaccctcattgcccgc 
 
Pa Cedar_Virus_J  13651 cgtctatcaatgaacatatcgatctaaacgattcacccgaaagagacatatttatacatcatccgaaagggggtatagaaggatacagccaaaaactgtggacaatagcgactatcccttttctattcct 
Pp CedPV FINAL_3  13651 cgtctatcaatgaacatatcgatctaaacgattcacccgaaagagacatatttatacatcatccgaaagggggtatagaaggatacagccaaaaactgtggacaatagcgactatcccttttctattcct 
 
Pa Cedar_Virus_J  13781 cagtgctcatgagacaaacacccggatagcggcagttgtacaaggtgacaatcaatcaattgcaattacacataaggtccaccctcatttgccttacaaaatgaagaaagaactctctgcaatgcaggca 
Pp CedPV FINAL_3  13781 cagtgctcatgagacaaacacccggatagcggcagttgtacaaggtgacaatcaatcaattgcaattacacataaggtccaccctcatttgccttacaaaatgaagaaagaactctctgcaatgcaggca 
 
Pa Cedar_Virus_J  13911 aaaaaatatttttcaaggttacggcacaacatgaaggcattagggcatgaattgaaggcgaccgagactatcattagtactcatttcttcatttattccaagaaaatccactatgacggggctgttttat 
Pp CedPV FINAL_3  13911 aaaaaatatttttcaaggttacggcacaacatgaaggcattagggcatgaattgaaggcgaccgagactatcattagtactcatttcttcatttattccaagaaaatccactatgacggggctgttttat 
 
Pa Cedar_Virus_J  14041 cacaatctctgaaatcaatggcaaggtgtgtattttggtcagaaacccttgttgatgaaactagagcagcatgcagtaatatcagcacaacaattgcaaaggctattgagaatggttatagcaggagatc 
Pp CedPV FINAL_3  14041 cacaatctctgaaatcaatggcaaggtgtgtattttggtcagaaacccttgttgatgaaactagagcagcatgcagtaatatcagcacaacaattgcaaaggctattgagaatggttatagcaggagatc 
 
Pa Cedar_Virus_J  14171 tggctatctgataaatgttcttaaaaccatccaacaaattaatatatcattgagttttaatataaatgaatgcatgacagatgacataatcagaccgtttagagataatccaaactggatcaaacatgcc 
Pp CedPV FINAL_3  14171 tggctatctgataaatgttcttaaaaccatccaacaaattaatatatcattgagttttaatataaatgaatgcatgacagatgacataatcagaccgtttagagataatccaaactggatcaaacatgcc 
 
Pa Cedar_Virus_J  14301 gcattaatccccgccagcttgggaggactcaactatatgaacatgtctcgattgtatgtgaggaatataggggatccagtcacagcatcgatagcagatgttaagagaatgattctcggtggtgtactac 
Pp CedPV FINAL_3  14301 gcattaatccccgccagcttgggaggactcaactatatgaacatgtctcgattgtatgtgaggaatataggggatccagtcacagcatcgatagcagatgttaagagaatgattctcggtggtgtactac 
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Pa Cedar_Virus_J  14431 ccattggaatactccacaatatcatgttgcaagaacccggtgatgccacttatttggactggtgtagtgatccatactccatcaacctaaagcagactcaaagtatcacaaaagttataaagaacataac 
Pp CedPV FINAL_3  14431 ccattggaatactccacaatatcatgttgcaagaacccggtgatgccacttatttggactggtgtagtgatccatactccatcaacctaaagcagactcaaagtatcacaaaagttataaagaccataac 
 
Pa Cedar_Virus_J  14561 ggcaagagtgatactaaggaattcggtcaatccactgctcaaaggtctatttcatgaaggtgcttatgaggaggacactgaattagcaacattcattttggacaggagagtcatcttaccacgagtcggt 
Pp CedPV FINAL_3  14561 ggcaagagtgatactaaggaattcggtcaatccactgctcaaaggtctatttcatgaaggtgcttatgaggaggacactgaattagcaacattcattttggacaggagagtcatcttaccacgagtcggt 
 
Pa Cedar_Virus_J  14691 cacgagatcttaaacaactccatcacaggagcaagagaagagatctcgggcttactggataccacaaaaggattgataagaattggcatagcaaagggaggattaactcagagaacattatctcgaattt 
Pp CedPV FINAL_3  14691 cacgagatcttaaacaactccatcacaggagcaagagaagagatctcgggcttactggataccacaaaaggattgataagaattggcatagcaaagggaggattaactcagagaacattatctcgaattt 
 
Pa Cedar_Virus_J  14821 ccaattatgattatgaacaatttttgaacctaatgaatatgttgaagaacaaagaacaaaacagtgtcatttccctgtcagcttgctctgttgactttgctatagctttaagaagcaggatgtggaggaa 
Pp CedPV FINAL_3  14821 ccaattatgattatgaacaatttttgaacctaatgaatatgttgaagaacaaagaacaaaacagtgtcatttccctgtcagcttgctctgttgactttgctatagctttaagaagcaggatgtggaggaa 
 
Pa Cedar_Virus_J  14951 attggcaaaaggaagattaatatatggtttagaagtccctgatccaatagaagcaatgattggctttctcattcttgggagtgaaaattgtctactctgtgattcaggaagcaaaaactatacctggttt 
Pp CedPV FINAL_3  14951 attggcaaaaggaagattaatatatggtttagaagtccctgatccaatagaagcaatgattggctttctcattcttgggagtgaaaattgtccactctgtgattcaggaagcaaaaactatacctggttt 
 
Pa Cedar_Virus_J  15081 ttcataccaaaggatgtacagttggataagattgataaagatcacgcatcaataagggtaccctatgtcggatcaactaccgaagaaagatcagagataaagttaggatccgtgaaaaatccaagcaaat 
Pp CedPV FINAL_3  15081 ttcataccaaaggatgtacagttggataagattgataaagatcacgcatcaataagggtaccctatgtcggatcaactaccgaagaaagatcagagataaagttaggatccgtgaaaaatccaagcaaat 
 
Pa Cedar_Virus_J  15211 ccctgaaatctgctataagactcgcaactgtgtacacttgggcatttggcacaagtgatgctgaatggtgggaggcttggtacttgtctaatcaacgagcaaatatacccttagatgttctcaaaacgat 
Pp CedPV FINAL_3  15211 ccctgaaatctgctataagactcgcaactgtgtacacttgggcatttggcacaagtgatgctgaatggtgggaggcttggtacttgtctaatcaacgagcaaatatacccttagatgttctcaaaacgat 
 
Pa Cedar_Virus_J  15341 aacacctatatctacttcaacgaatattgctcatagattacgagaccgatcaacacaggttaaatacgccagtacatctcttaacagagtatcgcggcatgtaacaattagtaacgataacatgaatttt 
Pp CedPV FINAL_3  15341 aacacctatatctacttcaacgaatattgctcatagattacgagaccgatcaacacaggttaaatacgccagtacatctcttaacagagtatcgcggcatgtaacaattagtaacgataacatgaatttt 
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Pa Cedar_Virus_J  15471 gaatttgacggggttaaaatggataccaacttgatttatcaacaagtcatgctgttagggctttcatgcttggagagtttattccgaaataggaaaatgacaaatagttacaatatcgtgtaccatttac 
Pp CedPV FINAL_3  15471 gaatttgacggggttaaaatggataccaacttgatttatcaacaagtcatgctgttagggctttcatgcttggagagtttattccgaaataggaaaatgacaaatagttacaatatcgtgtaccatttac 
 
Pa Cedar_Virus_J  15601 acgttcaagaacattgttgtgtaaaggctctgaatgatttaccttatacaccgtcaacacatccagtgccaaattatacagaagttagagataataggttaatttacgatcctcaacctatattagaatt 
Pp CedPV FINAL_3  15601 acgttcaggaacattgttgtgtaaaggctctgaatgatttaccttatacaccgtcaacacatccagtgccaaattatacagaagttagagataataggttaatttacgatcctcaacctatattagaatt 
 
Pa Cedar_Virus_J  15731 tgatgagctaagattagcaattcagcaaacaaagaaagtagatttggaattttcattgtgggatacaaaagaacttcatgagaatttagctcaaagtttagcgattacagtaacggatattatgacaaaa 
Pp CedPV FINAL_3  15731 tgatgagctaagattagcaattcagcaaacaaagaaagtagatttggaattttcattgtgggatacaaaagaacttcatgagaatttagctcaaagtttagcgattacagtaacggatattatgacaaaa 
 
Pa Cedar_Virus_J  15861 tctgataaagatcatattaaagaccaaagaagtatagatgttgatgataatattaagacactaataactgagtttttattagtagaccctgaaatgtttgccgtaaatttaggattgcatatatcaataa 
Pp CedPV FINAL_3  15861 tctgataaagatcatattaaagaccaaagaagtatagatgttgatgataatattaagacactaataactgagtttttattagtagaccctgaaatgtttgccgtaaatttaggattgcatatatcaataa 
 
Pa Cedar_Virus_J  15991 aatggtcatttgatattcactttaaaagaccaagaggacgctatagcatgatagaatacttgactgatcttttggataatacttcttctcatgtttatcgaatccttactaatgtattatctcatcccag 
Pp CedPV FINAL_3  15991 aatggtcatttgatattcactttaaaagaccaagaggacgctatagcatgatagaatacctgactgatcttttggataatacttcttctcatgtttatcgaatccttactaatgtattatctcatcccag 
 
Pa Cedar_Virus_J  16121 agttatgagaaaattcactaatgccgggctactagtaccgaaatacggtccctaccttacaagtcaagatttcaaaaagatggcggtagatttcataataacagcgtataccacatttttgaccaattgg 
Pp CedPV FINAL_3  16121 agttatgagaaaattcactaatgccgggctactagtaccgaaatacggtccctaccttacaagtcaagatttcaaaaagatggcggtagatttcataataacagcgtataccacatttttgaccaattgg 
 
Pa Cedar_Virus_J  16251 tgtaataataacaagttttcaattctaatacctgaacaagaccctgatatacttgaattaagaaaagacatcactcatgcaaggcatttatgtatgatctcggatctttactgctactctttcaagcaac 
Pp CedPV FINAL_3  16251 tgtaataataacaagttttcaattctaatacctgaacaagaccctgatatacttgaattaagaaaagacatcactcatgcaaggcatttatgtatgatctcggatctttactgctactctttcaaacaac 
 
Pa Cedar_Virus_J  16381 cttggataaaggagcttacaccacaagagaagatctgcgtcatggaggacttcatagccaattgtgttgctaatgatcaaacaagtgcgggctggaacataacgcccttaagagtttacaatctccctgc 
Pp CedPV FINAL_3  16381 cttggataaaggagcttacaccacaagagaagatctgcgtcatggaggacttcatagccaattgtgttgctaatgatcaaacaagtgcgggctggaacataacgcccttaagagtttacaatctccctgc 
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Pa Cedar_Virus_J  16511 atcgaccacatacatcaggagagggataataaaacaattaagaatccgtcaaagcaatgagcctattgatctggaagatattaggattggtcagaaccccgattttgtgaataaacctattgagttttgt 
Pp CedPV FINAL_3  16511 atcgaccacatacatcaggagagggataataaaacaattaagaatccgtcaaagcaatgagcctattgatctggaagatattaggattgatcagaaccccgattttgtgaataaacctattgagttttgt 
 
Pa Cedar_Virus_J  16641 agcagtgaattcggtatcacaatttataaccttgaagaaattcttcaatcaaatgtgcatctcagtgtaaatatgaacattgactcctcaacaagtaacaatactgaaaatcatttatttagaagggtag 
Pp CedPV FINAL_3  16641 agcagtgaattcggtatcacaatttataaccttgaagaaattcttcaatcaaatgtgcatctcagtgtaaatatgaacattgactcctcaacaagtaacaatactgaaaatcatttatttagaagggtag 
 
Pa Cedar_Virus_J  16771 gcttgaactctacttcatcttataaagcactatctttaacacctgttattaaaagatatcatcaacagaacactaataggctgtttataggagaaggatcagggtctatgatgtatctttaccagaaaac 
Pp CedPV FINAL_3  16771 gcttgaactctacttcatcttataaagcactatctttaacacctgttattaaaagatatcatcaacagaacactaataggctgtttataggagaaggatcagggtctatgatgtatctttaccagaaaac 
 
Pa Cedar_Virus_J  16901 cttgggggagacaatatgcttctttaattcgggagttcagtacaatgaggatctgggtcaaagggaacaatcattatacccgagtgaatacagtatctgtgaacaaggagtaaaaaaagaaaaccctctc 
Pp CedPV FINAL_3  16901 cttgggggagacaatatgcttctttaattcgggagttcagtacaatgaggatctgggtcaaagggaacaatcattatacccgagtgaatacagtatctgtgaacaaggagttaaaaaagaaaaccctctc 
 
Pa Cedar_Virus_J  17031 accgggcatgttataccactattcaatggaagaccagaaaccacatgggtaggcaatgatgattctttcaagtatatattggaacatactataaatagagacatcgggcttgttcactccgatatggaaa 
Pp CedPV FINAL_3  17031 accgggcatgttataccactattcaatggaagaccagaaaccacatgggtaggcaatgatgattctttcaagtatatattggaacatactataaatagagacatcgggcttgttcactccgatatggaaa 
 
Pa Cedar_Virus_J  17161 caggaatagggaaggataattatactatcttaaatgaacatgcacatcttatagcactgagccttacagtaatgattgatgatggaatcttggtgtctaaggtagcttatgcccctgggttttgcatctc 
Pp CedPV FINAL_3  17161 caggaatagggaaggataattatactatcttaaatgaacatgcacatcttatagcactgagccttacagtaatgattgatgatggaatcttggtgtctaaggtagcttatgcccctgggttttgcatctc 
 
Pa Cedar_Virus_J  17291 ttcattattgaatatgtaccggacatttttttcattagttctatgtgcgtttccaccgtatagcaattttgaatcaactgaattttacctgatttgcttgcaaaaaagtatacccggacctatcacacca 
Pp CedPV FINAL_3  17291 ttcattattgaatatgtaccggacatttttttcattagttctatgtgcgtttccaccgtatagcaattttgaatcaactgaattttacctgatttgcttgcaaaaaagtatacccggacctatcacacca 
 
Pa Cedar_Virus_J  17421 gctagagccatccaacaaacgacgaagcaatctagagaagaggataatagtataactaataatatcctcaaaatcaaaaatcttgttcagaaagaatttatcaaaacagtaaagaaaaaatacgaaatcc 
Pp CedPV FINAL_3  17421 gctagagccatccaacaaacgacgaagcaatctagagaagaggataatagtataactaataatatcctcaaaatcaaaaatcttgttcagaaagaatttatcaaaacagtaaagaaaaaatacgaaatcc 
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Pa Cedar_Virus_J  17551 atccttcgtttaactgtcctatcaacttcacaaaggatgataaatatttaatgagtgttgggtttcaagccaatggtcctgatatgatacgtaaagagacgggctatgacataggtagcaatgtagagaa 
Pp CedPV FINAL_3  17551 atccttcgtttaactgtcctatcaacttcacaaaggatgataaatatttaatgagtgttgggtttcaagccaatggtcctgatatgatacgtaaagagacgggctatgacataggtagcaatgtagagaa 
 
Pa Cedar_Virus_J  17681 tctccgagatgtcttaatcaagttgtttgcagatgcagtcaccttctatgatgatgtcacaaataaaaagaactttttaaatccttatccagtctacacaagaactcagtataaaattctgatggataaa 
Pp CedPV FINAL_3  17681 tctccgagatgtcttaatcaagttgtttgcagatgcagtcaccttctatgatgatgtcacaaataaaaagaactttttaaatccttatccagtctacacaagaactcagtataaaattctgatggataaa 
 
Pa Cedar_Virus_J  17811 atatgcaagaaagtcaccttatacaccttaatcatatcatgtaaaggatccaatcaatattgctgggaaattaaatcccaaataagaaagcattgtctcatacttgatttgaaaagtaaggtttttacaa 
Pp CedPV FINAL_3  17811 atatgcaagaaagtcaccttatacaccttaatcatatcatgtaaaggatccaatcaatattgctgggaaattaaatcccaaataagaaagcattgtctcatacttgatttgaaaagtaaggtttttacaa 
 
Pa Cedar_Virus_J  17941 aacttattccaaagggattaagagaaaggggtgactcaaaagggatgaagagcatatggttcactaaactaaccagtcaagaggtgaaaagatggtggaagatgatatcttacatcgtgataataagcaa 
Pp CedPV FINAL_3  17941 aacttattccaaagggattaagagaaaggggtgactcaaaagggatgaagagcatatggttcactaaactaaccagtcaagaggtgaaaagatggtggaagatgatatcttacatcgtgataataagcaa 
 
Pa Cedar_Virus_J  18071 tccataaccacatccaacttgtcagttaaacacttaaatcacaataaacttgtcatcagattaaagaaaacttataattcccttttttaggt 
Pp CedPV FINAL_3  18071 tccataaccacatccaacttgtcagttaaacacttaaatcacaataaacttgtcatcagattaaagaaaacttataattcccttttttaggt 
 
Appendix 6. Whole genome sequence of TevPV-Pp compared to reference sequence. SNPs highlighted in red 
 
Pa TeV-Genome_LF      1 accaaggggaaaatcaagaggggtctttaaaccacgatatcataaaagatttcgtgagcccagaagtggtgaattccgtgatcgaggtcgacgctgaataatcgcttctgggcacttgcacaggttgtct 
TevPV-Pp_RM_and_S      1 accaaggggaaaatcaagaggggtctttaaaccacgatatcataaaagatttcgtgagcccagaagtggtgaattccgtgatcgaggtcgacgctgaataatcgcttctgggcacttgcacaggttgtct 
 
Pa TeV-Genome_LF    131 gtcctcctaacttgctttttctcactgtgcaaggatgtcttccgtgttcagggcgttcgagctctttaccttagagcaggagcaacatgaactcggtaatgacattgaattacctcctgaaaccttaaga 
TevPV-Pp_RM_and_S    131 gtcctcctaacttgctttttctcactgtgcaaggatgtcttccgtgttcagggcgttcgagctctttaccttagagcaggagcaacatgaactcggtaatgacattgaattacctcctgaaaccttaaga 
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Pa TeV-Genome_LF    261 gcaaatatcaaggtttgcatcttaaatagtcaggatcctcaaacgcgtcatgatatgatgtgtttctgtcttcgccttattgctagtaactctgcaagagcagcacataaagccggagcaatcctcactt 
TevPV-Pp_RM_and_S    261 gcaaatatcaaggtttgcatcttaaatagtcaggatcctcaaacgcgtcatgatatgatgtgtttctgtcttcgccttattgctagtaactctgcaagagcagcacataaagccggagcaatcctcactt 
 
Pa TeV-Genome_LF    391 tgcttagcttgcccacagctatgatgcagaatcacatcagaatagctgataggtccccggatgcggacattgagaggattgaagtggatgggttcgaacctgggacttacagattacgacctaatgcaag 
TevPV-Pp_RM_and_S    391 tgcttagcttgcccacagctatgatgcagaatcacatcagaatagctgataggtccccggatgcggacattgagaggattgaagtggatgggtttgaacctgggacttacagattacgacctaatgcaag 
 
Pa TeV-Genome_LF    521 gacaccacttacaaacggggagattactgctttagacctaatggcaaacgacctgccggatacctacacaaatgacactccgtttgtaaatcacagaactgagggagaaaattgtgacgagacagaacag 
TevPV-Pp_RM_and_S    521 gacaccacttacaaacggggagattactgctttagacctaatggcaaacgacctgccggatacctacacaaatgacactccgtttgtaaatcacagaactgagggagaaaattgtgacgagacagaacag 
 
Pa TeV-Genome_LF    651 ttcttgaatgcaatatacagtgtactagtgcaactttgggtgatggtctgcaaatgtatgactgctcatgaccagccgactgggtccgatgagcgccgtcttgccaagtatcagcagcaggggcgcatgg 
TevPV-Pp_RM_and_S    651 ttcttgaatgcgatatatagtgtactagtgcaactttgggtgatggtctgcaaatgtatgacagctcatgaccagccgactgggtccgatgagcgccgtcttgccaagtatcagcagcaggggcgcatgg 
 
Pa TeV-Genome_LF    781 atcagaaatatgcactgcagccagaactgcggagacagattcaaacatgcatccgccggagcttgacgatacgtcaatttctcacctatgagctacagaccgccagaaagcagggtgcaataaccgggag 
TevPV-Pp_RM_and_S    781 atcagaaatatgcactgcagccagaactgcggagacagattcaaacatgcatccgccggagcttgacgatacgtcaatttctcacctatgagctacagaccgccagaaagcagggtgcaataaccgggag 
 
Pa TeV-Genome_LF    911 gtactatgctatggtgggggatataggcaagtacatcgacaatgccggtatgagcgcattcttcatgacaatgaggtttgctcttggaacacgatggcccccgcttgcgctctctgcattttccggggag 
TevPV-Pp_RM_and_S    911 gtactatgctatggtgggggatataggcaagtacatcgacaatgccggtatgagcgcattcttcatgacaatgaggtttgctcttggaacacgatggcccccgcttgcgctctctgcattttccggggag 
 
Pa TeV-Genome_LF   1041 ctattaaagctcaaatcactcatgcagctctacaggaatttgggagaaaaagccagatatatggccctcttggaaatgccagagatgatggaatttgcacctgctaactacccgctgtgctacagttatg 
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TevPV-Pp_RM_and_S   1041 ctattaaagctcaaatcactcatgcagctctacaggaatttgggagaaaaagccagatatatggccctcttggaaatgccagagatgatggaatttgcacctgctaactacccgctgtgctacagttatg 
 
Pa TeV-Genome_LF   1171 caatgggtatcggaagcgttcaggaccctatgatgagaaattacacatttgctcgccctttccttaatcctgcatatttccagcttggagttgagacagcaaaccgacaacagggatctgtggacaagaa 
TevPV-Pp_RM_and_S   1171 caatgggtatcggaagcgttcaggaccctatgatgagaaattacacatttgctcgccctttccttaatcctgcatatttccagcttggagttgagacagcaaaccgacaacagggatctgtggacaagaa 
 
Pa TeV-Genome_LF   1301 catggccgaagaacttggtctcacagaggaagagagaagagacatgtctgcaacagtcacccggctgacaacaggcagaggagcaggacaggctcaggacatgataaacatcatgggagcacgtcaggca 
TevPV-Pp_RM_and_S   1301 catggccgaagaacttggtctcacagaggaagagagaagagacatgtctgcaacagtcacccggctgacaacaggcagaggagcaggacaggctcaggacatgataaacatcatgggagcacgtcaggca 
 
Pa TeV-Genome_LF   1431 gctggcggacgagccgcccaaggaagagcactgagggtgattgaggaggacgagacaacagaagaagagagcgatgatgaaattcaggacgaagtccaaggcaggccgcttcctccattgccagcacagg 
TevPV-Pp_RM_and_S   1431 gctggcggacgagccgcccaaggaagagcacttagagtgattgaggaggacgagacaacagaagaagagagcgatgatgaaattcaggacgaagtccaaggcaggccgcttcctccattaccagcacagg 
 
Pa TeV-Genome_LF   1561 tcagagaggttgattgggaagcaagacttgcagagattgaagagcaagaacagagaatgagagatcgaggacaagggatgggaggtggtgcaccagctacaggaccagcccaaccccgacaggcgctaca 
TevPV-Pp_RM_and_S   1561 tcagagaggtcgactgggaagcaagacttgcagagattgaagagcaagaacagagaatgagagatcgaggacaagggatgggaggtggtgcaccagctacaggaccagcccaaccccgacaggcgctaca 
 
Pa TeV-Genome_LF   1691 tgaggaacaggtactcttggatctagacatgtagatcaatcccccatccacagccacaaacaagcagagtcatcccctagccgcagctatcactagaaccctactatgtatgcttgcacagaactattgt 
TevPV-Pp_RM_and_S   1691 tgaggaacaggtactcttggatctagacatgtagatcaatcccccatccacagccacaaacaagcagagtcatcccctagccgcagctatcactagaaccctactacgtatgcttgcgcagaactattgt 
 
Pa TeV-Genome_LF   1821 ataattatagatttaagaaaaaacaagtatcagaagcaatagagtaagatagaaacctgaaactgagcccgaacagggtaaacccgctaggctctccttgttcggggtagattggtgctttacacctgtc 
TevPV-Pp_RM_and_S   1821 ataattatagatttaagaaaaaacaagtatcagaagcaatagaataagatagaaaactgaaactgagcccgaacagggtaaacccgctaggctctccttgttcggggtagattggtgctttacacctgtc 
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Pa TeV-Genome_LF   1951 tactaaaagagctggtacatccagagttcttctgcctcgcttcgcaatctagccattagctacagatcttgggactgtccagatggacgcttcacccagtgatgcagagatatccgcatggatagacaag 
TevPV-Pp_RM_and_S   1951 tactaaaagagctggtacatccagagttcttctgcctcgcttcgcaatctagccattagctacagatcttgggactgtccagatggacgcttcacccagtgatgcagagatatccgcatggatagacaag 
 
Pa TeV-Genome_LF   2081 ggattggatacagtcgaacatttccttagcgtcgctacaccacctgtgagaagtctgggaaaatcatccattaaacccggaaacactggagagttgatcagcgctgcagaaaagttggttagtaatatgg 
TevPV-Pp_RM_and_S   2081 ggattggatacagtcgaacatttccttagcgttgctacaccacctgtgagaagtctgggaaaatcatccattaaacccggaaacactggagagttgatcagcgctgcagaaaagttggttagtaatatgg 
 
Pa TeV-Genome_LF   2211 aagggattactgcatcaagccccaccatgaaaggccccgatcctgctgtcagacccaaagaaagaaccaagccgcctcaagataatgcccagaaccaagagcaggatgacatctacgaagaagtgatccc 
TevPV-Pp_RM_and_S   2211 aagggattactgcatcaagccccaccatgaaaggccccgatcctgctgtcagacccaaagaaagaaccaagccgccccaagataatgcccagaaccaagagcagaatgacatctacgaagaagtgatccc 
 
Pa TeV-Genome_LF   2341 atctgagagcacagctctcatccccaaaagtgcaccaaagaagccgtctagaaacaaagagaaagtcatgtcaatgatggctctaagtccgccagaggataattcggccaaagagaaaccttccgtattt 
TevPV-Pp_RM_and_S   2341 atctgagagcacagctctcatccccaaaagtgcaccaaagaagccgtctagaaacaaagagaaagtcatgtcaatgatggctctaagtccgccagaggataattcggccaaagagaaaccttccgtattt 
 
Pa TeV-Genome_LF   2471 aagaggggggattcctccgccacatggccccgccgccacagacaagggggccacaggagggagattgcaatcagctgggcaacaggggtcccacgagtcacagaatggtgcaacccaatatgtcacccaa 
TevPV-Pp_RM_and_S   2471 aagaggggggattcctccgccacatggccccgccgccacagacaagggggccacaggagggagattgcaatcagctgggcaacaggggtcccacgagtcacagaatggtgcaacccaatatgtcacccaa 
 
Pa TeV-Genome_LF   2601 tatctcaatccacgtaccgaggatcctgtcggtgcgggttctgcccagatgtctgctctctgtgtgagggagattatgcattacttacagacattagagactcggattactaatcttgattggaaagttg 
TevPV-Pp_RM_and_S   2601 tatctcaatccacgtaccgaggatcctgtcggtgcggattctgcccagatgtctgctctctgtgtgagggagattatgcattacttacagacattagagactcggattactaatcttgattggaaagttg 
 
Pa TeV-Genome_LF   2731 acaaattgttatcacaacaatctaccataacacaaattaagaatgatcagcacaccatcaaagcttcacttgctaccatcgagggtttgataacaacaatcaagataatggatcctggagtaggaccagg 
TevPV-Pp_RM_and_S   2731 acaaattgttatcgcaacaatcaaccataacacaaattaagaatgatcagcacaccatcaaagcttcacttgctaccatcgagggtttgataacaacaatcaagataatggatcctggagtaggaccagg 
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Pa TeV-Genome_LF   2861 agcgacagctgcccaagcaaagaaaatattcaaggaagttcctgtagttataagcggcccggtattaggagaaaaccaggttatccatgctgatacaatccaacttgatgagctcgcgcgcccatcacct 
TevPV-Pp_RM_and_S   2861 agcgacagctgcccaagcaaagaaaatattcaaggaagttcctgtagttataagtggcccgatattaggagaaaaccaggttatccatgctgatacaatccaacttgatgagctcgcgcgcccatcacct 
 
Pa TeV-Genome_LF   2991 gccaaagggaagcaggcgaaggccgcatccccgaatcctaatgctgttataggatacaggtccacactgcagtctcttgtcaaagagtgcattactaatcccgggcttcgacaaaagtttgatgttgcca 
TevPV-Pp_RM_and_S   2991 gccaaagggaagcaggcgaagaccgcatccccgaatcctaatgccgttataggatacaggtccacactgcagtctcttgtcaaagagtgcattactaatcccgggcttcgacaaaagtttgatgttgcca 
 
Pa TeV-Genome_LF   3121 tcaatagtgtgaagactgaacaggattttaaacaggtgaggagggacatcatcagaagtgccacctaaacagacccttgcatcctgcgctcaaggagtcaaaatacaggactcagctcgccatcctccag 
TevPV-Pp_RM_and_S   3121 tcaatagtgtgaagactgaacaggattttaaacaggtgaggagggacatcatcagaagtgccacctaaacagacccttgcatccagcgctcaaagagtcaaaatacaggactcagctcgccatcctccaa 
 
Pa TeV-Genome_LF   3251 catacacgtccctaatgctaccgcacaccacaaagcaacccatcacccgtttccacccaagcagctgagcttaaaactttgattttaataaaaaatcaaaaatgggtccgaacccatcttgagttcgggc 
TevPV-Pp_RM_and_S   3251 catacacgtccctaatgctgccgcacaccacaaagcaacccatcacccgtttccacccaagcagctgagcttaaaactttgattttaataaaaaatcaaaaatgggtccgaacccatcttgagttcgggc 
 
Pa TeV-Genome_LF   3381 attaaatcatggctcttcgtcaagctaccatccccattgcagtagataacgagagtgagaagaacaatctcaacccattcccaattgtcccaataacacgggatgatgggtcacccactggaaggcttgt 
TevPV-Pp_RM_and_S   3381 attaaatcatggctcttcgtcaagctaccatccccattgcagtagataacgagagtgagaagaacaatctcaacccattcccaattgtcccaataacacgggatgatgggtcacccactggaaggcttgt 
 
Pa TeV-Genome_LF   3511 acggcagctgaggatcaagaatctcacacctagagggtcaacagaactgccgctgacctttataaacacctacggattcattaagccattgatgacctacacagaattctattctgagctgcaccaccag 
TevPV-Pp_RM_and_S   3511 acggcagctgaggatcaagaatctcacacctagagggtcaacagaactgccgctgacctttataaacacctacggattcattaagccattgatgacctacacagaattctattctgagctgcaccaccag 
 
Pa TeV-Genome_LF   3641 tcctcaacaccttgtctcacagcttgcatgataccctttggagctgggccttacatcgagaacccccaccgcatcttggatgaatgcgacaaggtgaatattgtagtgaggaagagtgcaagtgtgaaag 
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TevPV-Pp_RM_and_S   3641 tcctcaacaccttgtctcacagcttgcatgatacccttcggagctgggccttacatcgagaacccccaccgcatcttggatgaatgcgacaaggtgaatattgtagtgaggaagagtgcaagtgtgaaag 
 
Pa TeV-Genome_LF   3771 aggaaatcatttttgatgtcaggcggctgcctccactattcaaccggcaccagatctctggcaatagactgatatgtgtaccgtcggagaaatatgtcaagtctccggggaaaatgacagcgggcacgga 
TevPV-Pp_RM_and_S   3771 aggaaatcatttttgatgtcaggcggctgcctccactattcaaccggcaccagatctctggcaatagactgatatgtgtaccgtcggagaaatatgtcaagtctccggggaaaatgacagcgggcacgga 
 
Pa TeV-Genome_LF   3901 ttactcatatcagatcgcatttgtgtcactcaccttctgtccggagagccagaaattcagagtcgcaaggccactgcaaacaatcagatcccctataatgaggagcgtccaattggaagtgatactcaag 
TevPV-Pp_RM_and_S   3901 ttactcatatcagatcgcatttgtgtcactcaccttctgtccggagagccagaaattcagagtcgcaaggccactgcaaacaatcagatcccctataatgaggagcgtccaattggaagtgatactcaag 
 
Pa TeV-Genome_LF   4031 gttgactgtgcagcaaattcccccttgaagaggttcttgattgtgtcaccggactcaaaagagtatttcgcatcagtatggttccatgtttgcaacttgtacaggggaaacaagccgttcaaatcgtatg 
TevPV-Pp_RM_and_S   4031 gttgactgtgcagcaaattcccccttgaagaggttcttgattgtgtcaccggactcaaaagagtatttcgcatcagtatggttccatgtttgcaacttgtacaggggaaacaagccgttcaaatcgtatg 
 
Pa TeV-Genome_LF   4161 atgatacatacttcagtgagaaatgcagagctatgcagttagagtgtgggatcgttgacatgtggggcccaactttggttgtcaaagcacatgggaagatcccaaagatggcgaaacccttctttagctc 
TevPV-Pp_RM_and_S   4161 atgatacatacttcagtgagaaatgcagagctatgcagttagagtgtgggatcgttgacatgtggggcccaactttggttgtcaaagcacatgggaagatcccaaagatggcgaaacccttctttagctc 
 
Pa TeV-Genome_LF   4291 aaaaggatggtcatgccatgcatttgccgactctgcgcccacactagcaaaggctctatggtccgtcggggcacagataacccaagtcaatgccatactgcaaccttctgaccttcatcaactggtacaa 
TevPV-Pp_RM_and_S   4291 aaaagggtggtcatgccatgcatttgccgactctgcgcccacactagcaaaggctctatggtccgtcggggcacagataacccaagtcaatgccatactgcaaccttctgaccttcatcaactggtacaa 
 
Pa TeV-Genome_LF   4421 gtgagtgatgtgatctggccaaaagtaaaattggatgagaaaattcagctatatgctgctgcaaagtggaacccattcaagaaatctgcaaattaagggattgttggcagtatcgtaatagtatccagct 
TevPV-Pp_RM_and_S   4421 gtgagtgatgtgatctggccaaaagtaaaattggatgagaaaattcagctatatgctgctgcaaagtggaacccattcaagaaatctgcaaattaagggattgttggcagtatcgtaacagtatccagct 
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Pa TeV-Genome_LF   4551 ttgttactaagaaggaacgcctttatactgtattatgcttatttgtttaaaagtcccagctaacctactgacagcccattcagtttcctgtaagccgccaactaagctcgcaacctttgcctctctgatc 
TevPV-Pp_RM_and_S   4551 ttgttactaagaaggaacgcctttatactgtattatgcttatttgtttaaaagtcccagctaacctactgacagcccattcattttcctgtaagccgccaactaagctcgcaacctttgcctctctgatc 
 
Pa TeV-Genome_LF   4681 cgctgtctcagcatctcaatatccatgccacagcacattataagactagttgaaacaagtagaagctccaataagcatttaagaaaaaattgagcccggaagggtatcctaccaccgaaggccccggatg 
TevPV-Pp_RM_and_S   4681 cgctgtctcagcatctcaatatccatgccacagcacattataagactagttgaaacaagtagaagctccaataagcatttaagaaaaaattgagcccggaagggtatcccaccaccgaaagtcccggacg 
 
Pa TeV-Genome_LF   4811 gcacccccaccaacagaaccacccggctcaccatcatgaacctgctcaaagttcatctgctcttgatgctttacccctcatgcatctgcggaataaataaagacaagctattaagtatagggttagttca 
TevPV-Pp_RM_and_S   4811 gcacccccaccaacagaaccacccggcccaccatcatgaacctgctcaaagttcatctgctcttgatgctttacccctcatgcatctgcggaataaataaagacaagctattaagtatagggttagttca 
 
Pa TeV-Genome_LF   4941 taagtctgttaagaatcttatgttttattcacaaggatccccgtcgtatattgtagtaaaactagttcccacactaggaaatttaccggagaactgcactcttaacagtcttaagaggtacaagagcact 
TevPV-Pp_RM_and_S   4941 taagtctgttaagaatcttatgttttattcacaaggatccccgtcgtatattgtggtaaaactagttcccacactaggaaatttaccggagaactgcactcttaacagtcttaagaggtacaagagcact 
 
Pa TeV-Genome_LF   5071 gtcacctctcttcttactcctttatctgataacctcaattatttgcagcagacccttactgtcagcaagggaagtaggaggcgcaggtttgcaggcgtggcaatcggactagcggcactcggtgttgcag 
TevPV-Pp_RM_and_S   5071 gtcacctctcttcttactcctttatctgataacctcaattatttgcagcagacccttactgtcagcaagggaagtaggaggcgcaggtttgcaggcgtggcaatcggactagcggcactcggtgttgcag 
 
Pa TeV-Genome_LF   5201 ctgctgcccaggccactgcggcggtggctctagtggaagcacgccagaatgcagcgcagattcaaagcctttcagaatccatccaaaataccaacttagcagtcaatgagctcaagactgcaataggtgc 
TevPV-Pp_RM_and_S   5201 ctgctgcccaggccactgcggcggtggctctagtggaagcacgccagaatgcagcgcagattcaaagcctttcagaatccatccaaaataccaacttagcagtcaatgagctcaagactgcaataggtgc 
 
Pa TeV-Genome_LF   5331 atctgctgtagccatacaggctatccaaactcaggtgaatgatgtgataaacccagccatcaaccgtcttagttgcgaggttcttgatgcacaacttgcatctatgttgaatctgtatttgatccatctc 
TevPV-Pp_RM_and_S   5331 atctgctgtagccatacaggctatccaaactcaggtgaatgatgtgataaacccagctatcaaccgtcttagttgcgaggttcttgatgcacaacttgcatctatgttgaatctgtatttgatccatctc 
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Pa TeV-Genome_LF   5461 actactgtgtttcagaatcaaatcacgaatccagcattgtctccactaagcatacagtccctgcaaagcttactccaaagtacatctggtatcctcacgaacatgactgcgggctcaaacctagtattaa 
TevPV-Pp_RM_and_S   5461 actactgtgtttcagaatcaaatcacgaatccagcattgtctccactgagcatacagtccctgcaaagcttactccaaagcacatctggtatcctcacgaacatgactgcgggctcaaacctagtattaa 
 
Pa TeV-Genome_LF   5591 atgacgcccttgcaaccggactcataactggacaagttgtggggatgaacctaacttctctacagatagtgatcgcagcttatgtcccgaatgttgcaaagctaacaaatgcaattgtccatcaattcat 
TevPV-Pp_RM_and_S   5591 atgatgcccttgcaaccggactcataactggacaagttgtggggatgaacctaacttctctacagatagtgatcgcagcttatgtcccgaatgttgcaaagctaacaaatgcaattgtccatcaattcat 
 
Pa TeV-Genome_LF   5721 cagaatcacaacatcagtaaatgggacggaggtcattgtgcagtcaccgacccaaataatggagcaaaatgaggtgatgtatgagctaaggtcggatcactgctctgagagtgtgatgaacatatattgt 
TevPV-Pp_RM_and_S   5721 cagaatcacaacatcagtaaatgggacggaggtcattgtgcagtcaccgacccaaataatggagcaaaatgaggtgatgtatgagctaaggtcggatcactgctctgagagtgtgatgaacatatattgt 
 
Pa TeV-Genome_LF   5851 ccttatattgatgctcagctcatgcctcctacttcaactaattgtataaatggacaattgaatgattgcaccttctctaaagtggtcggttcattccctactaggtttgctgcagtggaaggcgccattc 
TevPV-Pp_RM_and_S   5851 ccttatattgatgctcagctcatgcctcctacttcaactaattgtataaatggacaattgaatgattgcaccttctctaaagtggtcggttcattccctactaggtttgctgcagtggaaggcgccattc 
 
Pa TeV-Genome_LF   5981 tggccaactgtaaatacttacagtgcaattgtctggttccaccttacataatcactcctttgaagggggagatgatctcaatgataaatctttcaaaatgtcaacgccttgacctgggaactgtagtatt 
TevPV-Pp_RM_and_S   5981 tggccaactgtaaatacttacagtgcaattgtctggttccaccttacataatcactcctttgaagggggagatgatctcaatgataaatctttcaaaatgtcaacgccttgacctgggaactgtagtatt 
 
Pa TeV-Genome_LF   6111 tgagattaataatcctgtcaatgtgacattcaacggcaattatcgtgcagatgtaggtcagttgatcgtcacaaacccgttggatatttctgctgaactcaatcaaattaacacctcactttccaatgca 
TevPV-Pp_RM_and_S   6111 tgagattaataatcctgtcaatgtgacattcaacggcaattatcgtgcagatgtaggtcagctgatcgtcacaaacccgttggatatttctgctgaactcaatcaaattaacacctcactttccaatgca 
 
Pa TeV-Genome_LF   6241 cagactttcttatcaaagagtgatgcatggcttcgcgtatctcaatggttatcaaactcaggtacaatcttcataatattgctgattggactcggcatcggagtaatctacatggttatcaacacctatg 
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TevPV-Pp_RM_and_S   6241 cagaccttcttatcaaagagtgatgcatggcttcgcgtatctcaatggttatcaaactcaggtacaatcttcataatattgctgattggactcggtatcggagtaatctacatggttatcaacacctatg 
 
Pa TeV-Genome_LF   6371 ttgttgttcagataatcaaggaaatcaatagaatacgggataaagatagagctcacctgcttaaagggtcggtatcttcaatttctatgtaatctaatatatttacagaagagtgatagctaccattcaa 
TevPV-Pp_RM_and_S   6371 ttgttgttcagataatcaaggaaatcaatagaatacgggataaagatagagctcacttgcttaaagggtcggtatcttcaatttctatgtaatctaatatatttacagaagagtgatagctaccatacaa 
 
Pa TeV-Genome_LF   6501 atcaacaatcatctacttgtatatctatatatcagtttaaagaaaaaattagtgattgctatcagccgtagatgattagctaaaacgtgggcccgaacattgcaaaggcacgcacatcaaccggcccata 
TevPV-Pp_RM_and_S   6501 atcaacaatcttctacttgtatatctatatatcagtttaaagaaaaaattagtgattgctatcagccgtagatgattagctaaaacgtgggcccgaacattgcaaaggcacgcacatcaaccggcccata 
 
Pa TeV-Genome_LF   6631 cacaacacaaacaatgtggagtactcaggcaagcaaacatccggctatggtcaactcagccacgaacctggttgacataccccttgatcacccaacgagtgcccggtttcccatcaataggaagagaaca 
TevPV-Pp_RM_and_S   6631 cacaacacaaacaatgtggagtactcaggcaagcaaacatccggctatggtcaactcagccacgaacctggttgacataccccttgatcacccatcgagtgcccagtttcctatcaataggaagagaaca 
 
Pa TeV-Genome_LF   6761 gggaggctgatatacaggctgtttagtatattatgcaacctcattctcatctcaattcttatctcactggtagttatctggagtagatcctcacgtgattgtgcaaagtctgatgggctatcaagtgttg 
TevPV-Pp_RM_and_S   6761 gggaggctgatatacaggctgtttagtatattatgcaacctcattctcatctcaattcttatctcactggtagttatctggagtagatcctcacgtgattgtgcaaagtctgatgggctatcaagtgttg 
 
Pa TeV-Genome_LF   6891 ataaccagctttccagtctctcaaggagtatcaatagtttgatcacggaagtgaaccagatcagcgtaactacggcaatcaatttacctataaaattgtctgagtttggtaagtcagtggtcgatcaggt 
TevPV-Pp_RM_and_S   6891 ataaccagctttccagtctctcaaggagtatcaatagtttgatcacggaagtgaaccagatcagcgtaactacagcaatcaatttacctataaaattgtctgagtttggtaagtcagtggtcgatcaggt 
 
Pa TeV-Genome_LF   7021 gactcagattattcgtcagtgcaatgcagcatgcaaaggcccaggggagaagccaggtatccagaatgttagaattaacatcccgaacaatttttcaacctattctgaattaaatcgcacagctaacagc 
TevPV-Pp_RM_and_S   7021 gactcagatgattcgtcagtgcaatgcagcatgcaaaggcccaggagagaagccaggtatccagaatgttagaattaacatcccgaacaatttttcaacctattctgaattaaatcgcacagctaacagc 
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Pa TeV-Genome_LF   7151 cttaatttccaatcaaggacagccttatttgctagacctaacccttatccgaaaacatgttccagatttccaagctacagtgtgtatttcggtatccactgcttctctcatgctgtgacagacagctcat 
TevPV-Pp_RM_and_S   7151 cttaatttccaatcaaggacagccttatttgctagacctaacccttatccgaaaacatgttccagatttccaagctacagtgtgtatttcggtatccactgcttctctcatgctgtgacagacagctcat 
 
Pa TeV-Genome_LF   7281 gtgagcttagtgattcgacctactaccgattggtgattggagtggcagataagaatctatctgatccggcagatgtgaaatatataggggaaacgacaacccctgttagagtgcagactcgtgggtgctc 
TevPV-Pp_RM_and_S   7281 gtgagcttagtgattcgacctactaccgattggtgattggagtggcagataagaatctatctgatccggcagatgtgaaatatataggggaaacgacaacccctgttagagtgcagactcgtgggtgctc 
 
Pa TeV-Genome_LF   7411 agtggtaagttctatttatggatgttacctactttgttcaaaatctaatcaggattatcaagatgatttcagagaacaaggatttcatcagatgtttatcttatttttatcaagggaacttaaaactaca 
TevPV-Pp_RM_and_S   7411 agtggtaagttctatttatggatgttacctactttgttcaaaatctaatcaggattatcaagatgatttcagagaacaaggatttcatcagatgtttatcttatttttatcaagggaacttaaaactaca 
 
Pa TeV-Genome_LF   7541 ttctttgacgatatggtttcttccactactgtgacttggaatggtttgtatccaggagaaggttcagggatctggcatatgggtcatctagtcttccctttatggggaggcatcagattcggtactcatg 
TevPV-Pp_RM_and_S   7541 ttctttgacgatatggtttcttccactactgtgacttggaatggtttgtatccaggagaaggttcagggatctggcatatgggtcatctagtcttccctttatggggaggcatcagattcggtactcatg 
 
Pa TeV-Genome_LF   7671 caagtgagggcatcctgaattcaaccttagagctaccacctgtagggccatcatgcaagcgcagccttgcagataacggtctcatcaataaggatgtactgtttagtccatactttggtgacagtgtgat 
TevPV-Pp_RM_and_S   7671 caagtgagggcatcctgaattccaccttagagctaccacctgtagggccatcatgcaagcgcagccttgcagataacggtctcatcaataaggatgtactgtttagtccatactttggtgacagtgtgat 
 
Pa TeV-Genome_LF   7801 ggtatttgcatacttatcgtgttatatgttgtcaaacgtcccaacacactgtcaggtcgagactatgaattcctcagtacttgggtttggatcccgagcacagttctatgatctaaagggaatcgtttat 
TevPV-Pp_RM_and_S   7801 ggtatttgcatacttatcatgttatatgttgtcaaacgtcccaacacactgtcaggtcgagactatgaattcctcagtacttgggtttggatcccgagcacagttctatgatctaaaggggatcgtttat 
 
Pa TeV-Genome_LF   7931 ctgtatattcaaagtgctggttggttctcctatactcaattatttagattatcattacagtcaaaaggttacaagctgtcggtaaagcaaatcaagaggatccctatctcaagcacatcaagaccgggga 
TevPV-Pp_RM_and_S   7931 ctgtatattcaaagtgctggttggttctcctatactcaattatttagattatcattacagtcaaaaggttacaagctgtcggtaaagcaaatcaagaggatccctatctcaagcacatcaagaccgggga 
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Pa TeV-Genome_LF   8061 cagagccgtgtgatattatacataattgcccttacacttgcgcaaccggattgttccaggcaccgtggatagttaatggagacagtataagagatcgggatgttaggaacatggcttttgttcaggcatg 
TevPV-Pp_RM_and_S   8061 cagagccgtgtgatattatacataattgcccttacacttgcgcaaccggattgttccaggcaccgtggatagttaatggagacagtataagagatcgggatgttaggaacatggcttttgttcaggcatg 
 
Pa TeV-Genome_LF   8191 gtcaggggccataaacacattccaacgaccatttatgtcaatatgtagtcaatattcctgtcctctatcagagctgctcgattcagaaagtagtataatgaggtcaactacgacttactgcttcccaagt 
TevPV-Pp_RM_and_S   8191 gtcaggggccataaacacattccaacgaccatttatgtcaatatgtagtcaatattcctgtcctctatcagagctgctcgattcagaaagtagtataatgaggtcaactacgacttactgcttcccaagt 
 
Pa TeV-Genome_LF   8321 ttaacagagagcatattacaatgtgtatcttttattgaatgggggggccctgtaggtaatcccataagtatcaatgaagtttattcttcgatctcttttagacctgactgatcttgggactctgtcaaca 
TevPV-Pp_RM_and_S   8321 ttaacagagagcatattacaatgtgtatcttttattgaatgggggggccctgtaggtaatcccataagtatcaatgaagtttattcttcgatctcttttagacctgactgatcttgggactctgtcaaca 
 
Pa TeV-Genome_LF   8451 tcacccacatggggaaatcaggattacagtgcgagtagttttaatcatccaagctcacaacctaggcatcttacacttaattcccttactttaagaaaaaattgactccatacttggtaactgatcaatc 
TevPV-Pp_RM_and_S   8451 tcacccacatggggaaatcaggattacagtgcaagtagttttaatcatccaagctcacaacctaggcatcttacacttaattcccttactttaagaaaaaattgactccatacttggtaactgatcaatt 
 
Pa TeV-Genome_LF   8581 gacgatagttctgtaatcaaccaagggggagacattaaggcagcaatataactgggccagaatggcgtgccccgagcaagtgatcctccctgaggtacaccttgactcaccgattgttaaaaataagttg 
TevPV-Pp_RM_and_S   8581 gacgatagttctgtaatcaaccaagggggagacattgaggcagcaatataactgggccagaatggcgtgccccgagcaagtgatcctccctgaggtacaccttgactcaccgattgttaaaaataagttg 
 
Pa TeV-Genome_LF   8711 tattactatctcaaagtaggtggtttcccacttccagatgaagagttctgtgacactctcttccccaacatctcgtgggagcaagttagacgtgaagagtcacgtttgtctgcaaggttactcaaggtac 
TevPV-Pp_RM_and_S   8711 tattactatctcaaagtaggtggtttcccacttccagatgaagagttctgtgacactctcttccccaacatctcgtgggagcaagttagacgtgaagagtcacgtttgtctgcaaggttactcaaggtac 
 
Pa TeV-Genome_LF   8841 gcaatttggcaatgtcaagattagagccaaagaagagaaaattacaatatcagaataagtccgagagcccatcagtggtactctggcctgaaataataccagagttgagaggatatgtccttgcaagttg 
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TevPV-Pp_RM_and_S   8841 gcaatttggcaatgtcaagattagagccaaagaagagaaaattacagtatcagaataagtccgagagcccatcagtggtactctggcctgaagtaataccagagttgagaggatatgtccttgcaagttg 
 
Pa TeV-Genome_LF   8971 tctgagccgctttgcagacgcagaaaaatgccttatttctgctttgtctcctttagtcacaggaacccaagacttactgaatcagatgggtagcaagatctctagtaaaacattcctagttacacataat 
TevPV-Pp_RM_and_S   8971 tctgagccgctttgcagatgcagaaaaatgccttatttcttctttgtctcctttagtcacaggaacccaagacttactgaatcagatgggtagcaagatctctagtaaaacattcctagttacacataat 
 
Pa TeV-Genome_LF   9101 tctagtgcctgtaagcatcatgacaaccactctcgccctcagtctgcgctcgatttctgccatatttatgactctagtgaatacagagattctttttacacttggttcttaattagacatcagatgcgag 
TevPV-Pp_RM_and_S   9101 tctagtgcctgtaagcatcatgacaaccactctcgccctcagtctgcgctcgatttctgccatatttatgactctagtgaatacagagattctttttacacttggttcttaattagacatcagatgcgag 
 
Pa TeV-Genome_LF   9231 gcctaatcctcaagacccagacaaatttgtcactggatctaatagtagttctagatgaaaggaaattttgcttcatagtaacaccggagctggttaccatagtagatccctgcagcaatagactctcttt 
TevPV-Pp_RM_and_S   9231 gcctaatcctcaagacccagacaaatttgtcactggatctaatagtagttctagatgaaaggaaattttgcttcatagtaacaccggagctggttaccatagtagatccctgcagcaatagactctcttt 
 
Pa TeV-Genome_LF   9361 ctttactttcgagatgaccttaatggtaacagatatgctagaggggagaatgaacattcttgcaataagtagtgcaagctgctacttacaacctttacgaacaaatttatcatatttgttcgagatagta 
TevPV-Pp_RM_and_S   9361 ctttactttcgagatgaccttaatggtaacagatatgctagaggggagaatgaacattcttgcaataagtagtgcaagctgctacttacaacctttacgaacaaatttatcatatttgttcgagatagta 
 
Pa TeV-Genome_LF   9491 gaccatctctgtgccatcctaggtcagaatgtctattctgtcattgcaaatttagaaagcatggtatatgccatcctacagctttctgatcctgttgtagaactaaagggagagttcctctcttttataa 
TevPV-Pp_RM_and_S   9491 gaccatctctgtgccatcctaggtcagaatgtctattctgtcattgcaaatttagaaagcatggtatatgccatcctacagctttctgatcctgttgtagaactaaagggagagtttctctcttttataa 
 
Pa TeV-Genome_LF   9621 attcagagatctatgccatactaagtgacagcggtgaattcaatgaagaagaagcaacatctgtcatagacaagttgaattcatgctttctccacttgcctacagatcttactgcagagctactgtgcat 
TevPV-Pp_RM_and_S   9621 attcagagatctatgccatactaagtgacagcggtgaattcaatgaagaagaagcaacatctgtcatagacaagttgaattcatgctttctccacttgcctaccgatcttactgcagagctactgtgcat 
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Pa TeV-Genome_LF   9751 tatgcggctttggggacatccgatgttgagctcagcaacagcagcaagaaaagtcagggagtcaatgtgtgcaccgaaggttatcgatctcacaacaaacctcaaaacattggctttctttaacgggatc 
TevPV-Pp_RM_and_S   9751 tatgcggctttggggacatccgatgttgagctcagcaacagcagcaagaaaagtcagggagtcaatgtgtgcaccgaaggttatcgatctcacaacaaacctcaaaacattggccttctttaacgggatc 
 
Pa TeV-Genome_LF   9881 atcatcaacggttaccgaagaagacatgatggaatctggccaaattgtaaactgcctccctttgcatcggtaagtttgcaggaattgaagcatgataactcggaattatcctatcaatatatattgaacc 
TevPV-Pp_RM_and_S   9881 atcatcaacggttaccgaagaagacatgacggaatctggccaaattgtaaactgcctccctttgcatcggtaagtttgcaggaattgaagcatgataactcggaattatcctatcaatatatattgaacc 
 
Pa TeV-Genome_LF  10011 attggaaagagcttgccatgctagaatttgagaagagtatagaggctgaccctggtgaagacctaagtatctttatgaaagataaggctataagtgcaccgaggaaggagtggctcagtgttttcagaaa 
TevPV-Pp_RM_and_S  10011 attggaaagagcttgccatgctagaatttgagaagagtatagaggctgaccctggtgaagacctaagtatctttatgaaagataaggctataagtgcaccgaggaaggagtggctcagtgttttcagaaa 
 
Pa TeV-Genome_LF  10141 gagtctgataaaacagcagtgtgagaagaacaaaatacccctacctcagccttacaataggaggttattgctgaatttcttatcagatgaaacgtttgatcccgagaaggaactcgagtatgtgactagc 
TevPV-Pp_RM_and_S  10141 gagtctgataaaacagcagtgtgagaagaacaaaatacccctacctcagccttacaataggaggttattgctgaatttcttatcagatgaaacgtttgatcccgagaaggaactcgagtatgtgactagc 
 
Pa TeV-Genome_LF  10271 ggggcctatctggatgatgacaccttttgtgcttcttactctcttaaggagaaggaaataaaggagacaggtaggatctttgccaagctgacaaaaaatatgagatcatgtcaagtcattgcggagtcac 
TevPV-Pp_RM_and_S  10271 ggggcctatctggatgatgacaccttttgtgcttcttactctcttaaggagaaggaaataaaggagacaggtaggatctttgccaagctgacaaaaaatatgagatcatgtcaagtcattgcggagtcac 
 
Pa TeV-Genome_LF  10401 tgctagcatcacatgcagggaaattctttaaggagaatggcgtggttctagatcagatcagcattacaaagactctccttactatgtctcaaataggtctaatttcgaagcatgctaggaggacaacccg 
TevPV-Pp_RM_and_S  10401 tgctagcgtcacatgcagggaaattctttaaggagaatggcgtggttctagatcagatcagcattacaaagactctccttactatgtctcaaataggtctaatttcgaagcatgctaggaggacaacccg 
 
Pa TeV-Genome_LF  10531 aaacaatgttacagtagtcaccaaatcggagcgacttaagcctggtaagtcagcacatactcgcaactcaagcagtccacaatcccagggacccgatgaaacaacagaaatcgctgcctgcttcctcaca 
TevPV-Pp_RM_and_S  10531 aaacaatgttacagtagtcaccaaatcggagcgacttaagcctggtaagtcagcacatactcgcagctcaagcagtccacaaccccagggacccgatgaaacaacagaaatcgctgcctgcttcctcaca 
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Pa TeV-Genome_LF  10661 actgaccttagcaaatattgtctaaattggagataccagtcaattgtgatgtttgcaaagagtatgaatcaattatacggctacaaccatctattcgaatggattcaccagagactgatgagatcaacac 
TevPV-Pp_RM_and_S  10661 actgaccttagcaaatattgtctaaattggagataccagtcaattgtgatgtttgcaaagagtatgaatcaattatacggctacaaccatctattcgaatggattcaccagagactgatgagatcaacac 
 
Pa TeV-Genome_LF  10791 tgtacgtaggtgaccctttcaaccctccaaggaacttagatgagacagatctggatcttgtggagaacggggatatattcattgtatcccctaggggagggattgaaggcttatgccagaagctgtggac 
TevPV-Pp_RM_and_S  10791 tgtacgtaggtgaccctttcaaccctccaaggaacttagatgagacagatctggatcttgtggagaacggggatatattcattgtatcccctaggggagggattgaaggcttatgccagaagctgtggac 
 
Pa TeV-Genome_LF  10921 catgatctctattgctgtaatcgtactttctgctacagaatcaggttgcagggttatgagtctagtgcagggagataatcaggctatggctatcacaaccatggttccgcgcagtctaccacatcaggag 
TevPV-Pp_RM_and_S  10921 catgatctctattgctgtaatcgtactttctgctacagaatcaggttgcagggttatgagtctagtgcagggagataatcaggctatggctatcacaaccatggttccgcgcagtctaccacatcaggag 
 
Pa TeV-Genome_LF  11051 aagaagagaatagcatacgagaacagtcagctttttatccgccgcttgagagagaacaactttggcatgggacaccacttgaaggagcaagaaaccattgtgagttctgaattcctaatctacagtaaaa 
TevPV-Pp_RM_and_S  11051 aagaagagaatagcatacgagaacagtcagctttttatccgccgcttgagagagaacaactttggcatgggacaccacttgaaggagcaagaaaccattgtgagttctgaattcctaatctacagtaaaa 
 
Pa TeV-Genome_LF  11181 gaattatatataatggtagaatcctcaatcagtcattaaagaatgtgagcaagctctgtctgatcgctgatatccttggggaaagtacacaaacctcatgctctaacctctcaactactatcatgaggct 
TevPV-Pp_RM_and_S  11181 gaattatatataatggtagaatcctcaatcagtcattaaagaatgtgagcaagctctgtctgatcgctgatatccttggggaaagtacacaaacctcatgctctaacctctcaactactatcatgaggct 
 
Pa TeV-Genome_LF  11311 cactgaaaatggagtagagaaagacatatgtttcttcttaaaccaatatttaacagccaagcagcttatctttgatctcttatttcccctcacaaaactgtttgaggacaaaaccacatcaacatatctg 
TevPV-Pp_RM_and_S  11311 cactgaaaatggagtagagaaagacatatgtttcttcttaaaccaatatttaacagccaagcagcttatctttgatctcttattccccctcacaaaactgtttgaggacaaaaccacatcaacatatctg 
 
Pa TeV-Genome_LF  11441 gatcaccctatcttaatttcaaggataataaccattccggctcagttgggaggattaaattactatgccctaacacgactgttcaacagaaatattggcgacccattaacatctgctattgcagatctta 
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TevPV-Pp_RM_and_S  11441 gatcaccctatcttaatttcaaggataataaccattccggctcagttgggaggattaaattactatgccctaacacgactgttcaacagaaatattggcgacccattaacatctgctattgcagatctta 
 
Pa TeV-Genome_LF  11571 agagatacattcgctcaaacatgattccaaaatgggtacttaaaaatctgatagcaagagaatctggggacggtgattggaacacccttgcatctgacccatatgcactaaatattaattacttatatcc 
TevPV-Pp_RM_and_S  11571 agagatacattcgctcaaacatgattccaaaatgggtacttaaaaatctgatagcaagagaatctggggacggtgattggaacacccttgcatctgacccatatgcactaaatattaattacttatatcc 
 
Pa TeV-Genome_LF  11701 tccaactaccttcttaaagaaacatgcacagaaggtcttgatggaagggagtgtgaatccgatgctcaacggagtgttcagcgagaacaatctcccggaggagaattcattagctcagtttttgctagat 
TevPV-Pp_RM_and_S  11701 tccaactaccttcttaaagaaacatgcacagaaggtcctgatggaagggagtgtgaatccgatgctcaacggagtgttcagcgagaacaatctcccggaggagaattcattagctcaatttttgctagat 
 
Pa TeV-Genome_LF  11831 agggatgtagtgatgccgagagtagcccacataattcttgagcaatcagtgtgtggaaggaagaaacaaatacaaggatatttggatactactaggacaatcatcaagtatgctatcaataaacagcctg 
TevPV-Pp_RM_and_S  11831 agggatgtagtgatgccgagagtagcccacataattcttgagcaatcagtatgtggaaggaagaaacaaatacaaggatatttggatactactaggacaatcatcaagtatgctatcaataaacagcctg 
 
Pa TeV-Genome_LF  11961 ttggaaatgccaagttgtgtaaaatattagactacaatattgcttttctatcctacaacctagactatctatcagctcccaatacatcagttattgtgtcaatgtcgtcgagttcattgctcaaactctg 
TevPV-Pp_RM_and_S  11961 ttggaaatgccaagttgtgtaaaatattggactacaatattgcttttctatcctacaacctagactatctatcagctcccaatacatcagttattgtgtcaatgtcgtcgagctcattgctcaaactctg 
 
Pa TeV-Genome_LF  12091 tagtattgatcttgcaaagcttgctaggaggctatcatggagatccttactaggaggcaggccgttagatggactagagacgcccgatccaattgagcttgtcaacggatcacttctaacaaaggggttt 
TevPV-Pp_RM_and_S  12091 tagtattgatcttgcaaagcttgctaggaggctatcatggagatccttactaggaggcaggccgttagatggactagagacgcccgatccaattgagcttgtcaacggatcacttctaacaaaggggttt 
 
Pa TeV-Genome_LF  12221 tcttgcagccactgcttatctggggataagaagtacacatggttcttcatgccttctggggtggacatcaatgcagatccttcagacaatccaccactcagagttccttacataggatcaagaacagacg 
TevPV-Pp_RM_and_S  12221 tcttgcagccactgcttatccggggataagaagtacacatggttcttcatgccttctggggtggacatcaatgcagatccttcagataatccaccactcagagttccctacataggatcaagaacggacg 
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Pa TeV-Genome_LF  12351 aaaggagggtagcctctatgagttacatcaaaggatcttcaagtgcactgaaatcagcattaagattatgtggggtttacatatgggcattcggagataccgagaagaactggcaagatgcatctcaact 
TevPV-Pp_RM_and_S  12351 aaaggagggtagcctctatgagttacatcaaaggatcttcaagtgcactgaaatcagcattaagattatgtggggtttacatatgggcattcggagataccgagaagaactggcaagatgcatctcaact 
 
Pa TeV-Genome_LF  12481 cgctaatacacgagcctctctcactactgagcagctccacattttgaccccactcccaaccactgcaaatttgactcaccgtttagacgatggactaacccagcagaaattcactcccgctagctcttac 
TevPV-Pp_RM_and_S  12481 cgctaatacacgagcctctctcactgctgagcagctccacattttgactccactcccaaccactgcaaatttgactcaccgtttagacgatggactaacccagcagaaattcactcccgctagctcttac 
 
Pa TeV-Genome_LF  12611 atgtactcctcatacgtgcacatctcaaatgatgaccaaaatttagagatacaggacaagactgttgattccaacttgatttatcaacaaatcatgttacttggcctcggaattctcgagacctggctac 
TevPV-Pp_RM_and_S  12611 atgtactcctcatacgtgcacatctcaaatgatgaccaaaatttagagatacaggacaagactgttgattccaacttgatttatcaacaaatcatgttacttggcctcggaattctcgagacctggctac 
 
Pa TeV-Genome_LF  12741 aactaccaaatgaaatcaacatggaagacataactttacatctacatactggatgctcatgctgtataaaacaggtggatgcatgcattataaacgaggcagaggtacaattaccaattttaagtgtccc 
TevPV-Pp_RM_and_S  12741 aactaccaaatgaaatcaacatggaagacataactttacatctacatactggatgctcatgctgtataaaacaggtggatgcatgcattataaacgaggcagaggtacaattaccaattttaagtgtccc 
 
Pa TeV-Genome_LF  12871 acaatacaacaaattcatttatgatcctaatcctctaacagagcaagacttaattgatgtagatagattgcaattcgaggctaaaatcagtgggattgagacaattccggattgtgacaagataagaaca 
TevPV-Pp_RM_and_S  12871 acaatacaacaaattcatttatgatcctaatcctctaacagagcaagacttaattgatgtagatagattgcaattcgaggctaaaatcagtgggattgagacaattccggattgtgacaagataagaaca 
 
Pa TeV-Genome_LF  13001 ttgggccatcttacaggcattcagttggctaggtctttaacagggcttgatgaggtcacctctttgatgaatgatgctatcattgaggctgattatgcaactaactggatcagtgaatgtctaaatacta 
TevPV-Pp_RM_and_S  13001 ttgggccatcttacaggcattcagttggctaggtctttaacagggcttgatgaggtcacctctttgatgaatgatgctatcattgaggctgattatgcaactaactggatcagtgaatgtctaaatacta 
 
Pa TeV-Genome_LF  13131 agcttgatgacactttcatatatgcagcatggaatcttttactggatatgtcttatcaactctactatctacgcattcttggccaaaatgcgatactagattatctttctgttgtcttgagtagaatccc 
TevPV-Pp_RM_and_S  13131 agcttgatgacactttcatatatgcagcatggaatcttttactggatatgtcttatcaactctactatctacgcattctcggccaaaatgcgatactagattatctttctgttgtcttgagtagaatccc 
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Pa TeV-Genome_LF  13261 aggattggcgctatcagggattgcatccacaattagccatccgaaaatacttcggagattgataaatcttgaaattatacgtccatacaactcaccatacctggctacattaaattacacaaaactaacc 
TevPV-Pp_RM_and_S  13261 aggattggcgctatcagggattgcatccacaattagccatccgaaaatacttcggagattgataaatcttgaaattatacgtccatacaactcaccatacctggctacattaaattacacaaaattaacc 
 
Pa TeV-Genome_LF  13391 tgtgatgcgctaatgtggggagcccgacatgtgctcaacaatttacgatctggatttgatatagaaataattgtgccatcagaatgttcttcggaactatcaaacagagttctcaacttggttgcaagga 
TevPV-Pp_RM_and_S  13391 tgtgatgcgctaatgtggggagcccgacatgtgctcaacaatttacgatctggatttgatatagaaataattgtgccatcagaatgttcttcggaactatcaaacagagttctcaacttggttgcaagga 
 
Pa TeV-Genome_LF  13521 agctgtctctcttatgctgtttgattgcatctcatcatgaattgcctcatgtgagaggtatgagtccagagcagaagtgcgggttgctaactgagtacttgctatacaagagtcaaaatctccagtatgc 
TevPV-Pp_RM_and_S  13521 agctgtctctcttatgctgtttgattgcatctcatcatgaattgcctcatgtgagaggtatgagtccagagcagaagtgcgggttgctaactgagtacttgctatacaagagtcaaaatctccagtatgc 
 
Pa TeV-Genome_LF  13651 cggatttgacctcagattatgggagaggagtgtcaaggagcccaaaatctctgcattcccatgcaatatatactatctaacaagaaaagtcttgaattacatcagagattcgccttacttgcagcagcaa 
TevPV-Pp_RM_and_S  13651 cggatttgacctcagattatgggagaggagtgtcaaggagcccaaaatatctgcattcccatgcaatatatactatctaacaagaaaagtcttgaattacatcagagattcgccttacttgcagcagcaa 
 
Pa TeV-Genome_LF  13781 ctagttgattactatgaggcgagatacgccctctactcagacagctcgttgtcatcaaaggagtctggacaaaaaacaccaacagatttggctacactatgtgatctcgactgggcaataccacttttca 
TevPV-Pp_RM_and_S  13781 ctagttgattactatgaggcgagatacgctctctactcagacagctcgttgtcatcaaaggagtctggacaaaaaacaccaacagatttggctacactatgtgatctcgactgggcaataccactcttca 
 
Pa TeV-Genome_LF  13911 ctcaagatgacaaaattgatacctttcacacccccttaactgatgacacagtgcctattaaatcctctataattgcggatccaccggtccatcatgttctgcggcccattggattatcatcaacttcctg 
TevPV-Pp_RM_and_S  13911 ctcaagatgacaaaattgatacctttcacacccccttaactgatgacacagtgcctattaaatcctctataattgcggatccaccggtccatcacgttctgcggcccattggattatcatcaacttcctg 
 
Pa TeV-Genome_LF  14041 gtataaaggactgagcgttgtaagcctattggagacctatcctttgttagatggcaatcatctataccttgctgagggaagtggagcaatgatgacaataattgagtcccgttttagaggagctaaggcc 
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TevPV-Pp_RM_and_S  14041 gtataaaggactgagcgttgtaagcctattggagacctatcctttgttagatggcaatcatctataccttgctgaaggaagtggagcaatgatgacaataattgagtcccgttttagaggagctaaggcc 
 
Pa TeV-Genome_LF  14171 tactacaatagcctattctccagtggccaaaatcctccacagaggaattttcagccgctacctacccaatttattgagagcattgtttaccaaaacatatgccacgaagaagaccaactagatgtggaag 
TevPV-Pp_RM_and_S  14171 tactacaatagcctattctccagtggccaaaatcctccacagaggaattttcagccgctacctacccaatttattgagagcattgtttaccaaaacatatgccacgaagaagaccaactagatgtggaag 
 
Pa TeV-Genome_LF  14301 agaaattctttgttcccctttggagcggtgtttctgagcagacagaccttagatgtgcatcttgtgttaattttatgttagagaggataccttcaagaagtgtctctctcttgaatgtggatctagaaga 
TevPV-Pp_RM_and_S  14301 agaaattctttgttcccctttggagcggtgtttctgagcagacagaccttagatgtgcatcttgtgttaattttatgttagagaggataccttcaagaagtgtctctcttttgaatgtggatctagaaga 
 
Pa TeV-Genome_LF  14431 catctcgtcaatgcatgattgtgaattatcaagagccactatgaatattctcttgctatctgacatccttataatgccgggcggcatcttaatattcaagacctatctttcaccatttgcgaagctctcc 
TevPV-Pp_RM_and_S  14431 catctcgtcaatgcatgattgtgaattatcaagagccactatgaatattctcttgctatctgacatccttataatgccaggcggcatcttaatattcaagacctatctttcaccatttgcgaagctctcc 
 
Pa TeV-Genome_LF  14561 actctgtgtaaattgctgcagataacattttcaagatgtacattgttaaggtctgcatattctgatccatcgtcggatgagattttcttaattgcagttaaatctgataatccttctttaaccaactacg 
TevPV-Pp_RM_and_S  14561 actctgtgtaaattgctgcagataacattttcaagatgtacattgctaaggtctgcatattctgatccatcgtcagatgagattttcttaattgcagttaaatctgataatccttctttaaccaactacg 
 
Pa TeV-Genome_LF  14691 gagaggagctgatctctcaatttcagagggaagacgtcaattttactaatatagatccaaaaacaatatccgcagtcatagagaaattggtcttccagcagcagagagttaaagatataattgtaaacca 
TevPV-Pp_RM_and_S  14691 gagaggaactgatctctcaatttcagagggaagacgtcaattttactaatatagatccaaaaacaatatccgcagtcatagagaaattggtcttccagcagcagagagttaaagatataattgtaaacca 
 
Pa TeV-Genome_LF  14821 gatttgtagcgggaggtgcgacctaaacttggatgatcacatcagactgagccaattaggcacttgctctcaaacaccaaaaattttggatttaactgcagcatccgacttcaatgaattcctataccga 
TevPV-Pp_RM_and_S  14821 gatttgtagtgggaggtgcgacctaaacttggatgatcacatcagactgagccaattaggcacttgctctcaaacaccaaaaattttggatttaactgcagcatccgacttcaatgaattcctataccga 
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Pa TeV-Genome_LF  14951 gttgtacaattactaactatgtttataaaagaattcatttcaattcacgaagacttatcatcagaccgtaatagtttactgtttagttcatacaatttaagctatataggtaagctcagcacaaataatc 
TevPV-Pp_RM_and_S  14951 gttgtacaattactaactatgtttataaaagaattcatttcaattcacgaagacctatcatcagaccgtaatagtttactgtttagttcatacaatttaagctatataggtaagctcagcacaaataatc 
 
Pa TeV-Genome_LF  15081 agactgtgacagcccatatgttagatttgactgtgagaaattggccggtcttgcccgcctcagtcaataatcaagtgagaaatgatcttgaattgggtctcttccaatgcagatctgttatcccttggga 
TevPV-Pp_RM_and_S  15081 agactgtgacagcccatatgttagatttgactgtgagaaattggccggtcttgcccgcctcagtcaataatcaagtgagaaatgatcttgaattgggtctcttccaatgcagatctgttatcccttggga 
 
Pa TeV-Genome_LF  15211 tgtatttttagatcttacacctatcagaaaacacatcttaaatagaatgaatcatcaagtggtaaaagacctcttcactcaccatctcattgtacaattggaccgggcagaacagaaaagagtgtggaaa 
TevPV-Pp_RM_and_S  15211 tgtatttttagatcttacacctatcagaaagcacatcttaaagagaatgaatcatcaagtggtaaaagacctcttcactcaccatctcattgtacaattggaccgggcagaacagaaaagagtgtggaaa 
 
Pa TeV-Genome_LF  15341 gcagtgggaagtgtcatattgactaatacactggattctgataccccggaagatttctccctcttatttgatgatagagagaatcttgatttcgacatctttggcgacgaaatttaagtacagcaataat 
TevPV-Pp_RM_and_S  15341 gcagtgggaagtgtcatattgactaatacactggattctgatacccctgaagatttctccctcttatttgatgatagagagaatcttgatttcgacatctttggcgacgaaatttaagtacagcaataat 
 
Pa TeV-Genome_LF  15471 acaattagatctttagtttaaataaaaaacctatatggattttccccttggt 
TevPV-Pp_RM_and_S  15471 acaattagatctttagtttaataaaaaaacctatatggattttccccttggt 
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Appendix 7. Amino acid groupings 
 
 
Appendix 8. GenBank accession numbers of selected members of subfamily Paramyxovirinae 
included in phylogenetic analysis 
Virus Name Genbank Accession Number 
Genus Rubulavirus 
Achimota virus 1 NC025403 
Achimota virus 2 NC025404 
Human parainfluenza virus 2 AF533010 
243 
 
Human parainfluenza virus 4a AB543336 
Mapuera virus EF095490 
Menangle virus AF326114 
Mumps virus AB000388 
Parainfluenza virus 5 KM067467 
Porcine rubulavirus BK005918 
TevPV-Pp KP271123 
Simian parainfluenza virus 41 X64275 
Sosuga virus NC025343 
Teviot virus (reference) KP271124 
Tioman virus AF298895 
Tuhoko virus 1 NC025410 
Tuhoko virus 2 NC025348 
Tuhoko virus 3 NC25350 
Genus Respirovirus 
Porcine parainfluenza virus 1 NC025402 
Bovine parainfluenza virus 3 AF178654 
Human parainfluenza virus 3 Z11575 
Sendai virus M19661 
Genus Avulavirus 
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Newcastle disease virus AF077761 
Genus Morbillivirus 
Canine distemper virus AF014953 
Measles virus AB016162 
Rinderpest virus Z30697 
Genus Henipavirus 
Nipah virus (Malaysia) AJ627196 
Nipah virus (Bangladesh) AY988601 
Hendra virus AF017149 
Hendra virus strain HeV/Australia/Bat/2009/Cedar Grove 11c JN255803 
CedPV-Ref JQ001776 
CedPV-Pp KP271122 
Mojiang virus NC025352 
 
Appendix 9. Location of SNPs in CedPV-Pp genome and associated amino acid changes in 
comparison to reference sequence 
Genome Position Coding (C)/Non-coding (NC) Gene Reference CedPV-Pp AA Change? Conserved/Non-Conserved Change? 
641 C N T C N 
 
963 C N G A Y Non-conserved (GlySer) 
1311 C N G A Y Conserved (ValMet) 
1468 C N T G Y Non-conserved (IleArg) 
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1919 NC 
 
C T 
  
3098 C P G A N 
 
5053 C M T C Y Non-conserved (IleThr) 
5178 C M G A Y Conserved (ValIle) 
5575 C M C T Y Non-conserved (Thr-Ile) 
5882 NC 
 
C A 
  
6224 NC 
 
C G 
  
7987 C F T C Y Non-conserved (IleThr) 
8433 C G G A Y Conserved (ValIle) 
8697 C G T C Y Non-conserved (SerPro) 
9218 C G C T N 
 
10,400 NC 
 
G A 
  
10,949 C L A G N 
 
10,983 C L C T N 
 
12,347 C L A G N 
 
12,822 C L C T N 
 
14,554 C L A C Y Conserved (AsnThr) 
15,043 C L T C Y Non-conserved (LeuPro) 
15,608 C L A G N 
 
16,050 C L T C N 
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16,376 C L G A N 
 
16,600 C L G A Y Non-conserved (GlyAsp) 
17,012 C L A T N 
 
 
Appendix 10. Location of SNPs in TevPV-Pp genome and associated amino acid changes in 
comparison to reference sequence 
Genome 
Position 
Coding (C)/Non-
coding (NC) 
Ge
ne 
Refere
nce 
TevPV-
Pp 
AA 
Change? 
Conserved/Non-Conserved Change? 
485 C N C T N 
 
662 C N A G N 
 
668 C N C T N 
 
713 C N T A N 
 
1463 C N G T N 
 
1466 C N G A N 
 
1550 C N G A N 
 
1571 C N T C N 
 
1574 C N T C N 
 
1797 NC 
 
T C 
  
1808 NC 
 
A G 
  
1864 NC 
 
G A 
  
1876 NC 
 
C A 
  
2113 C P/V C T N 
 
2287 C P/V T C N 
 
2315 C P/V G A Y* 
*Amino acid change in P & V proteins. Non-conserved 
(AspAsn) 
2638 C P/V G A Y* 
*Amino acid change only in P protein due to RNA editing. Non-
conserved (GlyAsp) 
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2744 C P A G N 
 
2753 C P T A N 
 
2915 C P C T N 
 
2922 C P G A Y Conserved (ValIle) 
3012 C P G A Y Non-conserved (AlaThr) 
3035 C P T C N 
 
3205 NC 
 
T A 
  
3214 NC 
 
G A 
  
3250 NC 
 
G A 
  
3270 NC 
 
A G 
  
3679 C M T C N  
4297 C M A G N  
4539 NC  T C   
4633 NC  G T   
4790 NC  T C   
4800 NC  G A   
4802 NC  C T   
4809 NC  T C   
4838 NC  T C   
4995 C F A G N  
5388 C F C T N  
5508 C F A G N  
5541 C F T C N  
5595 C F C T N  
6172 C F T C N  
6246 C F T C N  
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6336 C F C T N  
6427 C F C T N  
6497 NC  T A   
6511 NC  A T   
6725 C HN A T Y Conserved (Thr-Ser) 
6735 C HN G A Y Non-conserved (ArgGln) 
6742 C HN C T N  
6964 C HN G A N  
7030 C HN T G Y Conserved (IleMet) 
7066 C HN G A N  
7693 C HN A C N  
7819 C HN G A N  
7921 C HN A G N  
8483 NC  G A   
8580 NC  C T   
8617 NC  A G   
8887 C L A G N  
8933 C L A G Y Conserved (IleVal) 
8989 C L C T N  
9011 C L G T Y Non-conserved (AlaSer) 
9607 C L C T N  
9724 C L A C N  
9865 C L T C N  
9910 C L T C N  
10408 C L A G N  
10596 C L A G Y Conserved (AsnSer) 
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10613 C L T C Y Non-conserved (SerPro) 
11395 C L T C N  
11738 C L T C N  
11818 C L G A N  
11881 C L G A N  
11989 C L A G N  
12073 C L T C N  
12241 C L T C N  
12307 C L C T N  
12328 C L T C N  
12346 C L A G N  
12506 C L A G Y Non-conserved (Thr-Ala) 
12529 C L C T N  
13210 C L T C N  
13385 C L C T N  
13699 C L C A N  
13810 C L C T N  
13906 C L T C N  
14005 C L T C N  
14116 C L G A N  
14410 C L C T N  
14509 C L G A N  
14606 C L T C N  
14635 C L G A N  
14698 C L G A N  
14830 C L C T N  
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15005 C L T C N  
15241 C L A G N  
15253 C L T G Y Non-conserved (AsnLys) 
15388 C L G T N  
15492 NC  A T   
15493 NC  T A   
 
